@antibody_1_multiplicity_4_copy_1-1/2
GTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTTCCCTTCACTGAGTCTGGATAGTATGTGCTACCAGCGCTATAAATAAATGAGACGCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCC
+
???,5<B5@BDDDB@DFGG-FFIHII/HEIIHIFHIH7IHGHD/IFHFFDFHHCFG.FDEF,IEFFCIGCHIHHIH@G5GHGDFHHIH>A)HBHHHD,FHDIH+HGHHIHEHDG8HD*GE@GHEFGHGGDE(C'*IEGGEE<=GGBG#CECE?AGG(FEG(#GA'G?EE0';?:.(EG(GEC?FE0EEG*EG*?6*8CEGEE(GG0H<*H.E@A;)CFF@G;:GEA(GGEEC:E=*G:?(6CCCGGEAEA
@antibody_1_multiplicity_4_copy_2-1/2
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTATGCAGACACCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGGGCCGAGGACACGGCTGTGTATTACTGTGCAATTCTGATCATAT
+
?<A??B>BDBB-BDBDFC/FCGIH,HCHEHHIIHFHGHHAIHCCHGHIHHEIHAHHHHE-G+*EHFH4IECH1FIHIGGH@HFHIIFHHHHDHHGF6EFIHHHHIFDHHHE,FHHFHC?FHHGFFBHGFEF:)@GIF*GEG=ECGEGFEG?EGG;D;:1FEFGEGEEEFC1EEFGE6E>GCE?:CEEEEFA;D;GCGC(EG0/CGG'(C:FGE//7EFG@E:E*CACAGC*EE86D/6ECAAC:CEA:A<
@antibody_1_multiplicity_4_copy_3-1/2
GTTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGTACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCATAGTATGTGCTACCACCGCAATAAATAACTGAGA
+
A????BBBB-DBEDD@+FCGFGFHA-IIH>HHHHFIHIHI+GC+FIDF@FFHDHFFHEAFFHIIFCHIBFHCIICCHFHIIIH7H-GFFHHHCHHHHGFIIC=H?E#HHGHGFFG9F0FHG@FHGDEFGGEF*FE=GE/F*G?EDGEGG1GEACE*EGECF,*FFEGEGG?'GEE>A38?;GGE??EG66?G;AEGGDEGCGGA??EECH'EFG:*7G(@(>:;EG:C?G?GE::*E(E/GEGCE6EG*E
@antibody_1_multiplicity_4_copy_4-1/2
GGTGCAGCTGGTGGAGTCTGGGGGAGCCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTATGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGC
+
<5?<?BBBBD@5DB?EGGGECFHEHF*AHHIIIIIEIIH@GIC7AE5I8IDDFHGA@GEHDCH'IHDHFIIHI/I-FIIFICHEIDG7HHIIIHIICCHHBHF.HE9ID3F4D=ECEHD;FA4FG.EHC9FEGHEDBFCEFGEGGG:AGEDBEEGDE?CGCG?*GFC1AFE(E8GB.0EGE(6:DGE(8GGEG*EFGGG6EC90E6CF<0EG7G*EFEE#EDCEE/AC/<EGGG(C.C:?E(:GF?CC2:
@antibody_2_multiplicity_4_copy_1-1/2
AATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCAATCCAGCCCCTTCCCTGGAGCCTGGCGGACACAGCTCATGTACTTGCTACTGACGGTGAATCCAGAGGCTGTACAGGAGAGTGTCAGGCACCCCCCA
+
5???A?BBB@DDD?DDF8?FFC/B/AHIFFFHIABIFIGH@FEHGDH/EHFIIF8IGHHI/AF-DHIHGFFHHHFAIICAHH5HICHHIFFIHIIHFIFHDHGIFH6DHDFFHF+HHGEF,GFFFFE+EGHFFEFIAFA(GFEG?EFG9GE=F(GCE<CG'CEEG:E'GG(GEEEFG@E0?2?(40BE?GEA0:GGACG;?G/GAFEA-6CA@GCC(G8@EGEF)EEA/EEACG:(EG?E*(6?GE(GC4
@antibody_2_multiplicity_4_copy_2-1/2
GTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGTAGCCCCTGGATTCACCGTCAGTAGCAAGTACATGAGCTGGGTCCGTCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACCACGTAGACTCCGTGAAGGGCAGATTCACGATCTCCAGCGCCAAGTCCAAGAACACTGTGCATCTTCAAATGAACATCC
+
?5?<A<B?DDDDDDDDGFFFGGHCEIEHIHIHIHHIIHIHCHFIH+HHFIBCHIFIHHFHFFBE-H-HF-EHHHFFH-I--ADH-HHHE3FHFH'GF.DH8HDHDHDIHD#HFDFFH9BA?FHF<H.FHDA-GEG=6?9GE:EGEGCB*EE?8DGABGGA?GC8EAAEEEC#EGG(G=?GGG0G8G:EG'G.':;CEE((*C(E?GE08()(H7G(07C(7?/6E?E/(E4*0:EC6CE?CE??G??*D(
@antibody_2_multiplicity_4_copy_3-1/2
CTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAAGTACATGAGCTGGGTCCGCCAGGCTCCAGGGAATGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATGCTACGCAGACTCCGTGAAGGGCAGATTCGCCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTAT
+
<??=??BBD<@?DD@DA6GFGAHII6FFIHIIHIC@.IHIIH9FGDIHEIIIIFHIGDEE+DEH-GH/E@ICH5HDEHHHFHHF?FEHHHIHHDCHHHI#IHBHIHIDEHHHFF=FHEAFH=?GEEF:?E:9EDGD,GEDEE1(G?EFEG8EGABAEGEGCEGFGG(GEEA>(C?GEGE;EEGEG-GEG;C?GA*E8.EGEG.F?AE'98:GH(@G./C.?GC8;CGCEC??CC0GGGG.*/('0:G:A:
@antibody_2_multiplicity_4_copy_4-1/2
GAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCAGAAACCCGCGTCAAGTAATAACCACTATTATCATACTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGACGAGACAGCGTGTTCTTGGAATTGTCACTGGAGATGGTGAATCTGGCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAAC
+
?5,?,BBBDDDD?EDB8/6GCGFCIHI;FIHH+HA7GHIE@IIDIHG*HHHIH5@EH-F-IIHIHI#IFICHIAHIHEIGIHFFHHHDHADH7+HHIGHFGHHFHHDHI8CHGGDDC*FH?GECGHHFEEHG<GC*EEFEEGE@EFEGFGEGFG6DG#*?D(6EGCEEGA(E;CFG-<EG:/EG*G;GG?::?AG;FCEEFF8#2GF:8<*AAE:CECC@GEE6*AAGG6CE'EE/E??'EA?08EEG26
@antibody_3_multiplicity_3_copy_1-1/2
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAATAGTCCGGAAAGCCGACACAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGGTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGATTCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGC
+
?????B<BD<DDD<@@GEGGCGHHIEFFEE7I.HHHHHFHIE0FFEGDGFIHDHFDHHH?IH#+DHHHEIC?5EFFHIH-FHHHBCIIIH=IC=IFHFCIDF=EHGHBFEDHH,F,DD+@H=3HC)EHEFHGH,,FFGG66,G(6E,CF3EE@EEEEGE/ECGEEG6.EG;G(8G6EGE?G+G:E;F?6:CEE:6*/?6F<AE?EAC0:(C:*:CEC:,ECC>/EC8GGAE.F:A?E#C'()8*:EGE*#
@antibody_3_multiplicity_3_copy_2-1/2
TGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAATAGGCCGGAAAGCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACTGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCATGGAATTGTCTCTGGAGATGGTGATTATGCCCTGCACGGAGTCCGCGGAGTATGTGCTACCACCGCTATAAATAACTGAGTCC
+
????<>BBD-BDDBBBG,/GGCHEHEI8B-FIHHHIIGGIHHFF7HH+HHHFIGHHHGHIH7HEHECHHHHCEIHFHFFE=5H=HGHEIH?HHIHFC'=IHH7HGH@8)FF=G@D=G#EGFF=,EHEFHFFF=FEFDEGD*<EECFGGF9E<FF?6FFGE=C:CGE*A.GE1G1FAGE?EEGF?EGC:E:GGE(<EE?GE0EG/EECC)E(EEF(/EA?AE8=8:EEGGED*1A8G(E?*A?F*4F6(:C
@antibody_3_multiplicity_3_copy_3-1/2
TGGAGTCTGGGGGAGGCTTGGTCCAGGCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCATAGCAACTACATGAGCTGGGTCCGCCAGGCACCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGAATCACCATATCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCCGAGAGCCGAG
+
,???<BBBEDB?5D5DCGGEFFCHHHH-I/I+HHFHFI=FHGGHFGIHFHIHC-FHH7IH@HHHDIEHHFHDICHDHHI5FHIHHEGEFEIG7F?EEFH8HHEHH.HGHHG@EFH4HBE<FCFFFGHH=G*HDEF:EEF=2ADEG2EEBGFG9ACG(@F9GG1A3FEE//F:A.E0::EE4A??EE*EGGGGEG:EEE:EG'G2-E;<FHFG<-:GF<EE.?EE<G?GEEEAECEE/G*#GGG1)//GAE
@antibody_4_multiplicity_4_copy_1-1/2
TGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTTAGTACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCGCAGTTATTTATAGCGGTGGTAGCACATATTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGGCAATTCCAAGAACACGCTGTATCTTCATATGAACAGCCTGAGAGCC
+
?,?<?<BBDDDDBDD?CGCGC+HHHHEH+HGFHIGHII*HHHH.E.CGIFF@FAH?HIHHH5-FIGIIFIG.FI;H)E?IHH5-HHCGHHCFIDHHHHH7H@@2=DH=GH0BF>D@HEGGBH33/HHGFFGBG#DGA*GGG(GC:=E-E8GGGGG*FGG@CEE*EGGGGGEFGE*(GE.CFG=EE8EAGEEA86CG(?FG6CE(*E)G:0?G(EEEG?,GGE6*GE#G#EF/4A6:/:8??E?A:*0/A:
@antibody_4_multiplicity_4_copy_2-1/2
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGGCTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATATTACGCAGACTCCGTGAAGGGCAGATTCCCCATCTCCAGAGGCAATTCCAAGAACACGATGTATCTTCATATGAACAGCC
+
<????BB?DDDBDDDDFGEC8GIIIFI>EIHGFID-IIEGHCHI>FHHA9IDII)HEIIHIFICFCDC5GHHHFGHHEHIFG=FF>@H<,EIGEBIGF;HHH=G2HDHHHHCCHFGHGEHGGH?H;+EF<HEG.GIF/GEGEF*=@F.GH-EE*GE:GGFGG*GGGGE(E*GGGG0GE:GE?D9?:FD(E8GE:GC2E*60/(*GG:GEAF0E:@)C.DCFEC?(?G0(G?0)?:#?AG(GE/E(CEAE:
@antibody_4_multiplicity_4_copy_3-1/2
GGATTCACCGTCAGTACAACTACATGAGCTGGGTCCCCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATATTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGGCAATTCCAAGACCACGCTGTATCTTCATATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCAATTCTGATCATATTGTTATGATAGTTGTGTTATTACAT
+
,????A=BDB@<D@BDFGFC+FEIFHHHHHCHGHGI/HFHHHHFH-I.HDEHHGH>4FIH+-DGHHFHBHFIEAFIBE+IHEHEHEFIHEHHEHCIFHHHE?GHDHGF=GEHHHHHDEFHG4GHHHHCEFGGGDD/=GECEGGCGG'*CE'GFFGEEGGGEEFAG)C2GGCCFCFEAFEE?EEG?ECG?<GGGE/GECGEAAG1FEE*?<EEH@E8G*,8?G):C1**E(E*?C:06(:C:*86?G?:(C
@antibody_4_multiplicity_4_copy_4-1/2
GGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACCTATTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGGCAATTCTAAGAACACGCTGTATCTTCATATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCTATTCT
+
?<???,BB?BDDDBDDFFFGGGIHIHHFICGHGHHIHFHIHGHCHAHEHEDF>?IIIHEHIHFFEICIBHHHCF+IGHC@+FH?HH/FEF6DIFHEDHCFHHDHDDHHIHHIEF;H-@DEFEFFG?G,HHEEGGC2HHGGGGG;@**B?CFFF@;EEGECG,GFG:GF8FE(DE:FE<#GEEE?GFGAECFEEE??G8*(GF(??:((C)G*EABE8;(GEEC;?GE:*E:(C;?GC?G*AE/66CG?GG
@antibody_5_multiplicity_8_copy_1-1/2
CTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGACAGGGTCAAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCATGAACACACTGTATCTTCAAATGAACAGACTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCAAT
+
?????BBB?DEDDDDDGFEGF8>F>FIHFCIIIGBGIII/HIHFGF+DIEAHFD+FHIII7IH5EIHCIFDHAI5HE5IDF*IHEI=IH-HHIHIDHFGFHH<HHBFIDECGE.DGHEFGECEEHDFEG,GEGGCE+GEC4FGEF:,EEE@GGF?E#GGFGF6FEC6E:EGA8GGGGGDEAEB.AEEACE.CA:/GE:EGGE8G?GH?G;G6':<?G(F@EGF(0G'G0CE(*G'AGFGE*E(.#:CG:;
@antibody_5_multiplicity_8_copy_2-1/2
ACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGTCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCAGCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGACCCTGTCGGACCCAGCTCATGTAGTTGCTACTGACGGTGAATACAGAGGCTGC
+
?=??5?>B@?D5DDBDGBGFFGIFH>HIHHFHHIBIAFGFG=F.IHHIHHEDFCHADC-IHFHGDHFFIHHFH?FHHDHHIIIF=GHFHHFFIII=HCGGICHHEEG9G@HG5GHB*EFGHH4HGHHD?EG6FFGG(D)EEG9EC)GCEC*DA5=*09CAE8C:G<0GE6C-GEE:EEE(GEC.EE6GGE*AECECEE?;GF?E?)HGDA(A(ACE*ECG7E:G*G?ECE)?C?*GA(G)?G??:(0?EE
@antibody_5_multiplicity_8_copy_3-1/2
GTCAGTAGCAACTACATGAGCTGGGTCCGACAGGGTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGACTGAGAGCCGAGGACACGGCTGTTTATTACTGTGCATTTCTGATCATATTACTATGATAGTAGTGGGTATTACTTGGATCGG
+
?5????<@-DDDDBBDGF-EF@BACA8ICEFIFEGIHHFH@HFH+HFIIF?FHEGHFHHHI-HCEIAHGFEH@HD@CHIC6>HHFAFHH3FH=IHFHI@EFFHH+@HDHHFHH+FB@HHHHEF4DEE8DFEG*DD,EHCBFG>EGGFGFFGF(EGAG?D8GGGG8;GE:?GG(1@GGGGEEF:E6GG':A6*8)GA;G(C0G?6*E(GEHC8EEGEEFEG0GG?(GE:FEEGE*/EE/E:(6CC'?;E6.
@antibody_5_multiplicity_8_copy_4-1/2
TGGTCCCGTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGTCTGTTCATTTGAAGATACAGCGTGTTCTTGGCATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAAGAACTGAGACCCACTCC
+
??A??BB?DDDDDDDDCFGGEGAEICIH6HEHHEAII9CHHI9HHIHIFFHHAII;=HHBG-IID-I??5HI-HHHHAH=HFHHEHHFHHHIHGIHHHIHIHGIE4HIDE7HHHFHGDE>HH=EE8DHHCFHG8H=?F:EGA?F:FEGGGGGG0@C=EA;GG8F(,G<F(EF?GACEG;EG9AG>E:D6EEGCGECGEEEE??G:E?FEE>EEEC(:ECA7:AE*..*EGE:0*0?FA2A*C*F1CGA:?
@antibody_5_multiplicity_8_copy_5-1/2
CGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCGGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCCGTCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTACGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCACTCCAGCCCCTACCCTGGACCC
+
??59?BB+DBDBB@@BFGG/GG>HHFEI+HIID+IIIHIHIIH@IIFFIDFI7GHHIHFIFFHHFHGD8FHI@G-@GGHFHICHHHFGHHFI>CHFH*HHEFHFHHHFE=H5=HHGGD;B:F?CGGGFGEE,G@EF,6)EBGEEFE*CF:EGFF,EEGG:0C?GEGEEGE*8?EEGGE?EFGECEEG(AG9C6C?F8GA.?C<E'GEGCHE8E8E=GE?4BCEE('?6FE;0/EF/A?/#:G0**G?GAE
@antibody_5_multiplicity_8_copy_6-1/2
GTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGACAGGGTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACTCAGACTCCGTGAAGGGCAGATTCACTATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGAGTGAGAGCCGAGGAC
+
????=>B>DD?B@DD@EGEFC.FHC;EIIIHHF?@HFIHCIIGAH:E*9HFEHHHHH.HHIGCDHEHIEGIDFFF5GH5HDFIICHHIHFHHIIHFCHDG=DHFH3G?HHH*-GHCDFC'HHFHHEC+-EF?GAFEC?E*GA-GGG8;EC;EBG@:?E=A#FEFG60?BEA:GC.GA;GGE0?GGE*1*?C**GG(*G?CEEEC*E;AG:;E@EC;1EB:GG?#G0(G.??E((6*ECCEEF:.?F?D?G
@antibody_5_multiplicity_8_copy_7-1/2
TACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGTCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGGCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGACCCTGTCGGACCCAGCTCATGTAGTTGCTACTGACGGTGAATCCTGAGGCTGCAC
+
????AB9BBB@DDD@BFF?GGGEIHEH8FIH7EAIBIIIED-IHI+IFG8DFIFDEHHF5H?@IDI=DIIG;IFHIFHBHHFCHIGIHCEHIFHHHHIHHHFHHHFH+@HHHD+F=FFHGGEF:@EGHDFF@#E/FGGF)FEGGEE0/GGGE=BFCFEB(8G?8BAG;/E<G08FFEGGEEE/GGG:E?EEDDGEG0C(:(<(6CFH*EEE::E*0E;EGG?A?0*6<C:CECEG(?E.(AE8EA:G*EE
@antibody_5_multiplicity_8_copy_8-1/2
AGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGTCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTATCTGGAGATGATGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACT
+
?5???BBBDDD=<@ED-GGFGFHFHECHHHICHFHDIFIGAHHDHHAHDI@CGHGCIHIFFIH(C-DBF@HHHAHFHI5IHC=EIHGHFFDHDHHGHIHD-DHHFF.,E>H;E/ECHH#3BBGE)FHGEF1EGG=7C?:FD5GF<;GG#GG=8GE9?E'E///GG?G<E2GG<EECGE?GC?*E(EE<=EGAG':E;8GF?GEEE0HAE;:(E>EE(:G=GFEEFGC*/AGA:A)GD(:8:C:GGGCG.?
@antibody_6_multiplicity_10_copy_1-1/2
TCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTATATGAGCTGGCTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATTATTTATAGCGGTGGTAGCACATAGTACGCCGACTCCGTGAAGAGGAGATTTACCATCTCCAGAGTCAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCTGAGAGCCTAGGACACGGTTGTGTATTACTGTG
+
?????BB?DDDDBBDD8CGGFFHIIHFFHHHFIH=HHHI@DH.HIGG*HEH?HEIG-FIHIFIH-IEHFAHHIHAHDHHIIH5HI+AIF/GDFFIGEC-HFHECFFIH5HHHEHGCHH==HFECHDGDEGHGED,IG*FGGCG;*EDGAEG.6BC0E(C0GCG?F(;E*GDG:A*;GD(*GG6-?D:GEE(?G'EE(F:.EE(G'**GD.GC.*EAEG?-B?A??#*AE;C?(C:(E<G6AEECG?*?8?
@antibody_6_multiplicity_10_copy_2-1/2
GGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGCTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATTATTTATAGCGGTGGTAGCACATAGTTCGCCTACACCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTTTATCTTCAAATGAACAGCTGAGAGCCGAGGACACGGCTGTG
+
??<??>?BDDBDDEB-GCGFGECHHI6HHCIIHIEH>HDIFHGIHHIFIHIH8.FHIFAFHIF,IHHI=IHFGCDII5FHICGIDIHAEHHIHIIHHHHHGE+IGDHFEEC?FH4HGHHHFFGDEFHH=EFFGFFAGEF6GGBEED?:-:(EFFG.BF(E/E7G:G)GBF0=ECE8FGAG)ACE*<GCGGG*C(GEGGE0EEA:.*AG#FE(..E8?EE@BCAGC?C?:*CGFG6G(EF(?C*CEGE*??
@antibody_6_multiplicity_10_copy_3-1/2
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCGGCGTACTATCTGCCACCACCGCTATAAATAATGAGA
+
?,??=BBBBBDDDD<DFCGGGGFICHIFEFFIFHBH>HBHIIGHHHHFHFEHCHHF?FHFH-C8HFHHIHCHHHHFCAH*H+HHHFAHHICHIFHGHDBHIEFHIII@;HAHHHFFDFC6FEGEGDHEF**EEE3DE,EEGF;EEEGG1?GEEEGCGGGCGGG>?GEE*0:GGACCGC?'E?E:GCEG?C:0:.AC*G64*A(GEC=EGEECH8EFE?E'EG/(GCC(CE6C*:AFEEAC?./:;G.*:E
@antibody_6_multiplicity_10_copy_4-1/2
AGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGTAACCGGATGCAAGTAATAACCACTACTATCATAGTAATATGAACAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGCTGTTCATTTGAAGATACAGCGAGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCGGCGTACTATGTTCTACCACCACTATAAATAA
+
=????BB>DDB<DDDBFFGGFAFHEIBHEHFHIIIFHFHFIIFHH>5FHHFFIHICH9H7H-HH)F)HHHIHFEECFFHBB-G=IGFHH6HD=FI=HIHFFH)H-E(FHHHHH@HFGDC=EHEEDDF+CEEG7EF=GEFE>CBGE?E,EF?GEE@GGG(;;EGA*EEG)4B>CE6GGEGA?90GGCGF:GGCCGFD?:AAAFEGAGE:AEEEHEEE.CB@B?FG:C?EFE*1CE(GCE0'?EE:A:)EEA
@antibody_6_multiplicity_10_copy_5-1/2
CAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGCTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATTATTTATAGCGGTGGTAGCACATAGTACGCCGACTCCGTCAAGGGCAGATTCACCATCTCCAGAGACAATTCGAAGAACACGCAGTATCTTCAAATGAACATCTGAGAGCCGAGGACACGGCTGTGTATTTCTGTGCA
+
??A??>BB+D-B<DDDFF6FFC8H>HICH/HFHHIIIFFICFBEI/IFFIHHCHGDFEG5F=FHHDHGH5DHFF-FFIHHIGHBE-GHFIHH+DHHGD@,EFHHHH=DHH+HFGHHGFFHECGEE?,HE@HGFGEDFFEEEF@G=?EGF(G#?ECFEEE#EEF=?:EGG:=AGE;GEGGAGEA*#FFE6?EGG?(*CEG?G6EEEGE?EAEC')E'F?EGE7ECCEE(?D?6E(G?GAECGC*GCEG?*A
@antibody_6_multiplicity_10_copy_6-1/2
CTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGCTCCGCCAGGCTCCAGGGAAGGGGCTGGCGTGGGTCTCATTATTTATAGCGGTGGTAGCACATAGTACGCCGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCGAAGAACAGGCTGTATCTTCAAATGAACAGCTGAGAGCCGAGGACACGGCTGTGTATTA
+
?????BBB<B5B@DDDFFGCCCHHHIFHIIFEIB@GHIAH?D=EI-IFHHHHHDFF8HIIHDDHFFIIA5HDEHH=HFGFI5DHEHCFFAF=FHHHIHH?HFFIDH9/EGFEHH3HEDEGEGHHEFFE<EEGGGG*GG4:EFE;DE8GGEE?@C(EGEG#GEGGCFG;EGC:EGAGCEE:G6C:CCG?*G?(A8GFGEGEE?F-2/(DEEEEH1G?EEEEE(E'6DE.6EEE(AG6EGE8ECGAEEG;CC
@antibody_6_multiplicity_10_copy_7-1/2
TAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGATGTTCATTTCAAGATACAGCGTATTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCCGCGTACTATGTGCTACCACCGCTGTAAATAAAGAGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGAGCC
+
??,??BB5BDD<BDDDGGGGGGIIIFHHEACHHDIIIHIEHHFIGEGF/A?II.HHFFFHHHE@H@IHHIHFHAD:FHGGIHFHHDF6HHHDF+F-AFHIDFDHGG(HDFF74HHH,CHG*FHEFEEGG(F(EGGGEGGFEBGE1E?:G)GGEG;:?EGGEEGGEGGGGGE?*<G8G#AE(:CE*EG?8E?G:?FE:EE*D*?E?.F...E0@0FAFDFG:-ECAC2E:EEFF*?.669:>(AE0:0(G(
@antibody_6_multiplicity_10_copy_8-1/2
AGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGCTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCATTTATAGCGGTGGTAGCACATAGTACGCCGACTCCGTGAAGGGCAGATTCACCATCACCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCTGAGAG
+
??A??B??D?DDDDBD@FGFFGHIEHIECIFHHFIIIA/FEIIHHD>IH=E5HHI5FHFHHHCFI-AHCC5G54@IEDHIF+I=HICEHHIFCAH?CIIF6IHB+I)ECHAGH7GFIHHGEH6FHHG:GFEGED(FD*GEG*,E8F*8EGGGFGDEG-FEE?C:ECFGCEE8EEEG=FGGEFE?E-GA6EGGG;#EEEC(?G:'CGFEEED;A:E(?EBC:<<6E<E8*::?6C?E?6A*G*?>:)?ECG
@antibody_6_multiplicity_10_copy_9-1/2
GTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGCTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATTATTTATAGCGGTGGTAGCACATTGTACGCCGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATGCCAAGAACACGCTGTATCTTCAAATGCACAGCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCAATTCTGATCAT
+
?9?A?BA-DDDEDD@D@CFGGFIHIFCIAIIH.HHHIIHFHFFGIH-IHFIH.HFI@HHEGHIH@F?5BHFH-HAIFCI?HIIHHDHIHE=EIIH-DI=FHH?HEEHHFGH;FGH=HEHGG1HF#GFCGGFDBG0F6GAEB*FGFEGEGG;EG1(GGE<EAGGEFG1GFCC#C2F*EEEEEF'CG(CFEE<GE6C:0E)GGCGAEEC:;*EGHF;EFECA?E?GGG.*A4GAEEG:?:CE?:C8-G(GCA
@antibody_6_multiplicity_10_copy_10-1/2
GTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAGTACACAGCCGTGTCCTCGGCTCTCAGCTGTTCCTTTGAAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCGGCGTACTATGTGCTACCACCGCTATAACTAATGAGACCCACTCCAACCCCTTCCCTGGAGCCTGGCGGAGCCAG
+
<?A?<BBBBBBBDD-BFFFF+FFIHICHIHC@FAHHHHG-IIFHDFIHIG/IIFHGDHDAHFDIHIFCHHDHHHAH+-EIGEHFHGIIEA8HHFH:EIEHHGFD7GI;GD'.GHFDCECFFDD+G#=H#EGGH@H)GG7B?9DGGG*:9BFEEGF@GG?G?*F:?F;'EB?GEEECCEEEG;:E8GG8F*6'2G8CEAC8FF(:AEEG?:C?CEGEEFG@G(?)GCCAGGEEEE(*?E#EG?/?*.*EG(
@antibody_7_multiplicity_2_copy_1-1/2
GAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGTACTCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAACTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAAGTGTCTCTGGAGATGATGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCAACGCTATAAATAAG
+
?A???BBBD5DDDDD-;G;CFGFHHHEAHHHAHIH=HHHGHHF-FI7GIAHCI@IFHCHEH-FEI?FHH55AHFCIEDG=FCEFFDH(GEEDFHHDHIHFIIHGFHGH(IHFC6HGEFFHHH+?FFEEECGEAE(F<EB;E*EG8CCEGGAFGBGBG?FCEEGFGGB/CE?GEGFG;(>*GEFEGEGFGE6A9**0GC:A*DAEA*CE*FE(@CE2*EGG;.:C6?E0GGDGA'EG*0A0(62:EGAFCA
@antibody_7_multiplicity_2_copy_2-1/2
CAGACGTCCATGTAGTAGTAGTAGTAGTCCGGTACTCCGATGCAAGTAATAACCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACCCAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCCTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCAGGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAAGTGAGACCCACTTCAGCCCGTTCCCTGG
+
,??A?BBB<D@9?BBDCGFFFGAHFIA>8HIBCF=HIIDAHGDHHHFIFIEIHFF-EH@FEIHGEHIEHCF-HHHFCIFHIHHH--HFHHHIHEF,IFEGGHH=EDGGCH@8FHHFHEHE;GDHHGHH)BEFHHFA@>GE/GEEF@9EE*GFG?EFGEFGF1EE08GACEFDE?(;E:F0<EG#GCFGGCFFE:CEA?GFGE:E(;FDCCEE7CE*(CG'GEE?G0)>C(.AE?(EEG:/>(GCCEEC-C
@antibody_8_multiplicity_8_copy_1-1/2
CTGGATTCACCGTCAGTAGCAACTACATGGGCTGAGTCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGCAGGGCAGATTCACCATCTCCAGCGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACCGCTGTGTATTTCTGTGCAATTCTGAGCATATTACGATGATAGTAGTGCTTATT
+
<,A?ABBBDB@DDDDDFCGGFGI8IFIEH-HI=HF8+FGIHHHECGAHHIFIIF,HHH#FHHDIDHIDIF=GIHHACIIIHEHHHIEFHEHFIIEDGCFEHHHHEGHGFGF?HAHF'.HGEGHEFDF7E(E*F@FGGBE7GGBFG*;G0*EEFEGAGCC@CGAG(GGF:;G#G8EG:GG?GCFE#EGGG:*A(C?*?1GCAEC?G6>*(6?GE/CEE?CEEC*EG?E:CCE#8:<.AE4CGC?CE'2A:E
@antibody_8_multiplicity_8_copy_2-1/2
GCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGAGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGCTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGCGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGTCACGGCTGTGTATTACTGTGCAATTCTGATCATATTACTATGATAGTAGT
+
?A?9?BBB-DDDD-DD/FGFFCFEIIEEHFHIFF0IIHHI#HHGHF-HHIIF.EHI5IAHEIHHDHF-E5IEHHH?*HHHHH?HIHHIHHHIHFHH-+HF=HHHFFHFBG?H;DFI13HHHFGEHEDHE@DFHHADD*GEEGDF:GF?GEGF>G:88E7EEE1EEBGGCEBGEFEFEAGCGG66E??GGCCCGE-AG(8<EE:?:G(F:H98H@@EEEBC1G(.A/C;6EEG:G:CE:;*:C:2(EFE?:
@antibody_8_multiplicity_8_copy_3-1/2
AGCAACTACATGAGCTGAGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAAGGCAGATTCACCATCTCCAGCGACAATTCCAAGAACACACTGTATCTTGAAATGAACAGCCTGATAGCCGAGGACACGGCTGTGTATTACTGTGCAATTCTGATCATATCACTATGATAGTAGTGCTTATTACTTGCATCGGGTTTCC
+
<??,?>BBDDDDDBBDGBFB?CHHHFI+FIIHEHH9HFHFIF-HHFAFGHGHH;AEG-EIIDFDHIEFCIH-@HHH5IIHHGCFHFH7F+IFDDHIBIEFH#FHHCGH?GEH#GAGHHGEHFG=HD3HCED(EGG5GEG,#AG'G(EGG?,GGGGE3.ECEGCGEA#EGGEG2EGGEAECEF:AE:GE?E(GECE6EEECEA;EG*E?A?E(.GBE7??C#?>CF(ECE?*:F<(E?E(G*EG4E:G'E:
@antibody_8_multiplicity_8_copy_4-1/2
AGTAGTCCGGAAACCCGATGCAAGTAATAAGCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCGCGGGAGATGGTGAATCTTCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCGACCCCAGCCCCGTCCCTGGAGCCTGGCGGACTCAGCTCATG
+
??<??B=<D@DDE<@DF?GFFG/HHHHI8C@HIEDE=FFIHIHHIHDFIIIGII@FHHEHHFFHHHIHIEHH?E-5+EGIDFFBFHHICIHIE6HIHHHHIFC+HD<HFHGH+HHFFFFGE4FG?DFHHDFGFGGDH##EFE?FE80GEEEGE4FGEAECE:=@G0EG0EBF6ECEEEE?#'?E/GAE<GGG604*:FGAA?/EGD6E(EG(E8EF7'?C#:?/AC8E:6*EC6:AEA)E0'FG0?E??*
@antibody_8_multiplicity_8_copy_5-1/2
AGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGAGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATCCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGCGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCAATTCTGATCATATTAC
+
?????9BBDBDDB@DDGF+CCGIE@FHEHHDEEHHHHHGHIAFAF@-EH-HHIE-+HGEFAHHFCF?IIHHIHIII5*EH-IGIBHII.EECHIHIFHIFDHCHGCHGCDDD6HADD=8DEEF@D9=GG2/8FC*8EHFF?GGCE4EG@F;E*FGCGG/E*:GFEGGGGEEGCE?(EGGGE)EEFAGEA)6C:G0EFGEEC:EGGGHCEFA:HGGC>F,EG:.*6:EG8?CEE*CCGA(C8?G*:EEEAE
@antibody_8_multiplicity_8_copy_6-1/2
CCAAACGTCCATGTACTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAAGCACTACTATCATAGTAATACGATCAGAATTGCACAGTAATACACAGCCGTGTCCTCGGCTCTCAGGCTGTTAATTTGAAGATACAGCGTGTTCTTGGAATTGTCGCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCACTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTG
+
,?9??B?BDBBD5DDDFFFG.GEECIE>IHFIGHHIEIHIEIHFGIIHFEHGEIHFH'HHHIH+FFHHEGGHF#IIIIHFAFIFDHI-HGHDFFDHH-GIGIGHIEHIAFFEHDH4HG=F<HHF@+EG4GGFGCEGFBGGG;5EEGFDEGGFFG<GGEFGEEE@F'/C?G8((?EE4?GE0G?GEEEA.??EFGGEGGG-G*0G?F?C*808(C(E(E(-G?EE/C:'C6*;:91E(C..E:;FE>AF*A
@antibody_8_multiplicity_8_copy_7-1/2
TGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGAGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATTGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGCGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGAGCAAAT
+
?A=??<>?BDBDBED<.CFGFFHHEHE?II@HIFIHG=IIHCH/AFABHH==DHHFDIHAHHHGIH*FHIAHIHH>-HEHEFHH8EIFCHGICDF=IFGHAHE?EHDFHGHHHHF(HEE>HH*02E@+GFGGD4HFH@(EGHEFFGFEC*G?GGAG6E'G8GFEGE*GG.EF*#CFG4?<:)C*GF(G;(GCGDGF6GE.(1G*1:F*?*?E0GE(EE'GEF:E;.?C**E*8A6?E(C*.GE:E;::*:
@antibody_8_multiplicity_8_copy_8-1/2
GCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGAGTCCGCCAGGCTCCATGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACGTACTACGCAGACACCGTGAAGGGCAGATTCACTATCTCCAGCGACAATTCCAAGAACACGCTCTATCTTCAAATGAACAGCCTGAGAG
+
?5?=?BBBDDB<DDDDGGCGFFF6EIHFEAHHEIIHHICCFGFIIHHIHIHIE+IHHH)7HHHIFHHIHIBIEGICBG=HFHHHHHEHAEHIHFIB@HAHFEHHHFIIH3HDHD#FHD.HFGHE;GFDDGHG*FEGHEGGEE;CG;GEEGE*EEEF8G(EF#;GEFEE6CCEGE#EEG<6FG8?:E(AE*G?*'*EEE0G*DDG)DEF?HG*E-BGEC:@C,EE*E:E??ECG0A(E*E*GE0CFCAC*E
@antibody_9_multiplicity_72_copy_1-1/2
GGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCTGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCGAATGAAGAGCCTGAGAGCCGAGGACACCT
+
5?==?=/BDB-DB-@DGGEF/F8IIHIEIHG/IHEHHFFFHFCIFFGF=HI@@II+FIDFHHGGDH*IIFEHHGFIIIFIHD5IC6IH)@-HHH+)C,ICFEH*HB*H<EGHGGHHHGEGGEDFHDF9EFDGG1GFBG@D2G@FEGE;EGGC=<G4EC?GGEEFEACG*E?8CEGGE<()(GA:0:AEEEED6.:GAEEC8(EEECC(EC-FCC(EEA:;(GF8G))?EFGGGCC?((AECCC**CEF((
@antibody_9_multiplicity_72_copy_2-1/2
CAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTAAACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGAGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCTAGAACACGCTGTATCTTCAAATGAAGAGCCTGG
+
??=??B-BDEB@DDDBCGGCFFHIIBIIICIHIIFFFFE@FHF+CDFF4AHFHABHE>H?EHHAG+GIFHIHFEHHH5IHDGI.HBHIEH5H+HHHHDF?IFHEHHHBHHHHCHHHHHHBDHHDFFGEG=EGED*;GGDFE6EGGEFG@E(EAGGGCE=/FFG;(GCGFFE?G1,FEFEG6EACA0?EEEGA:EE;CG:0EGCCGD8E:ECA:GGE(0?EE/*GEE26EA?::FG:>*GEE?**9GE:**
@antibody_9_multiplicity_72_copy_3-1/2
AGACGTCCATGTAGTAGTAGTCGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTAAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTAACACCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGA
+
5???<BB<DDD@DDEDFGC;G+AHEHFCI89IIHEIHH+DHHGD@F>HDEHIEIHHF=HDCI5IHEIA5IFHFHIGB5BFFIFHH?EED+GFHHFFHDHI:HHFHHIHH?D=4HHHH3@+6GFHBHD21G)?GGFEDFB0GE?GB)G/3G8=EE8GEEGEBGF-ECEG#G(GC<EE?CFC@GEGCFEG8ECEC8E(E/GEG'?<:#HCAEGECCE(8;GAGAG;EC>4E;EE;.GC.G*CC(8*CG.E1*
@antibody_9_multiplicity_72_copy_4-1/2
GGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGAACAAACGACGCAGTCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGCGCCGAG
+
???=?B<?BDBDB-EDF@FFCFICHIHHI;IHHDHEHIHIHIH/IHHGIF+?HHEFHHIHHI@HAIHIHDHG5HHIFFFDHFFGDHIIFIHDHHHIHHHDHHHHBDHGGDHDHBHHHGHDFEFDHDCFG*GFFEFGGEDDF;EDDCA@G8EEE(GEA(G7)FGE?CE(GGCEGGGA?8E>?+FG.E?AE<EE(A:<FE?ECE6CE*FG:?8EAG@CCEGGGCC'GE:EAD:G:A?GC/GFC.?(*ECCAC
@antibody_9_multiplicity_72_copy_5-1/2
CTTTGCACCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGTAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTTTGTGCTACCACCGCGATAAATAACTGAGATCCAGTCCAGCCCC
+
?<AA?B+BDDDD@BDD9?GCACH8HHI@IHIFIHEDFEHIIFGIHFHHGHIHIFHG5HHIBGCIDF@HHIHFB-FHFDFI#EHIHFHHI=H-HHIHD=FHI+E?1HHGIEFIG:HDFFHEFFE=DEHFEEEEEFFEEE*EGEDEFDF-GEDD4GEE5EGEGA(D'EGC/#GGE;A8E(=CEEGFCA6EG/4GC8?CG<GG<EGGG9'D::GGHFE?/FG,G,G?::G*CE(GAGE?*E'<(G8GEG:GE6
@antibody_9_multiplicity_72_copy_6-1/2
CGGTGACCGTGGTCTCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCATGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAG
+
???<ABBBDDDDDD+DCFFFFAIFICHIFFIDIHFIIHFHAI.HH.DIFHFIICCHFHHH?GI5IDIIIFF=EFI<F=5IIFHHHIHIHEHHHHHHHHHHCIHGEHHHHHGH3DFG@=GHFDFBHEHGBFEEEEGG8EFH:@G@EAGFEEEGG.-FE(CFEG8*=*GCEEBEF*G?AGGFAEE6EEG*E;G</G??(:EEF*:D10HCGF:?:GCGE?G:EECEEG.E.G:GGC?*E8CE*G(;EC6<'0
@antibody_9_multiplicity_72_copy_7-1/2
TGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGAAGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCGGTTATTTATAGCGGTGGTAGCACATACTACGCATACTCCGTGAAGGGCAGACTCACCATCTCCAGAGACAATTCCAAGATCACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACG
+
5?????5BBBDDDEBD>FGCCFIIEIIE>IHCFFIAHIAICHHIH5IHHHIHFHHHHHIHHFIIHH;DHCAIIIIHIHFGHFEIC-HHHGHEHGEHCFHHHHHGHF=HDG9HHFH;FCH?GFFFHG+8:GHGGFAE0D+DG;6GEGG(HG;FCF;AD?DE(C?FGE:)G?CFCEEG?E#?C8GFG0(;ACGCG*4FE?GCE:6(EF((:(<E7:B(BC<FG.4F6?DFE?8<E???0??A?E/E(CE?-*
@antibody_9_multiplicity_72_copy_8-1/2
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTATATTCCTGTGCAATTCTGATCATAT
+
,?,A?B>B<DBDDB@DA>GACFH+HCIHEHIFFIE/IGHIGIHHFIEGI?H9F/=.D8HHHGI-F.5DGHCIHIHIHIFH5+HH6HHFICIHHHH,HHDCFF42DH-HHFGHFDDG*HHH+GFGE:G?GHEAEECF?DFGG=FDEGGEGGCGEGE(G@<G?E(F*AC?E*6E=GGEFF0EEEA6?G9?1C/C(0/*CE?.ECEG=CC(8EEG.G'CF7FGEG?E(CEC)*EEC8AGE(GGECEEAE8:(*
@antibody_9_multiplicity_72_copy_9-1/2
AGGAGACGGTGACCGTGGTCCCTCTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATCATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCATTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATA
+
????=B>BDBDDDDD@>GFFEGI+FIFICHCIIIH@HI>GDH-7EHDFGHIHFIHHHDH-HHIHHHIFFIHHHHHIHIC-G5IIIHHHIDHHIHFHDDIH@H=HHHH@HHC7H.HHHGFFHEDG0GEDHEG*=HGGGCGC28EG=EGG'CEGFGEGEG.BCGCEG0AED<(EACEEG<CGEGE;E>(6=0DE*G:(GDECFEG-6CE(E*G:(DCEGEG.EAFG:(G:CEE:<E?C0)CG/?02(E(G;'
@antibody_9_multiplicity_72_copy_10-1/2
TCTCGTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTCGAGTGGGTCTCAGTTATTTATAGCGGTGGTCGCACATACTACGCAGACTCCGTGAAGGGCAGATACACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTGTCCAATACTAATCATATTACTCTG
+
=???,BBBDBDDDDDDFAFF;>C>IHHHIFGD.HG=C+9IGHH=AAIHEGFFHHFFEB5DHGFHCIHFIHFEEIFF#DCEHHHEA-HFDHHHD=FFI=HHH@=B(FH(HHDFFHHFHFH?CGHEGEHGFFFEGFFG9=GG(6CE'.GGEG2GE.>@E/GGGECE9GCA6?88CEECEEA.CCGGE*;#6:GGFAEG?G:C8AEEG:HCF<D8EA8:CC:EE:ECE4?#/EA?**#';G?*8(;(?C:'*C
@antibody_9_multiplicity_72_copy_11-1/2
AGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAGGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTCGAGATGGTGAATCTGCCCTTCACGGAGTCTGGGTAGTATGTGTTACCACCGCTATAAATAACT
+
?,??5BBBDBDDDDD-GFFCEGAHEHFCHIFIIHCIGIHIFFHICHIIBF@GED9HIGHFF>DDHFB:FH-H=HHEFHDHIF5DHCIHHHI+H@DFHFHIBHHDFEHHHHFHDF+HGHFEFEEDFFG*'BH>GFE;H)GGGDF1GFHEEEG*GBB?G(@G??0(GE:GE6FCEAEC(E(EGGEF=G#:G<28E;:BGA:AEGG*=AC?GCGGCCEFBE(@G0CAAEG:2*EE*CF?G:EGGCE>*<0C(0
@antibody_9_multiplicity_72_copy_12-1/2
CCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCTGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATGAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTCGAATTGTCTGTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCAA
+
????A?BBBBDDDDD?FGGAFFIBCIHEEFHIIAHIGIHICEHIHE+F=HHG5EHDA?GFGACFEHFHHIGHA-HIFHEFFIIFCHHFHAHAE+HHHHDEHH6HHHH9E=GH)F?C+HFGHEHDEEG7D*E.GEHE@GFEG;CGFE:FAFD?4@EEFAEGC**/E(EGG=AFCEF(*GEAE+EE?-:'AG#FG)GC*C:GEEE.:A/<:HEGH:E7?F8EE8CC:?(?G:<CG*E*AG?EE*CC:0EE()
@antibody_9_multiplicity_72_copy_13-1/2
GATTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTCAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAAAACACGCTGTACATTCAAATGAAGAGCGTGAGAGCCGAGGACAGGTCTGTGTA
+
9,??,BBBBBDDDD<DGG?CGCIIHHHHCIHFI9HIHDFIHEH@IHHHFHHFIHEHEHFGH=HGBFFHHHG8IICHHIFIHDDHIHCDEHHIHHEHIHGGEIHDHHIFHEEDGGHF<*HEFFDA.F)HCEEFE4GCGGFE9#GFEFAFG*5BEDEE(EEA#6GC=FF8ECFECEAGAEE*EGA:8GG:CEECEAGG)E(DGG/?AC?F('GEF:G'/F8C:EGG*FG0>GE:EGE/:'G:(E(E)GE0E*
@antibody_9_multiplicity_72_copy_14-1/2
ATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTAAGTGCTACCACCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGCTCGTGTAGTTGCTACTGACGGTGAATCCAGA
+
??5A?B>B6D@DD-DD/FEGGFFHFIEFHBD-HFII(AH6HIH9IGH*IIHIHDFICHEHIGHGHHFHIAIF=HH55B5I<IIH@EHF)I=IGIFDHHIGIHI+EF:FHBFH4CFCF7FF/GEFFGG@FGGEEFEG1FBFGFEGGG,EGEG(ACEG8A*F(F8ECECE;F:GCEG?DGFCEECG(GE8>EG?C(GGE<?G'DGA/EEEEA(6*C(/CE?EB8*G:GEG6*F6EEEE?:?*E?:GG;(?*:
@antibody_9_multiplicity_72_copy_15-1/2
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTTCACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGAGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGAGTCTCCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTGAAATTACGAG
+
?????BB3DBD<DDBB>FFFFGIIBIF>C/HHGIF?HBA9HICDHHGHIIDEI-7.HFAIGHHIHI)C?AEH?GHH+EEIDHE@HFCFIFFF,+DH'DH=F<HGHGCGHFG1,HBGCEH,GDEGDGEDHBEDD?GGG*EEE*FEGG@0>?:GEEFG<*<2AFEEG@EEB*6G-GEGEF*GG:FEFACGCE-F?EC6G#F6(G*0EE.;?4*?AGG18<0EG:A9FG?EG0GG*G*FC6*'?5<F*:(:C0
@antibody_9_multiplicity_72_copy_16-1/2
ATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGAAGATGCTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGCTCGTGTAGTTGCTACTGACGGTGAATCCAGAGGC
+
????,BBBD+BDB+DDFGGFEFHHHH+HFFEAIIHIDEH,E.GH.?3HI)=EFHIICIGHEHH7HGIHHHHIHCHHEHDEHEHI-HIEHFIHAHIH?HFHEAHHFFGHHH'G8GF==FEGHDFHHEF6?*HE@GEF;HA5GBFGG?H'FDFEF:EEE*GF.F?@EEGEE0GCCE;<E;=AEGG?*:GE=FAACEEG<CEGEC<(GC:EECG?CEEC'E7:?EEF8:ECF?AAGEAE8E;(::?E**:*EC
@antibody_9_multiplicity_72_copy_17-1/2
TGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGTTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTAGCCATCTCCAGAGACAATTCGAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGC
+
??A??B?BDDDD?BBDGEFFFGF;IF8EIIHEGG/HIEGHEFFFHHIHIEDFCHF<IGFHFIIHE+G-EIHHEIIIHIGF?HHFEDGEHH'=HIIIIF#DDHHGFHFIFHFHG?HHEEA:CACH?8H>EGEFEA;GGEGEEB**EHGGE:GEC8EE?EFFA6CGCEE?(EEEGEE?EE**EGFG.<EAE:)'ACFEGCGG'ECG>G.GA4*(0F(:*CEEEEF/.CG)(G((AAGE?'EE/GG:EGCE?:
@antibody_9_multiplicity_72_copy_18-1/2
CTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCATCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTAT
+
??,??9BBBDDBDDBDCGGFAFIHFIHH-BHHHI@FIHIC(HHHGIHHHHEIIAGE8;H>DHHHFHADEIFEHIIBIHIH=@H+EDFFE=GHH6F+HHD.GHEAHDEHHCFHE.HGDDHFEF;*FF+D)DEE*GFGHHDG=GFEGF80G3FBEGC0ACDBFGGFEEEEEG?EE(6CE?EEC:GG':*?EEE??C*GGE<?CE((E4C:C(GG8EG8(GCEB0GEE*CCEFG*?G.(*C8CE.?GG:-G4E
@antibody_9_multiplicity_72_copy_19-1/2
TGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTAGTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAAAAACTGAGACCCACTCC
+
?5,,,BB-BDDEDDBDFGGFFGFCI>HFIIFHIGHIE@IHHHHFFIH.HHFIFH-FHHHHFDFEH-CIA=HIH@AIII-HGFFI8FFI(CHFFIHIIHH<IEIHF:GF*HIF*EF:HHHHHF?DFHDEG8FGEEBGFGDFED4EGEEE@E@9,EEEAF##GEF@)G;EGE?;GCEFG<:0GD?GGFC6CC6=GGE(GFEEAGG?>C*6E;?CFE@E?FGF7(*0GE2E?G;FE/0*E8:?CEG:8:(C*G
@antibody_9_multiplicity_72_copy_20-1/2
GTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCCACCGCCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGCTCG
+
???A=BBBDDDBD?ADGGGFGFHIFHFFEHIHDHHFFA.EIHHHHHGGFCIEHH@+EGFHCEDFHIH@IIFIGIHEH-HIDHDIFFIHIEE8HHHFFEGE=HBHHHHDHHDHEFHHHGFHHGHFDEHFFEHGB:EGG@=EGEE@GBGGGDEG3CECFC'BFG/G0EGGE.EEEGGC<F9;0E8:(EEF#E)EE2EEEEE>E/G6*EE??FECCFECB?:A(>0ECG=*?(?*.::8GGC:E0F/(CE?'(
@antibody_9_multiplicity_72_copy_21-1/2
CCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCACTGGAGATGGTGAATCTGCCCTTCACTGAGTCTGCGTAGTAAGTGCTACAACCGCTATAAATAACTGAGACCCAC
+
,???9BB?DDDD?BDDG>C8GFHCIHHHI>FIH-HHHHI+FFHHHFFFGHGGAIH@FEHFFAFIB-FHHEHIHEFDHHHDE5HG-GHHHFIAHD(HEFFHH'HEE;G+HBE=D.GDF?HDFGE?HEH@GDHFDFGFGEFFFGGGHC?EE(G/F>@EE;GEEG*GEGCAEGG/GF(G*<CE=;EGCGE..CEE?E?GEE0-E*:EG:DGCHCE8/EE(?F0F?E***GEE*GA/**(:EGGD?CGC:CCE:
@antibody_9_multiplicity_72_copy_22-1/2
CCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCTCTATAAATAACTGAGACCCACTCCAGCCT
+
,??<?BBBDDDDD<BDEGGFGGHHIEIBAEHCHIFDHI9DIIIHIE=C57H--DHHGHIHIGHFD5HHIHIHFHGF-HH?HCAHGIGIHGHFIFH@GDHGHHDDGHHHD=HHEHFHH)HDFEGEGDFDFEGD:)FFF;BGC)GFGCEFC;(GEE=CGFFE0EG?ECG;E<8G>GE7AGGE0GEEEF*ECF'E<GGF;F#GG1F:/?AC::0A0E-E?78G#8A:*9)>()8'6(6??EGEG(**E1F*?*
@antibody_9_multiplicity_72_copy_23-1/2
CCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACACACTACAGCCACTTCCCTGGAGCCTGGCGGACCCAGCTCGTGTAGCTG
+
,????=B?DD@DDD?DFGFGG-HHIIFFEIHFHIHG@GHI9IHIHHFDHH.GHHCHGHAHGH0CHHHH5FHAFF4=?HEIDFF-IHHFAICHHDHAIGHIHG=CHBEIHHHHI@IHHHEHGFFDGDEFGDFFGGGFG3FFGEEGFEFDCGA0EGD?0GGG8EEG?AE:DAG:GCGEGEGAE0C)GG?(E:GGFCG'EC86F(AEC<*AGHFA*9C(*G(E(GEF=AF*G(:E)E=CG?GG?E:A(FC*EC
@antibody_9_multiplicity_72_copy_24-1/2
ATGGAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAGTAACTGAGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCG
+
A??<?BB<DDBDAD@DGFF0FFIHF>HHHFIHFCHHIHIFF.CHGFED,HEF>=IGBFCHH8G8ECHCHHH-HHH+@IEAHHHHHFFIHHHHH?HHEF6IIH+HFHHHHHHEFD;7GFHFHG-FGGE1@F-@@5GFGD@EAHGFBGGGCFDBCEG4=B;DG?E*CCF8GGE(GCF;<E7E;EGE(FF:*GEG:?'EEEFCE?CEE:HGE(DGEAEE0<G8:E0AG0)CGF*E0C:GG/GC6?CGG/C)A?
@antibody_9_multiplicity_72_copy_25-1/2
TAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCACTCCGGCCCCTTCCCTGGAGCCTGGCGGAC
+
?A?<?BB7DD@DBD<DGGFCG-FFBHFHHIGFIEHHH8HEHHHHFIDCHHFHHHIIGCHCAIHIDIFI+I?HHIF-HHDFEHI-FHII+G=BGHAHHHHHHHBDHGED@GHF=GFFEFEEHFFE;G3GDGDGEE;I*E?>HGF7E?EGF(@EEGGFE*CGFFF2:G*<A?CA61DEA+C(/EEEEE?*EEGACEEEEEGGG;:(AEEFF*FGFAC?'GBED?)((CEC0AA*EE./?EG0GE*E/E*/AC
@antibody_9_multiplicity_72_copy_26-1/2
AGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCCGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGCTCGTGTAG
+
5?<?=?BBBBADDD?BFEGDBGFIHF;FBFIFI>I+FIIHC?HIHH0-/IECIH8H+AIBHIFFIFFE=EIEFH=5FB=GAFH8*HH+IHCGGHIFIEH,HHE*EF8HHC@HGHHGFFGF=HHFEH*E@GEGEGGG=GEG8EEFEECGGGE.FEF:BFEEEGBGF8EG.GF;E?GGE<GE6CEGGA*4.EEEE(CA6G>;G'CC:CCGE?CGE8EEEGEECA:/AECEEGGDG?**GC)CGC?EE68?*(
@antibody_9_multiplicity_72_copy_27-1/2
GGAGACGGTGACCGTGGTCCCTTTGCCTCAGACGTCCATGTAGTAGTACTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACATCGTGTACTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATCAATAA
+
A??A?B?BD@DE?@DDFEFGG+BAHIH+E>IFGHEH5H9IHHIIHHH9+=II=?IH5HHFHGHA-IH5FII5FHI-GH?GH=FHDFGEIBHHHEIHCHHHGHHHFHHHB+FH?HHE+?G)DEGHGFFGBDEGH/FEFEBGEFFFEE5EEGEG:;GGGCF(F2GE:C(GGAFE'C;CGAGA6@:?E(6?CG?.G/F6EF(C.EG/08EGEA=EED):E8E(*G/*(G:CE:)F((G18C/FGACE)C'EGC
@antibody_9_multiplicity_72_copy_28-1/2
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGCTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCGTCAAATGAAGAGC
+
,???9BBBDD?DDDDDGFFGFGHHCIH;/;I@I9FIIIHHII@EHHIFFFFI7IGDHIFI/AIIDEH-CHHIFIE+H@FIGIIHHFIHFCFFFFEHH.HHHEHIC/#HCFHHDGD,H2GED*GFE*@H3GGF:FFDFF8G6GEEEFEEG/G,3EFEEGEEF?BGGG6EE??G8F:EEE*?FGAGA*AGGGEE.GCGGEAEGEA*AEEG:F8GEEG(E7GE(C:0CE*A?C):/?<C(*C8GE6A;*A*:A
@antibody_9_multiplicity_72_copy_29-1/2
ACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCATAGTATGTGCTACCACCGCTATAAATAACTGAGAGCCACTCCAGCCCCTTCCCGGGAGCCTGGCGGACCCAGCTCGTGTAGTTGCTACTGACGGTGAATCCAGAGGCTGCACAGGAGAGTCTCAGGGACCCCCCAGTCTAGACCAAGCC
+
???<?B?>BDDD?5DDGECCGGIIHHHHAFF/AICHHHIH.IFBII=H@E-HB+HHHDFIHHIHH=G-HFHHBAH5*II@CIIFIHDHIHHHFGEIHHIC=HHDIHEIGD;H=1<-GEHFHD-DGECE;CFB,EE*,G#F34D@<EBGG(DGBE-/GCEGE);EEFFEEF6FGEGGG<GG?:EEEEEDG6CE:E:EAG8GE?EAGE?GG6E6A0F*FCEEE,<GECC*AE***FAGAGE?*>CAC=C:G1
@antibody_9_multiplicity_72_copy_30-1/2
CAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGGGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTGTGCAATTCTGATCATATTACTATGATAGTAGTGATTATTACTGGCATCCGGTTTCCGG
+
??AA?-BBDDDDDDDB>GGFDFIH/HHHHI9HH-GI/GFHIE9FIHHIFEHHHF=HIHDGHFIEFFDFHHIHIIIHHFHIHEHFHH8HFF/IH+D(FFFA,DHHDHHH5EHHGECE4DHEGHEDHFDE,GF4HCH@GF((GGGE7*G=CGE'F#BFEE.ECEGAGFEGCEG?AFGCFEE/C?0.=CGG*GECE?FC*??CG8E8GEEE8>FEEGEG?DFAC?G(EECFGG9G)(*'CEEE*A?E?/CEE?
@antibody_9_multiplicity_72_copy_31-1/2
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTACTAATCACTACTATCAAAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAACAACAGA
+
???A?<BBD?-ED+D<GFGGGFEIIFIHICHFHFFIHAF@EF>HFIHCFGI>ICIHHHDFIIHFEIFH-HIE#IIFIHHEDGFDHE-E-EHIDEFHCHECFCGFCFH8DEFFHHHF+HH6+F5DGFGHD4:FDF3E8GED<GGHFEEGCCGDGGEEEEEGEEEG?EACCGGEGEEE;-AEC:G;1EGE*?AEGGC6?FEFE??EGG/8#CFAEEEG?CCCGG*EECG(?CF*G/EG)E**:GA(E1G*E:
@antibody_9_multiplicity_72_copy_32-1/2
GACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGATGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAATTGAGACCCACTCCAGCCCCTTGCCTGGAG
+
??,??<?BDDBDDDDDFGF.FFHHIHIIEHHI.H+IHFIHIEDI-HEFGIF-FIHCFG*HDHFE=GBHH+FHEHHEFIHIH=IAIHFF8F+EIGHIIHHHH@F+HHEAH(7F;+G8GHFGEFHCHFBGD#E-;G3GGE,EE;GE?EFGE2EGEE.E(BCBAGCEFECEGCGAEGGGCEEGE+G:EGFE6*GDG<GEF?*EF((?GG0?CE;*H*:?G(G.*FE(*CEGGECEFC(EA0*G'?(EA:0?;*
@antibody_9_multiplicity_72_copy_33-1/2
TCTGGGGGAGGCTTGGTCCAGACTAGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGAAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCATCAAATGAAGAGCCTGAGAGCCGAGGACA
+
??A?<?BBDD-DDDBDF?FGFFF-.IFBHIGHDFFFHIEHFFGI7HIFIDDFHHFHGHIDHFHHH@@F+F-FHGFHDDA3GFFEIH7HH-H=FHIAH+HHFHI1<EHEHHF4EHEEGFH:FFBH39*G;FEF@DFDFEFBD,DFGF*E8GEEEGEEGE?+3EEAG<EEE@GGCAE<(FF8E?F(/;E(FG/GCF:CGG/E6*EEA:FCGCEEHAEGE8(C*/?DGE)GC1CE:*:E<*/:CFGA8C?#EA
@antibody_9_multiplicity_72_copy_34-1/2
CAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGGAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTATCAAATGAAGAGCCCGA
+
A?<??BB?BDBDDDDDFACFGFB/HAEHI7FIFHCIF@9HIFDFHHIAIAHHHHHFII>IIFHDII)C55I+F7FDIEFHG*FBHIHHIHHH=EI*DIDE35FGAHH+.AHFA=HH9DFHH3G+EG+FFDHGEDBE,'E8<DFDEDCEFGEEG?ECGFGEGGAA?EGBECEFF6/;ECG8?AF;EAEE*E*(EA?GG8:CEE:?G?EAFAE*F@@?EGGFE(G0?6(??:G(#.?GC(8:?G<64EE(EC
@antibody_9_multiplicity_72_copy_35-1/2
GGGAGGCTCGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTTCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCCTCTCCAGAGACAATTCCAAGAACACGCAGTATATTCAAATGAAGAGCCTAAGAGCCGAGGACACGTCT
+
<=????B7-DDD--DDEFCGCGIHHHHE?>HEF/H+EA=FHHIHHHHI/HHEHHIA+HF@HIF=I->DBCHHHGGE-5A=IHFGFFHF-=HH-II+I+D5DHHIDFDEFFFEDHHG?FHBGF*GEHGCHHD?G@<GFE@*GFE8EAFEGFGE:G.EGGFFF*GD?*CGEEGC>AEEE<?AG,F.GGEEEAC?C?FEA0EGFC?(GGE?*'E(*C0(<FEG/,:E?*:F8GE(?*(1GEC(E:*GE8G.*C
@antibody_9_multiplicity_72_copy_36-1/2
TCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCCCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTCTGTGCTACCACCGCTAAAAATAACTGAGACCCACTCCAGC
+
?A???BB-DDDDDDDDGGGFAFH>GBCIIFHHG9.7H.9HHH?=AGIIFHEH=IHHAIHIEDHHEHHIHIGFGHFH5FHHAI<EIHHIHFIIHHHHFFH=BEFHHHDHDHFFHGHFEFFHHFHEAFCFG1G'E:FA(G;AGFFE<C.EGEEE;C(CG?GFCEFFGBGG?0*/FFEG(ECGAGCE:DG*FGF-ECG?FF.*G66EGGEGC#FGH:@/F:8C/#EEAA#68*:/:AE0:>-F=GE:4*?(:E
@antibody_9_multiplicity_72_copy_37-1/2
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCATCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTAGAGTGGGTCTCAGTTATTTATCGCGGTGGTCGCACATACTACCCAGACTCCATGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGATC
+
?????BB3DBDDBD<DFFCA>GFFHFHIHIFDH.HIIFIHHHG=HHHDIIF5HHG8=IIHHEIFFHAEII,HHGHEIFHICI+HHHIHHHFE:CHFHHHHHHEGC:HBFE?HC@FHGDF?9HFAH3FGHDEF,F:BGGEA@EGEGD@EFFEGE(#E1E?GGEE(?G?*FFAG?<C(EEC?AG.G(.C/FE.E<FEECGE8EG0G6EHG6?.E@9C??GC,DEEG?A?G?(**':)0F(((?-CE;*1E(E
@antibody_9_multiplicity_72_copy_38-1/2
CGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTGTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATGTGCCCTTCTCGGAGTCTGCGTAGTATGTGCCACCACCGCTATAAATAACTGAGACCCACT
+
?A<??BBB@BD--DBDFGC.DF6IIH,HIH+HHAEBA9+FFIFFHHIFH.FIHFHHIHFHFFGIGH@HHAIA-DHHIF-GFFFAH8HHI?HDGIDIHFHGGFHGHCCHGD9(GF?FFHBE0GFFGGEE=)HFEF=;GDGCEGD@BEFGEG:EEG*CEEGFEFC(?E:(GGCEGFF*;CGE?(:GG<:AG'.AEDC'(E(GECC?0:AAE:*G;:F*D(C@(EFE*8E/GF*?8DE?G*EA?G?E06EE8:
@antibody_9_multiplicity_72_copy_39-1/2
TGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTGTGCAATTCTGATCATATTACTACGATAGTAGTGCTTATTACTTGCATCGGGTTTCCGCACTACTACTACTA
+
?????B>BBDDD<-DDGF;FCGHHHCH+FHHHDI.HIEHDIII/IHGH-H9DFHI8IF=EAHIFHIIHCFIBFHCFEHBFEDHH0HH-IIF=HEGFDF?GH+HBHHG4GHFHHHG*FF1FEEF+G+FHEFE=F0DEGGEEFGEEG,EEEFGG0EGGEDGG(<0F@E0<BEFGE9EC<:GFGGEG?EGGGEGGFGE)AF=EA(EG:<ACC::?*G@?B0:@E(?CG(C>GG*8GF0/*CECGG(GE<:0CC
@antibody_9_multiplicity_72_copy_40-1/2
CTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATAATACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCGAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTAATACTGTGCAATTCTGATCATATTACTATGATAG
+
5,<??BB?DD<DDDBDEGGGEGH.IFCEFEFHEGCHECIII=EHHH?HF7HH-EHHHI7/AFHFHH@-I@IHC=DHHFH>FDIGHHECHFEHHH6HGCHEEFIHGDEBGHE*=?FGHHHD79HHH*EEBHFFEF6GGE0ECEEEEG/BFGEG*EEGE)AG'GACED@EGCG8GCE?AEE)E8GEEEE:EGGEG?GAF:GEEFFA6?ED)=EECC@7#GBCG?*EE)*A:G*GEG:G6(C:;.(GC:*C:A
@antibody_9_multiplicity_72_copy_41-1/2
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAATAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTATTCATTAGAAGATACAGCGTGTTCGTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTGAGA
+
?=<?,BBBB-DEA<D-FF8-GFHCEIHIHHHDHHHHHEGIEIIG+HGHIHHH=CIE>HEH-IIHHGGBHI=IH-GHHIFHHIGH?GID-EI5?IHHFDH5=I.H+GHHF'E,HHH,DGDDHCE+6>GEEFFFFFEF7.CF1FF(ED.F*D#GEC(FEG:GEFE)AGEC#((.EF/4/:G6EG06:4GFG*EAF6C**.D*/E4G<;HACHE(EE:GG/EF7;6(CE*CEEEG0FEA*EGCA?E0/G*(*E
@antibody_9_multiplicity_72_copy_42-1/2
GTAGCAGCTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTACTTATAGCGGTGGTAGCACATCCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAACGAAGAGCCTGAGACCCGAGGAAACGTCTGTGTATTACTGTGCAATTCTGATCCTATTACTATGATAGTAGTGATTATTACTTGTATCGGGTTT
+
??A??B?BDD@BDD5DG8-GFG+IEIEBAICIHAHIIIGGHHHH9HGHHGHFFHDHGGHHEIG+7-IIIFFGI5+IIHHH-F3G-E=HHIC;IH=IH6HHFD3FE7FBH@HHGH=GCCB*=E9)3BHGDGEG7E8EEEF<FEG@EGGF?+FCEGCE(CCB<G.A?;GGFC#AGGEAGC#(EECGCFEE/GG?EGEG/CFGGF6EEE*C6*CEEGE:E8EE.E*GCEEE4CC(:EEG?G?E#G;EE*(?:E
@antibody_9_multiplicity_72_copy_43-1/2
ACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTGTGCAATTCTGAGCATATTACTATGAGAGTAGTGATTATTACTTGCATCGGGTTTCCGAAC
+
???,?/BBBD<EBDDDFEEBGGIFIHEHCIIHHHIFICDAHF@(IHIC5DFI+ADIHGGIFGHICFDIHF=EHDEH'DH5G/+GDEFIHHHCEG@GIFGGHHHHH=8HFHHHHHE;?G+HFH;GEDBCFGGEBF)*G3G2GFGGEBGGGGFEGG?=.EEF8?<CG=EEB?E@GE4EG.?G+GAGGE6G*EE:GGEF**?C?(F?EGHEG9C*8G((C7GCGCEE??CCAGGGGE6CC.0C>EECCEE*GC
@antibody_9_multiplicity_72_copy_44-1/2
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGCGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATAAAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCGCCGCTATAAATAACTGA
+
?,<A?B?BDDDDBDB5+.GGGGE+ICIB-IIII>IFH.IHHFFHIHHIHHHGE8GDDGFEGF>GFIHCIHHFIB>IIIHHGH5HHH(I=FDHHF=CCIF=HAFGEHEAG>HIHHHFEHEF?G;HHB3>=ECGFGAGDE1GFGGEFEG(DCEEGEEGGE*)#BGE.GECEE??C3F*FE*1GEEG;2G4EG9E:G??GGEDC(GG0EHG8*(6EE-GGG.EF<=(:E;:C*E'*CG8/G0>(6CE(EEGDE
@antibody_9_multiplicity_72_copy_45-1/2
GAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCGTCACGGAGTCTGCGTAGTATGTGCTACCACCGCCATAAATAAC
+
<AA?AB>BDDDD-5DDGCGGGFIHCCHIIHHAHHHHAI@/FHHFHF@HHIGFEEHGGFFGA-HIHCFIIHIF?GHHIIFHHII>AHHHAI<EIH?HIHGH-FCAHHHHHEEH>DHDHEH=E*EDGF'F4FE;GFDGF@EDEG(F'GGG4G8EGEGE8G=?@EC8AFGGGA?E/?:/(8.6+;E'GAEG0G:CEEEG?CE:GGFG:G(?0.C:@*:7BG0EE?(:(E/;*GCGG?E.;F?A'GE:)(CAGE
@antibody_9_multiplicity_72_copy_46-1/2
GTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTTAAGATACACCGTGTTCGTGGAATTGTCTCTGGAGACGCTGAATCTGCCCTTCACGGAGTCTGCCTAGTATGTGCTACCACCGTTATAAATAACTGAGAC
+
?????B>BEDB<DDDD?GEA8FFCCCCHHHAIGGF=IGHII@0FHI-HHEIHHCIIFBFIIHIFI8FIHAIGDIIIIIHHCHGIIHHDHC@HHIIH-FHHGF-HFHHEHFIH+FHHHG;GHDDFBA@CFGG*AGGFGEGEGGEGDDGCGG'G6AACEEE(?D,E?G,*AGE8G/(;DGECEE:GGE/?'EA;0CFC?GCEG*GE6GHEEC*<*>*GG8=GGE**0GCCE(/A*#/:F*GAC)EE>GE6**
@antibody_9_multiplicity_72_copy_47-1/2
CCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTATCTGGAGATGGTGAATCTGCCCTTCACGGAGTCGGCGTAGTATGTGCTACCGCCGCTATATATAACTGAGACCCACTCCAGCCC
+
AA???BB?D@DED5D58FFEFFBH>HIHHH.HHGI9IFFGHIFFIDFIIICCEFIFHHIFFII=EHBD-HHHF-ICEC;=CEEHHCIHIHIFHHG.HHEHBI6GIHHD=HFE5HHHHHCHG7?EHFEEBGHEF)GFGFG-DBEEHA?G*EFEEGGEEDGF0F0GG'CFEAGGE:DECEEE0:/E*/.EEG<EEAACAG1#.GGE0C?E/F*:(7G*>(EGGGCE:G*EE8EG0EC;-GG8E(CE6AFCCA
@antibody_9_multiplicity_72_copy_48-1/2
CACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAACGGGCTGGAGTGGGTCTCTGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGATGGGCAGATTCACCATCTCCAGAGCCAATTCCAAGTACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTGTGCAATTCTGGTCATATTACTATGATAGTAGTGATTATAACTTGAA
+
,????BBBDDBDDBBDGFG8CG8FEIIFI/HIHAD+IIIHFDDHHHHE9HFDHFHIEGEBHH--ID-I=IHF>HAHFIIFHFHCHF8<IFEF?EFIHGHHFF4FDD;H:-+HFHH@.HDHDFDEHGEE?C7FG?((E3FE<F=ED(GEG(C@EEFEB/GECG(.8*/E9F/AC?GF?E6<EEE:.6EC<EGEEGEE(G<8EAEGECEG/H:G>E*AGEG7<FGGFCCG?G(G8CGG*CG6?0*EG00G(*
@antibody_9_multiplicity_72_copy_49-1/2
TGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACAGAATACGCAGACTCCTTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGATCACGCTGTATCTTCAAATGGAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTGTGCAATTCTGATCATATT
+
??<=?BBB6?A-D<BDCFFFFGHHFIHHFFIIII.FIHHIHI.EIECBHHHCFDHH?EGGHFFHFFID-HDHFE:FHEHDIDFFG@EHGH?=.GHFIHHI=HHH=HIH8GH7HFFEFHH#F,8FFGHEEFEEE9*EH(A*F?:EFFG:EF:GGAEB,EGE(9GE@G'>G?@EED(-0G=EDCE:E,EFE?:EC/*F**'(??EGFEHGA0CGE(.:.E(EG:<A??0AC1CGC/E:FC/6EE.:E:DFGE
@antibody_9_multiplicity_72_copy_50-1/2
GCTTGGTCCAGACTGGGGGGTTCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCCCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTATATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTA
+
?5???BBBDBB@5@BDFFFGF'HEIEFI>FHIG9IIHIFF0HG?HHHFE?CI>HAI5FHBHG5DHI-BHFGHIIHHHH,IHDII-7H<HHEFIFHGCHHHI7GHIEHHHHHHHGFHGDHBHCFGF:@GGGFGH<FGE=FEGB8FGFEEGEFFGAECDE6:EGGCGEACFGGE:G8*EFEE;A?'EFA(AE:G;.<6EEE?ECGEC#H*EAEGEGG?E?B,GEG*E6:?GGE?<C.ECGG8?C6/C1C4C(
@antibody_9_multiplicity_72_copy_51-1/2
CTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCAAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGTACACGTCTGTGTATTACTGTGCAATTCTGATCATATTACTATGATAGTAGTGATTA
+
?<???<BBDDD?B9DDFGG-GEIIIHI7IFIGHHIFHH,HHIHI-GFHFAHEFF9CAIDIFBFIHBCHID5HBHGCEIHH-FIGH3HI-IIF9EEIGGFFHGHHDF5GDHDE@BHHDFHDEGGF-HEFEGH<AG*E=2*EGBG6EE*F*G(EEFGFF@?4(8@=GAF2CGEC(CEEGE;'C<C*GAFEE(FE8(G/?E;F?G6A:EH6:26EAEEA'C(ECF:EG/G8E/(.(8C8GA?/EEG.:CC:.C
@antibody_9_multiplicity_72_copy_52-1/2
AGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTAGTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGATGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAAGAGCCTGAG
+
?????B<5D@DD-BB<FAGFFFH.AHAHHH9HIHFCEFEIHIFHDHHHIHIFIEF--HHHAHE-FHCHIFHGFI+HHHAGC,I<FF?FIHB@HGAI)FHIHCF==FHH3HDDH@ECFFGFDGGHBHHB@E=HFF5GHGE*FGCE#FFE=C8E/GCBF<EGFFGC?G;<GG?CEEGE?E:DG@G(1??GEGE:EEEGEG*<E?E:GEH96(E/@E3C'C?CB,E(E?G06(AG>/*:EGCG'8*;G:GGG8
@antibody_9_multiplicity_72_copy_53-1/2
GTAGTAGGAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGCTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCAGCGCTATAAATAACTGCGACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCC
+
??=?<BB-DD-DB@DBFECEFGHHHFFHHBGGHHIIAHI(HIIHIHIHIAIGIF-FHFIFHFHEIH--FI-IHIHHHGEHHB=HHA5GH+HDFHGEDHEHFFF<EIHIF4H?DHHHHHEFH=GBGCF*GGFA;6DE24EE?8GEGECGCFB=G,EEBGE6F?CGCFBEGG*(GGEGAGEECGG:(>G?8CCGEGF(D-C?GE?G?GEEE??*@8@?C/EEC0E6(?8CAEG?86:C**:EACEFG./;:G
@antibody_9_multiplicity_72_copy_54-1/2
CAGCAGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCCGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCCGAGACAATTCCAAGAACACGCTGTATGTTCAAATGAAGAGCCTGA
+
?<=?=BBBDDDD@BD?FFCCFF>EFHIIEEHHGIEHGHFICDHFGHGICH=GCCHHHHHIIDHFBIIHHFHHHEA-IHI=F#HHCGCI=HH-IFF?EFHHHEHDHHEFFBGHACFEGGDHDHHDEBEFF;FDE@F#'GEE,*CAAGFGCGFFGEG>FCGCECFGE?GE8C-;ECEF1.EDGA/GG))ECGGG?EGGGFE*6E?E*FA6G(EGAFE;GEG:EG0*C((CFEC(:GE=E)CC*8AC*1GG(E
@antibody_9_multiplicity_72_copy_55-1/2
TGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCAGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACTATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCT
+
?<??,B>>DDBD@DDDGGFF?GIEHHFHHI7HAHFBGHFEGHIHIHFHHIEIHD=AIFIHFIDHFHHIII5FHI4HHFFHDHFIIH/IIIHFHHIEEH=EHCH6CHH#CIGFH#EGFFFFEHH@GGF+EFEGG3HIGFH3EEEAEGG.CCEFBEG*@C0EGEEGEEFE.FEE=4GG*GGC/C2CG(C:CEGC(?9EGG*GEEEGFEEG?E;C)AG(C?8GG(?(?DE6CE.6:E.*:G#E?80CE*C1AE
@antibody_9_multiplicity_72_copy_56-1/2
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGATCCGAGGACACGTGTGTGTATTACTGTGCAATTGTGATCATAT
+
?,=???BB<DBDDDDD+FFFFGHFIHICHI/IIEEDHIAHIHGEFEHEHEHD=FHIIH@FGBEFFHHIFHGDDIHHCDIHHH5HIHHIFHDIIHEE+IAFHHHHG@FHFCGHHHGGFCFHHGGHB23CHBFFGDEEEG5G0FGGCEEGFGEEFDCGEE4EFG/E,EGEE*CEF:C.EGG<GEGEG:AAEEGC?GGADGGG(<CFCGH*FE?E:4//BCC,)?C?:CEFAEECG::?61C('GE6*G?A>G
@antibody_9_multiplicity_72_copy_57-1/2
GCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACAGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGACTGAGA
+
<A??A9>BBD@EB5D-F@/CFFFF?EF6HIIIHGEHHGHIIIIEIFEAGFFIIHCI4H-HFIGBFHIIBFI5CHF+BHBH)HHIFHIGFI@HIHIEFHEHDBHFIIF@HHHH@FFFBEHGD9E=GEE6AGFEGCGGBC*GGGE0A0FEEE.FFEGEGBE1*;EGECGFFGEEG:F(?BEFGECE-?4#EE/EGEEA*E/GCFC<G8?6EHGECA:DEADA0E/*?GCAAE:G?E::(DCCAA0'GACEG.
@antibody_9_multiplicity_72_copy_58-1/2
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGTGCAGATTCACCATATCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGATTATTACTGTGCAATTCTGATCATAT
+
?????@>?BDB@@<9DG-AGGGHEFFACFIAHHIIHCCHH9,HE=HH5HHHHHFIIHIAIIEHH=H)EHHIIHH@IFHIDHHHA7H8HHDHHGE-HI-HHHHHHDHGHGFHBAHEDEFH*GGF;HFGHFFGEBD*E1E:F(*G>F=E/EE3@/ED*<2'GFF?G(AC0GEGGEE*AGECCGEE(7*.A8/:GGCGGF:GEGFCCAEF6*:E(F;*G?7?E<EA/*:(GC(C:E(E.CC:EEGEC8GCE*(
@antibody_9_multiplicity_72_copy_59-1/2
CGTGGTCCCTTTGCCCCAGACGTCCATGTAGTTGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGGGTGTTCTTGGAATTGTCTCTGGAGATGGTGATTCTGCCCTTCACGGAGTCTGCCTAGTATGTGCTACCACCGCTATAAATAACTGAGACCCGCT
+
<?<A?B?BB=DDDDDDGFF>FAIEH;FECHHF+HEIHHEIHHD?HH.H?HHHHF-GGFHHIF5*.FIHI?FHIHHGFH+GFHDD<EHHHHFHIFH)HHHHHHDGFIIHHIE@GGFHHBEFHG<G=GGHDDFH;GEFGEEEEFG*A;G1D9E;GFG#EFGGGEG3C;F;E6G*GE/0FG;*(G;GE6G(GGGG?EGEGEGCGEEE:EHGE*(EH:CCCAC@:?1E(/?GG:AE((A8E:2:?8G:CAE(G:
@antibody_9_multiplicity_72_copy_60-1/2
TGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGATCCCTGAGACTCTCCTGTGCAGCCTCAGGATTCACCGTCGGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACAAACTATGCAGATTCCGTGAAGGGCAGATTCACCATGTCCAGAGACAATTCCAAGAAGACGCTGTATCTTCAAATGAAGAGCCT
+
<????-B?DD<@DB+DCGFGGFHHH8IHHHIIIHHFHHHE=HF+IFHAE>IBHHHFHGHF:HDIDIDHFH+FFFFFI@G?DFE'I7FHHB(HIDHA=HIFHIHIFEECFHEHCGHCH+HEBH*9;GDCF@G==F;EGEGCB*(EFFFDGEFGEF,EDCGGEE4F0??#FGA((AEF(<.GGGF?EGGG6FGE?(CC?EC(EF*E.EC0GEGE@E(GCGGEEEA*GGC/C'6:E:(GGA*E)(??EA:8?0
@antibody_9_multiplicity_72_copy_61-1/2
GTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCGG
+
9????BBBDDDB@DDBGFGF6BIHCHH8IIC/HHHF-=IHII.-FHDF@-HBAHIFFFFDFHE55IF=+EHIAHIHFAIGBHHFCHHH(CHFH8HI+HI,BHHEHHHIIHF@C?FFHDHGEG=BHG8GF4GFGGHEFGEEEGGF*B8GE,EGGE:E@AEGCBE?2EFF?6AG(/E-CEGGEAGCG'.:>E(EGCG(GEF8F.GG9CHE*FCF.@:*??<EG?<GG9GEGE'EEGC(?ACC:.:?ACAG(G
@antibody_9_multiplicity_72_copy_62-1/2
CCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATTTCCAGAGACAATCCCAAGAACACGCTGTATCTTCAAACGAAGAGCCTGAGAGCCGAGGACACGTCAGTGTATTACTGTGCAATTCTGATCATATTACTATGATA
+
??=??BBBDDDDD9ADFBGGGFCIIIFEEHEHEG>HIH@G>H9HHEHCFHIEIACHIG+D-EIEHIIHHI-HH?GFF>HIHHAHHFEHIFHIHHCDH*HFIHAHIHHFHFDFHF*GHEDGG2FBHGEFGDHG>8D=G@EEFG'FB)C*CEFHEC>E2F#GGGE8*GAG<GCGGCE*CG0GCGG*8(E?EE:EDGGEG9C//G(G:EHED-C#H>*1?EC,0EEEEE8CGEE(CEGF>GCG**G)?(6ECE
@antibody_9_multiplicity_72_copy_63-1/2
CTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGTCTGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCTGAGACAATTACAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAACCGAGGACAC
+
?A???B@<D<EDDDDDCGGF?E>A/IFIEHFHHHIIFDIIFIH=GHGHGE5HHAHH--HEHII,GHIIIHHDHFFDIIIF;'IHBHECHHGCHEDD)77IHHAHDFH=EHFFHF2+3ECH?GHH#@9)C@H=+6GCFGEGFGCECEEEFG:GE5GEAGEE0DF8EED0AG(GFAC*FGEEEEA*F6E**(E8CAAGGG*:E-6ACEC6CHE0E*:?:GB@G,C:CG:?E=E?AGFGA:.'8F.GG?808E
@antibody_9_multiplicity_72_copy_64-1/2
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTTGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGATAATTCCAAGAACACGCTGTATCGTCAAATGAAGAG
+
?????BBBDDDD?DDDC.GCG5IH>/CFFE+I@FDII7FHHI,HHHHIHG-HHI.HIC5EG5CHFFFAGHH5HHIEFF@IIAHG?HB=HDFEEHIH#EHF3GGHCF+GH@FHE.DFGEFFGHGHFGFFHD*(GFGIHGEGG#EA,GFF:A<G?GEGE:DEEEE<(B8G0EF)E?@F((C8?EGEEE?:FFG:8AC9EE8G;GGG:8E::-ACE@(?#?EE.?';FACC*E?<E::GA#0E*E8G):6*EG
@antibody_9_multiplicity_72_copy_65-1/2
AGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAGCACGCTGTATCTTCAAATGAAGAGCCTGACCGCCGAGGACACGTCTGTGTATTACTGTGC
+
,???,?>BD@5DDDD@GGGFFCIHIIHHHHHHGCIHG?HGEHI9FHEFH.I5DIH5HDHEIFIFHII,IFFCIFEC5HHHHFHIEGIIHHEHBD=H5IH+ECD;HGEH;HEHD6GFFFFCDHHE)+?4)H8D;DEGGFE'EGFGGCEDGGE0FEEFEFGEEGGG?AE:(G:EEGEE;GG*GE6C*E8E@'?GG:E:E:AE0E:GCE?EE;FAHGGGE*E#*GG(.E9EGE:*6CGE::AGC9:?60;G:(
@antibody_9_multiplicity_72_copy_66-1/2
GTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAAACGTGTCCTCGGCTCTCAGGCTCCTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGTAGCCTGCGTAGTATGTGCTACCACGGCTATAAATAACTGTGAC
+
?=???+B?DDBD-DB-CAFGFG/HFIEHICGIG-E/-IFGHHEHIHHAHFIDEIHHHIFHCHHHHHHIHIEFHHCH-)HHFHIHHHEEHH,IGHGDF58=)FHGHH+HHHH=DGHHE18+G<HBGEE8EFBEGG(GE*FDGCE*GAG?CGA,/<AGEGG*A9E<GEGEEEGBGACGE=.G:AG?E:/2#*:?:FE6?DEG6E;0GE(AG/?0C;C*CE8CEAGG6?*CGEA*:E8/?:C??GCG8)(EE:
@antibody_9_multiplicity_72_copy_67-1/2
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACCTTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTATATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTGTGCAAGTCTGATCATGT
+
???A<B?BDDDB<DDD+BFCEGACHEHFH;HHIAHI-HIIGIFHHDGHFHIHH=IFFHH-HFHHH'GHHFHC?IHICDHH-HEHHCA/HI;HFH6IHHGFH+H+IFH?HGHH@*FHBFH#F+FHGFGD=BG,CD2AFHDBE3GF6CECGECCEG=?EGEE=@FEEGF?F.E?:E'?GEEE4G(FG:G::EGCGEGC;EE(F<?GF?:EGH:*H;GECFGE?E8180ECG<CCEGC?8F(0E::CC.2/#*
@antibody_9_multiplicity_72_copy_68-1/2
CACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGAAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGTCTGTGTATTACTCTGCAAGTCTGATCATATTACTATGAGCGTAGTGATCATTACTTGCA
+
??<=?>BB-5@DDBBDGFFGFFAC>IHAFIHHIIHCIF=-GFHFH+,FFHBH>EICBHFGH*.FIHHHAHIHIHIFHIHIHIHHDHIF?DIHDI--HHHHCHF6CEGHCDGHBCFFHDHHFGFGGFGE=FDDCGEE4G=C?G.EHEGGGFEAE9G6FFEGCG=EFE3GEA0G0::/E(GCEDF.EE:ACG:GFCCC.E:EG?C(EE0:E(EACAD-.GCEEE??4GF;A((??C?G:C0(CG?*:(6?GE
@antibody_9_multiplicity_72_copy_69-1/2
GTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTCTTTATAGCGTTGGTAGCACATACTACGCAGACTCAGTGTAGGGCAGATTCACCATCTCCATAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCCAGGAC
+
????=BBBDD@BDADDCCFDF?EH>FAFIIIHF.IHIHFIGH>CHIHI9ICH-FC>HEHHAF@GF5+EIF=DICFH--HAIHIIC88IFHHHIH/EH6HHFHHDHEHHEE7D6HDD+EDFHH+HG4AF?G@FE8GDEFBG'D03CCEDFEGFEGE<GGF8EGF(*ECE;E?<)CACFFGCAE*GEE.DCGE(GA)GGCA6.EA6*FEGC?:G'@FC(G(AEECC*CA)(F8.AE:C?G?G:EF:(CF(AG
@antibody_9_multiplicity_72_copy_70-1/2
TGTAGTAGTAGTAGTAGTCCGGAAACCCGATGCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATAAACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACTAAGAACCACTCCAGCCCCTTCCCTGGAGCCTGGCGG
+
AA???BB?+D@DDDDDBCC>FGFHEIIHIEHICICHHIIHHCC5IHH@IIDFHG9:FIHC?FIEFBI(?IHHBIHAHFEFFGIC#IEFIIHIEHDHHDHHDEFF>BGHHH=HD+?D+FGHECHGG1DEDHDFAGHDHE*EC;EF>FG?:E1EGG:E'E/BCCGE;GG8CGFF0?AA(?E8GEEFEGAE?CGEGG:*E1:*.GF:</E=A/C?F7*?(A#@GG(EE8GA?*CC*;E?A<EGA4::?<EAFE
@antibody_9_multiplicity_72_copy_71-1/2
GAGTCTGGGGGAGGCTTGGTCCAGACTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACACGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATCCACCATCTCCAGAGACAATTCCAATAACACGCTGTATCTTCAAATGAATAGCCTGAGAGCCGAGG
+
=?A?AB-3BDDBDDB@FFFFCFBAAF/II+H9HHFHIFHF/DHGHIH@EIHGFIHGCHF.HI>CFFHFHCHHFEC5CICGHI+AHHH*E+/IIBCDHHHE.D4FGEGH=HDHHD5FHHFCGFBGGEHDBEFDGFGDGC,.*C(GE3?EGFGE?G?GC8?EEGGCEEFDGGE(0EFFEG?DE((G(<GAC/G)GGCCE6GCGCE*G<HE:**G0/G7BEEGGDGFA?:(C0CCE*CC??1EC:CE?AGG1C
@antibody_9_multiplicity_72_copy_72-1/2
GCAAGTAATAATCACTACTATCATAGTAATATGATCAGAATTGCACAGTAATACACAGACGTGTCCTCGGCTCTCAGGCTCTTCATTTGAAGATACAGCGTGTTCTTGGAATTGTCTCTGGAGATGGTGAATCTGCCCTTCACGGAGTCTGCGTAGTATGTGCTACCACCGCTATAAATAACCGAGACCCTCTCCAGCTCCTTCCCTGGAGCCTGGCGGACCCAGCTCGTGTAGTTGCTACTGACGGTGA
+
?A???BBBBD?DBDD-FCFGGFC6EHCHHGEIFIAIHIFBGGIH?IHG@FCI=FIF8AIHHBFIAHHIG5-IH-HHIF=5IEIIHIFH<EFHGHHHFGGHHGH4GFHFHHGH<FHHF=GFE'DHHHECEH:*EG4IDGE@F*)FEGE+G8EC8G:GGE?CECCGAEGE@DGGEGE-F86E?G#CF6CEFE'?-A<AG:(8EG.6GE;EGC::::EGB/E7GECG(F?G(?/E?:G9(6GGE.0G?GGG)C
@antibody_10_multiplicity_26_copy_1-1/2
GAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTAGTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGAC
+
?????BBB7D=BDDBBGGFC/GIHIF8E88F+IEHHHFHIHIAHEGIICHCDEIIAFIFG-HHIIEHHHEGE5HIF5HFEFHGHHFIIFEGG3IF,DIHHDC=DH(HHHIBDFHH+:HIF@FHCEDDGBHEE@FG(FDGED5FGGFGGEGEFCCGGF;EG;(CCE/C?EAFGDCE=*E8ECE?FG9EEC*EE.GGF(A(CEF?8:#C<CEGG:7E8?:GF?A?C??8AF:GC*:E::6EFGCE*EA:/E6
@antibody_10_multiplicity_26_copy_2-1/2
GTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCGTCTCCAGAGTAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCAGG
+
=?A??7B?<DD-DDBDFGGFFGIHFCHICHHH/HIHHHII9IIHH?F.,CFH9?EFEHEGG,IHHHEFFECGD5AICGICHEHHF/CHHGDEHCHAI@GFFHHHHIGHFF>=HHH@H4HHF:6.DHBD2GFEEE==DF4G<AGG:G21GGGE0GEEGGF'EBEGGF-6C:GEDGEEFEFEEE6EEE/CDGC#6'GGE'**8(EEG0:EFH??CC(*90EE',E/*E*EE/GG0CC.EFFAE0F:EGA#**
@antibody_10_multiplicity_26_copy_3-1/2
TCAAAGTCCGGTACGTAGTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGTAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGTGACCCACTCAAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGT
+
??A?,BB9D-DD9A<DFFGFCFFFEHFHC+AIG;HGH=H+@HHCHHHFEHHG=8HFHA=IBDHHFFIHGGHHIGHHEHIHAH4EHIHF.HEDI+HDFH5IDHGAFEHHHHD<FEE?B#FDGHFGHCHD*(BBGGEC8?G.G?>DEEEFE+GBGEGGFG6FGCGG6C6?E.AE?EGG0CEFEE(CG#:EGACGFCEGGG6CGC(:)G*6?EGG.G;*GCEGG7EEEACA;EG::GC<GDC:6?/>>AA:):
@antibody_10_multiplicity_26_copy_4-1/2
GCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGTGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCAAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATATTCAAATGAACAGCCTGAGGG
+
=???<?>BDDD5DBDBBGFC>FI/EHIHEEIHIEI+HIH@HGC-HHFIHI+HFIHHFHFHHD@HGIHIID-FHCFFIHCFHC5DAHIHFFCBHEH+DHI7HIFFCHH)HHFF=FHDEGHGH*HFEGFFCFF*E:EF(=FF77?AFGEGECFEDE1F?FAE;GEF/HC1:.GA;(EGG.GECC/GG:E:GGE/G;GG::*C?GFDG?AGA6CGEEEEG>GG8CG-FE**'6C:/:G/E6**?E(*:EE8*C
@antibody_10_multiplicity_26_copy_5-1/2
CTGAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTAGTATAATAACTACTCCAAAAATGCTAAAAATATTCGCGCTCTTTCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTTAATCGGCCCTTCACGGAGCCTGGATCGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTC
+
??5??BB?DD@DDAD5FFCCGFI.FCH+F;I8HIFFIHHGHI9E7HEGIGHHIHHEHHF>HDBFCGHAAFHHEHIFDEHCHG)H-I=HFGI-H6FHHB+HHHFHDFDFH+HFFHEGFEEHHDHFEEEHFEF@H#0BECG6CEFG8GEFDGE>2EFE)0CEEGGEGGFC;EEEG6C*.GFEEBEG#C<(EEE'EDCEA:GEEA4EEEFECC/1HG#G::GEGEEC/:*CC(0:?>'(GEE?:FC0EC*GG*
@antibody_10_multiplicity_26_copy_6-1/2
CCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCACCAGAGATAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGACCCGGGGACACGGCTGTGTATTACTGTGCAAGAGCGCGAATAT
+
?=???/+BD@DBDDDBFF8/GEF0HIHI+.FIE.HH9HHHIHIGGHH?CIA*=F.HFHHFH.EI5IHAH>HFHHI?EHDGGFGHIHFDCBHIDIHEHFFFH=HAHHEHFGFHHHFHFHHG+FFCFEFEGHGD4GEGEGGGC:G@*AGE9G2;EEE-#GEGGA0*(EGECECFF;GFEG<EGAGCG;EG:GF8?G:?C*GGE<E?CC/'A?E:ECEEE:EG:C/C??GGAEE.(:CCEEC.*6?FE/C??8
@antibody_10_multiplicity_26_copy_7-1/2
CGGTGACCAGGGTTCCCTGGCCCCAGTAGTCCAAGTCCGGTACGTAGTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGTCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAAGCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGACCTTT
+
??<??BBBD5DDBDBBFFGFFGCIFHFFHIH-HHIIHHI5IGH--HFGEF>HCEHGI<HHIFHHAFHHBGHIIEII5FFFHGAIHIGHIDEIHIHHFDGGHDFHGFFGHHHGD:G1#(HHD8HH*FGEG?HEEE.GGEEFDE@FEGGEGEE*FEGFGF*FGG;>C?2:GEG:G*GEGE#E:EFGGFEGAEE:EGCG(E2G6'*4*GEGEEEG0AE*/:GCGDFC?:AAGE:*E?:E?GE(C:GEECGGGG
@antibody_10_multiplicity_26_copy_8-1/2
GGCCCCAGTAGTCAAAGTCCGGTACGTAGTATAATAACTACTCCAAAAATGCTAATAATATTGGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAAATACAAGGAGTTCTTGGCCTTTTCTCTGGAGTTGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTTGCTTGGCGGAC
+
,?AA?B>BD@DDDD5DFGEEGG/FEHHI>FHADHAHFFH9GIGIFHHIDIEIIEF8HIIIEG-G+A#EFGFIFIHIFFHHB5H+FI=DI+@AHCHHEHHH<CHG2FFFHC6HDHHHGHHF#+FFBC*FHGDH/HE:CGF#1FGDDG,GGGEG(*@?AAG:9.8>(ECAEGAEE:((G/GF-CD.CFAF(0G::*C:FGE?GG(C.*C*6CG:H>B?*E//G,?.0G?GEG:CG:((?A*C(GGG:::;*A
@antibody_10_multiplicity_26_copy_9-1/2
GGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCGGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATACACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGAAGTGGGTCTCAGCTATTGCTACTGCTGGTGACAGATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCAAGAGAAAATGTCAAGAACTCCTTGTATTTTCACATCAACAGCCTTAGAGCCGGGGACACGGCTGT
+
??=???B?B9DBB<D@GCGFGGIICFHHH6FEGH9,H/E+A,FH>.H.DFH+AGHFIE-HFFIHIIIHI9H5=IHC*EDDHIDHF<BDFCIHHHHGHF=GGHHHHBHHF9+:HDHDE2FHDEFH,?CFFE;9=GGGGFFDFFEF(DGDEE=FGGEGGGEE8EFACD<@(GEFE0CEE?(GF<EE(8CGGGE.E:C(EE?EE(C8/GHE0HEG1:C7C'7A'ECE(GEEE*?4*G?6E:GG6AF?E;C8<G
@antibody_10_multiplicity_26_copy_10-1/2
AACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCAGCAGCAGTAGCAATAGCTGAGACCCCCTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGCTATGAAGGAGCATCCAGA
+
??<5AABBDBDDB<DDGGFGFFE5/HFI8IGIFH7FIH?G.HAFHI.HIFHCHHDHEHHFG<FHHF9H5CI>I?GH-HFIII:HHFH7+DGGEHEIDFHEHGFFHHBHFGGEGH'E(FE*HHF1GG+H:F=F,F<FEDDGGG>EE>GEG<EE(2EFGEE#;FF?AGGG:@E0:GEG*CAGEG?E*G=GEGGEEEGGCGEE:?GC8C::GE*?EA'E<:EG.ECE:CCEC6CEC;0EE?)C(.(CC(9G:G
@antibody_10_multiplicity_26_copy_11-1/2
AATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCGCCAGCAGTAGCAATGGCTGAGACCCACTCGAGACCTTTTCCGGTAGCTTGGAGGACCCAGTGCATGTCGCAGCTATGAAGGTGAATCCAGAGGCTGCACAGGAGAGTCTCAG
+
?????>B>-DD<,DD-EA?GGFHHFIHHHHH+FIGACIFDHHFHGIHHIHHI@DFGA8AHHHHIH>=IIFAGCGIHEGGE@5BEEHHGHI?EHHDGIFFIHGFIIFHDH=G(CHDFD6HH.7=GHEBGGFGE65E.E.DC?GDEFFGGFGGG#GEG@GFGDEEEEGE'GGB:GFEEAEC*C6GC(C??;*?EDF8(EG)EEAGE.A*CGCC?E@GEG0(,8?EE*GEEEG?C:6*?E1GCE?(:EG*C(*
@antibody_10_multiplicity_26_copy_12-1/2
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTAAGTAGTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGACCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAAAGGCTGAGACCCACCCCAGA
+
<?A????B6DB-9DBDFGGGGFFH?EBIHHIIGIBICGIEICE+HHI(EHIIFBFFFHF@CFIHC;HFHGHGHIGEFFEH=?HGECIHHFI(HHHHIACGHHIDHFG.HHHHHFEDHE(FGHFEG5DGCE=GB76GEFGCEF?D@EEGGEEEEG'A(AG@G66G??GGGG/AEAFFGAEGG+CD#CF(EF?CGCC/E?GE*(GE?E::GH*GHCBGG7(EG</FEEGCGG*(G(C8EGCEECCE*(E*1E
@antibody_10_multiplicity_26_copy_13-1/2
CTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCCAGGCACCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGC
+
?????BBBDDDD5DEDGFFGGDI/FHIHCHHIDIGHIIFHH7HHHHHHIIFHDDHHIHD;EIIGIFIHDFFHFIFCH,HG+ACEFIIEH6FIIEFHHFHHHHH3H.DE5IH8?HEFHBHGDCFCFH*.DFG*EE3@EDEFDCGEB0,?BGGE9DGECGFFEEFG,G*E:E?EG#*;-2CC)?G8EGG*EEF/6EG:?(GEE0.E06H:?;E?EEE:BA?.(.:6E8A(:?CGCECEG?G6ECC964CEEG
@antibody_10_multiplicity_26_copy_14-1/2
ACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTAGAATAATAGCTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGCGAAGGTGAATCGGCCCTTCTCCGATCCTGGATAGTATGTGTCACCAGCTGTAGCAATAGCTGAGATCCACTCCAGACCTG
+
?=<??BBB=5DDDDDDGEFGFFHIAIIFHEHIHIGCFI.HIHCFBHI8.EIGIFC/ECFIG.IIID:C>@H,HIFIHFIHHI?HFFHHH-HI;FIIHI=H=HHHH@HCFHH=HIH9EEHHEDHFGGEEGF2HDGGG'E6ECHF,GD;CFG?8A3EGG.BFECEG?CG?G'G@#CCGGE?EEEEFE?FEC*<(DG'F;G(:GGEG:GH(C6CGE8EACC#GE:#..'G?GGEEE6E'.C(CECCCE?G:G#
@antibody_10_multiplicity_26_copy_15-1/2
TCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTATTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTTTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGCGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTAGCATGG
+
5??AAB?BADD5BDBDGGCGF@I6HIC>IHF0F*-FIFIAIHCFEG9AFEIIFIIIHCIHHFH7FHFD5CF5HHF55GDGHCFC=F0IH,HFFEFH.HI@+EDHHHHH6AFHEH+FD7DH;HCF9G@?F;DFEEED;BB@EG1GE8BG?EGCD(GEF*F<:(GEE3GFC?GGG(FE8GECE?FG?EDGE::G:GCG*CDCECAEC-?E*F.E*GE?C/?7?E*ECC?E(G/E?C?GEEEECE?EE**48?
@antibody_10_multiplicity_26_copy_16-1/2
GTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGCCTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTACTGCTACTGCTGGTGACACATACTATCCAGGCTCCTTGAAGGGCCGATTCACCATCTCCAGAGATCATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCATGAGAGCCGGGGACA
+
?5??=BBBDD<DDDDDGFGGF.-IIHHIH.HHA7IFHHH,FII?GGHDIHCGHDEGHHEFHIIIIHDHDIHHHFHEIGGHCHDIIHGHEH/=HI-HHE-HDHF.HCEHHHGHFHHFDB8GH?GF-G3G.:FDG+EFAFEGEGG*FEE(GEFFGC?G:BE?E0E88GGCE:A90*;GEFGA?E((G<G)EA?(CG:EG((C8?E?AG0(E(?GCAGAEEC:*F<CEC6CC8GECD*(A8(*:?GEFG6ACE
@antibody_10_multiplicity_26_copy_17-1/2
TGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGTCGGGGACACGGCTGTGTATTACTGTGCAAGAGCGCGAATTTTA
+
9??,AB?BDD@BBDDDFGDFGCFHH>-FIIF9DDAB+GHHIIIDFHH+HIHH?I7HI==I/GIDH5FHG5FFIFHDAEEICHGEHH=HHDGHHFIEGFIIFFEEHHHHBHHEHDHDHHHF(ECGGB#BFH?*DEE,EHGEGGGE*FGGEFEEGF:FG:GE88EEEGE*GEEE?E4@?G:GEE<E>C;6E:EFA8;(*G-GAFEEAF#EE6C8HFE.7(;F:#CE0GE:EE6*CGE(CEE:(6AF(8'6::
@antibody_10_multiplicity_26_copy_18-1/2
GAGTCTGGGGGACGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGCAACTGCAGGTGACACATACTATCCAGGCTCCGAGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAAAACTGCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGA
+
????=BBBBDDD-DDBGFAFGGHHH/HFFH=.6HIECFIGDF/DAIHIEHFIFIGCIIHDHHDHF?IHFH-H-5IC-GAEDGEHFHIEHGHF@HIHIH?FHAIHDHHDFIGHFHEHGBAEGGGHFGEEFEG?FGGGFF9*FFF2E'G??:EGGDFD8*GFEEG;CF.*C</(GG0EG.G(<CG/GEEGEAE:GECA?ECFFEFE?G<0#*1:C*@?EG;@;(E:E*E(E0E?EC0*AA8AC?E*C*?6*E
@antibody_10_multiplicity_26_copy_19-1/2
GCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCTGACCCAGTGCATGTCGTAGCTATGAAGGTGATTCCAGAGGCTGCACAGGAGAGTCTCAGGGACCCCCC
+
?=,??BB<DBDBDDBD;CFFGGHE-FEFHE=CG>IIHI9DCHHHHICHAH0IHHDHIGIHHIHD-HCHGEIHIFCGEF?FACFHIHEICCFI>ACBHFHDHHHHI3.DFBHGE?ECHG3HHFHHG93EEGF6EEFEFGG.GEFBF*EEFEEE.CDFEE9GCG.GCGAGE**CEFE9G:EEG+GGCAEGGFG;E'.GFCG:C(E(G?8EEH*?H*:?CG<@E:E::E:(.::E:'E.<GEGEG:E'C*?C?
@antibody_10_multiplicity_26_copy_20-1/2
GGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTAGTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCGCAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAACGAGTTCTTGGCATTTTCTCTGCAGCTGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCGCCAGCAGTAGCAATAGCTGAGACCCACGCCAGACCGTTTCCTGTAGC
+
??A<AB?BD<DDDD9DGFGGGAIIHHIHIIDFHCGF@HIIIHFHDGECI9IHCIFIHFFHDHIHHE5I-IHIH-HIGI5FI-+AIH>HIHA@?+HIEIHFHFDGFHFIHFEGFEHFHH3GECHFCGEFF=HEF@H0(E*FGD@EFGGEG(B;?:FEG,*E?#GG;GG;BGG<A0E**EEGEG)G.FAGGCC(CCGEAGGFGE'0GE:G:HGGHGEGE.GAC?CGG?D88A()0(6*EA(G:GG0EC*?E(
@antibody_10_multiplicity_26_copy_21-1/2
GGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACAAGCACTGGGTCCGCCAAGCTACAGGAAAAGCTCTGGAGTGGGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTGTCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACT
+
????A?BB<D@DDD@DGGFGF-8EII,HIIDHEIFEFDIG+9>HHEGF++CF-DHHDHG.HHHHH=+#FIFFIHIHHFIHFBDGFIEHHHHDGH*AH+AIIHDH=CGHHFH.GIF.HHHGFFH#HH=FHDEGGGG*GCGEGFFEF;EFG?CEFAEF<E?:GF*GEGGD:G(GEEC<GGGG6??GEFEFCFGCEG>'G8C*)C*E/CHGAFEE*(BEFG?:E;E8:G800E:80;G:GE:8C(FE*89G1E
@antibody_10_multiplicity_26_copy_22-1/2
CTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACGGAGCCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGCCCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGCTATGAAGGCGAATCCAGAGGCTGCACAGGAGAGT
+
???AA>BB-DD5@DD@GFGFGCEEHCAHHFAGHHFHIFCIIHI.HFDHHABGEFHIHIGFDHHIE5FAFH+DEIEIDHHIHHFICCII-GBE9I@FIHHEAHHFGHFHEIH*HBHHEHHEEHGFGGHGEE6E)FHEEEBGD(G8?G*EGGG?FEFEEEAG*CC**AEEFGC2G?>/8?EG,E:G>G?FEEEEGGE(::E'-'/(=A.CEFCFAEEEEGC,C,EA(:C:C*:E*?E?FEGAC::((GECE:
@antibody_10_multiplicity_26_copy_23-1/2
CCCTGTAGTCAAAGTCCGGTACGTAGTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACCCAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCCTGGCATTTTCTCTGGAGATGGTGAAGCGGCCCTTCACGGAGCCTGGATAGTATGTGGCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTCGGCGGACCCA
+
,??,?B/B+<DD?DBDEFGGGGHHH6HF>HI@9FCIHDHHFGCFIHIE-IEIHIHB+FH>IFCIHFHFHFCIIFDIIC;I-FIHEHIFIHFHIHHH+EIHHBFHGHFFHFFHHEHBHGFG6HEHF)FFDF@,FFFAC+F>E69EEGF@E;GE3CEFC'BFEEF<6CEEE8E(?GEFE6G(?GEC;(0E(C?E#(G0C:EGA<GE*CAEE?FG:@@C?C0A(C((CF0'*EGC*G20>CG((E'8*;E?G(
@antibody_10_multiplicity_26_copy_24-1/2
GTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAAAGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGG
+
??A?5@@>D?DDD9D?GFCCCFHHCIEIEH-IIIHIFI+AIHHIH@IFHAGHH;CIIFHCIH@HHHHIGH@FCHEIIDCHFHE5HHIHIHIIH>HDHEDDHFH5?IH0B=GGHHGHFGFFEFEHF8,DEDFDFBEG>CGDEEGCDEGG;EBEGFCEGDG>FCEBEG2G;G:EC2GGFGEGCGC?EFGE0EFG(<6E6=CA;E)EF(ECG:A?9FEGCCBE*7C.CEEE(:*:G/(E0C8/GEC*A4(*EA
@antibody_10_multiplicity_26_copy_25-1/2
CCGGTACGTAGTATAATAACTACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCCCTTCACCGAGTCTGGATAGTATGTGTCACCAGCAGTAGCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGCT
+
??,??BBBDBDB=?DBFGFFGFHHHFHHIHAHHDFIIHHHIII=@IFHH,5HHG/EHGIHA=FHEHG9FIHFIGF7EIIIIIFGFHHE*HIAHEH8IDCECHH@D,DGH8FH(HDFEIGEGGFFHDFHFG@GFGGGG5EG?GE@GGF?GDEE/=*,EF#*E<G.(EGGGCE(A?=1*GAG?GCC8ECE8DFEEEFF8FEG2?'CE:EE6HECH(G0CAGEGE?E01??G(?*??D'E8EF68:1::?GE:
@antibody_10_multiplicity_26_copy_26-1/2
GAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCATAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGCTACTGCTGGTGACACATACTATCCAGCCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATATTAAAATGAACAGCCTTAGAGCCGGGGA
+
???=??BB-?9@DBBBFFGGGFIFHEIHHIHFFIHHECEFFFGBHHHIFFH8IHGGIE>HEHIHHFD.HGFHIHIGHGG+ID:HHHEHIFDDD;H,F78IHFHFDHHHDFH3GHHFFA=FFEGHFFHHFHGBEFFFDEEEGBFE?EHGF8@BEG6GEHG:GGCAC*GFEC?EEG8GC8E0?GCGGEGAEEEEC#GG*FEE0G?FEDE1E;<(7EG(>EBG?(AG(:E**8G:)6*EEE#A(:A6)>:>*E
@antibody_11_multiplicity_7_copy_1-1/2
AGTCAAAGTCCGGTACGTACTATAATAACCACTCCAAAAATGCTAATAATATTCGAGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGATATTATGTGTCACCAGCGGTACCAATAGCTGAGACCCACTCCAGTCCTTTTCCTGTAGCTTGGGGAACCGAGTGCGT
+
?<???B?B6DDBDDDDFGGG6FIFI7FHIHHHHFCHIGF+FHFIHEII.HI=5HF*IHHHFDGIHHGG>HGFFIFIABICHHEHHHIHHFEIHHH?FEHH+,IFHEF+FECC?F+HCHDHDFGHDFHGGFCGFBCEEGE#3G@A@A*E8CADGG@6E@GBG4:ECEGG;EGA<0EECEGEG;GF::GFCF*?G:G;EF6G:*:C8G#ECH/?7*0A:*0EG8*EAG(1E5*G:=AA0A*D?8(D:0*E:6
@antibody_11_multiplicity_7_copy_2-1/2
ATAATAACCACTCCAAAAATGCTAATAAAATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTCCACGGAGCCTGGATATTATGTGTCACCAGCAGTACCAATAGCTGAGACCCACTCCAGACCTTTTCTTGTAACTTGCCGGACCCAGTGCGTGTCGTAGCTACTGAAGGTGCA
+
=5=??<B?6EDBDDD@GGG?/EHFAHH>.HHFHIAFIIH/IHFFFCHE=HF@H>GIH7/HHHI=HIFHI,HIHIDIAHADFHFCHI@CICHHIHHFH-IG3GFHFHFHFGHH9DIH?;H;DGG@EDFHDFEE)GHEED4GGHF+AFGEGGE,E;@GEGFGC<6C(-GEEGACGGE;E?EC(6CEAE?GE(EG<E??F9F:8*E6(4AEC((C8C(E7??E?GEEE(GA:EEAF?EGC*C*.CC<*D':(;
@antibody_11_multiplicity_7_copy_3-1/2
GGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTACTATAATAACCACTCCAAAAATGCTAATAATATTCGCGCCCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGGTCATTTGAAGTGACAAGGAGTTCTTGGCATTTTTTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGATATTATGTGTCACCAGCAGTATCAATAGCTGAGACCCACTCCAGACCTTTTCCTGGAGC
+
????5?5<DBBD?DD9FFGGFGIHCII+HFFIIHHIIH.GIFD07H@HF,GHHFDIB=IHFEHEIDCHHC-HHDHH-IFFII=HEFHGGHDIHICHBFEIHFHBHFHHEB+D*>HDFFH#,HHHH3F3EG+#;G=G;(EE>EG@EFE3<?4@=(062E>EC@EEGFA6FFEG8C8F*EG>GGE/(E;/:DEEF:8FGDGE:EEAGG2(C(?C(GE(CG4E?G>/*CG**GF:?CE?=GAGGE>(E(*.G8
@antibody_11_multiplicity_7_copy_4-1/2
CTGCTAATAATATTCGCGCTCTTGCACAGTAATACAGAGCCGTGCCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGATATTATGTGACACCAGCAGTACCATTAGCTGAGGCCCACACCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCGTGTCGTAGCTACTGAAGGTGAATCCAGAGCCTGCACAGGA
+
<???5B?BD@<DDDDAEC>FGGH9CHIHH7FIHHEH+H9IHCGE/DGFFHHDGFEHI@DGCHFH?HB@5D.HFH;GHHHACHFH+HFIIHF-CHHEDHFE6G=G#DHHHHH)EDHE*=CHHFHHDFDFEGGF?H(??GG(FG)(:GD;GE*F<GEEEG#(EGEGGEG'EG(:G):GGE/E:6AB0GGEGGFEF>?EG>EA:EE(EFHCA*.E:C'?CG,@FGGC.6*'CE?E8GEGEE;/FAE*'EA?EC
@antibody_11_multiplicity_7_copy_5-1/2
GTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCGGTACGTACTATAATAACCACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGATATTAAGTGCCACCAGCAGTACCAATAGCTGAGACACACTCCAGATCTTTTC
+
???<<BBBD@EDDDBDF>F>GGFH-HHHHFFIID/IH.IGDIIIHDG@F5D=HHHHCFGHHIHH-HGHHE-I5IHHBDIGE=H8HDIIHFHFDF)E=GIHHIHHHHH3HGG=G@CEE;D*F*FGEE)FHHEGGBFGGCGFGEGEF*G);2*F6EEEGE/GCEF?FC,EEG?EC/G(6F*AG/'GECEEGEE;0;EGEEC<EFF#GE((C*?>9@;GGGCEC(GE:CCG.(8EE(EEEEE0G*C*AG(:EA
@antibody_11_multiplicity_7_copy_6-1/2
TACGTACTATAATAACCACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGCCTGGAGATTTTGTGTCACAAGCAGTACAAATAGCTGAGACCCACTCCAGACCTTTTCTTGTAGCCTGGCGGAGCCAGTGCGTGTCGCAGCTACTG
+
???5?BB?<DDDDDADGFGFFFFIIH>-FIEDAHFHEAIFIG7GIEFHIFDHHHHHEHHHGIIHHCCIF+C5FDHEHIIGC?-IHHHIDGHHFHFIHHH7H#B+DHEHGDDHEDH+HF+=HGHDDDC,G-;E.DED(G4E.DDEF3EEEEFE?EFEGGEF'F8,)EC*EEEEG'(E/E.E(G*:?FF6E?GE(#G*E810EGEEGE0G::E:(EC?B:C.E?GE?EE)GG6CEG6CE?AGE*1EEE*/(E
@antibody_11_multiplicity_7_copy_7-1/2
CCAGTAGTCAAAGTCCGGTACGTACTATAATAACCACTCCAAAAATGCTAATAATATTCGCGCTCTTGCACATTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTAAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGACGGTGAATCGGCCCTTCACGGAGGCTGGATATTATGTGTCACCAGCAGTACCAATAGCTGAGACCCACTCCAGACCTTTTCCTGTTGCTTGGCGCACTCAG
+
<????>BBDDB@DDDDFB8=F+HHFIFFIF-IIGHHH+EHHHHF.HFFIFGGFB.H5FDIHDIHHEDDEGHI#HD-CHG5IIHFBHAD*F;HHIFDCHGG7DE6HH=I?H+;GGFH@GHAH3HF(EGBHDG+F*;CFBBGGCGEGC?-G=AGA?EAEAEEE=E2?GCG)FEG'ECGGEGGG<F*E8A/CGE).A8A/E:6?G-?AC::*:*GCFG('</C7GC;6EE??GCEGE(:/9C6AD*(?*)??0
@antibody_12_multiplicity_3_copy_1-1/2
GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCACCAGCAGTGGTTATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTTGGTACATCTATTACAGTGGGAGCACCTACTACAATCCGTCCCGCAAGAGTCGAATTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGA
+
???,A@??D+@BDDDDGFGFFFICHE?A(FIHBHH@IIGIIHCI;IHIDEHHIFIHH5HHFHDGCIHCI*-IHDHH5DHEGC5FH-IB<HHGC*IFIHHHHHH@HEHHGFD-HEFCEEEFH=H6=HF1E,G+FE@EG'EDEGE0.GCE;FG1GG=GFF*:GG>EEDGADEFG<6G@#?F8GE?GCDG68GAGGEA>(AECG>A.CAACE6EEHGC<B;CE7GC(AG<C<G'68?;EEE/?#E.EEE.*(E
@antibody_12_multiplicity_3_copy_2-1/2
AGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCACTGTCTCTGGTGGTTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTTGGTACATCTATTACAGTGGGAGCACCTACTACAATCCGTCCCGCAAGAGTCGAATTACCATATTAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAACTGAGCTCTGTGACTGC
+
A???55BBDBDDDDD?FGG8ACICIHF>FEHFHE@IFIFIE+G>HCDII5I5DHDCDHEHIHIH*IGEIHE@IHDFIGCIH<IHHCI-IEHH6GH7F*FEHHFHFHIF?BDHD@F+EF3DHG2H<FHFFDGE*C3EH.G2B.GE@BEEGFGECGEEEC*8FGEF:F;6G(>*/(EAA:G.GGE:F.F?CGC8E(GGE0(C6;E<?6EEAEE:AAC7C:C(*G6EG/EE:E6A#EE:#?G<*EEC/0EEA6
@antibody_12_multiplicity_3_copy_3-1/2
GACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGACGCGTAATTCTTCCATGGGTAGTCCCCATAGTCAGCGCGCGATATCTGGCACAGTAATACACGGCCGTGTCTGCTGCAGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGGAATTCGACTCTTGCGGGACGGATTGTAGTAGGTGCTTCCACTGTAATAGATGTACTAAATCCACTCCAGGCCCTTCCCTGG
+
??,??B?BDD@?B@BDFGGGGFFAIHIEIIHFFH.IIFIII-9BCG@HE+ECHHFFCDHACAGHHGGHHEHHEHHG<I-FIFHHIIIDEHFGHHIGEF8-HHH+EFGFDGH=HFGHFG<GEF@?D?FFFGFDEAEFFG,GEGGECECGBEEEGFG;GDFE6BGEE686(<GE/GGCE?;GFFCEA;G:EEEGGC?CECEEEE6GE.:/AC'.8CEEEEGA8C90#CED(:8EG?CCCGE#>E*C/G4GA*
@antibody_13_multiplicity_2_copy_1-1/2
ACACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTTGTATTGGAGTTGGATTCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTGCATCTATTACAGTGGGACCACCTACTTCAACCCGTCCCTCAAGAGTCGACTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAACTGAGCTCTGTGACTGCAGCAGACGCGGCCGTGTATGACTGTGCCAGC
+
?9?A?BBBA5DDDDDDGF>GGA;HH.IHHIHHIFHHIEGCFII.EFHEHHBHHD@EDIIIHHGHIIEIDH-HH)HIF>ACHEHGHIHIIHHHEDFCAH,FF/HH2GHFHHHEDFHHEGGBEFHGGBGGHG?CH2@#FHE=G;E=ED)GGF:B:GGG?GE6EGCEGEEEE*EE<;FGEFGECGGEGGC6E(?<GEGF?C9GEGCF./EEGA<<@7G?(?CEBGG:CE(G88FE*:C8?2#8E:C*AA?AG'
@antibody_13_multiplicity_2_copy_2-1/2
GTAGACGCGTAATTCTTCCATGGGTAGTCACCGTACTCAGCGCGCGATATCTGGCACAGTAATACACGGCCGTGTCTGCTGCAGTCACAGAGCTCAGTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGTAAGTCGACTCTTGAGGGACGGGTTTGAGTAGGTGGTCCCCCTGTAATAGATGTAACCAATCCACTCCAGGCCCTTCCCTGGGGGCTGGCGGATCCAACTCCAATACAAATCA
+
?????BB5DDDD@DDDFFFF6@EHII8H/>IGHH/IHHI-HIHIDHHH.FI=GAHF>H-AI)HGHHEDFCD/IIICHHHHCHHHHF7ID>-@?HHHCH)H4DH.DHDHE+EGH+DFFEDGFEHFHEE?DEGEFDEGGFFAFGGD#-GEE68GEGEECGEE;C(GFEFE6AGG?E;?F(F86G(EGE*:?EGE*GAFA*AEC:AEGE(EEHGGEGCEBEGF<E<?EE0.FCE:E*(EE*?AG::C8F6E?*
@antibody_14_multiplicity_48_copy_1-1/2
GGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGA
+
?,?=?7BBDDD@@DDDGFGFFGIAHFCFAEHIF@7HCIF?HDFII.HHHHDIH-?CFFHGH5FIBFHFFIG>>H-IHHHGHHFEIHHDI7HHA=FEHIHHH=IIH+IHHGAFEGHBB?F:C>GEC+GG(EFGEFGEFG1EDBGFGFG0GC>(EGDGG/EGE>GGGEAEDC8GE1EEFDEEGGE?FG/E*EEEG?CGGFCA8E6GEECC60(((E@FECBE0G1*8EG0A:CEGECEA(*E0/E6E*):C?
@antibody_14_multiplicity_48_copy_2-1/2
TGCATCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTCCAGTAACTACGAAATGCACTGGGTCCGCCAAGCTACAGGAGAAGGTCTGGAGTGGGTATCAGCCAATGGTACTGCTGGTGGCACATACCATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCT
+
A=??A>/B<D@BD<DDFGFAGG/FEHIBEHGEHH?HIAFI@HFHH9ACIHFIFFFHIDHDHDGGIHAHHFHHI5FGAHHA5+@GFGBFHIHHD<#AHAIFHHBGHGII7H?AHDH3HHFFH5*+@*@H?>BGHECGHBG,GG@E;GFGF:EE@EEEEGBFGEEGGFEG(C#G?<EC6?BGCGCE?(0GGCCG(GEGE?GEEGEG1;A=DE6GEEEGEFEC:0::*#:F:1C(*9G:C;C**F*EAEC/C8
@antibody_14_multiplicity_48_copy_3-1/2
GCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTAGCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCA
+
?????9B7DDBBBD?DFGGGGACHIFHHF8H?GHHHHEHH-=IFHID.HA+GEB>.GHHHIFIDIFIFHHIHHH-EHEFFFFIHH-H+HFIHHHIHCHIHFHH,FHE7HHGDIFIFFHFE;EHH?HEEFEAH;G(FDDF?H?EHFEE=?(ECDE=ECEGG'8G8GGF??CE?EG?ACFEEG+(8E:FGGEGGGG(FFF)):E?GCE9G?FE/HE@AG.?FG:EE*ECGCCGE*:EEGGD:E:?A(EGGG:
@antibody_14_multiplicity_48_copy_4-1/2
TGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACCACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCGATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTCAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTACTTGTATACTCAAATGAACAGCCTGAGAGC
+
?????BBBDDB<DD@<GFGGAFHH/HFEAF@GIF?HHIEHHHHEEIFBECIFHH5HEF5FIBIHGIGCIHIGFHHHGCHHFHCCFE#HH2=HDIFHIHIHHHDIE-HHDFGH@HHF0HDHHEE?DGH@FGH:FA4GCFFE-?@@G5G*H(GGC:0FGGGCGGEA.E:C@GGC(6E(?C*=CG:G*?EG<C?(<G?ACEEE?E.AGEC*/C?EAC@CGGB-;E/ECCG((EE?=GF0C89EEC:60EE)C6
@antibody_14_multiplicity_48_copy_5-1/2
TCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTTCTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCATTGTATCTTCAAATGAACAGCCTGAGA
+
???A?BBBD@DD@DDDCFFGFGIFIHEBHHHF/FFIAIEI/IHDHFAHIGHFDFH,AICIHHCHAHHEFHCFHIHFDHB<FHGHBCHECHBIHFHHIEIE9CHH(FDDCFEG=H<D+HGCFH@0=HG+@GDDH*:IED?FGE;GEB;E#GFEEGEFGCGG7/@/6C*EG?8EGAC>EEFEAC/G;EE(*A':C>?EEA0CE?'EEAF:GCG<HG70EF7E07(EC;66E?E?EEG:*EC*:??0?C=.?C
@antibody_14_multiplicity_48_copy_6-1/2
GGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGTCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCAAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAAATCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCT
+
?????BBBD?DBDDDD-GGGFFFHHFI--IIHHF?EEHH+IDFH-IF/H9HFGCIIHHIHHICFAEHF+DFIGHHGHIHF5EHHHHHAHHHEFIHHDBIDFE?H>HEHHHEHB=EHHHHEFGGHFDDGEB8GFBGGH.FFGGE;0GGGGGD@E.**CCGGE(F;@EG?EE'EEEFEDEE?CGEG(EGCGG<EG'G6CEC*:CEE(?=CGHF?F@7FG/8G'CCGC<*()C*:(E)*(<C'4?:(ECGEE*
@antibody_14_multiplicity_48_copy_7-1/2
ATCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTATGCTCCGTGGAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATCAACAGCCTGAG
+
??<???BB+D<B?BDDFFGF>EIF'AHIFIIEE9IIFHIFEIHFFAIHHH@II=DIDHHHHHHIHHHAEHHGHDIIFHH@FHIEIDC>IIHHHGFHC8HGHCIDFH?HHHH+GHEFAFF>FCGBG(GH5EEGFD*3?;GGGGGEG<H*FE=9GGCEG6EGEGG?;GBCG?<G9.E(?E*G+?-G0CC(EG(8EFCGEF?E(EE:E*:GE?GEE'CECGF,GF:CEEC6CGFC??E*A*((?GE*G6G?1E
@antibody_14_multiplicity_48_copy_8-1/2
GAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGAACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATCGTATGTGCCACGAGCAGTACCATTGGCTG
+
?,?A?BBBDDDDDDBDF;GGGGEHIHHIIIHF.GEFB@@9IIIHFEHIFFIFA9I?HF8HFH.GDEHFFIGFHF*5HH5;IIF=+FDHHEHC?HHFHFHDCDHHHHHEC#F@HHDHDFG+HDCHHHDGC-HECFDGB@@E@FF;EG2GEGG?,09GGEE?EEFG=#FE=GGEEEE:EF(GEG6EG?EGF:9?GG/)GGE/GEEC0:EE(EEEDF9C.FCG(E8GC>GA6AE((8C0A0GCGC*?:;(?/A
@antibody_14_multiplicity_48_copy_9-1/2
TGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACTCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGTTA
+
?AAA?BBBDDADDDDD@F-DGFH9IIF>8IIIIHIFFFI/EAIIHIHHHHIEAGFIFH5GHIFFHEHIHHIIHIHEHFIEBIHFFIFHHFCBDHHHIFHG#HEHF+8CF4FHH6HE*D7GGDGHHEGGGEDGHFEEFFF9F8GF?GH@*0GFDEFB(C8FFEEF/G-GEFG;GFG*EG?EG6??GGEG?GE*?'FAGG6CE*EAGEC<AFG?H.EE*ADA:.CC/:G*..EE8;**GC>;:6E:;A*?GD
@antibody_14_multiplicity_48_copy_10-1/2
ATGCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTACATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGTTACTGAAGGTGAATACAG
+
,<,??BBBD7DD-DDDFFGC;FII>CFI?HGCHGHECFC9F@IFIHCF@IHCDFAFHG>H,HIHIFI>H8C5C-G-HHGHH=IHHA<8HCHHHHFH8DHHFIHHIEHHI,FF?EDGFEH=FFHD@;HDEG0GFHDFCGCAGFG10#GECEGG)E:=F.E*GEGEE48G(E,G:G*?GGG:?E*@6;EG?)G0EFE0GFGG:(GCGGEEEEG*:(BA;':E)7EEG?GG0FEAGEGECEC<8A?CCG'GG8
@antibody_14_multiplicity_48_copy_11-1/2
AGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGGGTTCTTGACATTTTCTCTGGAGATGGTGAATCGCCCCTTGCCGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGC
+
,9??,97B@9DE@DD5GG.GCGIHEFCBIHDIHIHHIHHCIFCI@HI.F-IHHI@I@EAIIFIGCH@ACHFIIHI=CIAHIIAHIEHIHHIGAIIFF3GHHHHHEGHGFH=FHD=HGHHBGGGHFF=)FFFEE@:GGGD=GEEGGGFDEEE?@A(GG;GEGEGAF,6E(EEG*?GG(E?E(GG?1G6((*EGEE6?E?GEGCEGFCFF(*?)H7@.(C0(EEG::(EG?AC8G./ECGCC(GE(**./C:
@antibody_14_multiplicity_48_copy_12-1/2
CTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGCAGATACAAGGAGTTCTTGGCATTTGCTCTGGAGATGGTGAATCGCCCCTTCACGTAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGAACC
+
5?<?,B>BDDDDD9D5AGFAGCBHH/IICI=FFDIGI+FIHIGGIDG>=BD/FFHIFFHHDIIH5H'-HFIEEFHDHDFHFHIHIHHFIHI=GIHHHHHG7HHFIHHHHHFDFD/FHHHGFHHHGFEFA**DFGFEEA?A?FEGGE?FE*DGG<GFFB;GC>;G,GEE0FGAC?*@G?(?AC::E*G?A/;FACEC?4GCGEF:'GEG*E0A)@EEBE(GE:E*E:C*AAC:1:C1*.*0E4CFC:C*GC
@antibody_14_multiplicity_48_copy_13-1/2
TCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCGCTGAGTCTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGA
+
=????BBBD@B-DDBDGGGFGCCE;-IHEHHHIF-DEHIIH9(H.DA-#IFI=HCBHAHIHEFHHFIHIHHHHHDI+FI+EDIFHAHFEEE+HHH=IHIHDHF)FHHF,HFEHFHHGD@HFFH+,F>*:3HEGEEB+?G3GAEGF7EADG:G<*G@E6AG=<8'EE?EF'FE?8EG?+;EGCE(CE<.EEGGG(GAE8(?8FGCGCC:CEG?*C@C*EEE8CE(DE?0GAC*4AC/G(?AE:FEF0:GG(
@antibody_14_multiplicity_48_copy_14-1/2
CAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTACTACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATAGCGCCTTCACGGAGCCTAGATAGTAAGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTAG
+
?????BBBBD-DB?BDFGGFCFIIIHFFFHF7GAIHHFFIEGHHHII?IHH9EH5=:FHG-IHGIFAHHHGII5FFIFHI5EIFIIHIG+GGI+IIF9FIHHHGIEHIHFHHHHBGHGG?G=GF@FEFGHFCGEGGGGGE@EA(AEFG8C5GEGEFCG?(GGAE</AGG*C,EE.G/GG;2G*EEE?(AE)6AAFEC)E?.GAEECEE<?GC:)*GDAGG((.??G(GGC8*CEE00:GAEGG'(*GCAG
@antibody_14_multiplicity_48_copy_15-1/2
CGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCTGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATAGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGAC
+
5???=+BBDDDDDDDDFFFFGGHAHH/IF+CGG+CH+B?HI#GFH'I@EEHCIDEHHFGAFHHHHHGHIHDHHH35HICICICA?HHIID=DIH-HFGDD,GHHAIHHHHH+H+BHFHHEAHG7FGGH@H=BE*GFHEEGCBG,C-GG(GB?FGB?F#;GGC3ACGGCCA;FE/GG8FG:E.C6*FCFFEEEGF(AEGF/:GGG*EH:CECGEG0FEEC@82*6G*EE(>E::E/??#EGC*F:((/DCE
@antibody_14_multiplicity_48_copy_16-1/2
GAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCTGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATATTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCACTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCAGCGGCTG
+
??A??BB3@DDDDD-@@FFFFBHFAIHIHICFH/I,II/AHIHEGHGH?I-H-HIBFH5IHCDDDBDC-EFHEIHHHEFHBFFCICFFHGDFHGHIHH=H7FCFF(<?EFHFHEHHF.+DFDG?G@0EH?,0FCE1BE@E#>*GEFE(GECBGGEE6EG4F*;CAEEE;F8:G:'CGECE+F#GECEG'EGFE2*GGEC(:E:/G:CFEHCGECE?G:8GF0E?<F8/?E0D??E6E:(?6A6#'(;G:C
@antibody_14_multiplicity_48_copy_17-1/2
ATCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTTAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAG
+
=??A5BB>?-BDDDDD-FGFFEHIHFFIFHHHGIHHIDH.EIH.GEHGHF+=HG+DHFDAIHHEHEHHGFHHFDHHHFDEHDFGHFHHHIHHHFIFHHI@'HHFHH>E*FHHG)EEE6H@-FHG*G@GE=GEGFGEBGGBAE8GEEBGE=3EGGEGFEE*GCEE/:(C*GEACG:G?EGGE#CEGG?EDGE=?/FA?GFAECE/:G*CAH?-HFEGEGC1G7A0=:CE)=(EEEG(E(C*(G6(EGG?G?
@antibody_14_multiplicity_48_copy_18-1/2
AGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCCCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGGACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCGAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCAGAGAGCCGGGGA
+
<??A?BB5D<DDDD<DFGFGFGCIH6.HHFFHAIHHHIHA=FHH#IFFIIFGHHDCHEIAHCII>FFHFIHHDH5DGHHFF-HIH5DEF=F5EDIFHD9=;HHEGHG#DDEGD@GHDH?FHFGBGFFEGGFHFBB9GG7<*EGCFD?G:CE*G:AFGG;EEGE?(GCGEE8E#GGE?6EDE+EC:G6GEAE?6(E9GG8AC?(C>#/E0E*EEE/'B<#.ECAGE(*?(:FAEGG#G*C(EEEC:GCE0C
@antibody_14_multiplicity_48_copy_19-1/2
GGTGCATCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACATTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTTCTTGTCTCTTCAAAAGAACAGC
+
?,<?AB?BDDBB?BDDGGFGCFFEHF;IHHHIIHHHGIH9IIFIAIGIIHI<DCFIGFH,CF+IAHHHGCHE++ECIHBHH+IHDDHHHHHI8HIDFHHHHFBHFFHFD;?H=*GEDF;H:HHAGGE5DCH,G;G=FGEGGFF(FBDGGEGGDG*0EE<GG:GEAGEGE:FEGCEEEGECCE?F?AGGG*GE<G*EEED:G:EFE:??/HECA(;EB4E::CGC?(/)EE:EG)AD:GG?EE'0E9(2?E
@antibody_14_multiplicity_48_copy_20-1/2
AGGTGCATCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGCCTCCGTGAAGGGGCGATTCACGATCTCGAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAG
+
??<??B<?DD<-@<@DGGGCGGHAHIFHEIFDGH7DCCHIHH+IHDGF.FHI@F.H>FFFEHHHBHIFIFFHIFGHHI5HFHGH?HFDIHHCFDIHIHHH?CE=GHH4HHH,G@GHHHHGFGHHHGEGEDEFEGG*EE6<DG@GGGFFFFCAC=>=GFGEGE,E=GEFAEGFD6ECGC.E.CGCE6EEGE(G*/??GG*=E'#(0EC.(EF0(EEEG::FG?E(C(<AG?EC?ECC?*EADCEE:8:8CD
@antibody_14_multiplicity_48_copy_21-1/2
TATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGAAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGTTACTGAAGGTTAATCAAGAGGCTGCACAGGAGAGTC
+
A?A??B?B6<ADDED5FFDGCGFIIEFHHHIHFI7HHFGHHHEFHBGIHHHHFIHFCIIIHIGIHHGFII/FGFH-GCI-IHHFHEHHCHHHH.HDH+HFHHHEIGFFHEFHHD+FFHCGFHF:H+EE.HGHEFBE;FGGGEEGFEC=EEGGDD0@EEFECEEG;FCCA?=?FG8CBEEG+EFCGGFB?CGE'AE:.GEC8GFGEG?#CHFCCCG?BEFE/EA//'?:G#E.FC*?A??G:6?EE?14.(
@antibody_14_multiplicity_48_copy_22-1/2
GGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTATAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCGGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAAGATC
+
?????AB>BDDD<DBDFG@F;GIHEHFIHFH9H=HBGHFICIHEG/HHIID/H.HIHCHGHFHEFEGIIHH@HGFBHC(G>DHHEFHIHGF?HIFDCI=?HHDFDHGHHGDIHHH+?F)G)EHHED1F=?GG(HACFG1ECDE0?C8DG9/GEGFG;GECG;=G8E?G;C@EFGEG/FAGGCGCAECE=GG:62:?EC/GGC?E:GE?EH?E@//EEE>GC:0EA?((G0GED8>G6G8'GCC:EE*>:?
@antibody_14_multiplicity_48_copy_23-1/2
GCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAAGATCATGCATTCGATATTATTATGCTTCGGGGAGTCATTATAATTGGCCACAGCCCGGCCAC
+
??A??BB@B<DD@<BDCCFGGGIBHIHIFFI,IHHDDEHHFGGHHHFHIIHHIHIFHHF,-A-IIHB>IHHC@CHHI;FII@HHHHCGFHHFHHFH@HHIDFAFHH,GHFFHG3HFHHH4FEF9HHG,EE*FG@HD,HG(E@G/CFE)EE6)GE8FEGGG:GCG)C?/B/1GA)GEFCE?GGAEADAG?8EE((C*AE6EG?E/?CF*GA?F7EBE8GBC((*(*C.A6:6(EE/(:G*2:A(C6?/?:C
@antibody_14_multiplicity_48_copy_24-1/2
GGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATCGTATGTGCCACCAGCAGTATCATTGGCTGAGACC
+
??,??BB@+B<BDDBDFFGFFEIAFGIHICEG-FCHEHIEI=HHHH?EDHHH?HHG8G=IHFEHHGFICF>CGHHBFIFHHBEHI)EIHFHEH>*FHFDHHFIDIHFFGH.@+EHHEBHHFF<DG=FDFG8DA3F@G)FCGFEG'EGCEE?=;CEGE0?*GCC;E(C>((EGF(GFCE**:??AEF?1GE:GGE(AECEED8E::CHE*(E:@(E(F(0EE?CC(DGE*E<EFGG(?GEAGAE:CA:;AA
@antibody_14_multiplicity_48_copy_25-1/2
TCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGGCCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGTTACTGAAGGTGAATCCAGAGGCTGCTCAGGAGAGTCTCACGGCCCCCCCA
+
?????>B3BDBDDDBDGFGGGFHHFCIFFI=IHIHGAFGHII=GHFFGI/FIHAEIEDEH=FHHECCFGHIFF(HAF=HFA-CHCHHHH-DIFHHHIHCFF7HH8F(GGHHHH;FHGDEEDGDGEHEDGFG@GE.GG,DEFBAEDGC((FECCF*GEE*B;GEG?EG:F8FCCGGGF2GFG:*:G/GCE(GGG?G-GE=EF'(6GG'E(HCG)C.GE*B;070(C#.CCA/=A4C?*C**?C(A*.?E8G
@antibody_14_multiplicity_48_copy_26-1/2
TTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGAGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAATAACTTCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGCACACGGCTGTGTATT
+
???,=B?9BDDB5DDBBF8GAFFEHHIFFIEHDHHFEIGHIIIIIHFIIFH?-5FHHE5IDFHG.EHECDI=@I5IHFIGIHHIH+HEFHDHIH)I5HDE5?FC*FAGH:.HHHGFH=G*GHFGGFFGEG*EHEG(GGEGGFEFC32(?G*GFEEC?>/E-59,EG/DFE;F?FCEGEE*?E(G?E<EGA:GDA((:0C#GEE/C*E;E??G*AF?**GGB7GGEG(G*CGG8C*EEF(:1>0:E(EG*E
@antibody_14_multiplicity_48_copy_27-1/2
TACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGTCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATTTCCAGAGAAAATGCGAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCTGGTACACGGCTGTGTATTACTG
+
<<??ABABDBBA<DEDEFGGGFHHEH;GIEH.GAIGIA+GGFHH9HGFDFC?IHH9FIHDCCEHE--AC.HHFDBFIHHA=IEIH<.)IHDCHHH3HHCHHHED*GHHCF2EEEDHFEHFHCFGGEGDBH*9GEEGG'F0EFEG,FGEGFGGGEEFGA(:=)AGCEEAFAC.(GG/CEECAE??0G(*/(<A*E?C;GGG=9(?(GCCC*GGE7/G)0G714C:EGE*FC(.E*AF(G:A*1:E?ACAEA
@antibody_14_multiplicity_48_copy_28-1/2
TTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCTCGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGT
+
?=???@BBDDDDBDDDFFCC5FII8IC>BHAHIGHGIHIH=H-GHH-9ICE.HDIHC=HFII@IFHD>>CHCIHHHFHHFIIGGDF@GHIHFHID=HGDHHIHHHGDADHG:H3G7FHFIFEEEDFFH0GFGGFEE8FFDE?EEB*EGG0GCE6GGF?FGGCEFG#30EFE<GGE:G;GF?F*FGGEE-?A*EGGEGGGEE<GE:EH8FFG.C(G?GCGGF?*C;G::F*GA?F*C?GF0EE:4F6CEEC
@antibody_14_multiplicity_48_copy_29-1/2
ACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCACAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAACTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACT
+
???,??9>9D?D@DDB-FGGGEIHAI+>IEFI=IIFEIHFIHIICFECHEIGHI,HH-HHE>HF4HHEHCHFHHF#-HCHIBEH.EDIF/HHBD-DHHHEICHHHIHHHHHG=H,ADD+FEGCFHDGG*C'HEFGBFE2@EGGEFGGG6GEEEGGC,F*0G**CFGEB>GEEEC;<:G:?FFG6EFEECEFCEGGAEDFG<?CGEE*GE;:C*(EEF8::G(ECGCGA(E:;*F0EC8E:C'EE(A:EEC
@antibody_14_multiplicity_48_copy_30-1/2
GGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACAATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATGTTCAAATGAACAGCCTGAGAGCCGGGGACAAGGCTGTGTAATACTGTGCAAGAT
+
??9??B=BBDDDBDDBGFCFFGF>EIIFFEHIIHFGFGEH.I>EHHHFFIIIHEIICHEH5IHIHIFIEHGFHHHDEDHH@HHHIHH?F5HFIFFGDHEHFHHIEFCHHHEHFHHFEFFHFD@FGFHHDBEG#DFDGGGEGAEB21FEE@?/EDE>GE8?FEGFGE(GEGA=;FEAG<GCE(D(C(<CDCE:(EG#:GFEG.G0GCCEE:*:>E<FEE7,(G<)C9)E2GC-GA:F'ECE*C(?0:0FG>
@antibody_14_multiplicity_48_copy_31-1/2
TGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGATATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTATCAGCCAATGGTACTCCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGGACTCCTTGCATCTTCAAATGAACAGCCTGAGAGC
+
?<<???BBBDDDBD<D@GG6FFHHH;HHIFHHHHIIIHFFHACIHEHH@GHH.FCHFHGF5IIHHHFHGHI=H55FFI5GFI=FCFCH-HI=HHHEH+H+HH=FHCH73HGFHHHH**F-GF@EDHFHHEHF5**G@GGCGEGE?EE?E(BBEEEGC?G=FEGGEGEGEE:D*GG?ECE.CGCG?(GE?EGG:EFGCAG0G'E(GE?CGHD?EG@#'0E:EC:G.(GE?EE>E??EGE*GCD::CE:CFG
@antibody_14_multiplicity_48_copy_32-1/2
CTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGATACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACGCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCTAG
+
?????BBB-DD-B@<@GFFFGGIICHHEHAIGFGI9FHHG9FGFHHHGA(I9IHI=GFFDHDHIHHIIBHFDIHHGED#FDIHBHFEDHHGEI<DGHBFHHH-HGHCHHCDA?HEHCG;)DFE:GFFDGH9EG>;BGD/GEDGF8CECGFC?AFCG?G?GGCCEEEGCG(<EB:6EEFGEC:FEG*E1(G.G?EEG*E<'ECCGEEC;?;FFCCCAE4DE*EE?66::EC:>*E:F?E*E*GCC?-(*:C
@antibody_14_multiplicity_48_copy_33-1/2
AGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTGACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTCGCTTCGCGGACCCA
+
?????-BBDD-@BDBDFGGFFGHI/HIA9FIHDHFIHIFFHFHHIIEHHCBB7H=>F-DGF9IHHEFIDHFH*IFIHHHGIHHIFH.IHEFBFEHIHCIHHDGH>HHHHFEF?#EGHFEFGGG;*E+FFHEF@GEDGC?EGEGGEAECFGGEEEEF(E?FEE;GEE0AGAFFGEEEG-GEGEGE:E?<6EGF:0EFFE*FGGCGC*??02G0HGF*B*?EE;>GAGE:CE(CCA?(CE:E#6GF*EGCE:
@antibody_14_multiplicity_48_copy_34-1/2
TGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCGGGAGATGGTGAATCGCCCCTTCACGGAGCCTATATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCA
+
A??==B-BDD-DE5ADFGFGFFIFII/HEHHCIFF=0FIHI+GI7HGHHIFEGEHFCH>FEIHA?IDBFDIFDFEE5HIHHD-DHHHHGHCHHHIHH=H7FHFHBHHDGH*D*2FFH:DCHFHEDG2)HH6CGEGG@G9GE<(E@E1*EDAEG?G1)G6GG??EF.EGGEFCGFG*=(/GCCA;E:AE6DE*FGECG4CGG26EG.E00F(E4AGFE7BGE)GAGDGGE?ECCG2A(GD/EEEG*CEEE/
@antibody_14_multiplicity_48_copy_35-1/2
GTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTGTAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGGCCCCGGCTCTCAGGCTGTTCACTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTTGAGATGGTGAATCGCCCGTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACGC
+
A5??9?BB<BDDA@D@GFFE?FF-CHHIIEBHFIFHCI;EEHHGIDHIH-AHHHHHDFH+HIH-I8H-IHEDE+HCDF0HFCF<H@I(HH+CHHDGHHGHEH7HHHH3DHHH6EHHFHHHEH<(GEFF0HDEGE(FBGFEFE?GG'FCFEB6DE7*GEEGEG@DA@*E5G*GA?E=?AE#GG/;A;?2GG(EF?G(E#EFFEE/G<A8E'8CH@F:E*BCGC(EEGE?G?/E(EG(*84E8?80E*??/G
@antibody_14_multiplicity_48_copy_36-1/2
GTGCATCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCGCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTATCAGCCAATGGTACTGCTGGTGGCACATTCTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGCAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCC
+
??A?5B9BB-E@BDDDAG-CGGH8IEHIEIHIFGHGFHEHHDIIIEH'DHCIHHIFIFEDFHIHAG5G5E@HHIHFDEFGIHFHDFI@IDFDIFI=HIHIDHHHHD@HGGFG;H:ED.F?DHEC=DEHCHHEFEDDGEBD#FG6E*EG0G)CFEEGFGGGGGEEAGG/<1E<GCACCG?EEAGCFE?CC6CAGGG:EE?GGG/E:C/E;A6'E-BCEEG.G?CG:?*G*AG':(ECAF0E8?E(C6C/(C
@antibody_14_multiplicity_48_copy_37-1/2
CGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTTTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATATTATATGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGATCTTTTCCTGTAGCTTGGCGGATCCAGTGCATGTC
+
?A?5<BB5DDDDDDDDA>GF.GFFCCI;CFHHFEHG-HHICCHIAFIDFIHFH>HIEH5H@H,FIHII5EHDGEDHHCI,5HGIHEI98IHDHHHFDGEEH7GDFHHIHH**FFHBHGDHFH3=FGFG=G2HHF>DD+CCGDDBG?EEGGEEFEFAA>/E/:C*GEC8EFEE-GGG(?EG++EGE6*GA7ADAFE0?G?GEFCFE6EEC;EC@/@(<AGEE>6G*E.AEA?A6F:G((CA:0)E:>EEEE
@antibody_14_multiplicity_48_copy_38-1/2
TCTGGGGGAGGCTTGGTACAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGTGATACACCATCTCCAGAGAAAATGCCAAGAAATCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACA
+
????,<B9DBDEABDBFGFGCCIIHI6HHHII=HH@HEDHHCGIGIC/HGHIHHHFHHIDHIAHHHHCIIHG?@EH5GHI#FHH=GCHDC+HACFHH@HH6G?CHFHHHEGHHDHHHHGH*GG?G?GFDFDE<EFGGDEGF*GECEB/CG.CEGEC(CGC#?F8EAGEEDCCE9GGE0GG(#?EGGGG6G:8*G?F;=<GEE?:G1*C;'C>(FGGEEEGEG(EG?A6EE/??AE:EEEGE::E*/DE'?
@antibody_14_multiplicity_48_copy_39-1/2
GTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAGGGAGTTCTTGGCATTTTCTCTGGTGATGGTGAATCGCAACTTCACGGAGCCTAGCTAGTATGTGCCACCAGAAGTACCCTTGGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACTCAGTGCATGTCGTAGTTACTGAAG
+
?5=?<B.BDB9E-DBDFFGGF>>I88CH/HGHIHCIFCF0GG-G7EDGH7FABGIDH@IHIFEHIGHDHIE5DFHEHHHEICG-HFEEHDIFHCIGHGHEE'FHEHHHHHDGHHGG:HHG@H*GH)BFFHHGHDECBC?('EFG>BEC?EGD?G9?#CGECGCA8GEC/GD0?*(EAEGE#FG:F1CFEA?G6E8?CFFEE9EG<EAE;6:;H:CEB'CG?FGCA)GGGEAAG0>/GEF0G*AG:)EE)0
@antibody_14_multiplicity_48_copy_40-1/2
TACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGTTACTGAAGGTGAATCCAGAGGCTGAACAGGAGAATCTCAGGGCCCCCCCAGGCTGTACCAAGC
+
??=??B<>BB59BDADCFCGFCHHI+H-FIHIDIFIIG+BH9D0HGIHIAHHEE;BEHCHGIHHIIHHFHI>H5BCG=-GEH5H7CHFII,FIH/HHHG):E=HFEHHFHFHHFDHG+@F(AHHHHGEF@EFEFDGG@GC;=(GFBFBCGGC'G@GFGC?:GGFE=ECECFEEFE?(6EAGCEG1GGGG80/((GC:CGEGEAC?GF?(?E'FAGG?FF@'GC(G=C8F?'E(?8>8(E:?A:0G:.:*'
@antibody_14_multiplicity_48_copy_41-1/2
AGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACTTGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGCTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAAAGCAAAGAACTCCTTGTATCTTCAAGTGAACACCCTGAGAGCCGGGGACACGGCTGTGTAGTACTGTGC
+
??A??@BBDDDD@9EDFGGGFFEH>IFEFHFHFEEIHDIFAHAFH@IAIHIDFDIF-CHFI.-DFECIG-DHHFIGGIHFHHHIIHFIH=DHBDIGH.F#;HHHIGEFFHHHGFHF-DDHEFFFGD(DEEDEHGDIEFEGE@G;GFEGGGEBD*G:CGEG?G??EE;0<EGGGF#ECEC?C#EG*C(C?D;E<EGG.()?E#6AE6'*F?A8@(*AC*GEE0?GE/FF0G0EG?4CC4E;C*C(*EACE?
@antibody_14_multiplicity_48_copy_42-1/2
TCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGACAAGAACTCCTTGTATCTTCAAATGAACAGCCCGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAAGATCTTGCATTCGATATTA
+
5AA?AB<BDDD@D@EDCF+GF;HH/IHHIIHIIHHIHIIEEHF.IFG>HGIAHGIHFHFCH?AFIICGHIHIH=IHGGHBIHFHBCDHHHHFHHHHHH+FHHEHHEDEH'FHHHFH+GEHB*@HHHEFGEHF@DA+FEDEEGB;FFHFBCEECGE?EGGCAG'E/>EFFG;;GECE:C;EFG'*EC?8?0EEGE0(GEFEE'FCC2(ED:6:)8@EEEGGFACE(EFGAEA.D6E-?EFG#(4(8CEG8A
@antibody_14_multiplicity_48_copy_43-1/2
CAGCCTGGGGGGGCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCCAATGGTACTGCTGGTGGCACATACTATCTAGGCTCCGTGAAGGGGCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACGGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTG
+
5?<?=?=BB@DDDDDDGGGF?>HHCHFICCHFIHIAI9HFE-IHGHD@GAHHDECFIHF-HIFHHDIHEFHHFHFIEHIHHHFIHHFHCHHIH+HEDGHHHH9DDF=GI=EHHHHFE=@FHHFFHBH=GFGFBGGE@H*?4DGG6FBEGE.FCEA?G8CEG,8(G#E.GE@.G<G(G6EEEE?G;E6/FEEEEGEDG*EGEGGE0GE(G0EEF(C(EE0@:GGGEAACC)?6';F./?0.CGE?G:?A(D
@antibody_14_multiplicity_48_copy_44-1/2
CTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAACAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTAGCTTGGCGGACCCAGTGCATGTCGTAGTTGCTGAAGGTGAATCCAGAGGCTGCACAGGAGAGTCTCAGGGCCCCCCCAGGCTGTACCAAGCCTCCCGCAGGTTCCACCAGAA
+
???A,BBABDDDD@DD-/FFFGHH>HHIFIHIHGIHIH+DFII7=HI>HFF;CIHDGEAIDHIIBHH5FHEHFCHHIHHHI4HAIFFGHHFIFEHH(EHFHH+E3HHHFFFEF=FFFHHDFECHF.EFEHHBG'EGGDG7GCEDEGG(GGBA5E0FEECHDA??AG:,2(;GCE?GE6GCG6E(EGF?;/?ECEGF?2GC8*AEEEC?G<FFCCG2:ECCEE80;6GE?E*CGA0E1D'*GEG?8ECC:.
@antibody_14_multiplicity_48_copy_45-1/2
GGAGACGGCGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGGGCTGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCGTTGGCT
+
<=?==@7B-DDDBBBDFGFFGGCIFF/IIHHBIIFIFGHF7FDFHHECGHIFG5BHFCHFHEHHEIHHEFIFHCHFH8HEHGHCHI*+.HGI,IGEH<ICFIH@=EHHFCB=HHEDGEDG3GF:G4EF@EGFDCGEFDC(EE9ADEE*GGGGECG9EEFFGEA.F/EBEGC(CE?FGGGFEEE(GE6C(G0GACG.ECC(?G*E??A;08(EFEEF;G8@G?66F/;?EE?GEAEGG*8(::E*(AG:?/
@antibody_14_multiplicity_48_copy_46-1/2
TTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATCGTATTTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTGTTCCTGTAGCTTGGCGGACCCAGTGCACGTCGTAGTTACTGAAGG
+
<,???<BBDDD?DB5DGF.G@GH@FICIBFIFGHIDIHHFECGHFGHDHHBIFH,HHCHHHH-IFI@?FIFH,IGFE#H=HI*IH-HEDG+HA5HG)HHFH'AHHH@@HHDBHD@EEHFFFFDFG+1GHG:FFCDEGEFECGGGAGBEGG2CEEG4E(GCFG#C<BG6GEE6EC0GACC:<EEEGCGCDEG8EGEF/CGG*E0E(:C?EHEG@/E<ECE.*C;E;GAA??AA'E/(GE?CC(AG./8EC(
@antibody_14_multiplicity_48_copy_47-1/2
TGAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACTCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGAGCCTAGATAGTATGTGCCACCAGCAGTACCATTG
+
<??=?BB@BDDDBD-DFGGGCGI88IHFFHIHFFHCFHHHFFHH@HFHHDHH?FHCEGHHIH=FIHHCE-IHFGFH@HEHIIG6DFEHHICHGE<F+HHEHFI+HEG-+HHHHD+HGDFEBG@GHDHHHFDEHCEGF2GFGFFFGFEEG3G;G8GFDGFAC(G@AB6GE(ECF;*EGE=GG:)EAG?FF((**GAA8D?EEG*;00H(G:GEC#7GGCEEDEEEC*(EE>?1:AA?DAA?E?*0?:(:FC
@antibody_14_multiplicity_48_copy_48-1/2
AGGAGTCGAACCAGTTGTGGCCGGGCTGTGGCCAGTTATAATAACCCCCCGAACCATAGTAATATCGAATGCATGATCTTGCACAGTAATACACAGCCGTGTCCCCGGCTCTCAGGCTGTTCATTTGAAGATACAAGGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGCCCCTTCACGGGGCCTAGATAGTATGTGCCACCAGCAGTACCATTGGCTGAGACCCACTCCAGACCTTTTCCTGTAGC
+
??=A?B=BDDDDEDBDCC8C,CFCHIHAHI9FHEEEIGIIBFH@H+HIBHABIHFFF@H@5HFHIHII=HID<HFIH-IHH,IHHEB.FHCGGH=FE+DFH/HHH-H=9HHHHHGDHHDEFFHH4HDEHFGGFEF@EDDFH;EFG9GGG:@DE1CF,F7*=GGGED*(GCFGE>CCC@??EEE.E(GFEGGGGEFC*GCG:8EFC1:GCC/G-G*FGGCCG?CG(:?**G(:*E*CG;??GC?(?AF8?=
@antibody_15_multiplicity_92_copy_1-1/2
GAAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTCGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCAGTAGTAACTACT
+
?,???<B?DDD?DDDBGCGGGFBIHIIHI6HH9A+HEGIABHEIFH/DII=HHDFD.FIIGHFHHFDIIB-IIEHEIIHIIHGFIIHIFHHI6AFHHHHFHHFHIA+I(GHHBED3EH(GFHFFHHDEFHGEFB6FE8FEFEAGGEG<EGGGGDEFBG9GF(?C?CGEEE*;,@1GG/6?/(<GCFEFEEE?FGEG;EEF<E(A(0?G:C0?CA:G7FEFC:.:0G:ACG8GE:6E?CCE*E*C*;C:01
@antibody_15_multiplicity_92_copy_2-1/2
CCAGGTTTCGTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGAAGTGTCTACGGATATGGTGACTCTACTCTCGAGGGACGGGTTTTAGTAGGTTCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCATCCCTGGGGGCT
+
A????-BBD-DDDBBDAF8CFGHH?FFCFIHFDHAHHHGGHI5@EFIFIIHHH@DHFGIHFH>H8DEHIH-GH>HIHFFGFI-*8EHHHHFBEGHFHI#HH--EAHDH;G?FGCFGFD@DHFFD#@GG>GCGGD;GHDE2GGEEG(9EACG?G=EGD;EEGGDE:EE:G*?GGGCFGE80GGAF0GEE*6/G(EE:.(A(*EGGC?E?GHCFEGCGE.BG:CE<-:C8;G:?E:<0E(CCG*<D(GCE)(
@antibody_15_multiplicity_92_copy_3-1/2
AGTAGTTATAATGTATTCAACGTACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTTTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCGGGGGGCTGGCGGATCCAGGCACAGTAGTAACTAA
+
<??5?BBBDDB<DDDDGFGGCF-HCHHIHIHIGCIHIHBIEG-I.IHIFHIHCI;FFHEAHI-*@IH/FIIHEIHFIFDFI5IAI;HFHHHFHHFIH.IIIIHDHDHHHHBGHBHHDDC'.GEHDGGGGGGFGEGFGEECCFG?GE/1GC2G,EGC6E?GB,E(EDE?G*E;FECE-EEGGFGG8E??:E:EEFE988C/;-?'EGEE?6E6HC//4CCA(EGEACGEE?F(C0(*(CF:EACE(EG1/<
@antibody_15_multiplicity_92_copy_4-1/2
CAAAGTAGTTATAATGTATTCAACCCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATACAGGCCCAGTATTAAC
+
???<?BBB@@?DDDDBF,EGGGHH'-HIHHHIDI7IGIHH+IIIHH8IHFHH-DE-D.IHHFH*EHHHHFDHCDFHIFHHHHEHHHI,HHHFAFFF-D3HHE;HHFHGHFBHHFFH4DHG+F>@HFFHGFEEHFEE***GE@EDFG4G@GEBCFE<A.15FEEF8(?:(A,EEEG?EG*GGE/8?ECEEEFC.A6<ACCCEEG<6FEEFEEE:EGE;97(EGAG:E0E(E*E6(*?FE0C:E1CA)6E:?
@antibody_15_multiplicity_92_copy_5-1/2
GCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCGGTTCTCCCTGAAGCTGAGTTCTGTGACCGCCGCAGACACGTCTGTGTATTAC
+
?<9???5B@BD5BDDEFGGGFFHCF>.HIHHHHH9FIAEAHCCHH@HIIHHHDEHHFHBCFHI-F(FF@HGHHHFFHADHIIEADIHHHIH5HH=@HGGH2IGHHHCF(F=HFF/GEHD=H9BFHEGFGBFG?*GGGG=GDCGGGGE8GGAFGE?FGGCE<GECG;:G6CGEFEADEGEAEG'CA;6::EGCDAGCE(AEC8:0GEEA?8FG*F@C(CE:*CEEGE*CEA9*EC6C*G(A*E?/CFEE;;
@antibody_15_multiplicity_92_copy_6-1/2
TGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCTGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCTTCGAGAGTCGAGTCACCATATCGGTAGACCCGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGATATTGTT
+
?<??A?>BDBD<-D@DG/BFFFF@HA?HFC-HFFBEHFH8H=CHHFGHFHF.+HAGIDDCFEIHH*+;FHB-HFHGHEB-IH5IDDH=HHFI+CHHCHHHFHH=?FHHHHHHDHGFB8GGHHGH@EEE;2HFGEF+GAGE)G=CFGGGGEEFE@EFE(3G0*A(EG*E<G(?E:ECGD?G'GEE09<G:AE?CG?(GCC.AD?*EGCEAEEAE8GFB:EEE0(**?.#EE*00A8G?EEG?8:*A8GGCA
@antibody_15_multiplicity_92_copy_7-1/2
TTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCCATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAACCTGAGCTCTGTCACCGCCGCAGAGACGGCTGTGTATTACTGT
+
?,??AB?B@DDB<DDDGGGFGGHEIFC>HFCDFFIEI?+7IIFIHCHG+H?HHH5GIEHHHHIIAHCIHD-H+FGHHADHHFFEIHHIHFHFCFFEIHEHHEDHHHGEHHHG?EH5HG'F8FHDHDFHGHFFAGEGFG@EF82GEHG?FGGGEG.C(F?GEGEGGGFCFGGC0G?EG;GE8ECE?E(A:?:G8EEGCA?8A6EC0G(-/HE<A8GFE(0#<?FC*AACFEE4'?E.:E8?D(E*8EG(E*
@antibody_15_multiplicity_92_copy_8-1/2
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTAGCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGTCC
+
?,???B>BBDDDEDDBFFDFGFIHHIHIHFAIHIFDHHI-9HH5FGEHHH5HIIFGHHGEEH5HFFI5'I55GI@HFFGCIHIIHEGFAIHFHH?IA3IAI.DFHFCDHHFHDFHHHB@H9HDFFEFGEEGEF7GEE/GBG?*5FGGCG0=0GEFEG?;AF,F@:EGEFEGEF#EBGEFGEGGEAE*8G=DEA:GEGE:E24.G4F:G?#E(HEE::EC,GGE;6CG)6*E?:E:ACC?GC0GAGAE*06
@antibody_15_multiplicity_92_copy_9-1/2
ACTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTTTAGTGGGAGCACCTACTACAACCCGTCCCTCGATAATCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCCCTGTGACCGC
+
A,???BBBDDD5?,BDCDFFECIHHIIIHHGHII-FFHI>HIBHIFD@HHHIHHGEGFC5CHHIGHDHEDII@-H.FIC-GIIDHHH=IHCAFH9HFEHHHFHHFEHHCHHHHHHFFFGE?HFFFGD+HGGFDEAGGHFGGFEGEEB'GGE*FGECEGCEF::(ECGACE>?/G*E?CE:?/;(.GAFEFCAGECEG:G?E.EGGED:-8AA@ECACG70EECC0G*/6GCG*0G)G?:(CE?G?G?'EC
@antibody_15_multiplicity_92_copy_10-1/2
GACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCGCAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGGTATAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGTCTCTTCCCTGGGGG
+
,,???@?BDD@DD5DBFFFGCGFH@AEHIIH+IIGFDHH9HIHBIGGFHH05HFHHGIFGIIGHHI5IHH,*HHBH?H-IG>+7HHH.HAHF,-?HICHG#HGHFHFGEFFHGFH3<G=GHG*HG=FGEE>E3F-EDE*FGEEEHEE68FGGCGG.GEGBGGFGEFCG:EE.G:EGE.,FFGF.EE:E(G#GGEGEC:DEE6EE?<E'AEF0EC::*CG/CG(?EFG*(AEEEA?)E(*.EG::=CCA*C
@antibody_15_multiplicity_92_copy_11-1/2
GCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCGACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGAAGGTGCTCCCACTATAATAGCTACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGAGGATCCAGGCCCAGTAGTAACTACTACTGCTGATTGAGCCACCAG
+
A5A??-BBDE-?=BABGG+GG;IB-IEIFI@FI-.A.H?HHAHHGI+FH-DH=-H>I,.EHBHHCHHCFIHI,HHGHHIEH:II?H-*H8EFDI8FHHHIHFHH#HEGF?HDDHBEDCEHDGDFFEH;CF**+HG+F3E-ADDE*EGCG?=*GEEEGEE:;E;?E(A96G>C?EG?1FEGGGGG?E?:6GCADEE)EG:FGC6***A8G(.FH*E8EGCGGG6=CG?/FEGE.-E64/A)6CG*EC:;AG
@antibody_15_multiplicity_92_copy_12-1/2
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCCCCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACATCCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGGTCTCCGTGAAGCTGAGCTCT
+
?????BBBDDDDDDDDE8>GGCHICH>HIFHFHII.HFHHB@CIHHHIHHHG,CFCIGIHIG5HFIH-EEHFFHFIF?IAIFHIH-CHHADFHEIIDH,GHHHDFDDHF2HEFGD6GFG<GHFB;FAE;BG#GGC?*EHEEGG*E/:*EG;=EFDF@E*CGGCFEEGF:G4GGGG?#GAEFEF?:6(EG*GE(?AE'?A8:CG(CF?AFE'C0FG?GGGEGFAG/GE/6(?AC:C'.G?GA??E1:*0.(
@antibody_15_multiplicity_92_copy_13-1/2
AGGAGTCGGGCCCAGGACTGGTGAATCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAACCTGAGCACTGTGAC
+
????<BBB9D-D-@DDGGFFGCI?H+II/H9FCHDFA@IDHI.HAHF>GHHAIHEHH;HHHHIH5C5CF-FI+GHBCIEHHIIHH>>@DHHHEHHFIHHEHIDHFHHHHCEG?=2HDAHFHFD6EHEEFHFEHG>EG2*FCC?EEB;FEG=BEEDGEG@1GGEGGF;EG=?6EEE(FGG:FGE?DG;GGE*ECEC?<EG.G6:CEGEAE?EA@7EG/(FGCGE(A*;EE8GE?.6*(ECE./*A<G:AG-
@antibody_15_multiplicity_92_copy_14-1/2
GAATCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGAGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTACCTCGAGAGTCGAGTCTCCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAAACACGGCTGTGATG
+
,?,,?B?<D<DABDDBDGFFFGIFBF8H-HF0IF=EEGFCHDGH9I@FIHIHHHIH.ID5FH?CICG>HIE--HI?HIGHHE=EII<*IF7FICHHF.HIHB,IHH.GHG<FHCHHCHH?BHF83<HE@GE0HE(GE,D?EEFEFE?GD)3EGFF(GEE'CG.AE/1G8E*F#G:F?CEECG;ACGA;EG<GGA8?C?:EG?AG*EE?':(A(:GC:7EF*(EG?G;G8CA*GGG'AA<AE?GEEE8#((
@antibody_15_multiplicity_92_copy_15-1/2
GACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTCGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTGCCAATCCACTCCAGCCCCTCCCC
+
A?A=?BBBDDD@?BDDFGG?FEFHI8HHHCCHH9HHIHGGHIHHE5GHIFHDH.HH=CFHFHF@H-HFH@I<?FHFGCIEHHHDHEIHHDHIHI*FIHHHHHHI+FEFGEH=HFEGGDF@FH.CH2FGGEDFHHF(CHEGBCG?FCGDEAE*?EA+FGGE?3:>*G?AGF:(*6<GD+:(AF*ECAE/:CECEGEEEG'AE6AF?EEFEFG*CGEG:=,CFEGACE*0E*C?:(0CEE??C6A*.0*?A0
@antibody_15_multiplicity_92_copy_16-1/2
GTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATAGTCCCAATCCACGCCAGCCCCTTCCCTGGAGGCTGGCGGATCCACGCCCAGTAGTA
+
???9?BB3<DDDDDDEGF*F6F/IIIFIIFIGD=HHH7HIHFFHDAH=HHGHIGHIG-HFFGHHHDCEEIB-DGHGHCHFH-CHHIH-IEFEH8HEE.HHIHHCDEHHFCDDDFHHEFHEHBGFDFGFFEBE>HGEBDAGEE(GGGFBEEEAFBGGGEEEGGG8GFE(*GGEAGE;G8E?E6EAC?A?GGFGGE*EAEECCC/G;E(*GE?CEGG8;7C:0:0'(8E?G:G?E(1(E8*AGA(C?GFE*<
@antibody_15_multiplicity_92_copy_17-1/2
GGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGCCGTGTCTACTGATATGGTGACTCGACTGTCGAGGGACGGGTTGTAGTAGGTGCTCGCATTATAAGAGATACTCCCAATCCACTCCAGCCCCTTCCTTGG
+
???A??BB@DDDDDDDFFC8FFEIIFIFFFHHIIHEEE=GC.DIIIHGGIHIGHHF@HHFIE5IEH-HI@I-AA+I5HGHH#HEHFHIIHFHHFH8-HHIHHIIHIHHHFEGFHH@BF572FHHHFHH?FGH8GGGGGEE@G2FGGGGEG*ECGE?EE8E'GE4GEGECE*EA8?*..#E#(8AGEEC*F**EE:C:/(EE.<G;E#?E#GE(0((FECG?CG*:4EC<E1GEAG)*G?EG??GCA#?.?
@antibody_15_multiplicity_92_copy_18-1/2
GAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTTCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCCACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTGGGTGCTGCCATTATAATAGATACTCCCAATCCACTCCAGCCTATTC
+
,?,<?BBBD<DDD<D@CFFGEGHHFIHFI>FIIFIHIIFHIIAHIHIC.FIFCHIHGH-DHE=HH55GIF=IEDHDIFGIIFD6?EHHHHIG+I,H+:?IHDHHFG8FHGEH(GH=HFHGDF>DF@HFD,FGCEFGHG6GCEFC(EEG2;ECGFECGEG:EE'GGEEGCGGF<E)?0E6;EEECC:G?GFDC;D?:6(8EG*?)EA?FGC(E3E)EGGGEE?*GGA.*A;E:?(;)?EF:/GG:A'#:GG
@antibody_15_multiplicity_92_copy_19-1/2
CCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCGTCAGGGAGAACTGGTTCTTGGACGTTTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATATTCCCAATGCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCA
+
=????7B?DD?DB@B=GG8GFEHHCHIAHCBHIIHFICHHHIHIIHIHG.FIF8HHHGHCHIIHHH*HHHFEGIBFHACBCH>HHH8FAHHHHHGE5G*H@F6HED+(FDBGHE<GHB*;HFHF=EHBHGH*C1FFDFFGGGCG8EE1FE?E.;9?E#EEGEE8E:GGGCEG=GECC+E(EEEEGGGCG?GEGCG?EE:E*G??FGE6(6:EHG8FE*:C?7:6E*C?EEGFE:/?6GE9*GG'F*EC0)
@antibody_15_multiplicity_92_copy_20-1/2
GAGACGGTGACCAGGGTTCCTTGCCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTGACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATCGTGACTCGACTCTCGAGGGTCGGGTTGTAGTAAGTGCTCCCACTATAATAGATACTCCCAATGCACTCCAGGCCCTTC
+
A=???=>=DDDDDDDDFGGGFGF*EFII;IH.8EHIFIIEHHBFB/EHH@HFI-FDFECH@IHC;D#G>IHHHI@HIFGHHB?HCHHHIICIIHCI+CF???HH(+FHFHH-,HGDEFH@E:?DHEBHFF*FGHDGHGFEFDEF38GEEGEGGG?G6EGE,GBGFEEFCC6(FEFGGE?@EG?CEE?GG*C(GGGECE?GGCGE*ECG?E6GEC<;'E,GEC(E?G6GACE?'E**<CGE:/C#EG8EA?
@antibody_15_multiplicity_92_copy_21-1/2
GCACCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCAGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACGCGTCCCTCGAGAGTCGAGTCATCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGC
+
,?,<?B57DDD9DD<DCC.GF@HEFCICHHIHEIIIHIIGHIHFFHAHHAG@EDFHFEI@IHICHH>EH8H5IAFFHHIHHFH-H6H?FHDFD5HHHH4DHHEHHH,HEID5FH;=(HDEEFGFFBEDGEFF@GC5EDGGC#HGG3GGG;CAF(G@??E/F*FGGG(EAGCEGAEFDCECE(E:(DE<F*AC0*A(*ACA8G*':EEEGA*CCEEC8:EG?/AC6GC:8*EAGFA0?0G:E(G*EEC'G?
@antibody_15_multiplicity_92_copy_22-1/2
TTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTGTACGGATATGGTGACTCGACTCTCGAGCGACGGGTTGTAGTAGGTGCTCCCACTATAACAGTTACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCA
+
?A???BBBDBB?DDDDGGFBF/A8BHFHFH>IHIHDH,HGF9HHI.FIIHIHH=HIH8F5HFIFDEHHFE@HFHGFHHBHGAECE+5I=F-IHIE5CIHGDICHHHHDF8HHDD@FDCFEGFDFEFFFFD4GCCDGG?3EC*DECE0EGEGE2@GEGE0CG;,*ECGCE'GG*;EAFEGE6GG;6GF(?GA**C/EG('C(G?**GCGAAAE@@GC:ECCCGEE?E6:E8EG**G0G?(?F?(/FGE*C8
@antibody_15_multiplicity_92_copy_23-1/2
TGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCAGAGAGCTCAGCTACAGGGAGAACTGGGTCTTGGACGAGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTACTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCGTCCTTGGGG
+
?A??5>B>D@DEDBBDFGFF6FEHA>CFHBHF9.IADHF9II/FDFHIEDFFGHHHH+5EBHHDHFFIIHIIHICHFIHHC-IHHHFGHGHI7EDHHHHHDGFHFHHHHDFHEFG#DHF9E?4FEDC#HGF;D(HGFFFAG80=EF=GEE(*G1E?DG?BEGEGGEFE)AFGCG/*C?G*GG/F*EGEC9G-'?(GFE<G('ECGGE:/C?*CCGE/F,E'GE(8EG(C.FC.C(G?C1C*CDC(?0/8:
@antibody_15_multiplicity_92_copy_24-1/2
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCGATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATTCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCT
+
??5??BBB--DDD5D-BGAEF-IICIA/@H7I+BAG,HA7HHIIHG+HGA7IAIHFIIF+HGIHHIIHG=H-HG-EI-5FCAEF58HI(=IHHHAAH>HEDFFHHFCHFDEHFGIFHGFGHFDEDEF7FDEGGGGF=GEF?GAFEA:=GEGG*=7CEFE=GG(FEFBGEGEGFFE:GECG??EAEGF8D9CC*C0F8CEG?*F*F?<F'EE<(AEE:AEEE26EE?CGG*E60A:'FDEF:A.?GF(.8E
@antibody_15_multiplicity_92_copy_25-1/2
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGCGAGTCGAGTCACCCTATCCGTTGACACGTCCAAGCACCAGTTCTCCCTGAAGCTGAGCTCT
+
5=,??B=BDAD<BDBEGG+GFACF'6HHFEDHHEICHIHHAFIHI9GHIGFDHGHHHDAIHFF-HBCF7I-DCIHAIEHIH=5FHH7DIDCGHHGAHHGHGH-HFHHF-HCHHDDEHEGHFGD=DGD,EGGHDHFGGE7G2DFGFG<E?GEGEFGGE?GG)GGCFE6E(??0EGG?G0G'G>GCGF?C#:C((?CFGE:GGD#CAGF6(E6GH(@GEE?EGFF#-8E'F(GECG0'EG0GC>F??6:/#E
@antibody_15_multiplicity_92_copy_26-1/2
TGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTCTAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGG
+
?<??=B@?BDDBDB@DFG8CFGIIHHIEHHBIHIHIGIAHFH.IICHFAIHHHGFC9FFHIHHHFCHIBHHHFHFEHDHI?FGHIIIIEFHCICHFFEDHIH:EFGH?HE4HHGGGFFGHHCHHEGEG*FEHEECG*GGG?*FGECE2G@GGEGGGE?GEG;ECFG:FF4EG8?GGEEGEGGC?E?:6E(FC:?GG8(EG0:G?CG-*A'E6F*C?BEC'F;C(E;GG<EFCGEF?CGAG#//E8E/E?E
@antibody_15_multiplicity_92_copy_27-1/2
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTAATACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACTCGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCCCCGCAGAC
+
?A???BB3DDDD<DDDGCFFACHCEHIIHF9CFIHHFDIHHHHIFFHEH9HHEBIHHHHF8HGFH->IDIHIFCIHHH-CHHIIIIHHH=*HHH6EHC=H;HHGHHDF>DHH)GHHFCG9EGH,9HEF3EE@==F+GGEG==F=GD6@EFCGC;GE/A0;GECGF*GEGEC6F*AECDFG8-GE=GGA6*EGEGG=(GF#A10*9CEEG;E0@CEE?E)CEEC?E<EE4?ECCEEF:6?8C*?GC*C(EE
@antibody_15_multiplicity_92_copy_28-1/2
GAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTGTTGGACGTGTCTACGGATATGGTGACTCGACACTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCC
+
?????B<BDD?DDDD<FGG>/FIIEIHEGIHIFIFHDGGHFHG>E/DHI*IIFIHHHFI@FFIHCDFFHHC-FHAHHFFHFEFIAEHHHHIAIHHC5DHH+HHFFI+-EFGHH+GHE?G1GGCGF0HFDEDDC9GF2GGE=C>GDGGFGEGE1#CE,<6CFEFGECEE8C0BFA?/.+G(EEEEE(:E:A(GGFGA4E(?G1EECGFE(EEE8@8G?ACEFCCE:?#CG(FG0CEEC?:C*G.:8;*CED
@antibody_15_multiplicity_92_copy_29-1/2
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACTCGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCT
+
?A??ABBBDDEDDDD@GFGGGFFHCCIAI+FIIHAIH/HFIHIHFHHEIH=IIGHCHFEHGHHFFHCIHIEHG=EIH-@HHDHHHFIGHD=EIHHEFIE=HHHCH++E4@+HFHF?+EGHGG=FEHGGG4HEFFFCFGFGGFECC,EDE*?,GCE:?CGGEGE3E8C?G()GEE*(EEC6EE:?(GE;:C:EAEGGG:6E::CGGEHE*?EE(G((FC;((CE?8C:*FCF*E:(EG(1(?GE?GEAE:F
@antibody_15_multiplicity_92_copy_30-1/2
TCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCGTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAATCCGTCCCTCGAGAGTCGACTCACCATATCCGTAGACACGTCCAAGAACCAGTTCGCCCTGAAGCTGAGCTCTGTGAACGCCG
+
??,A?B=B9DADDDDDCFFGFCHIHHEI?IIHFIHIIII/H@GGI05@HHICIHIG@CFE5EIFEHEDGAEIEHFCHFEF-CHIHHFIHHCH#B@EHFGDHHCHGH*E*EH4GDIEHEDF9EB9FEEEGHFDFG=@E<EEE?E.EEE;GFE*/G:F;E.GEGA3EEA*EGE8*.=EEEFE?AEC6G*A?6?GGEGE*:EE.6G6;0EGFAC.F/CGGE<:FE*E:#:<8G*=*GC?*::GEE)A#C?G0E
@antibody_15_multiplicity_92_copy_31-1/2
CGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAATAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCAGTAGTAACTACTACTGCTGATGGAGCTACCCGAGA
+
<????@BB<DDBDDEDFF;GFGHHIHHFHBIIHF/IHHHH.H@G==DHHEGIEAHCHEHGGGDBHE?FHH?HFDDGFGIIHHI?HFFHHIICFDF=HGGDDH,HHE,CH,7GGHHDE3H5HGDDHFEE0HGDFGGE1HEG(FEEF@GGCE/ACCEBG(G*GECEA?GC>EA?8GGG*EGC?GEE:?G:?E;?<EGEGE(46?C?6;6:GHE:H@G*EF;(CC;E6*?.FA:(EE?((C:(C'6?;*C*GG
@antibody_15_multiplicity_92_copy_32-1/2
CTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTAGTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTACTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACTCGTCCAAGAACCAGTTCTCCCTGAAGCAGAGCTCTGTGACCGCCCCAGACACGGCTGTGTATTACTGTGGGATATTGTTAATGACTACA
+
???=?B>B9<?DDD?BFCE.G.HIFICFHIHFEFHIIHH+IHHHFHIIIEIIEFHHFI89HHF55IIIHFIF>H>HE=FDFEBHHIFIHG7HDGHEFHE#+EF=HGHBH+F+EGHHF.HEF+HGFG+HCDHDFEEEG,FE54EEFBE?CDEGEEEG;FGE(GGE;:60?GECG?GEE>GGECG.GC./*(E.GAF*EG6GEG8E1(?E<6EGEA*CG7EG8:)*EG00E?(C860?:C/CEFC:8EG.GA
@antibody_15_multiplicity_92_copy_33-1/2
GTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTTGTAGGTGCGCCCACTATAATAGATAGTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCAGTAGTAACTACTACTGCTGATGGAGCCACCACAGACAGTGCAGG
+
A????BB>BB+BDDDDFFGG8EE>FH>HFHHF@F/IIH+CI+GHHCFIGCHHGHHHGHEIDIAFDCC-HCCHCHBHHHHEHDIE/H-HFFGHDHIFH7GGDH)FEBD=HHFG=EHBHHHDBBHEGGHFGE*1.+EEAGE#FGEGCDG?@GEEGBGG*GBG:CG=CEEE?6EG0;ECEEEGC6?AC:0E(CC8GAC;G)G08E(?GEFAAC<FEE4*G<EGF).EACG<EGAG?C08:#EE?(A(EE.C(E
@antibody_15_multiplicity_92_copy_34-1/2
AGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGAAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGGACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACG
+
?????@B+BDD@BDDDFFFGGFEHH6BHE.H?IGGHIEHCIHFE@BIHHFHHHIFE-GIEHHFF=H(I-H4I@FDEH=-DGHIFHDHIHH@DEHHFEHDFDEEFHGHEHHG=FFFEG9@EGDFHH@E=GFE+HGEFD2*GGF3D.EFGFG5D;FC(GG:FCEGBE<(GA-G6FGEGC:E/+EE:AG;?EC((*GAE(AAAC0E:(((C:EE<9*DEGGGE:(E?G(GG?::GAG/AG0G/ECA(C)ECGC
@antibody_15_multiplicity_92_copy_35-1/2
CAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACTTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGATGTCTGTGACCGCCGCAGAGAC
+
?=<??BB?6BDEB@D?CFAEGGIHI+IIIC:9GEIIDH?E@HDGIIH/EHFCG8HD7H=IICIEFHAHHDIHI-5HIHHDF;GICE=DIC=IF+=HHDFDGBHFDI=CHHFIIHH@CHFB=F,FF@DDEFFHGED*EE@+DF*DFGEGGG,'E6E(AGCGEGF@C*AGEEGG?G?GGGGFGGF?G<?<.E(EEFG(G8G?FF;(EEHEAE?:E*CD?GGACG(1EG6?**EGG)GCEG6*EC:9EGG(EE
@antibody_15_multiplicity_92_copy_36-1/2
GTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGAGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGAATCCAGGCCCAGTAGTAACTATTACTGCTGATGGAGCCACCAGAGACAGTGCAGG
+
????,BBBDDDD@D@B8GCFGCI>III+HFFIHIGHHIHEE/HFHIHIHICHAIH9IH>FIFFHDHEHHI-HIHAHHIHFIH--HHAHFD3DHFHI==HH+HF#GGHDFEHE7HFHFFFHHF@EH)E-;3G=G,=EFGF+?EEC:G;FCFE9?GE:GG?G*G8GHAAE;(ECC*FEGG?<EGCGF'GEG:E*6E#4(?F:?AEFCC???EEGC(F:(EG((A*0.*>/A*?FC*E(C'?GC(G0*EA.?;
@antibody_15_multiplicity_92_copy_37-1/2
AGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCCGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTAGAACCCGTCCCTCGAGAGTCGAGTCACCTTATCCGTAGACACGTCCAAGAACCTGTTCTCCCTGAAGCA
+
?A??A?BBDDDDB@BDFFFFFFIEE>HHHAH@/IHI.IIHIHFAHHHF=CHGIHH>HFHEGEFH,IG.HEHHIIHHGH-HHH-HHHHF=GHHH,?HIHHHIFFHCCGHHGDGEECH3HDAFHHAHHHHFGFE:HCD>G'HCBEFEGEFGGG?FFEFECE6:1EA/GE@EE?'GGEEE?:C/+EGF-EAD(DE2*':GEEE?GE:E?F?E'FE*CEGC.8)0EE;FECE?/AE(*'EAE**EGGG;AEGC(
@antibody_15_multiplicity_92_copy_38-1/2
GGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGCTACTATTGGGCCTGGATCCGCCAGCCCTCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCAACTAGAACCCGTCCCTCGAGAGTCGAGTCACCATGTCCGTAGACACGTCCAAGAACCAGTTCTCCCTGACTCTGAGCTCTGTGCCC
+
?AA??-BBDDDDDD<BCCGFFG6HHH-CHFIFEIHIIGHIIHHG@HHFHHIFE+IIHI>FEIHHIEFHH-GHHI-HHH-FFIHH#HHHHH#IHHGHIHCHHHDFHD:CI?GE=E+=)GHGEHG6F<FEHG,GECA;ECDEEGGE?GG?EEGGCE*GFF@EEBE(EF:8(EEEDE0EDGG(CGGFC(E.EGF;:;?GGC##(ECC:E4EC*EGHEE?E?BC:8EAC(:AC:AC'#)4D6G/:D.8:GC*8*
@antibody_15_multiplicity_92_copy_39-1/2
TGAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGGATCCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGTACGTGTCTACGGATATGGGGACTCGACTGTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATTCTCGCAATCCACTCCAGCCC
+
???A5A<BDDDDDDDDCFGFFFIH-H0HFI=IFHIF@I>HHIHHH?-HHH;FEI#EF.HHIIHDHHHHHHFDH@ICDIIIH-EIIEEFF4?EIHHHF=DIHHAFH+H-HH+GGEFGGHH(H9DHHGEEHFDGCE>,EG6DE;G.EEF9CF:AGE/F?E*6(CGAG(C?GEE@EEC66(?EECFCGG6/?:;AE/EA0(E(E??8GE?*FEEC.@G(:.0E?AGGCE:EE#E6:*?8FE<CA(*C>(EE/F
@antibody_15_multiplicity_92_copy_40-1/2
GACGGTGACCAGGGTTCCTTCGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAAGTGGTTCTTGGAGGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCC
+
?????BBBBBD@E5BDFFGF0F-IHHIHFIHIFEHIDGHHH?HHA=@HHIAHDAFIIFGE@EDGGIEHDIDIIIH@-HHHHIBI-HHIIED?HFH,DHHGHIFHHHHHHGFDFH@FEHEDAFEG**GDHEGFE>DD6?BGGG#?E;FG1*/BEE(FEGGEAF*GGC4(ECFC:FEEG?C(AE?()AEE2E(CA/:<EA?6F)EGG:EEE*FGE-GECE<E:?*EC<G(E68C:GA*./GE8EEGECC:8'
@antibody_15_multiplicity_92_copy_41-1/2
TTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTCCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTATACGGATATAGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGGGCTCCCACTATAATAGATACTCCCATTCCACTGCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCAGTAGTAACTACTACTG
+
?=A??BBB<BDBBD?@FFGGFGFHICHIHFEIHCHI+CHAHHFI8G.HIHFGHHCHHHGGDHGII?HIEG#I)FH5IHHIH5EDHHIHEF6H,HGIHDHIHHHH@GH,DGHHGB4EHHH'D+FDF(BCC#@HGHGIEEHG/GFF.F.GF*GG1C@FCEGEE6E?1A;EG;CG,'E6FFGAFF?G(EEC*E'EEEGFG(AF:FE?F?CC(CGG07E8E:EGFE?A868/:EGC?EG1'?E(GCG(EC8CGG
@antibody_15_multiplicity_92_copy_42-1/2
TGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATGTCCGTAGACACGTCCCAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTA
+
???5,??BDED9DDDDF?FCFG+HF.HHHIHH.DH=HI.FIHFHBFDHGH-=H-HA.FIHDHEEHIFEHFHHIID,FGHHEII8IHEICCHFHIHHH.HHFF=EEFEHH>F=HECH,FHCGEGEEEH@EFGG*G;DAE(0FE@EGEEGG;/EEGGG4G:EEGCEGEG*(G6EAB;6GE#FG+?CG:BG(EEEEG)?CGADGE66GA?E*?AGAE@:GE:(;ECGEE00CCE?*GC(:GE>:/:EGC*G;:
@antibody_15_multiplicity_92_copy_43-1/2
TGGGGAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTCTAATAGATACTCCCAATCCACTCCAGCCC
+
??,<?BBBDDBB<EDDE-FFGG8HIHH+HHII0IIFHFIHIFIIFIHHI5=HIADIIIIFHIDHICIHHIAFE5EHIIEHIFFIHHIFHIH=H8HHEHDHGFCHFFFFEH?D6FDG6?+G+HGHHEFC+G6FBDDGGG48EBEEGF@GGBEG;AG7FCCG;ECEGF9EE?F'E:E@GG8E6EE?G?CEEGEGAG?6ECG*FE*?EEEEEH;ECG(C4C8G?EEEE(G1CE:::;C()6EC*G:CF;*(G:
@antibody_15_multiplicity_92_copy_44-1/2
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGTGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCGTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGGGCTCTGTGAC
+
,????BABDDDDB@@DFG>/CCH>HHIEIIFID)HHII@HHII@5/HFIHFAI?DHI>IHIFHAF=HF+IIHHHIHHHBHFHIEH?3HD2EBFHEHI#CIH*HGHHEFCFCG84HHBHFFHGFEFHBFHEEGE?C=GFF*2GE>GE*;DEEC;?GF8)=*EEGGG,*EEFFGE?GEF(F/EADEE>AF?EGF;EE-EEF?CC0*F/EC0AEEE*:??E,E:GCCA1E.G?C?GEAEE*/#CEC:GGE8CE
@antibody_15_multiplicity_92_copy_45-1/2
AGACCCAGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTTGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAT
+
??<<?A7BDDDDD@@DCFDFFFA>IIIEF7FIHH0AIAIGHH>GIEE0HGFA,HDIGC@IDGHIIHIHIIDHHFIGHDHEHIFHHHH+IHI@DH(CFIIEHDHFGHHA+FFHFHFIF@*FHHF?FFEHFEBEF2G6GGBGCGFGE@G<EGFCF?E;GG0E;CGGDGGAE:?GGGFE:EFE?AG#EC8C=?GCEF;*E1C6?E.:EGFG?CCEHAEAGGG//FEFEGG0*<<?)AEE:?EEG.:EC(6AG/
@antibody_15_multiplicity_92_copy_46-1/2
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTAGAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTC
+
??=??BB>9BDDDBD@FGFFFGHFHCAHCIFHFHI@CIEEEIC-EHDHHHFEH5H=DHHGHIIIHI4HIFI-D?5HIEFH-HIHIHH@DFHIFHHIGHHECHFFHF#HHECH@7F*GD?HGGG9DE1GDG3EDEH*GHFFDGEEGGEE;FBGEGGGD*EFGE?2*>8G<GEEE(.EGEG.@>GF9GEE'*?GEEGFG*E*G?EC?FH;AHAE3@C?<((<*?.FG*CF/:G(ECA(;?:E:EAA*(G?*G
@antibody_15_multiplicity_92_copy_47-1/2
TGAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCCACGGATATGCTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAACCCACTCCAGCCC
+
?,<?<?BB9B<-DDD@+-EFGGHH/>IHHHHGHIIH@HHDIHDF?=H??HHIHCHHEH7IAHEHH3GHHIIFH=IHCFHECFCHHIFIFGHHD+EH5HGHHF<EFH)HEH(GDCEH,GHF>F*EFD>F5FDG*E?ED==F(>?BEE9E?GGDEGGHAGECEG?E@D/EE??EEEGG(+C=GAEC?CCE?*GGG:E:EEG?G1GAEG<EGEGG(EB?(GG@GG:G0F/G?(0:2.EG((C(EA(E*?..8*
@antibody_15_multiplicity_92_copy_48-1/2
TTCCTTGGCCCCAGTCGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGGGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGC
+
??????73B-BDDDD+FF;FGE>I7IHIHHHGFII-CI0HIG/H9GHGIH+II=HI.FIH;HCFFIFHIG=HIAFIHIGHHGFGHCGHHFFHIH@EHHHF*IDI=HHHFFEIHHFFHHBFDGD=BEEGHEC(DEHE0G?ECEE@BHG?GHG:E2BGEGEE6GEECEGEC8*FFEGGEF9EFGEA*G:EFG:GFG?9?<EECFC/AA.G/;CG:*:?*C(F=:E.((<?:**EGCG8G(6*:E(DF8(GE*
@antibody_15_multiplicity_92_copy_49-1/2
TTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGAGTCTGCGGCGGTCACAGAGCTCAGCTGCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGAAACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGTTGGCGGA
+
?5???BB>DB<D?D5BAFGGFGHIH.FFC>IHCDH+HGCHHFFI@FCDI=@FHHADIFH0HFHHHEHFHIHFCADEHFHGHHIFHIHFGBF,HCH>GHFBFDHHFHHIDFFH@D=HDH,GHFGEGFF=-HDEBG=FG2FHF,GGCGEEFECE#,GFEEGFE:;G-CDGE*G*6EGEEA*:GCFGCFE*;CFFEGEE>GCF(=G6GEEC(EEG/CEE7:EAEA6:?EGEE?AEE;GE(C**:E#A8E.?(G
@antibody_15_multiplicity_92_copy_50-1/2
AGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCTTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCAGTAGTAACTACTAACGCTTATAGAGTCACCAGAGACA
+
????=BBBD-DDDDD@GGFCFFIIFHIHICCHHIHIFCHIEFH(EDCAAHEHBDFGIDEHFGF=DIIH-HHDICDEFFFH-HCDIHHII-HFH,FHHFFH(HAI5FDGHH7HFD;EHHDHHH=EHF@GHFGHEGHEB?,8G;*CE:FC(G:GGBCFGEEG8?GE0G8CG;EGCE:GFG6FG?EEE(AEEGAF66A<GEEGF8G/F(HCG*8EAG;(GECCDG;E*E((6E('GF-EG*0E0??D:EE9?8
@antibody_15_multiplicity_92_copy_51-1/2
ACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCCTCCTTCGAGAGTCGAGTCACCATATCCGTAGACGCGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTATGACCGCCGCAGACATGGCTGTGTAATACTCTGCGATATTTTTAATGACTA
+
?????>BBDDD-?+DDF-GGGGICHI8IHHIFI@IIEHGIDA,FAIHHIGGHFEHIEHHIFHDEHD5-IH-/H-FHIBHHHAF)G@IHIHHEFIHC;HDICD+HEFHCHDIDFEDHFCGFHDGE>DFC#GA?*B*DFFEBGEEDGGAD,GG(;ECCGGEGFG.F*6*FGE(G:E9.CCEEA?EEGGGFGCEE=E<?G?*E'/C8EE=2/FEC*:'G0GE(<>DE*GGG8*E80/AGGE*'CE?E)AC4::
@antibody_15_multiplicity_92_copy_52-1/2
GCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGAGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTTCCTCGAGAGTCGAGTCACCATATCCGTAGGCACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGC
+
??????B?D@DDBDDBGGGFGEHHEIHHHFFDAIIG9HHIIFH@HCFFI7HIFGFHE-FIFHAHG-IHHHGG+AHHFI@D-I>FFH-HHFHI3HHHHH?HDH,DHHI;H:EH,F;F(>CFFHFFG;=FFD9GG=9FG.GE=8;AEBFEEG<GGGEEGF0EG=EGCEE;EAEGDG0*0GEEGGEEE(6EF<.EDEEG20*GCFEGEG(EEE;CCG.0G:EECG?*?GGC-*?DG/CA(C4E8C0F::(6CE
@antibody_15_multiplicity_92_copy_53-1/2
GTCGGGCCCAGGACTGGTGAACCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCACTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGAGCTGGAGTGGATTGGGATTATCTATTATAGTGGGAGCACGTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGATCCAGTTCTCCCAGAAGCTGAGCTCTGTGACCGCC
+
???,?=B5DDDBDDD?GGCF+,HHFHHH8I.HFFH@H/CFHHHF9DGI#HF*HIH-GEHH5H9FIHHFHHHFECHFFAFFHHFGHIHCD0HFHIHGHDHCIFHDHDGIFHFCGHHDHCF+DDEH;6EFE=GDFEE:F/7*HEAEDGG8;E;EFECGEFE'GBBDGGECGFEG=FEEECFGGG?ECE?/AG0:0CEG?:?<GG:8EFH:8E*(CAE(*G.AE:EGE?E)E*<CGCEA<EEC4GDE:6E;/G
@antibody_15_multiplicity_92_copy_54-1/2
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAATGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATAGCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTC
+
<?9??BB<D5B?DDDB;GG?@FICI8HIHHGIEH8IAH9IHHI9>IGCHFEHI8IHAHHHD=HGHHGHBHHH+HI?FFEIHHHHHHFI@=HFCCHHHEHIH8HHHH(IHEHHHGFG?HFDH,G9CFH*GEHFFGF=DE9CG/,GFEEGAG6;GGB:A>;/F:G>GBCAGEEGEFEA8)6CG?EG)G'?69CGA:*?ECEC*:?EGG(0(6EGC:FC8FG@'?:?C?E/G;EGC'ECGEE#G?G?EE(GAG
@antibody_15_multiplicity_92_copy_55-1/2
GAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTACACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGATTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCG
+
9??A?>=BBDDD<DD<FGDEFFEIFIEHIIA=IH7HHDI@HHIHCGIHE?IHGDHH@HH9HHBHDDIIFI5=HIIIGHHHIHHEHC>I+H+HFCEHFEHHCHIHHHH;GDHFHFHGHHFHFFFHGGE?8H*DF#;:GGAD,<GGFEEEBG:GEFEAE'EEGEGEE,EAGGFG(EGFG?6;??(G#E0EEE0E-*(E0EG(EE(E.G?)6C;CF>@FGC<E*A00C6EEGEEA>E(AE=CGGG:E0EA//E
@antibody_15_multiplicity_92_copy_56-1/2
ACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGGCACAGAGCTCAGCTTCAGGGAGAACTGGATCTTGGACGTGTCGACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGC
+
?????B=BBB+DDDBDFGG8EFIF+ABHHIHGIGHHIIID9IIHH>H7IFACH/GHCHFIHIEGFI8@H5FI-CHHEDHDHIFFIIDCHH-CGEHHDHI(HDHHFFHHHF)DEFHEEHFHFF6HHGG<FF<DHH@EEG:(=;CEE(GGGDGEG#CGG7GAG6EF/G1EE?EGCGC*G<(FEG8EGECEEA'EEE;ECA.2EE(.CA6:E8(:17G.F:GCEG(0C:F(EG0?C1A'CE69G8C*A?68E*
@antibody_15_multiplicity_92_copy_57-1/2
ACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTGAGGGAGAACTGGTTCTTAGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATGATAGATACTCACAATCCACTCGAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCAGTAGTAACTATAACTCCTGATGGAGCCACAACAG
+
?????/B<DBDDDD<DGFFFFG+IIHIHFIIDGHI0HICE@5AHHDFGHIH=HH9HFIAHH-IAHHCFHFHHFHG-IIHHIFHGCI5HHDBHD#HIHHDEDHIHGFHFFCBDGHHHHHDGHE=CEG<?GEEG@EEGG=@DEEEGDBF?*GG*DGAGGE(EGEC(GGGG*(=ECGCG,.(5+G9CGC?EG?*EGCEF<CE?CGGGE:FG?HGAE0GEE17CC::;E(*(CE?(E0(??E8ED6/;?)G*4/
@antibody_15_multiplicity_92_copy_58-1/2
GACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAACCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGCAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCC
+
5=???5BBBDDDBDDBFGGE?GHF?HIIFHHHIFDFFIIHHGB-CIEHHCIH8G?CDI@HHH=H#EIFBH@I;EIE=CIHFIHGFHHHHHECHFHGHHHHF#HFDHHFHH@DFHHHEEFH?H6G@H=HF*GG*ECD+'FGFG8?EG9G=FGCEG)FF;E??A/?FCEGC@E*8G?FECEG1C:E?;A(CG?E;AGGFEF6GC;(:EFG(?F0F'G*:7.E0AAAG??E(0FGE*GGEEEE*CGGCEGGG*
@antibody_15_multiplicity_92_copy_59-1/2
CGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCCAGGGACGGGTTGTAGTAGGTGCTGCCACTATAATAGCTACTCCCAATCCACTCCAGCCCCTTCCCTG
+
?????=BB?BD@D<DDCGF6EFHCIHHFFEI.IFFFGFHHHBH5DHIFFFGH+IIHHECIH8'FFEHHHFF8G>AHH5@-GHHGHHE=IG9GH;HIFGHIH+6E@D+HE@HHHFDD-FEH+FEFFBFHG@HFB,GECG?F**EGEF0F?EEAGGGE;CEGEEEGEB<G<CE?EG**E8FGE?*E:G8CAFAG<GGG5(FAC;EG6F(EGEEE(E8:EAE#/,GAGE:*E*A8=02CG8:G(G?*CE:0**
@antibody_15_multiplicity_92_copy_60-1/2
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAACCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACACGTCCCTCGAGAGTCGAGTCACGATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAG
+
??,,AB>>BDDDDD5EGGFFCGHII>>IBFHIHHIHHAIIHHI@II=IHHHIFDHFEHFGCIFIHFHDGFD5I5CIIEIHIFHDHFHIAIGFIHEHCIHHE+HD<H@8C#H+FFD+HH#*HFEGDGDEF;6H=G=CGCDGC?HFFAGE;GE(=GGEE3G??*:DGBFEE,E(?EF'GEEG<8(C1GGGGG*8G;EGE?C<A(?EE(EAD;AFCA:E:7B2*C?(E'G?:?EE?(?(*-?C?G?G:ECCG(
@antibody_15_multiplicity_92_copy_61-1/2
ACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCCCAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATTTGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCGCTACCCT
+
5<5??B?BB<EBDDDDFFFDEGCHCHIFHHHIIHGGHHIIHI?BGHHII8?AIFHAIGFHE8FCHIHFGHCCFFFIIIHH5II+DHB6@HHFH6HGICHFH,HAFI.DHHI)HH+HFB'GHG,FGG(FGG*FGFGAEGEEFEECDEAGGAEEGE/F?0B/GCFGGC*E;E(GGE9A.C;GFFCEADAEEEEE(AA(GCE(GEGG-(?6CE(:@CGEG:?C',*(CC*:GE<G/6G:::AEGC)6(('(::
@antibody_15_multiplicity_92_copy_62-1/2
TGCAGCTGCAGGAGTCGGGCCCACGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGTCCCCAGGGAAGGGGCTGGAGTTGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAATCCGTCCCTCGAGAGTCGAGTCACCTTATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAG
+
????A>BADDDDBD@DF-FF/FB+FH.IHHHFFGHEHHHHGHFHGHH5H9FHGGHI'HIHEH-HIHIHDG;HIGFF,IFHIHCGFIGFGF6HI=FHHCF8HFHHH7IHIFGHCHFFFHH+CHH30?HHEB**FGFFGFEG*,GAGBGD;FEDF?EFDCFGEFGAEEGC/E<6E)CAA:FEG6GECC?GGGECECF6GEE*/F:EGE#1GEEEHE@;(E/FEE8;8'C6E):EGCAE.?G'0CE*/*?0EC
@antibody_15_multiplicity_92_copy_63-1/2
TGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATTCACAACCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATCATAGATACTCCCAATCCACTGCAGACCCTTCCCTGGGGGCTGGCGGATCCCG
+
???A?B<BA@BDD@E@GFF;F+IIHFIHF>?0IH/HHBHHFIHHBHIIIF7FFIE>F/HHAIH?HIH?IFHFFF5GI#GIFHFIHHIIHHHIHGIFEHHE-FHFHHHHHFG9HHHFGHEDG+>FF:HGGE1GGFBED8=*EG:EG1GC(CFGDG?GG6FGEGEBEGGG*)GEG(*E1(G6CEGGC1EA>C6G:G8EF(EG*CAGCCEECCFG3EEEG?(0F8(((6EF:;E?E(::AGG'?EGDAC:<':
@antibody_15_multiplicity_92_copy_64-1/2
CCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGCTCCGCCTGAAGCTGAGCTCTGTGACCGCCGCAGAC
+
=?<?=BB?@DD5D-5DCF8GFF>HHII8@EHFIIDAE.GGIIHHIHAC9DIHI.AFI8G=FCGFIHGCHIHHH?CHHFIHHHFGIHIIHGI-HFFH3HHHHFEFGG@CH+HFHEHHHHFGDFGHH+FHGCGEF*H@E2EE:DG(FGGFFCCGG(GG*CGGEEDAECE6EGEEACE(;CFGG+GE*FC1.;)FGC*BGEEAE.(GEEHF/EEGFCEG:((@;,0.C9CAG*FC6G?EC?CE*6EGE8E*:F
@antibody_15_multiplicity_92_copy_65-1/2
CTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGCGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCGCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCCCCCATAAGCAGAGCTCTG
+
?????BB>DBD@DD<DFFFFGFCIHI>>IFGHICHHHEIFHFG.IHHHI-IHHAHA8HEI-HHIIIHHDFIIHEIHIGEHGEFCGIFHHHGHF(HBICHDHH1DHHHHFCFHFH:HHFFF4HBEHHFH)E=FHAGG;FFEG=EE*ECG.GE:FEEEE:EEEF(EGGC*E*EC?6GAG4;GGE(E:E:EFF6?C6GAG:CC<-GE:EH(G.GEEG@(CEE<?GEF(A0(EEC#E?C(*?*GC'E;G*<?E*
@antibody_15_multiplicity_92_copy_66-1/2
TACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGGTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGATATTGTTAATGACTACAGTAACTCGTGCGTTGAATACATTATAGCTACTTTGAC
+
???A?B?B<DDDDDBBFAAGFFIIFICIHHHF9HEI9HHD/FHGB7HHCIFHGFHICHIIDHCE=GDCIIFIDAFFDAIF-FAHHHGIGEHHHI*IFD=FAGEFHHHHHHDH5FFH>HHG?FDHFEHHF+DGFF;?EG+BFD>GGFEGECEFGGFC<FCGFFE?CFDFEE(AG:*EGEECG-6GGG86EEG><EEE;GAGCA:?E?HCGCGGE.ED(GEECEGE:A?C?ECG0E8F*0:*E:':?EG?CD
@antibody_15_multiplicity_92_copy_67-1/2
TCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCGAATCCACTCCAGCCGCTTCCCTGGGGGCTGGCGGAT
+
,<??5>BBDDD75B?D/GGGGG@IHCIAHAHHECHFFEHIHCIHF=CG,?CIHEHEGHF7I.HCCDHHGDF?FFIIG-EGAGFIHCDEIHFIH?9IFHGHHHIEDH?HHFB#HGHHHB3HHFGFFGFHE#GBGGE8FFGE6(E,EEGCEG5EDG5GEEGGEG6EEEE?BEFEE;E.ECD??EGEAGEGEEG:CGF(EC<GG(CC:'EG?(6EE'@GG(GCEEE*EC/:(A:GAE?EE'E.(FFCG4CE9A
@antibody_15_multiplicity_92_copy_68-1/2
TAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGGGTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAAATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGGCCCAGTAG
+
????,BBBB<B@BDD5G8FGGGICHHHHCIHHHI/HHH-IIEBDIIEHIIHHHGIDIGHBHGIAFIH:HI5H5DII5@H#'DHHHHIH;HHHCHHHHHHFFH,F+HF<*+<*DHHHEGGFDF1F@G9HEGEGFE=FBEGBEGCGF(G+EEEGGEE*EEGGCAE'FFEG<E?GAEE(EC/:GE2E:EEE.ECC#'CEE6EGEGEGE?(0F/?EFC:(*GE7E8EE82?G?*G((E'C'(EE//:(EC)ECE
@antibody_15_multiplicity_92_copy_69-1/2
GCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCACCTGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGTACCAGTTCTTCCTGAAGCTGAGCTCTGTGACCGCCGCAGACATGGCTGTGTATTACTGTGCGATATTGTTAATGACTACAGTAACTCGTGCGTTGAA
+
???A?>BBBDDBD?ADGA/GF5IEHI-HIEICHH:+HHH+GAFFEH+IH/IF=IHIHHFGICHFHHFGE=GHDH=HF>G-AFFEEI>-HHHFHDHFIBHDEE+G:=+FDFFFHHHBHHDDDHGH#EEHF@AGEBEFDE,FGE(GEF*=EBEG/;F/E.*<A?.GEECGGEEG(EFC6FEE+6A1?.;G8?4CE:<*EEGE2AD6G:E((:E*A*:E1CE@FGG?*-AGF?C'E(0E:FE:*??AAE9E/(
@antibody_15_multiplicity_92_copy_70-1/2
CTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGGCTGGACTGGATTGGGAGTATCTATTAAAGTGGGAGCACCTACTACAACCGGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGCTCTCCCTGAAGCTGA
+
??=?ABBBDDDD5DB9EGG;FFIHIF/-EHDHFGFEI7IHHHGHCHHGHGG7@FHIHH+IECHHHIIG-H>HBHAFEHHIEFIFHHFFFGEHHIEDIBHIHHG+FHFHFBFHFFCB*GFE3H2GGEHFFGFEE*EGFGE;)*GEE=GEGBGG6GEGCEEGC(AG*FFGE@GEAG6G-G<G:/G?*D9C0E?CEE?F?*EGACEEAECCEFAGH:5GE??G*E?F8ECCF*C6C*''ECA?:G60.?/GGC
@antibody_15_multiplicity_92_copy_71-1/2
GAGGAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGCGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGCGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCC
+
?,???<BBDDDB?DDDFGFF/?H;IFHFHH-EHHHIIHHHHCIHIH@GGHIHHFHHHCIFHIHBHDIFHHIDHHIHH+=+H)HDFCHDFHH7HEDBGCHDHFGFCF=HFDHIDEBGFHHHGFHBGBEDEHF=E*FFEGCG#,G@D(GGGGGEAGG*G?CC9GEEG=1A'C9'E#=G(2F'GEE6;C::EEEGC:AACDECGGCCGE?GG*GFEDGG(8,EGEE:((ECC?(A:AG08:*.;(GGCGFE/G
@antibody_15_multiplicity_92_copy_72-1/2
CAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTAATATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGACTCGAGTCAACATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGATGAGCTCTGTGACCGCCGCAGACAC
+
?A?A?BB?DDDDDDDDGCF;GFAAHFHIHHCFHHFAFIFCFBHIHEHFGEFFHHH@IC@FHEHFI#GCHHF@I-IHFHIH'FDHIHHI+IEHD+@/+HDHFHIEHHH*HHHH?/E5H=HH.CGDDGEDEF:GC34I(GHFGGCGGEGGGGEG;B1E8EFE-GCCGEAGCAE64G((E(F?GC/.F:EGE?CF8G06:C1EGFGGEGH>GEEG/EGG(CEEG7C((E6:-?GG0EGGEG8CCG:EE:EEF?
@antibody_15_multiplicity_92_copy_73-1/2
TGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCAGTCCCTCGAGAGTCGAGTCACCATAGCCCTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAG
+
<?<?ABB?BBDDDDDDAFGGA8HHEEBHC+HFII>IHH/=IIIHHGAHIAH+CDGGGHCHHIIHH.FFHFGHEF=IIDHHFHHHHE<EIEIH@ICHIHCH+H6E.BDIF*HHFFFDHFFHHFEHEFGD@HG@FHEF8GFEGDDDGGFFC?E8FG-,EGCFF?GA:EGA?EG.G?CG*/ECA(E)GE0CCE:8F0CGEC<GG6GGCCECE*GG-CG).*CEEEF?G:?CEE?EG?A:F*F?0E::88??<'
@antibody_15_multiplicity_92_copy_74-1/2
CAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAATAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGAGGCTGGCGGATCCAGGCCCAG
+
5?=5?B9BDDDDBBD<FGGFGGHIFHIHFFIGE-HIGHHIFFGHHAHEIHIHGHHHCHFH-DIEDFCH+IHFCI5I=IC-FAHIHGHI@=HCFGGHIHCIGHEHHFHHDHHHHGGH5EGCFBEGGHEFFFF,DGG)BEGE>FA:CGGD?EEFF(EDGG(EEEEFEAGFFE@G?E*ECGGECEA6EGEEEE(/:EGEGECE:FEE?E/FC.AGEF0?EEG;?GAEC<??#G(6ECEG0GEE*/EEGG0CE.
@antibody_15_multiplicity_92_copy_75-1/2
CTGCCGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGCCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACAACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCATCTACTACAACCCTTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGTAGCTGA
+
??A?,5<>DDBD@DDDFGFF/FFBIFH/FIEEHDIHE;I.HDHHABFHIH,*CFA5HH?@HFFAHFHIFHIIHHHIHIHHHHHH-IHHHIIAEEEHH5H)HHHFCFFID*HHHFFHEEFHDF=FGEEEF8E=FBFGF(GG*EGF*CEEFGEGCEE1HGEE*GFF,AEGAEFA)E(/GCEEAGCFE#GEG?(G0FF:(?G?GEEG8E((6EDEC(<*(0EGCEGEAEGA*GFGCCFE:GFA??*'??*ACE
@antibody_15_multiplicity_92_copy_76-1/2
GCCTTCGGAGACCCTGTACCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGATAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTAA
+
A?=??BB?@B@DEDDDG.@GEFCIAIHCHIFHHH9FDHHFIHEIDIFIIGH@II=IHHCFHGICIIH@H5GGIHF5HH+GDHH7HH/EGDHCHHFHGHH-IEGH+HHHHH4HGHH>E*FHD9+HFEF6DE=BGF.GFHD@GE8E30EE3-CC;CCGGGG*C-A/GCGBB:E;EFEFG?:GCE?EGEAEE?G(C.06CGEG1/*FGFCE*EEC:G(7DAG7EE80G?=<?G1C(::G)FC*C0CF*D*E*(
@antibody_15_multiplicity_92_copy_77-1/2
GTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTCGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCACTGGGGGCTTGCGGATCCAGGCCCAGTAGAAACTACTACT
+
?????<BBDDD@-DDD;FFFF5CHCFFHAEHHII@HAIFIF>BFHH.HDHDHHFDIHHFIIIGHIHE-FH*HHB=GHAE5HGHFI4DHHHHGHC?GHFG:-GHHHHDF-FGH*E@HEFH,3EFGFG8E3FE;8CGG=3B@FG*F;?EEECEFG:CCGEGG,<*:EGGE,?GF-GB?6GGF?DC*EGCC?:CACCEGCEEEGC:GCE6EE(?GCGG0EAE'E,?*CG((CEC?.E:C?A0(CCG*?G6-?G
@antibody_15_multiplicity_92_copy_78-1/2
ACTCGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGCATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACTAAATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGACTCAGACACGGCT
+
??,,,B?BBD@DD@DBGGGFFF6EFFEHI>HIIHIIF/HHIIGH>DII7HDHFEHHH.FHAIGIGDHIEHHDGIHHCHGEFHIH/HGHHHHIHIHCDH6G@HHHHG@H=H/FEHDFGHCEFGEDGAFHGFEH>=FGFGEGDFDGEE;>CDEG3G;G:FF(?/(C?E9GCFGFA6EGFE*/(F(4E:GGGEG0FGE(EE(GCGEFG0EEGEGGCG(//(((EG0AGEC?AC:G;GE:*:*G('FAGGE)GE
@antibody_15_multiplicity_92_copy_79-1/2
ACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCGCAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGATATGGTTACTCGACTCTCGAGGGACGGGTTGTAGTCTGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCGCCTTCCCT
+
?<???BBBBDDD<DBD/G@GCGHHHHHHHIIF7FHH7DIF+HC=HGIHF-EH(HCHFH?BHIGHF<AFE-HEHIF?FFHHFIFFHHICE.FI-HHFIHHCHFGEEHFHD;EG-HHHEH#FHEFH;(E*G1AEEGGGF7EG@GECEE7GA6E=EG;EGEEEEG'0EFG:GA(.0ECEGEE6EGA.GEFF*A?E8AGF*EGG(#(6CAH?G>CE:GE(CCFCG.6(C(FCEECEEC'8GFDG/0C?*:?CE8
@antibody_15_multiplicity_92_copy_80-1/2
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGCCCTGGATCCGCCATCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACTAGTTCTCCCTGAAGCTGAGCTCT
+
,=5??B7AD@ADDAD<GCCG8GEFCHIHFFHFHHIII.FHDHGHHEIHG5GHIHI@FHHHI>IGHIFHIHEBBHIIIHHFH#IHHII/HHHGHHIEHFIH+CHCHH3HFGEDGD*D@HEGF3?5G8EEEDHEEGFEEGAGDE1GG4A*(FFEFGEEGGGEAGGGEE;GCEGG(GFG('G(EEEAE*GE)FGAEG4:EA:GG)FGGCE(CE)0:ECFEA<E1:*G6:*EE:EA?C:<(*>CE?E((6FEE/
@antibody_15_multiplicity_92_copy_81-1/2
TCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACTACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGGCACGGCTTTGTATTACTGTG
+
???9,??BDBDDB9B@FGGGEAIHFFIIHH@CIFEIHHIHIHFDHHFAHFIIGHGI-FHH+HII>BHHHGCH-HIHDEIIHHHDFE8FHHCHG=HHEEEIHGHH;FGFHEDE.4GFEGH@E+HH=FEEHGEGCHFDE2G2E#EE..GEGGF:GE((@EE<?GGEGEG?EEC0EGEEGE6ECGG<CG?EAFGEEG-CCGE0E*;6GGHGC(CGH@4<:C(E8G6FG::>:#CG(E*GE#E1(:*GE:2'E:
@antibody_15_multiplicity_92_copy_82-1/2
GCTGCAGCTGCAGGAATCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCAGCATATCCGTAGACACGTCGCAGAGCCAGTTCTCCCTGAAGCTG
+
<?,A?B??BDDDDDD7G?FF/GCII8IFHHHHDHHI@IAGHHIFHHGFH-HHIIHIIHDF5I*EHHBHFE+IIIEFHHIEHHAHGIHFGHHHHHHBFIHHDHH@HIH@HFFGIHDFFHH*FGFBFEEHD?FFHDFFCBG,FBFFGG;EF(E@F*E=CG1F*G?(0GEC;EEGF0EE(G8FGEGEFCF0?GGAE*CF(*6:EE8>FG#FE0CCHC(EGFE:EEE<E**E/:'EG0(E)(AE0(6*A:E?*?
@antibody_15_multiplicity_92_copy_83-1/2
GGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGGGCTCAGCTTCAGGGACAACTGGTTTTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCCATCCTCTCTATCCCCATGCCTGG
+
A????B?BD5DDDB<<FGFFGAIHFIEHH/FHIAH9IIHH5BCHFEHIE9D=CIHGHICF-GIIHHIHHFCHHFDIHIIII<-C8HHIHIFHFDHIHHGGIHCG,FFHDEHDFHFFF;FD#H,E*GDHBGE@EFFE(;@CEGEGE'E*8GB8FCEG*GFAE,E6E:EFBG#GGEGAE?CF:EGG(?E.6?CGCGG**EFCEF<??*EG?*EEFCCGG0G(C?GG:F(<AGE#E*:(/('C*E-G/DE(FE
@antibody_15_multiplicity_92_copy_84-1/2
CAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAAGACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTGAGGGAGAACTGGTTCTTGGACGTGTCTACGGATTTGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCTCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTG
+
,???ABBBD<5DDDB5>CGGFGH>HFIAIIHIHIHHGACIEEHIH-IHDHHHHFHDHHFHG/FBIIHF-IBEAICHICH@+CHHHH-DCGHHHDHGBHHDGIGHHHFHH#HHBHHHDHHF@G;G#H;?FHE.GGGGF<EE=DED*66CG/G(GGFGGG(EGDEEA?CGCGEE:G#>(0EG:AG)<EG2AGE4A/GEA8EG(*C:GACGD*GECEGE:EGEECF(EEE(G<FG?8/?EE?6E6(:GG*1C(
@antibody_15_multiplicity_92_copy_85-1/2
CCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACCGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATAATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGGCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCCCTGTGAGCGCCGCAGACA
+
?????5BB@D-DDD@DFGGFEGIH,FCCHHHFAFIHFFFHAFEI#FHHCG-GEICEDFHHIC75GIHIEIFFFHFF5@IEHIHIIIE?FHIE#IFGI+EC*HHFE(HF?HHHGFHFFHGHHF;GFFDEFFFFCBGFAF*DCG:G?GEFG6EEFEC:.EEE?::EC06EG:*.G;*1*EGGE:E?GGDGE*EG;E?EGC?EECEEEFEE=CEGE0<E*FCEG(A/EFGC:6/(EGE:D?(GGEGEG68#*E
@antibody_15_multiplicity_92_copy_86-1/2
GTGACCAGGGTTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATAGTGCCTCGACTCTCGAGGGACGGGTTTTAGTAGGTGCGCCCACTATAATAGATACTCCCAATCAACTCCAGCCCCTTCCCTGGG
+
????,BBBBBB<D-DD/GFBGCHHIHEFIHHEI@HIHIHIEI..IHI(GEADGIHEFIHFHFHFGEA?EH-HH5HHIFHFHHHCHFHBEBHHHEBIHE=H3@FHDIF6F;F=H0EGEHHG)EFFGGFE*FB4GFG'FC22EE@DFEG)EGGE?BGG(EB*:E9G=(GGA*GGE;/=G.?<G(E/?E/A:CCA'E?:E?/G?/E#?G:6GCAGE/(GG/:,DECE:GGG/#GC*ECACEEA:*>G9?E.C*
@antibody_15_multiplicity_92_copy_87-1/2
AATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTGTAAGAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATGCAGGCCCAGTAGTAACTACTACTGCTGA
+
???=?BBBDDDDD@BDF;GCGGCFH/EHE8HIHI+IGIHCHEI>GE9IFI>9HEFFEH5HHHFFFFAIEH+HIIIFEIFHHFHHHCI/I+HHHI,IFCHHHHFHHEE5DHH.1FGHGFHFFFD;FD4HFHFEGHCEBEFE?DEBG<0EFG6BEDEGFEG?E@E:=GFEEC#FFE#EF-4E(=GCE;AAG4E;C<CE882EE4C?FCHCD*(E@G*(.CBGE)6*<EECGG:A*EEG1E?EG?;18?8?GE
@antibody_15_multiplicity_92_copy_88-1/2
CTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGCCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGTATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCGAGAGTCGAGTCACCATATCCGTAGACACGTCAAAGAACCAGTGCTCCCTGAAGCTGA
+
???A?BBBBDBDA@D-A>GGDCIFIIIHHIFEHHCIHIHIFIIHAEHEFF9HH8.H*IEHIHIFEBEIIIIEIHI>-FFFIG5HH@AH=GE47EGFGHDGH8HHHHHH#DDHHEFDFFHF*BG6F<E#HGEFGBDFG9EGDGF576EEFC>FEGG*'?*GGEEFGG@E(GECE:EE?G=G>CEG?CG?EG;ECF?:EEGE??*GEEDGEFGG:CEE'CGEB7<G'E0E9*<E?AC(**GEGEA/:0E:EE
@antibody_15_multiplicity_92_copy_89-1/2
CTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTTTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCAGACCC
+
A????BBBDAB@D<B-FFFFFGHI68HHHH/HIH7HH+GHEHHHHIHCGFHIABHCDFHHIHFIFFHIF5FHHIFHI-HFFGCHHIHIFHHEE.CHGHGHIHGHHHDHHIHEF@H>9G+F?GGEGH.DGF;GDFE*EGFEFFG?GFDGBECE:1GG*G?GECEG)1GEGEGE1FGGC6GEE86E=*E?)G:E?GC?'<GGFGCGE9H(?EEGHGE0G>C(:EEDE(GE:GA*EG)?.GAAC0?A**E*?0
@antibody_15_multiplicity_92_copy_90-1/2
AGGAGACGGTGACCAGGGTTCCTTGGCCCCAGTAGTCAAACTAGTTATAATGTATTCAACGCACGAGTTAGTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAACTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGGTGACTCGACTCCCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCCACTCCAGCCCCT
+
?????BBBDD-D=DD?GC+FGFIIFFFIEFHIIDHHH@CH+DI@HFEHHEFFHDC-HHII-HH+HFHGGI#G/IHIEIHIBIEIDHII@HHBFHCAIHHFHHIHHGHHFDHGA>FEGEDH:4HFG?FG*D8GH+EEF9E*DCFEE7G6E@GECG*)*FF0GGGGGCEEEGEG?9EF?CGFEG?(EA*F*FG)EEGC*CGECCEEE*AGC:E9():EB?CC.?EE)C80(6FAE?0?AC:(G*8G.CECG0
@antibody_15_multiplicity_92_copy_91-1/2
CGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACAGAGCCGTGTCTGCGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACGGATATGATGACTCGACTCTCGCGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCAAATCCACTCCAGCCCCTTCCCTGGGGGCTGGCGGATCCAGACCCAGTAGTAGCTATTACTGCTGATGGAGCCACCA
+
?????/75?D<BDDDBGGCE8;IIHFC8IF/IHFHAFHCHHFH0*HFIHHDHHCHCHHEHDFFIH@,IICFHG=HGH(GFHH;FIHHGHI+HDGHHHHHGI/IFAGHHGFED=FH,@EFHDFFF)DEF#+2H8.ECFC@<FEEG*3G?EEGFGE?(GEEGEFFFG0(CC?E0G#GG/G.E?+=;EE=C*G;EE'CA.CFEE?EE?ECCCD(EE;(:F;EG7GCFG(2*A#D1;:EEG60:E1*?A.E:?<
@antibody_15_multiplicity_92_copy_92-1/2
TTCCTTGGCCCCAGTAGTCAAAGTAGTTATAATGTATTCAACGCACGAGTTACTGTAGTCATTAACAATATCGCACAGTAATACACAGCCGTGTCTGCGGCGGTCACAGAGCTCAACTACAGGGAGAACTGGTTCTTGGACGTGTCTACGGAGATGGTGACTCGACTCTCGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATACTCCCAATCTACTCCAGCCCCTTCCCTGGGGGCTGGCGGA
+
?A??ABBB@@D@BDBD.FDCFFIFCHEHFHH5GGFFIHIIIFCAHFIHIAIEHHHIFHFHF>HHH-=FHIFHEGH,IHHHHH5GHHF+HHHIIHHGHHHDH?HHHFHG,HEHFED+-G.FFHEED*HHGF=DGH9EEHHEFCA3FE:F8?CE(GGCGG?EECGBBGGGGG<E*EEFGGE/(GF*EEC?EEG*(ECAE:4C(A(.GEHGE?GE.EEEB*(#EG*FCC6*E?CFEEGE>ECG.CC:88'E<(
@antibody_16_multiplicity_2_copy_1-1/2
CCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTTGAGTGGGTGTGGACTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAACGCAGGTGGTCCTTACAAAGACCAA
+
?<?=?==BDDDDDD?DGBFFFGH@FCHHIHEGHIHI7HIHHIHGCHF'IIFEHIFI.IGHGHD@HH5HHIE-HIHIHIIGHCHF5BF=AHIHHAH=IHHFH-GFHIDGH9IHEH3EHFF,CEGGFEGFDFHHFEEFEF3CF3((G0EGEGGFBEEGGBC?GC?EGE:;;?EGCEG<EA'8<GGEAAC?EGEE8G:GCA6EEEE)?C<GG<///)ECB/G/'AF08(/E?=:**G0??A?:EC?#C/A*::
@antibody_16_multiplicity_2_copy_2-1/2
AATGTAGTCGTACACGCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGCTTTTTGGAGGTGTCCTTGGTGGTGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCATTAAATGAGTGCAAGCCACTCCAGGGCCTGTCCTGGGGGCTGACGGATCCAGTCCACACCCACTCAACTAGTGCTGGGTGAGAACCCAGAGAAGGTGC
+
??,=AB?BDDDBDDDBFEF>GCHH;I>IIFFHIFIH.9AIIHEF/HHGICHIF/GFIHEHIHFHIBGIDHHCC(HDHDHHFEGHFICEHG)GIFCHHHHHEG#GFHH@HFHDHE(>DAEHGEEFGFEEC@=FF=+;GGCEA7G(EG;G*EEF'HAGEG;GGCCEECG?;*GE:FEEEECE<(;;(E*E?<A;EFG08ECAE=GG'ADD(H.;H@DGGEC7GGACE<EG#.:E?2C?C.(E**G(AA'?/A
@antibody_17_multiplicity_83_copy_1-1/2
GGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCTCTGGGTCCATGTTCGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTTATGGTGAGCCTGATCTTCAGAGATGGGCTGTAGCGCTTATCATCATCCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGAC
+
?A???B?-9?D@D<DBGGFEGGF>HH(AHHHFH+IIHFIHGHIFHHHHGI+CHFEEIEFGI>IH?HGH-FFG,AHHIFHFEHH5IIFIDHFDICHIIDH#H#FH>DF+HIFHF+(FHEEC;GFIHDHGFFG=FCGGEAG9@B0GC2>AEEEE=GE,?EGG?FGG#GFE(EE?GG'0G:CAFGGGGD(6*GG?EG:EFG6FCG(?E(CC:HG(FEGE:'G<GGECGG6CG???:?EGA0?E*:EG*EE:EC
@antibody_17_multiplicity_83_copy_2-1/2
GATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCTACACCCAGTCCACTAGTGCTGAGTGAGA
+
?????AB7DDDDDDADFFFFCGHFEBCIIIHG.-IFGHG.HII@HAIIGFFHEIIH8AFIIIEIIDFFIHFHHEHFFHFIIHHDHHHHHBHH;IH-BIF@HHHF-FHF.CFIHHDGF+EBB)HDHEE;EGD3E)FEEE*EFEEEEG:GGE7*EGCEDFEGEGGGGEECGEGEGE(A?:?/FC4:AEFG:CEE?CE<G*EGEE?D6?HCD0E:CECG8:EAE:*(EE:EE(C?EGGG8F<F'G*CECAGG0
@antibody_17_multiplicity_83_copy_3-1/2
CTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACAAGTGGAGTGGGTGAGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCCCAATGACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAAGGACCACCATGGACCCTGAGGAAAC
+
???<?B?BDDDDDDDDFG>EGFEH;FEHAII+HHCIIHFIIIIHGDEIAFDI5GF@IHHIHHI@5AI-HFIGEHDHIHH=I#I-GFCF=IFHGFHHGHH5@GHFCHC@FHDEHDFFGGHHF:F+EEFH@BHDGFGGEH0GGD<GEEB@=.(G<EGEGEE/FEEC6;BE8CA.GEGB/>E?AE*E6G8*?F8(?ECCGF('8?*GG)?G?H;EE@8F:AGE0,ECE*GCG'C(<E(6E?4*;CE(G(F0?E
@antibody_17_multiplicity_83_copy_4-1/2
GAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACACATTTATTGGAATGATGATAAGCGCTACAGGCCGGCTCTGAAGAGCAGTCTCACCATCACCAAGGACACCTCCAAAAACCAGGGGGTCCTTACAATGACCAACATG
+
?????@/.BDD-?ED@FFFGGGEIHHC/H?GGHIHIEHIHCGHFF9G+HIHFHIFHHGHFH-HAIF-ABIHFFAHHDAHI-HDIHHFC:*HH-EIIHI=HHHDEHH7@,HI7FDHHHE>HEGGEHFEFEFFDCGF?FFDFEDG)EGHD:9CEGGGGECEGGG8:FFCCCF*G*G'EE'(G6A@G??FFE:EE6FGGC6:GG?GG6GEGGEE*(G)?:G.((EE6CA*(E;GCEFCGE0EEG:EG:E8CC?
@antibody_17_multiplicity_83_copy_5-1/2
GAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGAGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCCAACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATG
+
???9?BBBDBBDD?DDGGGEGFEHCHHHIFIFHHGIFFHFH.HFCH.7GIFCFHHHFACFGCH5H-5IFHEAH/GIHG-5FFDI-IHF8HHHIGHGGHGIFH,DHGDFIEGEHHCHHHBHFIEDEHGHGDG=2GEGEFDDHGGFFGEEFFA8FEE5E@*BEGEEGGE:EGEEGA?E?F(GC?/,GE:EG?GC:C*(?E:GEGDE/G2AE8A(CC/C*?,GE'?G?AGE/4EF(6?/*CCEE(E:CGGE4G
@antibody_17_multiplicity_83_copy_6-1/2
TGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCGTGGTGATGGTGAGCCTGCACTTCAGACATGGACTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGG
+
?=9<?BB=DBD-DBBD0GGGGFIHIIIHHFFHHGHGCGH@HHAHHGHIFFHFHHIHFHF+CHGH-5?DGHFC=GIIIFHFHFHHIHFFHHFHFIFFIHHFCIHEFGCFHIHHEGEEDGGHE,FHHHBGEHDFGGHDE;GD:E0E3EGD2E=EEFBEEEC8EEGAEGE'GCC4GEE(GECG#EEE?G*'AC2G*G0EFGEF9(G0CE6A(E?(:GEEEEE,0FG:E*GCGC?*E::.GACG*G(?FC(C:E
@antibody_17_multiplicity_83_copy_7-1/2
GAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCCGCCCGCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTGATTGGAATGATGATAAGCGCTACAGTCCATCTCTGTAGAACAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACGATGACCATCATC
+
????9BBBDBDDDDDDCG;GFCCHHHHI8FIFIEDIICHHHHGEGAHHIIGH7HBHFHHFDHH?HI<H@HFHFHIHIHGIHIGHHHF-G-GHHDHFDH5FHF#,CHH=HE*@EFH#>A+FCFCHG)DHHDEFGEFIBE2GG6*2EG3G*:CAFE6EEDEEFG*E7EEC0E?GFA#A8/*:<CEG(EAE(F0FE8?EGF0GACG*FGAGGC0:HE1G:CE<;E*GG?EF6EEC6EE'C*GCC*ECE(C*C0
@antibody_17_multiplicity_83_copy_8-1/2
CAGATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGCGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCTGGTGGTCCTTATAA
+
?<?9?BB@DDDDD5BDF;GBGFHFHHHEHEHHHHIFIFHIDFHHFI=H4HIIDFDHIIIFDH>HCIIADH,GIH5EHBIHIHHCDHI?HHH+GHHHHHHHFHEEGEH=GGHFFFGGBFHHED#HHGFEEDBG?E3FGFGEAFGF(EA?.'=E@<A6GGEC:G8CB?(<GGE:EEGE(.E/.GEA*GD(E(AGGE:8G:CE*)GEEF(EGEEGE=@E7GEGG/EEEGGC8?6;A/G(G#EEE?E;E**#GG
@antibody_17_multiplicity_83_copy_9-1/2
AGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGTCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGTACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGGTTATCATCATTCAAATAAATGAGTGCAAGCCACTCCAGGCGCTTTCCTGGGGGCTGACGGATCGAGCCCACACCCACTCCCCTA
+
???A=<B>7DB@5DBDEFFFF/FIHIH8CIEIIIH-IHD-CGCD7GHFHCHAD.IIIHI8HCIG#HGIBHIFAAHCHEHFGDHHEHHDCHEHHDDHHHH+FHFGHHHFCDHHFEFHH+-.FEHCF2HEGFE?@GGIGEDGG9FBE36C9;EFEAG8CGE8E.CFG*FEE*E?:?EECE(EGC:CF6E**2:E:E?4E(G:*CC:E*H/FHEEAG)/*E:7ECF(*.0E/(G6AAC6C?>;?*(G'*(*E9
@antibody_17_multiplicity_83_copy_10-1/2
CTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTAGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGGGCAAGCCACTCCAGGGGCTTACCTGGGGGCTGACGGTTCCAGACCACAC
+
?5????BBDBD@-D<DCCGFFFIGIIHII8HGCF+GHHDEIIG,HHHIHDFFHCHF5EFIF8DHFDI4IAEIIHIHDGHIHIFFAAHDG=-HCEFHHEHFFIFFHE3HHGHFFDHHEFHHGHGHC,EGE0AG*FBGGDFFGE7EGG:@E*3/'GG?GC(>C=*EGA8EEGAECC(>B8EG;EG:CGC?4DEEEE(EG6:E#E*A#/E?<66CH*F:G:C,E,ECEE(CG:*GF0:F:#0E/?0(A(8?8F
@antibody_17_multiplicity_83_copy_11-1/2
ACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTTAGAGATGGGCTGTAGCGCTTATCATCATTCCAGTAAATGAGTGCAAGCCCCTCCAGGGGCTTTCCTGGGGGCTG
+
?=??<>79DDDA@DDDGCDFFGHFHHIIECCCGIHH?HHHHGIHCHHAIHHFGDH.HHI'I@CF-HIAFHHHIHF=F+EEI)HFEHF(DF(BGCGHIFHEHG9HAGHHGCHFBHHFC@FFFFG#G:FFE@GEFH?GE2E1CDEE(AG?EEFGGCGEEE<GF/BC-E;EEEFGG:C'DC;GGGGG>GCF?EEGF(?GEEC:8066?E8G(CEG@EEE?3BEF0EC6(?FCG(E(4(?G16GE'G*CCE(E2
@antibody_17_multiplicity_83_copy_12-1/2
CCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCAGTGGACACAGTCACATATTAAGGTTAAATTGTGTGTACGACTACAGTAAC
+
?<???B<9DEDDD?DDGGGF/FHHHHHFIE9HGFFIIHIHHHHCHF?H8HA?DIHHED=?HBIIHDHFHHIBEGFIIGGIEH-HGHDH#EIHGHFIIDEHIEHDHBBHHHGHDGFHEHFE*EHF:DF2FGGE=FGIGGFEE?DGGGE:E+EEEC6EFEE?ECGEGEEEE?,.DDG?@ECGEGE(?EE(=<;FE(CEE(<(>A0FG*(0EC)8@E:E8GEC/':F(E?CEEE)*EFGGG*C:0EEE(?(G1
@antibody_17_multiplicity_83_copy_13-1/2
ACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCAACTGGTTTTTGGAGGTGTCCTTGGTGATGATGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTCACGGAT
+
?A??=BB>BDD9<<DDA;GGFFIIH?HIIFAHFIIHHGHIAHIEHF9IGIHHGHHCHAAHHE@ICIFHE=HFHHHH+HGHHCECI+FHCHAHHEHICIHG:FIH-HF2FHG>=HEHHHF9DGH,HE,=EGFFDFEDAGEFG(GGG;GGGDG:,G>(AA:F6GADCFGEE;CC;:A6C<G?EGCEFEF(GGF*F*D6G?GCC:GFC:HGCH*0HCGD8EE0C?8:AEC:)>ECCE;(G8G?.GC'AACE./
@antibody_17_multiplicity_83_copy_14-1/2
TCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTAGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGACGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCACAAACCACGTGGTCCTTACAATGAC
+
<?,<,?BBD@DDDDDBCGGEGFB>EHIFBFEFIFH+H-H=CGHHFG/HF/H?FICHH95HFEBFHHF8HICIFIHHFHEHH?H7:,HH?IHH@HIHFFH*FIHHHFGB'HHHHHH0HFHHEEEF*D?EGHE*HCGGFDHF=GC;E,@@E*0GCECDGEGEE:ECDA;1E:GG*6(E:?GF?GEECG.:CGEG*8ADCEE0GC'GE(CG<?EE<:<E:AGE<EE?F*G:ECAC(A?ECGAF:*?C;E:C2:
@antibody_17_multiplicity_83_copy_15-1/2
TAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTGACAAGGACCAACATGGACCCTGTGGACACAGGCACCTATTAATGTTAAATTGCGTGTACGACTACAGTAACTAGATCTTAATCCGCGACTGTGACT
+
?,?,?B?>DDDDDDDDGGFFFCIHFIHCHHIEHHFIHHI(FHHIGGHFD=IHEHEHHIHHGHH-F-IIHIIIHHI+<HFEHEI8@AHI8HGHDDHHDGHHEGHH:HHCFCFDFEEGF6FFG+>HDGFF@0EEFCEF,@GEEEGGG=EAB<GG?(GEGC(GEDE(FGFG0EAEG6EFA/(E?GEEGC(EF*E:C::6.GG:C;FCC?:FA:AE7#:.B>G4?CAGFE*GE(0/:'EE:GCE0(A?(EC?*?
@antibody_17_multiplicity_83_copy_16-1/2
ACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGTTGGTGAGCCTGCTCTTCTGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGAGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACTCCACTAGTGCTGAGTGAGAACCCAGAGAAGGTGCAGGTCAGCGTC
+
55<??BBBDBBD?@B9CFGFFFE+H-HHIIAIIEHCEHHIIIH+B.9FHH+BADBHDHF@HG?GHHHICEI-EH5GHAIDIIF=7HHFF<G#HHGDE=CGF.GHHHACH#FHHHHHFFDHGGHBCEEFEF'GGEFD:GEGGGEEGDEAGG8EE(GFCA?GG?FEG@#G*EGGECC?GGEFFFA8F1G*C6GACE*:G*4GE'F*A9A86HGGE<.AC(CG7A;E)?GGA(G*)E/AGCE.CE*6(1EA84
@antibody_17_multiplicity_83_copy_17-1/2
GAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATGTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCAAAAAACCCGGTGGGCCTTACAATGACCAACATG
+
???A?B>BDDD-+B5DGFCFE8HHICHHHI(IHHIIHCH.HG7HH?HHGH>HIHFHHIEGIFGHIFHHHIHEFH*AHHIDGI#EHGIDFEHEHAHHHF=AFHFHEFH5=HEGHEH@HHE=B3EHBCEGFFHHAEFEGEF(BGEGBE1*EE;EEEEGGGEECECEG/:GEGGGGEG*GG0CC?((GCGF?C8FGEAGEEG?AE<611://ACEEEEE(C?@GC-G.CGG(E0A?AECEGEE:8?)F)EGA*
@antibody_17_multiplicity_83_copy_18-1/2
CAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACAGGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACTCCACTAGTGC
+
,??A?BBBDDDBBD<DFF@FCGHHHIFHHCCHGIH9HI,EHGHIIHGE@HIEDHIIFDFIGHFIFIIAHIFDFICDHHHHDGIG8IGGDIFHHHHIGG7CFGFHFH8*EHHG=H+CGFGHE*FHG0HAFHE(EGGGEGGGFFDGCEGHGFGCFD@CE1E**G*EGGCAG?6EGE::G6:GG+:CDCGGEC(EA*-8'CEGEE?E:EH4E((C.:'EEGE;9EGEE(FEC?D8)GG:AEA2ECEGEEACC-
@antibody_17_multiplicity_83_copy_19-1/2
AGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGTTGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGC
+
5A??AB<5DDDBDD?DBFFCFFE>HFI+FHIGHHCH,FHH-CII=+GDFBFIGHII9HIFGII-HIHHE55EDIDFIHHEI+CFHCFHIFCGF+GI*,HE=HHFGHHFGDHFDIHH@DH?GHFHH8HH;ECB*GFFFB*@EGFGGEG(GE;EEGEDGDC*GEAGEGE6:ECFC.E;EC=EGC(A:EG0G88GGCE?A9CEEGA/GG?E?E6:*:E<FACEEECA/:ECC:18.C?*CEEG?#0A1FF(8:
@antibody_17_multiplicity_83_copy_20-1/2
TCCCTGTCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGTTTTCCTGGGGGCTGACGGATCCTGCCCA
+
?<?<?B5BDDDDDB-DGCFGGGFIEIF>CHHHIIHHGIHFHGC.HCHHFBFEIHAAHFDH9HFIH?HIIADHHFHFHDIIFFCECFGHHHGIGHHIIFIHGCF-HIFCCF=GHEH+GEHF)CEF+@EHFEG#FC+AAEEEGE*GGGGEAE*AGEGGE?G:EF:@G<E;FGEEEFCAE8GGFG:ECGA):::GGC6GEE*?EEG/C?C-CA(:@:FF:3GC?,?<CC6.::AG)A)CGCE?GEE:#A*1E(
@antibody_17_multiplicity_83_copy_21-1/2
GAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATGCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAAAATGGACC
+
,??=AB?7DDDDBDDDG>CGGGIIFIBHIIEIH9IHIFHIDHIGDFICG/IDIH9CHDHF.-BH;A75FHIHCH>F@#HH-HIIDI=HCIADIEH-GI=IH/HHHHCHHHGHEFGGFHEGGFHFHGGDFGBAGG#FE?F=*=GEFE'*CEF(GEEG@A6G.C1G:0EFA:GCBGG#CG)G:FG0>CGEF*CGCEGEEA?(E:AG*2HDG'?0E/;(E:E@?(:GE(C:?G;(.EG8GGEGG.(C::EGC8
@antibody_17_multiplicity_83_copy_22-1/2
GAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGCAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCATGTTGTCCTTGCAATGACCAACATG
+
??<?A?BB@DDDD@@DGGGCGFCHHFIIHHIHIIIIDGGGED/CFCIFIHHHEHDHADHIIGGIFFIHID+5G5EHDACBIHIEHA-HFHHFC<DHH6CFECFHDHHGHHHHGG.7H7H=HEFIFGF,GGE;HGHAEEGECE@G-BGGDGG==E=F:GGGE<6E**GEEE*G(@G/EFG#EG:F?CCC8<CFCE<EE(:<E=8EE(E8FE8?CA*GGC?(GFF;A*G*/*?E?E?(E.8?FAE<GG6E?C
@antibody_17_multiplicity_83_copy_23-1/2
ATGCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTTGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGTATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATAACCAACATGGACCCTGTGGACACAGGCACATATTAA
+
??,???ABDD<DB<DDGGFGGFI6HFHIFHFIEFGIHHIEDIHH7DFH5IHHGHI-9FIF+CFEHH@?GIFHI5DIEHHFGHB*C.-EFIHF?-HHHHHDHAIHDDHGHFHD*1DC;EFFDCHEDG++EGDBHDH?EFFC5EE9FGDG>GCE8BGDGGEDFGEF0EGE<EGA:EEGCGEEFG.G>G?:GFEEE?:EG-?6E?DGG(E<GAGEA(DE(GGGEEA:GEGGE:*ADE?AE*ECCE2'FEEGEE
@antibody_17_multiplicity_83_copy_24-1/2
CCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGGCCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTACAGGGGCTTTCCCGGGGGCTGACGGATCCAGCCCACA
+
?=,?5BBBD5DDD?B@FFGFFGIHC/7CEB+IF9HGIHDHH;BEDFGHHFCDC5IF=-HFCHCHHIIHFCAIEEDGHHDGAFHFHHHHHFIIIBGH+FEFHFFHHHEFEGHF#HHFFG=BH:=HDFFD*GGFD4E)FGE*EEEE;EGEG/GG=GGEEEGEBE>EEFEBE0C)EGEFAC@@E0<F*/:EE(:GECE:80EG;GGGG?D:FHE?'G**#;EC?GCG?'0E/EA?E::EEFGAECFE?GE?6C
@antibody_17_multiplicity_83_copy_25-1/2
ATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACAAAGACCCTTACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGTTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGTTGGTCCTTACAATGA
+
??A??>BBDBB9DD,DEGCFCGCHIIHIIFFH=CIGFH9I,F#IC+FGIG/9GDHF,ACHHGGHHF8-ABIAHI-HIFAHICIFGHHGHIEEFHI6B,=EC5FH+GF(HGHHHH:DDHGHHHCAG@DHBE@EEF=E;EE(;DGG,G<CFGAEGEFEFHEGCFCGCECE8GEA???A8CEGAGC:D/G:.?8E(EAA6GG?ECE(FG?G?(GE(:GC?EEC*G(*C?CE6?(GGE#CE;C(??E?DEG(AE
@antibody_17_multiplicity_83_copy_26-1/2
AAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCTCCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCGCTCCACTAGTGCT
+
?????BB<BBBDDDDD@CGC;GI,HIHAI8EHHH+IGHAH-HCHF+DGDCHE7HFHHHIFI=.HH.HIHHHHCHFHHH43HHFHGHH+HFFFHGI3HH+CEHHGFD;DHAEFHHDEFHEHDHDGDDGGGG*?EHGI?GAHHEEGCGCGEGGGE/EGCEF?AFDGF4GGG(GGEAGG/:GEGEEEE1C(E/;GGEEEGCCFC?E0EE/GFHCEC*:.:E0GFAEE*A8GGEE?*?CF'EEEE2A.:E:C??
@antibody_17_multiplicity_83_copy_27-1/2
GCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTTATTTATTGGAATGATGATAAGCGCTACAGCCCAACTCTGAAGAGTAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGC
+
??AA?/?B6BBDBDBDFFGFGGHHAIFFIHHFIHFGHHFHIHAC/HIH.IEIHHHIHICFFIHDG-H@H-IHHIHHGHFHHHFEG5A+IFFFE6HH=DIHEHDHH)HBH(HCH@FACGBCHFFDG@*GEHFGFGFDGBEEBAF'E;=FGDGGGE*EE0C0)GGFFE*EGEG*GE,?G?GEEGCE?E:GEE*EEGA:CCF:(E>GAA6:E0G?'@G<G8:CG?0?:CEE'?G(*6GCE.F::EE:/ED*GG
@antibody_17_multiplicity_83_copy_28-1/2
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCGTGGTGATGGTGAGCCTGATCTTCAGAGATGGGATGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGCG
+
????A>BBDDBBDDDD-FGCGFHHBA+B0HFHDIFACIHIEIDHH-HHHFIHHH?IH@IHHFHHFIIHHGGIFHH#HCHFHH-DAA7IE6HIFCHH-HDH3HHFFEF;G7F6GFEHGEGHFDHHFFFF;GD@FHFGD**G:EGG*BEFF?F8EE(,)EE:EGC'G'G?*G6;E0'ECE?*GG:AC:CEG.E?**?(*<>1;CAFEA?#GE*FE;7*CEEAE?EGA*GC?/EEE*A2AG1?C:8/CA:/*G
@antibody_17_multiplicity_83_copy_29-1/2
TGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAGGCCCCTGGAGTGGCTTGCACTCATTTATTGGAACGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCATCAAGGACACCTCCCAAAACCAGGTGGTCCTTACAATGACCAACAT
+
?<?,?7-BDADDD5<DF8CGF,IAHI8H5>>HEHHIIHHDH+IH7IGGIHFEHFFDFG-GH?IIIFHHICIHDHFEHIHHHCICHEG.HGHFHGDFII5HBIGFHHHBHFHEHGFDHHEGFH1+DDFBCF+EEFG2EEBBH(EFF5GE.C>E<AEEE-GGEG?6C*>GEE:EEG:6G8EGEGEE6.:F8GEGFGG6G:)CE:*;(=CGC/GG(CE8EG'EGEEE?EF<FGGC*GG08:.EA*ECC>E/8E
@antibody_17_multiplicity_83_copy_30-1/2
AGATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGAGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCACGTAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTTAGAAGGGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCTGGTGGTCCTTACAAT
+
?<?=,BBBDDD-DDDDGEGFG/EFHFCFHHIEHFGHAIHHFBHIIEHHHHFEHHH5.HFHECIIHEHHCDFHFAGFFE5IHGEFBIGDHIH5=H*HIHF=HHHDH=HEFHEC?GGEF2FEHEE3HEGH*=*GHF7GGF@=DEEE?(GG1C1-FE:EGGEG/EG(?GG)E6=GFEEGE?FGEGG??(G:GE8*/(.AG(CE6EEG?*H(?EF(CE>FE;(EG:EG:G?:GFG*CC(GEGG(CE)(?>F*EG
@antibody_17_multiplicity_83_copy_31-1/2
ACTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTAATTGGAATGATGATAAGCGCAACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCC
+
<,A??<?BDD-@<DEDGGGF-FF>EHHHFHHHHHFFHH9HH=IHGHEFHDHHH-HIHDG.HCHBIIGHHHB5HIHAH+HEDDI-EG-IHHIFHHHHH3C5HF@EEHF4HIE@CBCFGDEEHEHFHE=EEDF/GGE*FG4EGEF*FGEC4GFGAEE>GEFCG@EE#GEEEG/D>GEGE(<FGGE:E.CCE8GEC:<C(G*EE6/'GEHEE1?E0(GE.?.GCGC(.EC0EDGAE'AEC?:8CEGEEE?G/C
@antibody_17_multiplicity_83_copy_32-1/2
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACTCGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGCTGGGCTGTAGCGCTTATCATCATTCCAATGAATGAGTGCAAGCCGCTCCAGGGGCTTTCCTGGGG
+
??AA??BBDD-EDDDB>AC+FF>IIHFB+HGH@FHHHGHFFHFDEDHFFHFI@FHII>4IIGHIHDGFHIHIF*CHDH-HGFFHI?HIDHH/-GIHHGDFFIEHIFGCDGHH#BEHEHHFFFFF#FDG1F*EFDDFGGG*EEGEG0C/G0EDE?GEG:CGGCEAFGGEEFE0?AE(CG/A(FFE'E?GFEGE(:GF(F<ECGGE6AEE?HG?EE(E:?C((:C(C?FC/*8CG*:/A)EEGE.C://CAE
@antibody_17_multiplicity_83_copy_33-1/2
AGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTATTGGAGGTGACCTTGGTTATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCGTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGG
+
????=BBB6DD?@D<DACCFGGIIFIF8IC,D=HGFFG9GF.HHHHEHIGFHFCHI-III@I=DHHG/IHGEH5IEH=<HHHE-HIIHHIHIHHBGEHHCD.GH=E;HFCF*HH0FGHDFHHFGGF;,CGCEGGDG+EGEF@ED)EGFE;=D8E(G@:GEG=(EGAE(F?ECE(FEEE;6GCEG*EG?FGGE(G:(:F(#'EACE/(9F:AEEGCEC?,:7'G:G0:.G<.GGC?CEAE?E0(?/C0E(:
@antibody_17_multiplicity_83_copy_34-1/2
TGAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGTTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCTTG
+
?????BBBDDBBB<DDGGFGGEHIHHIHFHEHFIFIGFIIICF/EEGB.I=IBHIIFHFHFHGHFIHIAFHIH>)IFH5FFBFHIDHF4ICGHHDIHHHHDHHHHHH.BHFH*HDI.HE<GFF=DG,HFGFHEBG+GF41EEFEEGEEFGECE?EG)EEFC>EGECGC'GEDE:GG6CCG?+>G<GE?A;'FCEEG(??(;GCG'AF0G8*-:@GE/CGCEG:8CF0C/CCA:*::A)A::C?CG:/*G*
@antibody_17_multiplicity_83_copy_35-1/2
GATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGGTGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATC
+
????,>B=DDDD@DDDFGCCFAEIHEH;FHFEEHHFIAGGIFE@EIIIHC9AFE@IHHIIGDDHIH-IIGEHHHI-FII,-ICFEFEIAEHHH4FGHFEHHHEH=DHG6HG?GHFH9HGD0FHFFD*EGDHFGCD(E*EFF=G?GB,,1GC;B?GGEGA?.=GGE:G(;EEGFC*FE6GGG.G:?E2GCC*EEGE65D:A*G:G:?CGC<EAAEEE?FEG:EAGEG*FA:6C0A??FG?:8*EEE??00(
@antibody_17_multiplicity_83_copy_36-1/2
TGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTAATTTATTGGAATGATCATAAGCGCTACAGCCCATCCCTGAAGAGCACGCGCACCATCATCAAGGACACCTCCAAAAACCAGGTGGTCCTTAAAATGACCAACATGGACCCTGTG
+
????AB?BDDDEDDAB?EG?FFFIIEECHAHFIIDHGGHFFGFIFHFGHEH@II<IBF5IHHDFFG5IIHCC=HAG-G+IHHIHH7HHGHHICIFHFFGD:HFCCHHD,H=HE8FH@9GGHDGHBHFFE7GEG@F(GEBG8EFEE;EFB,C*DG(EGE;AGGGE;EEGGGG(?EEGEGCGGG#AF(GEE6GC6F#A:EA.C8/EEEC?CH;CE;GC?G.((,A0GAC*(G8A.?4F(E0CEA*?EGG/E(
@antibody_17_multiplicity_83_copy_37-1/2
GGTGAAATCCACATAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCCCACCATCACCAAGGACACCTCCAAAAACCAGTTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGAACA
+
????9BBABB<5B-DDFGGGFCIFII+HCF@HIIAIHIF.CG>HGH>IHIIC?HH-HHHI+IHIHHIFHDFHHHEAEF?IF-8GIHHHEDFE5+DHH?CEFH34?FDFHEEAEFHD:BHEFBGFBHDH2FCE:DECGGFE8*FEEDGEEEG)GFEGFGGGC>=EEGGAEEGEEE9GGGEEEEE;:*;GG:EACGG(EE?8:4GGE(FE#?.CHEE.E((E8E*EC(E8E(A(6:GG?EC>(EGG:E**E*
@antibody_17_multiplicity_83_copy_38-1/2
ATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTTTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGACCATCTCTGAAGAGCAGGCTCACCATCTACCTGGACACCTCCAAAAACCAGGTGTTCCTTACAATGA
+
?,???BBBDDBD9DD@ECGEF4I/8FFCE/HC=GHI/FHHHIHIHD+HFI>II/*IFFAHFHIGCHFDI:#H5HGHIGFEFHDDHDC.HFHI@HGFDHH?IHHIDDH6H)F4GGD=HFBFHHFHGHDHGH.FEGFG3?GG@>GGG@GFF68E1EEGEGF>EGG6EEGFFFEGGEFFFECEGE(G/DEE:CGG:F(G:GEGE6GCEE:C?E#01(*;CEGE1FE?CE:EEGE8)EEE?(:EE:GG:(/FE-
@antibody_17_multiplicity_83_copy_39-1/2
CTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACATATTAATGTTAAATTGCGTGTACGACTACAGTAACTAGA
+
?????BB?@DDDDDD@BGGG,GIIHC/AIIGHI9E=IIFCG=I3HHEHH?HHIHFGHGHHF5FCAHE?GHEIH@IFICCGEH5AFHHD+EIFFDHHHHHEGHAD+4HIDHFGHFH/.ED4GCF*F9FDH>FE/GG5GC,69EFG+DG6G9?EDFEGGG=G9GA>E'BEACEEG@<#E.0C;AGE*?EG?FFCE(E:()EAC?GAE*A?6DGAHE*G(EG;;EFGEC.ECG/*8(AG*G::A/E<GF;G?8
@antibody_17_multiplicity_83_copy_40-1/2
GTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGGCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTTTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACACCAGGGGCTTTCCTGGGGGCTGACG
+
????9><>ADADD+DD-FE6FFIII@0>H-CIIHIIHICIHFFFF@FFHHF>DDIAF-EI5FHIIHIGG/FIFHFIIHDGFHHHIHHEH#=HFIHEFHHHH:H+H<HHH3=?HHHGEFHHF+GHHD>EGHBE*)EG9AEGCF01CGGFAFEFG?EFEG)AF?FF@.ECB)CFEDG'?EEE?=<(DGF'EF??(G(?*EFCE0/?EG?GC'AE:EFECCF/;,C?*CE//ADFEE/6EA*/ACGE0ECE8;
@antibody_17_multiplicity_83_copy_41-1/2
AAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGATTTTTGGAGGTGTCCTTGGTGATGGTGAGCTTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGGGTGCAAGCCACTCCAGGGGCTTTCTTGGGGGCTGACGGATCCAGGCCACACCCACTCCACTAGTGCT
+
?9??<?BBDDBBBDDBEFGGGFIF.HIEFIFD9HIE/FHHI@IDIHGCFE5EHIHHFH9IHF5H?IIBFHHAHHFHHIIIBICIIIHFHID@DEHFDHHHEEH-3=HHIHF@GH;FGHH<H>DHF,EGGGD*?01B?GG=ECD*GEEEDEF8FG66'EGFC<GE@GGEEEE4G(9GEFEG<:'G00(4EGGG0EECE?G:(E?'EEH/<C(EE(CG0C(FBGEED:(.EG>ECEE0:E:C.:/G<EEC0E
@antibody_17_multiplicity_83_copy_42-1/2
AAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCAACCTCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACATTGACCAACATGGACCCTGTGGAAAGAGGCACATATT
+
<5?5,?BBBDDDD?@DFGGCGFF>BH->HHFIIIIIEGIHAHF8IHIEFHGCCIEFFEFC-H>IH>HIHFFHAHH+FHEHFHIHHEI=HFEH7FGHHAH-H'HHHFH@<6HFHH;GB+GHEIFFEHBH4GHFGFEF2?G?CGF?FGGGGEFBE:GG0)G;GGGGEADEE?GG'E(ECGE?A?EGCAFECEF?CE/GGEECG??GGAC::-EEA/BGC/BGE0;/FA*F(D:GGEEG*6.::EGEG;C?A)
@antibody_17_multiplicity_83_copy_43-1/2
GTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTATCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACTCCACTAGTGCTGAGTTAGAACCCAGAGAAGGTGCAGG
+
?,=?5B/>BDD?<?B+GG/CAF;HHIAHIEHBFHGGHHHHIDI?FD@=IBD7GFGDCHH-IECD+HHG-CD-F?AHFEHEF5FIFICHGIHFCIHCGDHGFHGH+HHFHFHFFHEHHFFDEDGF;EGFFE0,EFGEBEG?GEFDEGB@EGEG4AE?EBG?GGA=E<EGFE(EGEGAE;E)-6G:CCC*G?AE:EGEGEEE(E8G60<EAHGC)FEC:0E,CGEEEEAC/G/0C>.EC?AG::??*.G<:C
@antibody_17_multiplicity_83_copy_44-1/2
TTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTATAGCGCTTATCATCATTCAAATAAATAAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCC
+
A???,B?BDD@DDD7DEFFCFGH-IHIHHIHGIFIIIFHIIIHHHHIIFFAIAHIIEHHHHACGHCEGGIEFHIIGHIGIEHIFEIFHH,FFCHHHH?CD3FHHEHDHFHHHEHBHFGDBGGFHDEF5FGDF<HEEEFD)E=GGGGEEEGEAE;2GEEG/CAFE?0GGGCG?EE,CEEG=CCEGEEG:?F?E*#1?.08GD*8*E<C?G?E:H08CF(E,F(EG(G8.*A*DC:E8C6CAC8E??(G8*E
@antibody_17_multiplicity_83_copy_45-1/2
TTGAAGGAGTCTGGTCCAACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAACGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACG
+
<???<BBBDBDD<DEDF.6FGGHIIIH/IHEIEIIFHHIHIHFIFFHIFIA7HHIHHHHFFIFHHBIFHIIHFDHHHFHICH)IGIG8H?GIIHGH#F4HEIDHAHFHBHHFHHD?GHD:HGHHFEFFGFB=FEGGD;EE4;GGG9GEG;EGGEEEG=#GG?GEFG?*GFE*GCGFEG6DGE:G6G?/(?GGEGC<EE?ECGE??E*G?:??HE4*BC7CF/A?*GEEC'AGG0;6E?.*EC?C.EEC/#
@antibody_17_multiplicity_83_copy_46-1/2
GGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGGCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCACGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGAACCAGC
+
?=?A?BBAD9-DDDDBEGFEC>HCCHHIHHGHH7FIIFEIGEHFIHH>GIFH)HIAFGIIIFFHGHGF=HEHI5IIHFIAEEIE=HGHEGGEHIIEHFHH@(D?38IHFHHHCH8EFFHH*D3H@H=GEGFFGGFIHFFEEFAGED/GGGFG;GGCGG;;GGFFECFE*C/E*BBEFCCEA/EEGCGFA*G;GE(E.E861?F:E0EAE*(G9EC0(?GABGE<CEGEA*GE?EG*FCA?EC>G/G-66*
@antibody_17_multiplicity_83_copy_47-1/2
CAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGACGTGTCCTTGGCGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATAATCATTTCAATAAATGAGTGCAAGCCACTCCAGGGGGTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACTCCACTAATG
+
=??,ABBBBDBBDD9DGGFGGFFIHHFHFHHHFCHFHDDIHHFFFFE.DHIABAIHHEFAIIID>HHHHHHFE5IHGAHHIGI0HHIF=CGI>EDDHH(HHH5HHHFE4.IHGH*@GHFH*(G=D(E@GEGD9G;GGE?GF@G<.GDGGGEGGBG=BAD3F?EG:EF(:GGG:G#>FA(D<E;/G4A8CF?0(FG8AE:EE6AG'A*EF.6(EA0CECE,:,6;G0C:GEGCG:>GEAE?CGA:;EG(0C
@antibody_17_multiplicity_83_copy_48-1/2
AAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCAGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTAACAATGACCAAGATGGACCCTTTGGACACAGGCACATATT
+
5A??AB-BDDBDD<DBEC8.CFFHFIHFHCIICHA=GA.0=EIHFHHHIIHCF=HH-F=HH9GHHHH(HI-H;IFGHA@HIHIFIH/I-BHHDBEHH5HGHHEIHHFHHHDHF@=EHADHEIFF>GEHGCEG;FGID?E8GGGA(-EGAGGEGC=*3EGGGCF()E(CFEEECDGDECAG?8C6EE;E<:E6E?8EG:(EGE.:(GED;)?E:EFE?(?E:'GG>(C18CE).G:/E(E***E:F?*6AA
@antibody_17_multiplicity_83_copy_49-1/2
GTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACG
+
?????BA?BEDD-?DD6GFGGFIFFIHIFFIIIFFEFHGHHCGHE@FF?HCIA7EH,HGF5DE-HHDIFHG-IIHA-<GBIH>5HFHHC?ADFFEI.HHFDFF5DCDEEHFCFGD@+HHB/7FEFGEFDCHEFEFGFG>GEF<GBE9CE2EE=(GFGCB*EAE=F;0C(AAE#EE?GFECG6G(4GFG6*(FAE'.G.CGCGCC?(E<E?EECEEEB?EDBE?F:?G*A?GG6?>C?*G/?CE#0:ECE9
@antibody_17_multiplicity_83_copy_50-1/2
CCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTATTCAGAGATGGGCTGTAGCGCTTATCATCATCCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACT
+
??,??<@BDB@@DD?BG@8GGGICHH@HFHHI9HHGIIFHEHHIIIAHICGHCFIHA9EGHIFHHI-HIF-=IHIHH5GHEIFGFFDHHHI8HFHCFHHD=HFIHEHDF@HH3EAFHEHBHHDEE*FGGE+H=EGGGE'4GGGG?GAGD>6A8DFEECB?FC:GG*EEEEECEC:FCDEFEG(G8FAE*EGG(*EG0??FGG6C?A:EGHCCEE@G?EEA?C8ACG:E8EC1CEEG*'E(G6CEFGD/C8
@antibody_17_multiplicity_83_copy_51-1/2
GCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCTCCTGGAGTGGCTTGCACTCATTTATTGGGATGATGATAAGCGCTACAGCCCATCTCTTAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAAGTGGTCCTTACAATGACAAACATGGACCCTGTGGACACAGGAACATATTAATGTTAAATTGCGTGTACG
+
5????<B<D-@DD+D-FFECCAIH-8HHE;@GIHHGHEHDEHHAHHAEIFGBHFHHFBCHEE?8HIHF52HEIEFHIHII-F+HHHD>HFH9HICGHHHHHFAHHH@GC(FDEFH++.>HFHH?H;FGGEFFGG:EDB*EBEGFGFFGFGF=GFCFG(EEE*:CGAG8EGFG?EE.;:GG(E6G?EE1E(F*.GCG<;*G0GGCA?EEECEE7FBC>(EG*C#6A?.EE6EG(A:?FG*??E(C?A.ECG
@antibody_17_multiplicity_83_copy_52-1/2
AGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTATAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGG
+
?????BBBDBBB@D<DGCGGGGIFHIEHHHH7ACFHHEH+HIFHGFFAHCIG?IHHH-EGHIHH-IEH@HHHHIF-FHCII;F=IDIHEBEI+HH.HIHHHDFDCHEHHFGHGHHFBGEFHFEHEHH+HFGFGDG*?4FGF;E>:DGC)0GGF:F*2E4G6GEG?CGEEEC2GGAGA-?C8-:G:GGAC(AE(GE<?EFG80GG/<HCA6GE;/BC(?GCB:0A8EEC;C?CE=CEEA:)E0D(:*C??A
@antibody_17_multiplicity_83_copy_53-1/2
GGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACA
+
9?=?A<BBDDD<DDD@GGGFFGHH/IHIFIGHFHIFHHIE?HFHDIH5HHFFG'IHHHGCHIHIHHCD>IHCGIHHIFHHIC*HCI8-GHD+GIIIH8CH3HHGHHDFI+4HD5FFHFFF8GFFFEF:EGGEEF,IACE?DE;EEF*E;EGA;EGGGCG?)FGEBGEE:GGEBG8GE:EGFC*GGGEE:EG=<FFEE69G((?AGE?EEH?C<A@8?*GEEGGGEEC:FE*GFA:F(E?ECE8G6E*CE(
@antibody_17_multiplicity_83_copy_54-1/2
CTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACATATTAATGTTAAGTTGCGTGTACGA
+
=5???BBBBDDDD@<DGEGF-CIHFHE6IHH7I-HHI.CEHHBGIEIHHHEHI@CEIGFHCIH+ICHHDH-IGCEEGE=+,FHIHHEFEH=HGIHE3@=EI@=FFFHHHHHHDFHHCICFGE(4@FECGFFFFF,*2GGGFFEG8@GD?HGGCGGEECG/GAFEGGE,ECG?2C??E(EG(EFACEGG*EGGGEDGC*(*DGAE?EHGEEGF*E/C<(B@E??E*GECGEEAE)/(E*(?EG6EC?:G?E
@antibody_17_multiplicity_83_copy_55-1/2
TCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTGTTGGAATGATGGTAAGCGCTACAACCCCTCTCTGCAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCATACAGTGAC
+
A?A???B?B-DB@EDDFCGAGC/CIFHHHICH>CEHG=II@H@EHHHCIHEHIFIIHFHFDHIFIA5FD,=FHDHCIFFI@HH=-GIHIHB=E8GCDHHGHHH@HFEHHHH*FD=FH8CFGEGHF<?GGG@AD*E?EG#EEFEGGEAFFE>BGGAC(E*F6?GEAAEG(E;EAE??:EGG(66G(C;*G?F(EEEG(6E*GGE8EGCFACECEG@E:EE7'C9E9EC:G6?E/G(EFCC8#8EC*.6?E(
@antibody_17_multiplicity_83_copy_56-1/2
CTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTGACTCAGCACTAGTGGAGTGGGTGTGGGCTGGCACCGTCAGCCCCCAGGAAAGCCCCTGGAGAGGCTGGCACTCATTTATTGGAATGATGATAAGCGCTACGGCCCATCTCTGAAGAACAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGACCTTACAATGACCAAC
+
=??<A?BB6BD@BB-5FGGF>FCHHCHHCEEGIHHHICC.HIDIEEIH+II>F=IIDFHFHIIFHFCHHFH5EI#HBIBCI=EFDBFHH+IDIHHH@HDHAIHFHH##H@BHDF+FGEHCEHEDG4HGH;E,+BEG#EGGF.EGEEE=GDE@BGE(GEGGECGEEDEEGDBEEGE*;G?*AF?EEGEEAEC#GAEEF:/EEC?8:G<CGEE:;GGGFEB70G6*6GE(*EEF8*(C(:(GGD*6C*.<EC
@antibody_17_multiplicity_83_copy_57-1/2
TTCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCACTAAATGAGTGCAAGCTACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACTCCACTAGTGCTGAGTGAGAACCCAGA
+
,???<B?BBDDBDDD?FGGGGGHAFCH-FEIGHHFIIHHFHHHGHEHIDFIADGEHHHH=.GHHIIHIFFCI-HFH5+HEFFGHIHEHHIHHGEFF?=EHHFGHDHAFHHHE@=H;HDHFDF,GHE:*FEF;G+G;GGEGF==GC;G?EFFFBFE<<E?G#GGGGE(GEEF8FGG((G?EEG;GEE.G?AE?6E8(<:GGFE#CCGECGH#AF:@CGA?:F)E#EF(((GGFAG:GEG?EE?*AE?(DG:
@antibody_17_multiplicity_83_copy_58-1/2
GGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACATATTAATGTTAAATTGCGTGTACGACTACAGTAACTAGATCTTAATCCGCGACTTTGACTACTGGGGCTAGTGAAC
+
?????@BBDDDDBDDDGGFGC>FIH.H/IIHHFDC.HIHFHIDIHIEGHHFIIHIHHHHGHD5IFDIIBFEHFHHCFIHAH3=HHI=FHHI.IIIFBHFFEH7HCHHGHGHEGHHEHHHEGFEGFD,G@E,E,;:BGHGEEEG:DFE;F?EDGG*C=6/DE8GEA(G:(EFE<EFE?:GGC?A:6CEAEEG/GEE6FE?F:*?CE(.G:HGE8;G?ECF<:EA-;0:*EEG(E0C?2E:?C8*FC(4:C(
@antibody_17_multiplicity_83_copy_59-1/2
TGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCCGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGTAGAGCCGGCTCACCATGACCAAGGACACCCCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTG
+
?A<??<?BDDDBDDDBACCGGGFFCCHIFFIIFI7@@F(IIHEGH>HHE.HIHIFI5HIFDHAHHCHIHHIFF;IICHGGH5FHIIF+HEFI-HGHHCHDHFHDFH=HEH?=HGGGF.G3E,HEFF=EGGFF6DGFGGAAEEEBH*GE0EEEEEG?G(EEF=?GE.DE)FFE/0G/6GE<C'E(CE<CEG/A*A:ECE.C?G/CG(E.G*?:.*:EEC,:B2ECCG0(C:CG.E<*EG6C*CE0E*F>EG
@antibody_17_multiplicity_83_copy_60-1/2
TCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGATGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATCGGAATGATGATATGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGATGGTCCTTACAATGACCAACATGGACCCTCTGATA
+
??=?5?BBDDDDD95@CG8FFCEFEIIEIIHEHHIHIHIIEGDAGEFHDFCHHF8HDI=DIHGEEFICIHIBCDEHGHEH-GFHIHGDGHGE?IHFDFHBDHEFHH3EDF+EHFHHHE#FHEG*EEEFG*G*F0EEGEG(GGCG@BE?FEFE#EECG'GE)EFEF6.EFGEEEGCG.G(FEF?E1GGGGFEGC?E6CEE0C/F-G/H(*HFEE**G'GGGEAG/EA;80G?E*/F):E*;EGG?()8)(*
@antibody_17_multiplicity_83_copy_61-1/2
CGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTTCTGGGGGCTGA
+
???<?BBBDDDDDDDDGFGFGGIFI/HHIHHHIEHHHHF7GEHICDGIHFFFFEHFEFIDIFIIHHHECIFH?IHEC-DIGHCIIICDD+GDFF75IHFBGHHHHFHHFBHHHHHHHHH(HEBEGDEGHGHEEG,?3H.E;GEGF@FE;FE82FEGGGEGGECB?CEBCEGECCE*E<EGGGG(ECGECEC?.GEA:6EEGE6:(E?EGHCGFAG?GGG@BAEC:<GACE*<::C:(G#(E?GCGFGFEG
@antibody_17_multiplicity_83_copy_62-1/2
TTAAGATCTCGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTGTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCCTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCTACTCCACTAGTGCTGAGTGAGAAC
+
,????B?<@-BDDDDDGCFGGCCH?II8HHHHH5H0HICHIGHEIDIHGCFCFHHFFHHAHCI5DF?HEEF@HIFHAECHGHIHAHEHGHHI*H-D.AIEFFFBEHHF@H/HFHFGFHD*F)#FF+HGAG#F@EGEDFGEE#41GEGEC*EG*EEFECCG;CECG?G6GGEEGFEF?A;EAFEC;*.GCCEEG**E?GG:GCEE8:ACEE/GAE@EFCC:G/GG8'CCG?GEGCA)GGC?CE?(?EE6:8
@antibody_17_multiplicity_83_copy_63-1/2
GAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATATGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGGGGTCCTTACAAGGACCAACATG
+
??<??BBBDD-<DDADGGGCFGHIE6HH+IHEHIHGHACHIDHH7IDIHIA@HI-IIHGIHACDIIHH5HCIIIG4HH(FHAGF-HEICHIHIAII<HHCFH:FHGFFDFHHGBDGGFGHDFG@GF0GBF(FE6(IFEDGG0GEB8=GFGGGDE;56?GCGGG?*#=FEEECFEGGE-GAGF??;DCCFAFEAFGCF.0:EGEA?CAGE??C*EG?/:FGECC(<?A*CE;8AGEEA*E)?*CCE?GGEE
@antibody_17_multiplicity_83_copy_64-1/2
GGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCGGGAGTGGCTTGCACTCATTTATTGGAATGATGATAACCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACGCGGTGG
+
?????B?BD@<BBDDDFGF.GCH6IIFHEFHHIC=HHG.GHBIIIHHFF0FDE-ECHHH5IFHIHHH>CHHHHFHH?E>HFHHHHAIFHHGHIDHG+EHDH?+HGHFH,FCF+*1G?H*HFFGFGEHGGFHGGHDAGFGG=0=?2AGA?G=GCG@*C?G9GGGEG:FEGE?,FE?GF/*GG?F>6G?E:2F(GEEEF?6EGCFEG*CE6EE/H@B)?FEEG?EGG8CECEAC066.:EFA:?E0F*80GG
@antibody_17_multiplicity_83_copy_65-1/2
CCTCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCATACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGGGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTACAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCCGCCCACACCCCC
+
?<,??BBBBBAB5D@?8-GGGG8IHHICCHDHIEAHH7F9FHGF/HG?HEIGI0EGHAHIIIGHAHFIHHIIFFFF5IGHAGDAHHHDHF?HDHEFCHDHFCHHHC=H.HFC6HEGDHHHDHFFFHHGF>FHEEF'FGFGE;GEGC86B'0E'E:EE-DG?,GEEEE@CB*GE(?CBCEECE?C:C(EECEGEEC/6*CECC?GEE?G*HECCGGE?(BGC,E(E//G8CAE*GEEC#CCF.*:**(?*?
@antibody_17_multiplicity_83_copy_66-1/2
TTAAGATCTAGTTACAGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCAACTGGTTTTTGGAGGTGTCCTTGGTGATGGAGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCGTCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCTCTCCACTAGTGCTGAGTGAGAAC
+
??,?<?-BBDDDDDD-GGFGEC8IFFHF8HIHFIIH9IIGFHEFF?FEI.ABCC-HHGIH>HDGHCIHAI-HFEIHFD5EEDGGFH---(HAHIHE@HIEFIHHDHHHHHICHFHEIHE*H<?F5GGBDGFGGDFI(=FGGF9G/G=,EE1CFAGG*F*CDE.6GE2GGGGGC(EDGGEDCEG0GEGGA(?GEAGE**EGGAE8C?E;/6FCHEEE;EEEE(C?AA#CCCA=G/C=A8ED??0:*G*<CE
@antibody_17_multiplicity_83_copy_67-1/2
CTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTAAATTGACCAACATGGACCCTGCGGACACAGGCACATATTACTGTTAAATTGCGTGTGCGA
+
?????>??DBDDDD-DFFFFGGIHCHFIFEHHACIIGAAAGIH9HHHDECHBIHH8:/IFFH8GIIFD=HFHF-H-HFE+HICGGIHHIH*EC<H+5=DCHHHIHE,FHEFECGHHFEDEHDG*EE+EFDF=HE=FG?HEEDGFGEEEGFGFGEFCGGGD,EE(GFEEGE(EGG:GAEC9A:G?FEEEAE(C*ECGA*E?EEGE?(EEE'G#:F<G?(EEEE6E:EEEE.(AEF**GEECEEA(AG(GGC
@antibody_17_multiplicity_83_copy_68-1/2
TCAGCTTGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGCTCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGAC
+
???,??ABDBBDDB-DFG8FGGIHHIEAHCDGIHHFIIIFCF9HH=F?/FH-EHH,FHA0+FGIIIDHICI(H+H>=4DAGHBHFHHIHIIHEFHAFHHDIHDGHIHH+H+FHCD+#/HG)HDD=GEFFDGE*H'GHFFHEFE6GF;GG*EGGG7GEEE;G@FG?FF<AC;G,EG'C+G:.E(G?1GGFC0EEGEGE?6GEAEF*EFCEEEE8EECGCCEGE<ECGD(8EGG1CE:0CEG:CCC8:*/GC
@antibody_17_multiplicity_83_copy_69-1/2
AACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTATGGAGGTCTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAATCGACTCCAGGGGCTTTCCTGGGGGCT
+
?,??ABBB@<<BDDEBGGGFCFHCAFHAIIIHIHIIEHFGHHHHEHICFHIHIHI.IHBHHIGHHGGH;IDIEIFHHDHIHHHHDHHC.IIHIG8GIHEIFGHHFDEHF?HDHGH*.GC:FBGFGGHFDBFGGEE;FG0*G#BGE@GFG(GE?EGG=GEE8GAGAG(GE0GE0=AFE/AB2+GAEG;FFE?GEEFGAGGGGGE(*GEEG*G.7FCEEEC@BF9*?(*EFGEEE;FG4C?1E?:G1GCGE*
@antibody_17_multiplicity_83_copy_70-1/2
ACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCCCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGACTGCAAGCCACTCCGGGGGCTTTCCTGGGGGCTGACGGCT
+
??A??ABB6DDDEDDAFGGFGGBHHEHIHH977IIFFHIF@HF>FBFH-CC-IFHHHDFFIHF'GCFHHABIHG*IHFHHGIHGEF=IHHEH5HHHIIEH=GHHIHHHHFDFEHHHE#G)FHGFFC>EAE:DHG,GCGE@;GFEGE@.EG16GFGCGGG<CGECEEAGAG:EEG(CC?EG6E.G?G>?F*E6(*EEEGE(FGDAEEH*G<((H0G8(:CF?,'?.C*FAEG6C?E0GA9FE:GEAGGC.?
@antibody_17_multiplicity_83_copy_71-1/2
CGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTATAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCGTCAGAGATGGGCTGTAGCGGTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGACTGG
+
?==?ABBBDBD-DBDD0GFFGEHIIHI/?IFGAH7@EH,.IH9IHIFIHIFH=;HIHFIHFF=HIAH5HH>HCCHI.IHIIDHIFEIIHIHACHH,HE=HIDF@FI?FHHEHBHHFBGFHF*2GGGGF+GB#+F=EFCGEABCE?,GEFDC;DEG6:EF>EG?EECG8FGFG6(CC/CGGF4G6EG?FC(GG#:AEE?E?8C<?CEEE*CAGE@(::?(E?(C?8G#G:E0A/AGE0C8:*E/E*1*:C*
@antibody_17_multiplicity_83_copy_72-1/2
TAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGTGCTGTAGCGCTTATCATCATTCCAGTAAATGAGTGCAAGCCCCTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACTCCAATAGTGCTGAGTCTGAACC
+
????AB-BDDDDDDEDGFGCG>FIHHI5HEIHIFIH/IHHHH/FH.EEFCG@EI5HE-HIEHH5IFH-?GHH@HIHHDI+FFAHFDHHEFHH7CH3GF;HIHD-DDHHFHHH@3HFDC=FFH<GHGGE?G04ED;GEGF*FEGGEFAGGDEE;E.8CGEEEFF.'GGEFCEAGE.E:AE(F(CGEE*)AEEGA?*A2GGG?E:<*?H;EA?CAGB*?C0E2FEC/FG:EG6(??:CE2FAD/G*(:0>G?
@antibody_17_multiplicity_83_copy_73-1/2
AAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGAACTAGTGGAGTGGGTGTGGGCTGGATTCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTAGAATGATGATATGCGCTACAGCCCATCTCTGATGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGGCCATCATGG
+
,<???BB5<DDD@B+DEFFF*CHHAHHHIHHIIIEHIHH.HHIHHIH-C-HCC.IFHGIFCFA.FFHE@CFHHAFFI-FC0IFE)EHHHHIII=,DGHHHHHDG+HH+HEDHDG*DHGHG<HG(HGDEDG+?GDFGHFGFG(DAFDEE)EA:AG:?EEEGAF:#(GGGEEEDEGF:C=GCE+EG(F:E9GECEGCEF:E:F:E?:AEEE?(?CE@C?E8ECG**ECECF?FEEC'GGCCC#CG?1:'CG0
@antibody_17_multiplicity_83_copy_74-1/2
CAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTTCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGGCTGCTCTTCAGAGATAGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACACCAGTGGCTTTCCTGGGGGTTGACGGATCCAGCCCACACCGACTCAACTAGTGC
+
,,,??B,BD@DB@DDEGGCGGFIIFCFFHIFIIGEGFEIIGHBHH+HEIHEHE.HHDIIIHEHHHI5,C-IHHIED#IHIHIHIIEHADH?IIIHHHHH.HFHFFIHFHDEG9*F#D;?FGDFF=9=HGG*F=G(FFFHEGD3+DE+EF?6EEE(EF:EEGF0*C1E0GEEGGGGACGG00-EEEE=AFGGEE(F(1A0G(GF(EE?(C?0EAE:*:EC(CAE-CA/EG:EG/?GE(:FCC(6)EC/(*E
@antibody_17_multiplicity_83_copy_75-1/2
AGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATTTGCCTGTGTTCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGACGTGTCCTTGGTGATGGTGAGCATGCTCTTCAGAGACGGGCTGTAGCGCTTAGCATCATTCCAATAAGTGAGTGGTAGCCACTCCACGGGCTTTAGTGGG
+
?????BB5D?B9DD@AFEDFG.IIEIHFHIIHHF8DFIECIHDGIFHFHIHHIHFCGIHCIHHGIHHDHIFHFH*F5HHHHHFHEHHIHE-HHH+HHHIAHFH<#HF3FDHIHCF@HC)GF.?DH@HEHHFFDCFD)9DEE?EAEGEE8E*EE=GBCGFAG?G8EEEEFG#/*CAEAFGE9G.E6''EGFGF#FGE?A.(://<ECHG:E?AEC.GC/B@G>0G**A?ACAEED'8*E/<CCF6*#*C*C
@antibody_17_multiplicity_83_copy_76-1/2
GACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACATATTAATGTAAAATT
+
<???=BB-<BBDDDDDG>CBF;.IFFIIIFH-EEFGEIGFFHE@FHIAH9EEAE:FHIGHF5HHFIIHIFI=?CDHI>HHCI-FEAII?EHGF.-HI+EHFCHGF-4EAH+EH3HICGHEHFHDFHHEGC<CEHGG*G9?F=EDACDEGCGGGE2CE0GCCGEGGEEGBG6('FC?*FFG/EGG8G;E(((CGE:G-GFCFGCFEG(EEFEE@CEEBG:CG:GGG0E)*CCG?(E(GEECA?:G')??(E
@antibody_17_multiplicity_83_copy_77-1/2
AAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAACGCTTACCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTGACGGATCCAGCCCACACCCACTCCACTAGTGCT
+
?????9=B<D---BDDGFGG>GCI>HEHFFHIIHHFHIIIH-IHFHAD8IIBH?.HHEGCHD?HIIIGHIDFI-5FHDHICH-IH8HGFEH-HHHEHHHFH+HH6HIH;GHE7HCHHHDDBHDGGH(EFGGBGFGGEGGEDEGEC3@:*EEAEFG<E#EAGEEE(CEE;C.EGG*:*AC5GGC<DCC2C-C:EGGEAC*EG28E/;H:E??A/FEE77FE:8GG6E?D.A4GE?EEEE(:(?E/6AE?EC
@antibody_17_multiplicity_83_copy_78-1/2
ACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTATTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTCGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTACTTGGTGATGGTGAGCCTGCACTTCAGAGATGGGCTGTAGCGATTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGGCTTTCCTGGGGGCTG
+
<?,??BBBD<BD<DDBFG5FFGIHCHHHH,IHHI7FHHECHH.IGI=IHAFE>FHEIEHFFH*IH/@GHFHGIHFFGGFAHHFHDE57HIGIHGHFHIHDEGHCC4HHGIH@HDH#FH3>HF8FHHHEGGG5DEDEEG;*G(?FC3FG,G#GA2D?'AFG*EGCG>GC8(C*(EFAFC:G6:FC?/E?CC0DG*GF?E.CEEEF0:0GE?EGDA<GC(7GB>C>?>*E*66FEEEG(EFE-CCEGGCAGE
@antibody_17_multiplicity_83_copy_79-1/2
CTGAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGTCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCCCTCCAGGGGCTTTCCT
+
A5?????BDDD@D9<9FFFCFGIHIHI/HIHH9IFFCHF.FCDEDFFHIIIFHI>HGIHCIFI'DDFFIHFCIHG=IIIIHIFHIGEFFIHFEFFHHHIGFFHEIBFI+EHHCDF1HHE@GHFHEHEHFEE*G?DGDGFD1F@CGGDFEGG=GC:/?E*G)EGGF;E.G;E)GFBGDFEGEA8?FACG(CG((EGFG?GGE?GC*::D(FCE.EGG*<G,FE/G<(E6?A*GF'?G8E?:?(GCEF?E.:
@antibody_17_multiplicity_83_copy_80-1/2
TCGAAGGAGTCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCAATAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCTACAGCCCATCTCTGAGGGGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGTTCCTTACAATGACCAACA
+
,5????BBBDDDDBDDGFFGG+HIF6IIHE>HFGAHH9ABH7>AF.0@GGICGHIIHHHE-IIFE+/-:CCHDEIHEIHHFH+IGIHCHHGHFFAHFCHGFHCH?+EFH4DEHD@DDHF+FHHHDHFG@A?F3EBAEEFCFGFEAGGEF@E;;E(EEE;EGC?GFE/6*GEFF/9(GGEE:0GAEGG#C*E8CG(:A0?CGG6EG?EG<:CCA@GG8E#EGEG>CGCG(G?(ECEEG?C6E.E.AD-E?.
@antibody_17_multiplicity_83_copy_81-1/2
AATCTGGTCCTACGCTGGTGAAATCCACACAGACCCTCACGCTGACCTGCACCTTCTCTTGGTTCTCACTCAGCACTAGTGGAGTGGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGCCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATGATAAGCGCAACAGCCCATCTCTGAAGAGCAGGCTCACCATCACCAAGAACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCC
+
???9?BBBDD@5DD<<GF;EFG6/IH6HIFIHHHHH9HIH'9HHGIICEIGHHGHHCIF/DCHIHFFHHCGHEDHH;GIFFFAEIIICIDD/FIIACDIIGFHHHFGHHFCEHEGHEF3?GDB7@=CEE@EGF?FDF99EFDGEFDE*GE<EGDE,EGEG0GGG(E0EE?*?EGGA;BA*GEEGG>GE8AE?:A*:G6GCCGG*GEA(*E.(<EG:)EF:.;C?EEECGC*:AG?:CE:ECAEG8C0::(
@antibody_17_multiplicity_83_copy_82-1/2
GAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGGCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACGCCAGGGGCTTTCCTGGGGG
+
?A?<?B/>D-DB@DDBAFGCCFHEF>HHFHI,HHCBHDF=ECFFIDH+HHCH8H8GHGC@0.AHHEHBH+DHBHC5I)5HHEFHIFBHIFI+FIH5EEDHEGHG?HG+HHGEHH+HEBFDFEDHEH*G?CFEG;HGGEGF=E23D:GFCEGG#@GE6G:A6FGGGGGGAFEE6EEEFE:.68'6CGEEEFGGDEFACD6F8E;?=GH)C.1E;4GE(A;E80EEG?*:G:)*';A:6?<ECC?GE6CEEG
@antibody_17_multiplicity_83_copy_83-1/2
TTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGTTACTGTAGTCGTACACGCAATTTAACATTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGCGCTTTCGTGGGGGCTGACGGATTCAGCCC
+
=?<??B?BDDDDDDD-CFFGCFIEIEF>HE9IHDHFHIEHHIEHFIHHHDFHHD>GGHH5HHIHIGIGF5I.IDHECDIIGCHCGHHIFE+AIIHHFHCHH?HHFFHGHHFAH=EEH+DEDDF@A>HFG:DCC8GFEF=@EFECGGFFGG*6BEBEF?,CCCFEEE?*:EAE/FGGEEEAEECG8GAG(C?CGG,ACACEGF>GC:H(GCAA/G=?EE:E7C1*C:A(EGECE(C88?:*GEC(CG<:CD
@antibody_18_multiplicity_61_copy_1-1/2
GGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAAGACCACCTGGTTTTTGGAGGTATCCTTGGTGATGGTGAGCCTGTTGTTTAGAGATGGGCTGTAGCGCTTAGGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTTGGGGCTGACGGATCCAGC
+
=??A,BB?DD+B@DDDC>GG.GBI>>FFHFFIHIIHFH-HH-+HGHHHIFHIEHHFH-HHFAF.IFHCIHIGHICEHH+HCHGGFAICCHHHHBHHGFIFCHHIH*DHHEBIHHFDHEFH:CFHE@GHFFCGF4GE8**GD@GBGDEFG2FGC>GGDEE#?GGG'E?4E?(GEG?CAG*0GF(?GG*ADEAFE4EEEGF?.G?EFE(*A.:AH:EG7F7ECCA/E(FAGCE#?*E0EE:-FCCEF8C)*E
@antibody_18_multiplicity_61_copy_2-1/2
GTAGTCAAAGTCGCGGATGAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAACAAATGAGTGCAAGCCACTCCATGGCCTTTCCTGGGGGCTGACGGATCCAGCCAACACCTACTCCAC
+
?A=??5B7DD?D-D-DGG/F-GIHEIHIIIHHIIFIIDIFH+FHIFGHBGICEHHGGDFFC,.BHFIHHI-FIF5HHHEI-D,EIHIF-EHDFHF@DFHHDH?5CDHHH3HHEH<CFHGFDEHFCAGEFFCGEEGFFFEEF8?*GCADCGGEBF<EGG*EEBBGF<ECGGGE((EGAG?EG:=-GCEGCFCG)FFGG:8G.(C0(-(A(<*FC@GCGE?:?F/?CG6C/A?:AG?C#AG(E(E:?EE6:/
@antibody_18_multiplicity_61_copy_3-1/2
CCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCCCTTTTGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCTTTTCCTGGGGGCTGACGGATCCAGCCCAC
+
?,<A?//BBD@BBDD@EFFC-EHICHHIIHHCHH77H?H-HIF9IIE9FHEGI.F/H'IHGHHIDHI+IH-HHFHGFIHHHIDGIHHHHGDC+I=EH9EHHEDGHHI<HGHFF@HEHFIF)BG+?HDHHFFGHGDGFBGEGG0@G-EGEEDEG:FG*GG(ECGE86AGC6C<GEDGE(E:E#GC1CA9C<:*E)EG8GEE*-G'E?H:?AAGA:BEEFF7((:E*GC:G8GG;FG'.E2A6EAEGG:EE.
@antibody_18_multiplicity_61_copy_4-1/2
CTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACCGCAGGCTTACCATCACCAAGGACACCTCCAAAAACCCGGTGGTCCTTACAATGACCAACATGGACCCTGT
+
?????B?ABDDBDDBDCGCGGCFHHHIHFIFHGHGB?HHFHIHGIII=HA5HFGDII;FE8H-GFFHF>AHHAGD*GA>CEBIHH<HHC-IEHIH=FFHHHEDHHFHDHHFH+EFHF>EG@DHHCG5F5F?FHEEGG8.EHEE)G*FC<)GCAGCEEE;E/CA,GFGGGGAGEGGCGEF*EECGEGC(;EEA(GCGE?EE;GAFG:8EGHECE7B*'G/:CFEEE*AA?*GE*<AGEEEAC?(6C?:C:A
@antibody_18_multiplicity_61_copy_5-1/2
TTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCTTTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTGACAATGACCAACA
+
?????7@?@ADBBB-@G8ACGGEFIHI-I+HGHCEIEHDHI9H.FHC>IFEHAHI9+H?IHHEFIHED=GHIHGIID@I5GEHHHHHHFIH5HIGHGHHHDHGH*FHDGHE*HHGHFEFHBCHHAEEG9DCDGG:G;G=FEEGEED=#GGGG(GG=:BGAE9EEGGE*EFG.:EEEGFEEEEEE?DEEGEGCFC(E:EFG:EGC*C/G:FEE@;:EFG3EE'*?A.*EEGCG?C?A*CA:;*)E?:?28C
@antibody_18_multiplicity_61_copy_6-1/2
TAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTATTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTTTGATCATTCCAATCAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGCATCCAGCCCACACCTACTCCACT
+
????,B+BDB,<DDDDGEEGGGFCI8H8FCEIIAHI7HHHIHHHHGDFHG>HFFHAGFDHHGHFHEBHIIFHH>DAHGHFIHIFAHGH=HHHCDIHH=FF(H6HHEHFHEHH+H?AFGHGEEDFFCD<EGEEEF#EGGGG3FE9EGC(E;FGEGA6?EAEBG(GC(;AG*/GFF(;EA=GEGE)GG86ECGG<GEEGGGE#*CFGC#;G:6A7GC.FE;</.4?GG*FF*?F/GC'AC::GAE):00.GA
@antibody_18_multiplicity_61_copy_7-1/2
AAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTGATATGTGCCGGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCATTGGTGATGGTGAGCCTCCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGGATCCAGCCCACACCTACTCCACTAGTGC
+
5==9?BBBDDD5EBDBGGFFGFAIH5HHE+HGEIHHEIICFHEEIIHHH(CHGEG+F+HH,A+DIGHCFHFHCHI5GHICG5IIFFIHFHFFHFHHIFHD/@IDHHECFCFHDDHHGHF*FHE=C0G;EFEEGDGEB,FFC5FEDEC*EG*GEE/GEGGGECE6F?E#A@EECA<GGEGA?G=GAAFG:FGE6CGGECG(EEE/GGHFCF.EE@E(EC##8GE?>A;(G8*EGEEEEEC*AEG/*C6F*6
@antibody_18_multiplicity_61_copy_8-1/2
CCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACTTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGTCCTTTCCTGGGGGCTGCCGGATTCAGCCCACACCTACTC
+
A,???BBBEDDDDD--GF@88GHHIFBIH;EHAIDHHHHH>FEHIEHHIHHIHDHHHHHAIIHIHIHFH8IHFDEDGIIFHHFHIICHHHHHHFHGDCHHDHFH9HHHHH#FGE)GEB@6*HGGDDAFE1DGHGE*EBF:8FFG(FCCGEEGE:EFEG;GGEFG:*GEAEGE;D:<0EE(++GE:E8ECAEAG?:(A0EEEC4GG?6(GF*(H(C*EEF(*??GEE(*EEFA0#?*;E0:?8::8G?GC6
@antibody_18_multiplicity_61_copy_9-1/2
ATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAGACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCCACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGA
+
<???<BBBDD-DD-DDGGCGGE>H/HCICIGFHC,HAHFHHFHHFEA?.EIIH,HHFHFHHH'EI+I5HFHDHEH?HIDHBAGHC5FHHHEHHEHGEHHI@ECHHHICHCH#EEHFE;@@HFGEGFH/EE+EGBDE=DE(EE(GFGE0GFAG2H:GE*GGEGC?=FEC,;CEEDEA;(C/EFGFE(E:.E0EEEGG<D;?EE'?1EEAE.C:HA(DBEFD:G1GC)EEC(/:E0EGE?::CEC?2E'E<E
@antibody_18_multiplicity_61_copy_10-1/2
TAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTGCTGGGGGCTGACGGATCCAGCCCACACCTACTCCACCAGTGCTGAGTGAGAACCCAGAGAA
+
9=?,?BBBDDDDDDBDGG6FFGCHHHIHFIHHIFHDD:IIHGHAI7IHHI@EHEH5HGH?FFHEH-HI=GHHIFHIHHHEGHH=IEBHHIIADGGIGIHHGGCFIIDFGHH+FD=FGDAE?5FEF)E,H=FEFGGFG14DGGEC;EFGGG:GGFCEFFEFG@;E6*:G8AA(9FAA<(-(G;(GGCCE/*A(AEEEEFCG*GG;E8EF:EG6HG.G:EEAE'A*D(E8F*)GGG6A*G:?C/CC)EA::*
@antibody_18_multiplicity_61_copy_11-1/2
GTGACCAGGGTTCCCTGGCCCCAGTAGTTAAAGTCGCCGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGATTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACG
+
5????<-?@DDD<DDBCFGGCFIIHIHH+FCAAGIGH+HHHEFH9DIDHHCIEIHHHFHIIHII:IFHIIFFDH-FI#HHHHHIHFIHIFGH7FHBF.HF->HEHHHHHCEGIHFHEEECHHHHDF)GFG*GHGHGFFDEGF*GFEE*GGAGG<E*GEFEEG8CE60<FEFE:FAGAGGAG8*EAEE8?AEF0G0EG;GEFE:GAEHEAE*:H1F?GCC0G0GGG*EG?EC-:F*E?GAFEC*EEG(C:C
@antibody_18_multiplicity_61_copy_12-1/2
CGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTGCATGTTGGTCATTGTTAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGACCATTCCAATAAATGAGTGCAAGCTACTCCAGGGCCTTTCCGGGGGGCTGACGGATCCAGCCCACACCAACTCCACAAGTGCTGAGT
+
A??<<B/?BDD@DDBDGCAGFBIICIB.;IH9GHDHIEIFIFHGIHIII=HHDGGFFHFGH,HIGHGF-EH+HDGH-GG,H>HHHCD+IHHFH<ECIHHI<FIHHFEHHHHFHEDFFFFE=+GH=H**GFHGHGFFDG??FGFE?G1FDE*EFGCGFCGE(GE#F*E(GG=FEG?GGCE6(EEEA(E0CAEC9.CG6)G4G8GE*4CGE(*EEE;*GG8:7GEA(8<4::?/C8EE?/C(1CCG>G(1E8
@antibody_18_multiplicity_61_copy_13-1/2
CAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAACGAGTGCAAGTCACTCCAGGACCTTTCCTGGGGCTTCACGGATCCAGCCCACACCCACTCC
+
?????BBBDDD@DDDDGCFFGFE>HIH+FBGIICHHHFGAIFFH>DDHFH@@AFCICIIH>EG-FDH5HICFEHIFH@DDIFF>HHIIHHHH=IHHDDHHDHDGE=H=D@ECFHEDDDDH;GFBG=GHEDGF:*>E<2FEBGFGFG1G@CFD2;EGCCGFFFCGFEAGEG@GGGFEGGC6:6E??06EE(C:EG(AAA<*<E(0DFEAE*EG:.0E:?;E?E'*D(C'?E*E?*GGGC;CEG?G*CC:GG
@antibody_18_multiplicity_61_copy_14-1/2
AAAGTCGCGGATAAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGCTGGGCTGTAGCGCTTAAGATCATTCAAATAAATGCGTGCAAGCAACTCCCGGGCCTTTCCTGGGGGCTGCCGGATCCAGCCCACACCTACTCCACTAGTGC
+
????<@B5DDDA+@DBF>/-CGIAIEHICHAIGHHH9FHICG9CHIFD+GDCFDECGI7HHCH,IEHIHCIHHIICIFFIIH-CIFFFEG=IHHIH-GHHHFFDFFFDHH6HF?HFFDHHGHGEGF*G(FEF3HGEDBF=8GGFGG-E(GAGGG;EE?DEGG9GG(D:A6CEG?/G(:A(0EG(EGE(:.E*#F(GFC(.EAEEEECEGFE(AC(GCE(EGEGG?GE.?E9**GEEC.A?G2?>EA<:8?
@antibody_18_multiplicity_61_copy_15-1/2
TCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGTGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGGATCCAGCCGACACCTACTCCACTACT
+
<?=5?<B?DDBDDDDDGAGFFEHF?IFH/EHDHIF@IHFGHHIACGIIHHEIIHF-HHHH-FIHCCH8I5HFHFGIIFHG--FIHHIFHH8HAIDEBIF+-IFHEHGCDDHEE:D5HDFE*FH@FAFG?HGAG9H?HEEBG,E4;G=*<FE?@ECGFGEGGA*EE'GCE?F?A@CE:EEC?(EEC(A0GGGE;(AE):0ECGGG0:<?GHF.H@E?B(C<'C(:CA#EE.0/#(#.::A*.:8(EG?*(G
@antibody_18_multiplicity_61_copy_16-1/2
ACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGCCTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACACGGACCCTGTGGACACTGGCACATATTAC
+
?????>B-BDBD@D?BGGF.FFFHHHIEIHFHIHEIIII7HCHHII-HHFH.I@HGHGHG-.I-HAIG5HHHHECHDCGIHDIGFHI:AHHCHGDFH+IHHFDFHFDIHHH?HHGEFFFFD*G2FHF:HEGFG+4FECE+*E?(>GDEDG;FGGGCGAEGFBEECE6GGFGG./G?GAG?:+G*GFCG(GEF?6?EECEE4CE:ECECGCF*DF0CCE?EE,?G:EE(0.E<C2E.E0CCE?E60GEEC1
@antibody_18_multiplicity_61_copy_17-1/2
ACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCCTGGTGATGGTGAGCCTGCTTTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGGATCGAGCCCACACCTACTCCACTAGTGCTGAGTGAGAACCCCGAGGAGGTGC
+
????=B@BBD?DDDD@.GGGGFHFIHHFHHHICDHFII=.HEHGHFHH,HGIB-EIGIF5GIIH>FIIF5IIEHFIIAHIH?IIBEIH@FHHEHEF2EDFFBEHHHHHHEHHFHHG#GD=+,GDG,GGDH;G5EDGBHG;CEGGBFCACEECF;FC?C8E?A?CGEA(E);GE1EGFG0*EEC?E*EGCGEE/G*GAAG'C6G(>EH)C'/.CDB:E-9,GEE*CG(G6G'E/GEA?CC#CE**6C?GEE
@antibody_18_multiplicity_61_copy_18-1/2
AAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACGAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTTGAGTGGCTTGCACTCATTTATTAGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCAACACCAAGGACACCTCCAAAAACCAGGTGGACCTTACAGTGACCAACATGG
+
????,<B<<DDDDDDDG;FFGCCIIHFH>FHGD0IEDHFFAFAHIHFHHI8HBDH.IIH8F8GHAFIFICH-GHHFG-?D#C#CGHDGHIH.I+H4FGFFH*FAH.HD:HF:HFDE@FHHEEHDEFEG'G=FGFGFFEGF8CG*G6EGE?G#EGAGBEFBDGH;CGG(>EFCGECEFGEA(EAE;EDE?8GF(GGCFEC#<:A6GFHEECGE(;:;GEG:GF'(EGCCE(CG:G..E(E:CE(C'8GG(E
@antibody_18_multiplicity_61_copy_19-1/2
TGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGACCAGCAGGCTCACCATCACCAAGGAGACCTCCAAAAACCAGGTGGTCGTTACAATGACCAACATTGACCCTGTG
+
5????BBBDBBD<BA@GFFGFFI=HIEFH/HHH9DGIHFHAHFDIHFH8IGHGFH9>IFHI=DHBFIIBEFEIHHIFIHGHC-EHHFHHIEHIH.:II.>DGFCEI@HHHCH0D+GHFDFDF9B;?D3;EAEGFF;FGGEF0AFDBCCFFG(?(?C;EEBGFFGAAGG.GEFGFD<'GEFCEFEEG)EEE(C:F:E*0C6G#GGEA*E6ECE0:=E9??EGA8.1AE:E2CC1??GFAE(//E:?((E??
@antibody_18_multiplicity_61_copy_20-1/2
CCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATAGTGAGCCTCCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCATGCCACTCCAGGGCCTTTCCTGGGGGCTGGAGGATCCACCCTACACCTACTC
+
?AA<AABBB@<-B-@DFCDGFFHIHIF+HIAFI.GIG+FHDHHHHIEBBHBH8HGHHHHEHIHGIIEDIHIC=HHHH5HHHIHHH,GHIAIHIF*HFE7FI+H+HFHFFFB4FHHAHCHGEF;E(;?EECGDDED)G#E;EEAGC***BGFFDG#DG;GCEEFFG(GF(6GEF6A(:C.E:F2EE1'C?GGFCDEAE<.EC(*40C8?G<G**(EE0E,CCG:GAE?#*ACCAEEE*G('4G*:GEG*?*
@antibody_18_multiplicity_61_copy_21-1/2
AGATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCTCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAACGACACCTCCAAAAACCAGGTGGTCCTTACAGT
+
????=B9BD@<DDDDBGFFFFCHFHHI;IHHF5HHEAHIII.IHHE@FHF=DHHHFDHG:DCFEH-HHHGHHGHHDIHHH6HIHGHCHAHHFHDHGECE/H)H=HEFGI+C4H?HDH+IHGHCF+H*D5DEGD=GIE@EEBFE,GECEECE88EF;EFEE(GCC)?AEEG(GEEGB'8GCEAEEG<GEG?0#:E?:GEF?CG*GAG?A-;GEEC:EF*-EB:EEF.GDEEG:C(:GGE=*G8ECE'0C*:
@antibody_18_multiplicity_61_copy_22-1/2
AGGAGACGGTGACCAGGGTTCCCTGGACCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAGCAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGCTGGTGAGCCTGCCGGTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGG
+
???<?BBB@DDDDDDDFCG8C>HHCI-IIICHHGIIIHFIGIHDFFIHHHHHHDFI@FH+F+HIFHICADCH-HHF7H5HDHFI/IHCFHDHHIH-HHDHHFCH@IDDHEHH=EHBBFEF?FBHFHH.E2GAEH,FGCGEFGCG;-GDECGGG0EEGEECEAE(>FF1GEEEEGCE#A#EFGCEGG8GCFAG*GG?EECE>)=FGEA#(AEE;'B:GE:@BE=CE:G:':G:?9*?GA<(G(E0(6A(GE
@antibody_18_multiplicity_61_copy_23-1/2
TGAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGAAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAGTGAGTGCATGCCAGTCCGGGGCCTATCCTG
+
=????BB@BEBD@DBDCFGGFFHHHHAIEHIHGHDI@HEHHH7HIFFAH..FGHHAFI5HHIA9FF*GIEIHH-FHFHI-HIFDHDF8BGHHFHIHCICABBHIC5HGHHGFHHHFA;FEFD?H8/GDHHE=9?;DBGG(FEEDE>GFCE#GF:GG?E/?EECFFE*GEG'2CEEGECE'GEGCEG;GDA8.GEGE/GEEGEE:/:/GEEGA7FGGE1G/C(:AE**E'E?F?**C=1?(G6?*(;(ECG
@antibody_18_multiplicity_61_copy_24-1/2
ACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTAACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTGCAGCCCATCTTTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAACACCAGGTGGTCCTTACAATGACCAACATGGAGCCTGTGGAAACAG
+
???A?<BBD?@B@<D5FFFCGCHHHHIHHIIIHBIDEEIIGIFH.BHGHDHGFC=0I+HGIGFFHAHIFFIHFCFFF*IIDHFHHHHHHGDFIHHHHGH5HFHDHCHICGHF@DBHHHHDFHGEFF)B(FDHH9=FCGEEDEGEF;EE9@FE=D#FG(GGE>GEC(,EGE::*6FFA<:DEG*E>*C:*A1EEG4G':EGGG(G#FE?(HFCFG:*GE:(*AEEAGEA*::'/;G/.CA/A:E:/(;*EE
@antibody_18_multiplicity_61_copy_25-1/2
TTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAACACCAAGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACATATTACTGTTAAATTGGGTGTACGACTACAGTAATTAGATCTTCAT
+
==?A?BBBBDB5@DD@F/GBG>HEHIFIHHDHIHHGEFIH@/HEGAG=CED>FHFHHHH=FIH>GFHHHFCIFHAIIHI-ICADIH8HFHHHHFH,HEHHHIG+HHHGDHG?(HFHDFFFB,DGF+GDEFH(EE*43GFDF<EGGGF8D5FE;#CF*6#DEGD3CE=ECGG/(CGG?E(EEG?GGECGFC;CCEEG0G?EE:EEECEG'EEEAGC8DG)@B;FG'?E/0*EG::CGF*GFEAA0?G?(GA
@antibody_18_multiplicity_61_copy_26-1/2
GAGGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGTACCACCTCGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTCGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGG
+
?==<?BBB<DDDBDDBFFCFFFHHHIHIF;IHF?IHHG9IF-FHII.CHCHIHGGFD.DHABFFED=IHBHICCH.4HDHHIHHG.IH=DFDFHHH#HHHHFH;H@AHHFDGFH?HH=GHE*BGGHEGF+EEE(F.<GGG>(EEGFEFG8F;:GGGGCGCD=GG>EGC?FBEFG,EEE?CFGEGGEGEGE(?GG:.A6DEGG2EF:8?GCEEC@C?G>(FG,/G(?GACC.A?:-.C:A?G8(:CAECFE
@antibody_18_multiplicity_61_copy_27-1/2
TGAGGAGACGTTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCTAATTTAACAGTAATCTGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGCGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAAATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGCGCCTTTCCTG
+
=A?AABBBDD-DD5@DF5GGFFHH8FFHFFCHEHHEICAIHCIGD9DH@DHFHF=HHGE-IFH;I=FIEGIIHHFIIHH#IFGFHH4F6FFIH,#H?EHFHHEFFHDDFHDEEHH/DHFE@HDHHCG,FDEDHGGCE(EHGGCAE1CGGG74FC*EEFF>*9EGGB@EBGE?EGE2GGGGE(GCC()*FF?GGGGG:/AEGGGEECEE?EA(E@C/BC80:C(8AG*E'C:G>0C(E:E'(*(E?AGG(*
@antibody_18_multiplicity_61_copy_28-1/2
GTACACCCAATTTAAGAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTTCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGGATCCAGCCCACAGCTACTCCACTAGTGCTGAGTGAGAACCCAGAGAAGGTGCAGGACAGCT
+
??<??>BBBD-BDDB+GFG/GFHF>HIFEHHHCH0GIIFEHGHEIIDHF>H5HFFHIEC=+HHCGIHFHIHFFDHF=I=FIIGHDIH?DHDDG)FIH+EHIIHEDGHEEHHEHEIHDF4FBDGGD?F=@HG;HFE=98EEGCGFEGEGBFCEG,:A?GEEG:EFG*GG:CC2F;FA(A:?(EG'EG?GFF?EGG;FG2E4E/=<?)E?AHECACC(CEG:C8FC.*8*8G:F*C.AEEG*ECC*)(*CE)
@antibody_18_multiplicity_61_copy_29-1/2
TTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGATCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCAGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTAACCATCACCAAGGACACCTCCTAATACCAGGTGGTCCTTACAATGACCAACA
+
,????B?BDDD-DDDDFFCC?FIIHIHICHDEI9IDHCIHHHHGF@EIHG5IAHIHHGGIIHCIH5?FD-IIHFDIGHHD5HADH,IFHFFG8HFIHHDHH.H7FIIHGH=GFDH@DGFH,HD=FG*=AB*GDGGFGGEBFFG:HGCBEG8EGEEA6EECGE6:?'GGGE?E86E8GGE?GEGE(CG6*AEGGE//E(.ECA(EDEHAE=ECHD.GG*/(BE(??.C(/DEE'E:C</G(AEA?:D?8EC
@antibody_18_multiplicity_61_copy_30-1/2
TGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTAGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTTGACAGCAGGCTCACCGTCACCAATGAAACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACAT
+
A???<7BB@DDEEDD@GFGFGFHHFAF;IIAIHIFHIEHDHICHHIHCGHHB.FHFHIGGIHFGHH=GIHHHGIBIHIACHIFHF8=#3HHICIFHHHCF5HIGH@GG=HHHG?FICGHDBFDEEG8H@DECADG#ECEFGCEEEGEFEEGG(?;CGAA0EECG':GEEC6DEEG0EEG.+GG*(*CGAF(GCCGCEEG*(*EEEDH9)E?.A88A;E?EBAEGGC>A0:C6?*G*DF:EAEFGG)?2EE
@antibody_18_multiplicity_61_copy_31-1/2
TCGCGGATTAAGATCTAATTACTGTAGTCGTAGACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGCTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCACGCCACTCCAGGGCCTTTCCTGGGGGCTGACGGATCCAGCCCACACCTACTCCACTGCTGCTGAG
+
?<???BBBDBDDDBDDGFFGF8EHHHFFFIEF*IHFFFI8HHICHHIH=GEHHHF88HGHHHHHHFIIHHIE>HGIGGGHIHDHEHHFEBIHIHFG,BEHHDIH)FHFHD-HIEFDH=GDDF3BDEGDF)HEBHBBE*GDBGCB6GE.G@C@GEE0G:DE;DGDC-EG2C=C:EFAA?C?EFEA6(C(8GEA??GECCEEGGG.AECF(H*EEEGEEAFG;<8EE(?*C#EAFEC8>((?G*#?EG6<:*
@antibody_18_multiplicity_61_copy_32-1/2
ACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAATAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGAGCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGAGAGCCTGCTGTTCTGAGATGGGCTGGAGCGCTTATGATGATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTG
+
?A?9?<BB@D?@DDDEGGGGFGHIH,I;IIHHHHIFHHFIFH>BIIAII>HF=CEHCCICIHIH>H5HFFHHIIHIHIHH+H,>HFIIHHCHE8DFHEC7HIHGHFFFE@9EH=FFFEF(9FFEGGGE,#FGHADFFF=*GCEEEG*GAEGD*EGG;E<?EG'EGA;E'CFGE/C/#E#?GGE#?CFE(GGEEG.E-??.E(GA1CC0GCAGA*GECE:CC,0:G:G(E<-<?*ECC:EAG0::81*FF<
@antibody_18_multiplicity_61_copy_33-1/2
CTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTTGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGTAATGATCATAAGCGCTACAGCACATCTCTGAAAAGCAGGCACACCATCCCCAAGGACACCTCAAAAAACCAGGTGGTCCTTACAATGACCAAC
+
=??A?@B>9DD+BD@@FFFGFGHFEEIHCFDGIHFHICHIIHI;F9DIHIHFHAH5FHGHIH*ICEF*GAIEHHF>IH-HGHIFIHFDEIIEHH?H@HHHHHHFHDGFHG+EDHH7G6EH(@=G*DF?GDGE1FGFGE0G)8;B2GDFGFEGGFEG#02GEGAEE;8EE??ECCGE?A:;(G8GEGGEG'??GEGCG(GC<:/EE*1GA?0C/@BE0;4,;CA8.:EG<E?EGC:CEAA(GEA(*GE66G
@antibody_18_multiplicity_61_copy_34-1/2
GCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCCTTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACTAACATGGACCCTGTGGACACAGGCACATATTACTGTTAAATTGGGTGTACG
+
?<?=?BBB@DDBDDDDG8C.FFHHBIH>HEHFHFHIE0GGHIHFHC7GDDHIH-EIHI=GCHIHIFFBGIHBIFHFGHIHIGHHHIHFHHI-FHHE@AGH+9HHFEEHIDHHHEGBBEF*=E/F=GHDHEHHEFGG(:GHDEG.GEB(GG*G@2EEGCFGFEG:AE*AGG@:A:?6EE8EC:CE?G*:?G((CG:FC?(?2?CCEFE8=HEE*1@?.AEA:ECECEA(*C<8GGE?DAEG:?E?C(EEA?
@antibody_18_multiplicity_61_copy_35-1/2
GTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTCCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCATGGCCTTTCCTGGGGGCTGATG
+
<?,A?B-B@DBDDDAEF->FFGIFIIHHI/H?IHIH5IAEHHCEGFD>FFH/0HFIG=FGA5H+HHHHHI-BFCFIHHI*-H1=DH/HHGDHHHHEEH/HF7IHEFHH=GH@CHDFFE@,HEHE=FFE3FBEGBD*FGGGEGGFG?6@EBBCF2FGFA?GGEAFFEFCEE8'E0F?AGEG/G:GGGEE:GC4AEG*?ECG<EGFFE./?E(CC::C3G7@EEC/??:E(EC:??.8(8?=G?GAE0)G*8
@antibody_18_multiplicity_61_copy_36-1/2
TGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACGACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTGGCGCTTCTGATCATACCAATAAATGAGCGCAATCCACTCAAGGGCCTTTCCTGGGGTCTGACGGATCCAGCCCACACC
+
??A==@BBBEDD9DDDC-FGBCH+EBHIAFHHHHHIIBHFA.HDIG..GGIHHFHIHDHHHFEF5-D5CHFFH-HHGHHI5HHH/CHHGEF)HHEHHHHIEDD;DHHHFFHF,DB9FHHH89HHGDGFGFE9GFB+EHGGEEEEGEECDBAEE?C=E(FAE8ECGECBE>?(GEEE?+'EA?8GEE('EF?4GFEFBG.*6A.G*EE?EE()H:GCFGC@EFCCC(:G'?(0F00GEF8AA:C?C?G;:?
@antibody_18_multiplicity_61_copy_37-1/2
AACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAATATGGACCCTGTGGACACAGGCACAGATTA
+
?=?=AB>-DD@B@-DDFGGGG>HFH6IHHIHGA>H/IH7HDEIFEFHHAHE=IIFH-FCHFH>GIHHIFHGHIF(BHIHIH1IG-F+4HDHB*IHIHCHIHCHHGHHDFH5*H+FHFFHCGFEGE*FHBDH*EFF,:ECE9DEGE*EGEB*@GEG@EE?FG;FEFCEGGGE/;(GE.CDEFEGEGGGCC./C?GG*<CG::C?CC;.EEE:C..**(GCC(EG?CFAE8?(CG?(<E.G?E0GG:(G;(?
@antibody_18_multiplicity_61_copy_38-1/2
TCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGCGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCAACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACTCCTCCAAAAACCAGGTGGTCCTTACAATGAC
+
???<?B?5DDB<DDBDCFGGFAHIF>IC,HFIHEI,HE:HDFH9III9GG,IHFIIGH?HFGFHHFIFHIHHEFICCHEHCEHIHGHECIIHFDF7HAF@.CIEGHGHFHFH3IFHFD;G@H>FBFFGF+HGBG*GFEE8CGGEGC?CECGGB8CEE'BA*@GA8(,GEEGGEF?C*EGFGGE6GGEEG(GG?G:CG??CG:?C(EH-0EG(C@7C8G,,GG(;G:FEE.6C?C(?2GC<E<?4ECEGAE
@antibody_18_multiplicity_61_copy_39-1/2
AGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACAGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGGCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAATAAAGGAGTGCAAGCCACTCCACGGCCTTTCCTGGGGGCTGACGGATCCA
+
???A?BBBA@?@DD9DEFGFE-FFHFHIC8EIIIIFHHAIHF8GHAC7G+HH-IAHFHGHHHGHHFIEI5BGFDIAF@CI@IHBHIHCHEHFID+HHIIF,9HFEHGHHHH/HECFC)GHDE=DF?HA9GF=HEFBC2H?GFBEGEG<EEGG*8/FB#GEGEEGG9(??(E8EGEEAEGG?GEAGF(;FGEEC?ACCAEFC:G*(EE?<C6E@GG;E(D@G:'?E?F*ECG6EF;E?**EC:<'2;:G>G
@antibody_18_multiplicity_61_copy_40-1/2
ACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGTAGGCACACCATCACCAAGAACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACATATTAGTGTTAA
+
?AA?,B=BBB@DDDBD-FFG-GHHHHIHHFIFFHIFD@IHFI9FHFCHIHHIFDEIHCFDHEHI+GFDHAHI@IEHCGF-5IIGDDFIGHA84H-6@FEHG9HHI#F@FHCGH:++EEHHB:HDGHEHDFFGGDEGDGGGF/EE=EEEGEC,F<CE4FCDC(?4CFGFEFEAGGG(CCE?GGAE)F.6CCEGDGGGEGE1E6CA0?AEFHGEF:BGGC(A(E8CC0?)'(6C0EG<*:GG:GC***(*C*
@antibody_18_multiplicity_61_copy_41-1/2
CCCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGTACACCTCCAAAAACCAGGTGGACCTTACTATGACCA
+
,?<?A.?BAA-DBDDDFCGEGGIHHHC>HFIHHAIHBEFFGFIHIHHGIGHHGHF.EHAII=FHDEDFHHHIIHHHEEDEH+-EHFFIIGIIHDGHHH@3EH,CFHHH5A,HB4?HFFHFHGEFHHDEFEFHDF8GD*EE?ECEFEA:G.FGG,DFGF6E:EEE<E?EFFGGA?AGFE/FEFECG(.GF:CGGGC/EEEAAE?E#EEF:FCGE*@A.C:GEEFEE6E>GAE:0*(0EEG(C?#.C:CEFG
@antibody_18_multiplicity_61_copy_42-1/2
CTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCACACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAACCCCCTGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGGAGGCTCACCATCACCAAGGACACCTGCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCTTGT
+
??=<<B/BBED-B?<DGGGEF6HA-GHIFFHHIII@FIHHIHHAHHHHHGIDHGFHIIFECC#BAIEGHIBHHIHBHHHF-HHHB7B@IHF@HFEIDHF+HHH6FFD@##G+GDGHEHHEEEF?GG:(DF*H=GHF<@G;@E?GFGF,EEDGGG9FEAFGGFG'CGEE*EFAGG:EGGECC(AAGE(CGFCEC;EG*?C6F:CE8E:#EHA(HF@F;A:.4EEEGAC(E(6C:E8A?AA#;G(9E>*(G:
@antibody_18_multiplicity_61_copy_43-1/2
ACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACATCCATAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGAGGACACAGGCACATATTACTGTTAAATTGGTTGTA
+
???9?B?BDD5DDB@-CFGEFGIEIIIIHIIIFH=>IFHHFHDHIFHIHHDBG>FF7DFH>CHFHIHHEIEHHGEFI=FHHHIDHEHHH8HHEF7IEHHHHI??FFGEGHHDFHFB6D#GEGDF*EFDHAGF;(GFE?G(,GCEFGFG6FDECF,C(FFGGEE(E?E*EE-EAC-#?GFCE6GGGG=GEGGEEAE6E0:0E?EGEFH(EEA0H;*E:?CG???GEG*?*?CEE:EA*EAE?GG86'(A:C
@antibody_18_multiplicity_61_copy_44-1/2
AGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCGACAGCCCATCTCTGAACAGCGTGCTCACCATCACCAAGGACAGCTCCAAAAACGAGGTGGTCCTTACAATGACCAACATGGA
+
?5???BBBDDDBDBD-CGFFGGHI+EHI.IGIIHHHH@IH/FIHHHHIG/CFIHDIIHIIGDIFIHIGHIIHCIFIH5H5>IH7HH-HGIHIAFF<IEHHAHDEFHC+HH<HHHHEFHHHHEHHHB,GFFDFBF*F;?FG.GFGEE:GE(G>EE:?G?HBGA(3G(G(>EGAAE6GG?FCAEEF-F(G((:G?;(8<G:EA.GEE(EE?<#EFEBG?AFAC)<F;?(E8:0E?(?(*GC?8C**1C(C(F
@antibody_18_multiplicity_61_copy_45-1/2
GTCGGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATAACCAACATGGACCCT
+
???5?BBBD@BDDDD<FFF;FGFEFICIH6IBIIEHII.HIFEGHHHCE)EHIH-DGC:DE-FAIHHHFHFFIHIHEF(HFEEFIFHFHHHIH)*HHHE-EHFEEE;HH;AAFFGDHBGFHDDGDDEHHGHCEEFGGFCEGEF;G?EGE;ACEE.GGEGG:F8E:F@GCEC9-(A*:GGE#8GCF*<EE(EEFF?GCEGG::)?:AAC:;/:C.E:7(GE(CCG:FFE?EEEGE#4/<E?EGE.(??1?:
@antibody_18_multiplicity_61_copy_46-1/2
TGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGAAGGTGCCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGTGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGG
+
????<B>BDDDB<DDDFFFEF+IFFII88ICHEHIGH@FFHIHHFC.HHG5EGIHHIHIIG0HHHG?EHFH5EEHHGHF@DGFHF=HEHGEEHH*ED?HHGDHHGHFIEH=GEFEHGH,EEEGH=GDEGH@E9/?FFFF(EGFGC#EGGEDDG,C1GEEEEFGEG8?DGGE?E-0G,EG(AAC?CFC8AGGGEFEAGFGEE<(?A0?CG?C6EGC*EG:,F,'AGCFG;ED(GE?;EEFE*:GE:>G):0
@antibody_18_multiplicity_61_copy_47-1/2
TCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCTATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGGATCCAGCCCA
+
,A???B>?D9DD9@DDGFGGFFFFIFEIIFEIEHIHF9IIBHHDI.BHFIFHFHACAF5AHEAII'HD5H5DDHG=HHH-HCHIIICAFDE?HG8HFHHHEHHHFCH,HF6FHHFGHGHDH7EEFFHHBFFFEC=GEGGCC)GGG@EGGE;FEE*,8G,CEEG*G4GAGGE?GD?GEGFEAG:GD>GE:((GE#GC/GG.FCAEGEDEE:0G.@FEEE:GE:E?:EGACEC:0G(-ECE8EG1G:(C(EG
@antibody_18_multiplicity_61_copy_48-1/2
CCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCTTCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGCATCCTGTGGACACAGGCACATATTACTGATAAATTGGGTGTACGACTAC
+
?5A???BBDDBDDDDAGFGFB/IICHHIHA.IEIF-EEICIDHIHH7HIID@I?8AIHIFHIF)IH-CIIFI>IHIHHHHHIHH+HIIFHECHHCHFDHE?A?D>HCHHHDEHH*HHHG>GHEEFF##GGDHHE=8BDGG?1?G*@GG0EGFCA.GG.GEGAEGFF(G(GG=G.:#@GGCAF4E(:EG?ED:G(/EE1EF(E#GE8H'1EACCE:CFGB/EG?EGC?EE*?EE?E?ED?F?G<G?D?8CG
@antibody_18_multiplicity_61_copy_49-1/2
CCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATGAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAA
+
,?,??=BBDDDBDBDDGGGGFFIA;HHF8HIAHIII.IDHH.IFFH.,GIHHEHIFCGHECHFHGEHG=H-HHII=G-?+*IIEHHHHFF/HIGDFHHIHGIHDHGFEGFEGFCHH*GHE(HHHD8E*HDHEAEF*H*EEEG6GG'GGEFCEE<EFAGF:AEEE-=E*?GEGFFGEFEEAAGGG6EDCE:EGG:?GCG(FGEEE?A:**HCAHA8*GECCG9?GCEF'EGEAA<)GE:(F0?8*GA/G6E
@antibody_18_multiplicity_61_copy_50-1/2
AGATCACCTTGAGGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATAAGAATGATCATAAGCGCTACGGCCCATCTCTGAACACCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAAT
+
??<<?B?BDDBBDDDDGFFGGFFHIFHHF-HIIH,HHFAGHGHGHGFHI-FHFHF9>HHGIEFHIFFGHGIGIHIH=FD<FHIHFEHH5H-IIFHHH(EHGDIFHH?HDF*H9HEF@;4DG<>FFGEEGGHDHGGGGGF8BFGDE4GG?'(G8;EFGG.GE(/EGGAGFGGGEFB<G?(*?(#C9E08D:G6:*F6G*#E(GEEEGHC:HED(E#8..BE??FEACF?EF'EEC??C?GF;C?<*?C6A)
@antibody_18_multiplicity_61_copy_51-1/2
AGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATCGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTCCAAAAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTGACGCATCCAGCCCACACATACTCCACTAGTGCTG
+
????ABBBDDDDDDDDFGEF?GIIHIH>8HFHDIGAGIIFIHIHED9ICFFEEFD-@IADFFIHFFHHFH?AEIHHCHFF?IHGDIHFIHHF.HIFIHBDGEFHD;EFHHH*GGFHFH?FFGHGDG+BFAE.EGGGH??GG1GEFDC;CEEGAEEE@FGGGAGC:G6:GC,GEGE/CG?FCGEEA?:E')DGAA>E4CF1GG/;GEA:CEGGEEE((GE(G8G:E8GFEDGCA*E:E1C:GC1C8EE:E?
@antibody_18_multiplicity_61_copy_52-1/2
TCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCGCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCCTAAGCACTACAGCCCATCTCTGAATAGCAGGCTGACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGAC
+
???=AB.B,B<DD@D?FAGGG8HH/8FFHCI=HGFHIFAIHEHHFCH-FHI-HGHHGIB+=I<HFFDDHF?FHHII)H,FEIF(FIHIIIIIIIHDFHG5DHFHFFHF+HHEH9E.06HH(HHHHF4@EFCF;FEE*BG,:FEGGGGGGGGGFFFE?GFEC'?EFF*F((G9F:(EGGCGG:EEGA/0:GFEG(/EF8=G:*'G<(C:(H)G-EC(.E0@CGG?(*GF:6EC:ECCE(GEGGE*E.*EE:
@antibody_18_multiplicity_61_copy_53-1/2
AAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGGTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTTCTTACAATGACCAAAATGG
+
?????B>+D?DBDDDD>GEFF@EE>CFHFFI/IHHFGIFIIIAGI.IIHCGFEHHFIIICEHDCFIGHHHHHHH-GHIFHBIIGHHIGGHHHHIIIHFHF:EIH;+DHIHF@GFG=HFGEED=H@+GHEEDEGDCGDEGD=CEGG;GGFE:,GBGGCEGG.<?GEEFG*E;=GF'EGG?ECDE:GE80<*GA?6:GEGEFCG(:E(HEG.6?EGE?CECFGA00E?(;:E*EE*'<.EG*G/?C*)(CFC
@antibody_18_multiplicity_61_copy_54-1/2
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGCGCTTATGATCATTACAATAAATGAGTGCTAGCCACTCCAGGGCGTTTCCTGGGG
+
??,?=BBBDDDDBDDDGGGGFGIFHH>IIIHFFHHH,/IIHHHHAHHIHHHDGHH5FHICHGGI-+G-3FIH,HFCB5-HHHIEHHFIFEB7HH4HHHHHHHEHDH6FH=?FH=HFH@E=FFCDAD-HGHFGFGFGFF?DGDGGEF@@GEDC<EEDGF@FEGE;F*(AF=FEEEA.AEA;:FECA:G?G.(EGCFEEF(?(FGEA:EEG)G*FEC1F?CECC:A()/CG4GGGFA<*4*#:)**CC:?(E
@antibody_18_multiplicity_61_copy_55-1/2
ACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTGGGTGATGGTGAGCCTGCTGTTCAGAGATGGGCTGTAGTGCTTATGATCATTCCAATAAATGAGTGCACTCCACTCCAGGGCCCTTCCTGGGGGCTG
+
???5?-?BDBDBDDD@GFGFFG>+H8HF?F@IIHIEHD@FHHHFHFGEIFHFBHFHI5+IF?IFHHHEIHHGGDHIHEEHHIIIHFHHFHHHHG=FCHHBFDHHGFHCH=HF:HFH@HFFF@EBFEFG>C)FEFE+1BBGE8CEGGE8FGF?:,EGE(EF@E@GAFGC'6=C?EG;?AA#?+:C0E>EEGC#EEGGAE?CGEG*1F=C-ECAEEGG?7E,/#*EEGE*E(C?E?CF.F:8AEE8AC/GGE
@antibody_18_multiplicity_61_copy_56-1/2
AGATCACCTTGAAGGAGTCTGGTCCTACGCTGGTGAAACCCACACAGACCCTCACGCTGTCCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCAACATCACCAAGGACACCTCCAAAAACCAGGTGATCCCTACAAT
+
?,???B5?DBD5DDDDFFGCFCHIH-E5FH/IHHFHGGIAHIDFHICIG/B?DH>HHFH+=IIIGEFIHC-FIDHHAIHHIHHAGII>DH@FG2CIEHHIHHEH@IFEH*HHHHHDGGEHEF?HFEGHHGGFF?EG9G*GGHEFFEGC6C:EGCBEF7CEG??CCE6EE:E?8.GGEG:E1A/GECCAEFGC(:GCGG'A0CE?EE9.?AFCFGCC?GGGEG?E*10(/0?:E(E:CG?(:/C-*)E?(C
@antibody_18_multiplicity_61_copy_57-1/2
TACGCTGGTGAAACCCACACAGACCCTCACGCTGACCTGCACTTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTCGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTAGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGAGACCTCCAAAAACCAGGTGGTCCTTGCAATGACCAACATGGACCCTGTGGACACA
+
<???5BBBB<DDDDDDGCFFFGH.FHBHIHFAI=H7IFHFHG+FIH.HHGEACIBHFEDEIGFIHIIHDHIH8I,-F4H?H+EHIGFDHHHH5IHHHGC+B.HDIHEEH+FE+H+HCE@(HGGHGCFEGGEGG==GGE;FEFGEEHEECFEACB?(EGE@FG:E.CCGGEEA;EGEEC=G+G:C8CCFAG(*G:E#E*GAEEFG9ECG*FE0EGEGB*EF*EGGGCGAEGG:CE4E;EC?C?C6<1*G:E
@antibody_18_multiplicity_61_copy_58-1/2
CGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGGGCTGGATCCGTCAGCCCCCAGGAAAGGCCCTGGAGTGGCTTGCACTCATTTATTGGAATGATCATAAGCGTTAAAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGACCTTACAATGACCAACATGGACCCTGTGGACACAGGCACAGATTACTGTTAAATTGGGTGTAC
+
??=????BBDDD5D5D.F6FFCIHIHIHCHHHII=ECF9HCHHDEHIE7+HFDFBCI*IAHHIGHIHHDIEFFHHHFH)FHHII>6=778DHH=>F.HCEHGH6EFHH-H=HF*GG6GG@HHHF(HH,G>EEF9FIECFF4GCEGG;GEG,CFGGFGGGE-:)FAEFGGCE(8FEGEGG;EGE?GE*ECG8E(:;?GG9F?EFDCAC*0??E>G*/B0EG(G?*0EA(EEE(;CCEG(G*?2GE.(GC.E
@antibody_18_multiplicity_61_copy_59-1/2
ACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTGTTCAGAGCTGGGCTGTAGCGCTTATGATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGGCTG
+
?A???BB<D<DDBDDDCEFCGGHC/I-E8FFHDHD9HICE=IIGEHEGIIHHHFHHAHID>DHFIIFGIHH'FHGHCHC-HIHEEG+GDIHFCFH=F0HEHEE)HHH=FH@>HHF;DFFFECHFGFG+FDD=FF?EDGFGGGHFFEGGGCCCE;G?FEA?GEEE=E(EEEEAEDG/GFGG+A1EE)G:E6DEGG*(E*E*F-A:EA?C/?:8EAG:CEC/GGEEGFEAG?CECGG*<:CAEFE?8CEE:.
@antibody_18_multiplicity_61_copy_60-1/2
TTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAATTACTGTAGTCGTACACCCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACCTGGTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGGCTGTAGCGCTTATGATCTTTCCAATAAATGAGTGCAATCCACTCCAGGGCCTTTCCTGGGGGTTGACGGATCCGGCCC
+
=?=?,>7BDDDBDD<DF..GGFHHIHHHHC,IIDEIGFFAEFGHAHFGHFFFHIIHFGD@HD,HFDHIHIIH?FHEIIHGD5I+,IHHFIH4CHHHIBGFIFD=HHFHH?CHD3HDHGHDGEEH+)EH?HE?EFD=EFG,G8G.>GC8E3E8EGGEGEE#CG:FEEGG:G((GG/6GC?AEFE*ECE?G6A;-EGE(GE8EE:EE?HCF-G?HAB?G*EE:,(?E((EGEGE<*:(A.C88AC*G*AE.6
@antibody_18_multiplicity_61_copy_61-1/2
ACAGACCTTCACGCTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAGTGGAGTAGGTGTGCGCTGGATCAGTCAGCCCCCAGGAAAGCCCCTGGAGTTGCTTGCACTCATTTATTGGAATGATCATAAGCGCTACAGCCCATCTCTGAACAGCAGGCTCACCATCACCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACAAAGGCACATTTTACTGTTAA
+
????<>=-<DD+DD?DFFGCCFH;I>HHIFFHHHCHIFI0IF5GICDFH-HHHDIFFHIDIEIH+IEIF-I?F-HDDHHIIDHFHHIICH;/=IH=IH/DH-ED:HFEH=BGFH+HFHHGGHGHGDHG;*H*0CD=?GEGGFECEE@*E(F@GD0FF*DG/CG:E8BGGGGGEA::GC<CDGFA?G-(GEGGGE1CGC?GA-EGCG6A?AGG@E7E?;E:GD:E:?2/GC':EE:*CAA#G:E:G((::E
@antibody_19_multiplicity_1_copy_1-1/2
GGAGACGGTGACCAGGGTTCCCTGGCCCCAGTAGTCAAAGTCGCGGATTAAGATCTAGATACTGTAGTCGTACACGCAATTTAACAGTAATATGTGCCTGTGTCCACAGGGTCCATGTTGGTCATTGTAAGGACCACATGCTTTTTGGAGGTGTCCTTGGTGATGGTGAGCCTGCTCTTCAGAGATGGCTGTAGCGCTTATCATCATTCCAATAAATGAGTGCAAGCCACTCCAGGGCCTTTCCTGGGGG
+
???5,@BB@DDDDDDDFFFGGGIIICIFIFGHI:HIGEHHIHBH9IFHEIF?IE7IG+BGFHCDHIA-DHHCCHIEHF-IEG-CH@-EADHGHIHFIHF=G5EHHEIFH*FHFF;DG?FHEDB>AHF4G*@D6E(IG#EE(GEEDEGGFAF*EG>FGGGEG(GGEGGCGCGG>?DEG:ECD?EG:FE*EEEAEE?.E8CCE?CGEGCA0(GE@@ED-?EEG?(A(;CDC***?CG*C??E?::EE(;E:(
@antibody_20_multiplicity_2_copy_1-1/2
AGGAGACGATGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCGTAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTGCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTGTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTAT
+
?????BBB/BDDDD=AGFCGGCHFICCHCIIIH@DFHI7HEIBIHE8FIDBHFH>AIEH.AHIIH.@F(C=E@D?IHCEGFFAH?EI*HH3HDIHHIHDIHED)HFH9G?GIGHHHIHHFFHDGGHFGFGGE3HEFCDGGECG-*FG*EEE(BGF'GAFC*CG8AAGEEEE8GC<G*(GEEEEGE?G?EEFEGEG<GEGE:AF6F(0G*/AEE(C;??EGG?EG'C.G0)CAA>E8?E*AGC.ECC(((E
@antibody_20_multiplicity_2_copy_2-1/2
GGTCCCTAGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCGGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTGTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAGTACTACTAC
+
???<?BB3D-DB-@DDACGFGFHIIFF8HAIFHFGI=.IH0HI;IGI8HHHGI-FHFHIIIHEF-HD?HCHHIHIIIHIHEH@BHHIIDII4HAFHHHHHHFFHHDHHIHFD@GFH?FGEDFEHGGFFEA9BFE#EGFDGBG(EEE<FGG*@CE8(BEEGGFGD:HGGE?EG6FCE8EA/CCAFGEG:0AGG(GA:G?8EEGEEEGAECEGG/:E(EC:GG7GG0:0/D?E08;GG::CF*AE6EA:A(C
@antibody_21_multiplicity_2_copy_1-1/2
AGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGCGCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTATAGTACCATATGTACGCAGACTCTGTGAATGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGG
+
=??AABBBD?DE?D-DF8GGFFFIHH/,IAH8GD.GIHIHHHHHFHDIH.H?H#I?HIAH-HHGIHIIAHFHEIHHHHHAH?EG@CHI8HF@G,HFHGEHDHHGH@BDHHFHHH@HHHHHFC8HDGEHBGGEEEH?E;EEGG<GECFE3EEEGEE*AG#EEGG*:G?F8F:*EAG:FEEG+0CGEGGGGGEEEEEGCGEEEFE//D?G*(E0/*(G(GGGG?CCG(A?G))?GEC(:GF?GAC*CCGECE
@antibody_21_multiplicity_2_copy_2-1/2
GGTCCCTGAGACTCTCCTGTGCAGCCGCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGCGCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTATAGTACCATATATACGCAGACTGTGTGAATGGCCGATTCACCATCTCCAGGGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACCCGGCTGTGTATTACTGTGCGAGAGGTT
+
A??AABBB6DD@<DDDGGGGGDCIIA-F6HH/IH.IE.GFHIHIHFGHFEF7HH-EH/HHHFIHIIG5IIFHHIGFEIIHDFHH/H>IHHHHDHA.FH?FHG+FFGHHFHEH>,FBHG+GFG?GBDGFHG*FE,HGEFE*EGGEGCGEGG?EED/FFGCFFD?*E;G)G:-CGGGF6FA.EEE*GEGEC:A/EE6/GG6G6:6./0H;G1ACEGEECA?GEE*<A:A<:E/AG<C)C?;?DEG>EC*6(A
@antibody_22_multiplicity_1_copy_1-1/2
GACCGTGGTCCCTTGGCCCCAGAGGTCCATACCGTAGTACTAGTAGTACATGACACATTGGTTAATATAACGATAACGCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGACGGTGAGTCCGCCCTTCACAGAGTCTGCGTAGTATAAGGTACTAC
+
?5?9??BADD-@9<DDG+GFF.AFEFHIFFFHGII@CHHI7H?AHIIH+HIFH=HIFFIIHFH?CFDFIHEIDF@IF*GFHFHGHFG*HGIFHFHIHHFHGHHH,HGFH+HGFG++HF+GHH9GDGG+E+GHGEFGA==+@*FFEFGE9G?/FCG(GE*EEGC?=G#E::EC;63GGGAGEE(CGGCG?DAG?E0EE0(G?E?EECAC?EC(@CC:?G7E?CEE:E:GG:G8G/FCC1.G'E(:0ACC;F
@antibody_23_multiplicity_8_copy_1-1/2
AGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACTATAGCATGAACTGGGTCCGCCGGGATCCAGGGAAGGGGCTGGAGTGGTTTTCATACATTAGTAGTATTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCTAATGAACAGCCTGAGAGAGGAGAACACGGCTG
+
?,??A5BBBBDDDD@DGGFFFFI.HFHFHHEHHHEHHHC+IHIIF,FBHHGD9FDHHH.FFEI-I@HHIHHIGHHHHAIEIGHIIIHHHH/#II-I8HHIFEHHHHHEHHHH9DGH4CGGHGGHFGGGEEFGFEFE;DGG*EE9G:4GDFEAC=9GGGFBCC6(GGE);AG=GECEFEA.:GAE*EE(C;AGEDGE??EEEEFC/6(GE?GG:@C?G(?@;E8G:*ACA(.*EGCE*CEE(DE6(0CG6(
@antibody_23_multiplicity_8_copy_2-1/2
TACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGAATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGGATCGGCCCTTCACAGAGTCTGCTTAGTATATGGGACTACTAATACTACTAATGTATGAAAAGCACTCC
+
?????BB@B@D?EBBDFFGFFFHHIEH@IHGGICHHHHIIHHIHIFHFHFI9HGHHHFIH.E-IFHHIFFH-(HHI,EEHH=HFHHAFI+#-E-*HHHHAHFCH?HHAC3HHBFCH4EC2EB:GC;E1F1BFEEEFD@GECFEE=FCA(ECEGE3(EE/?EBG1G;G1DEFF?0<CFEFG.+:GE?G/GGAC?1E*??8GGGE8(FEF??DCCE@#*8.G7C?CEGD(:EF6E?AE1*ACA**#F?'GE*
@antibody_23_multiplicity_8_copy_3-1/2
AACGTAATCAGAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTAATACTACTAATGTATGAAAACCAGTCCAGCCCCTTCCCTGGAGACCGGCGGACCCAGTTCATGCTATAGTACTGAAGGTGAA
+
?????>B-D@-D-DB@FGGF8FHIEHHIFAHIHHI@IHAIHCIHH?IC,HH8BGIFDFFHHIH+HF?FIDEHF=E=DDED-7ECHDHIH+G8I*=FEDHCG=HHD2IFDEHEF*F(CBHHBEH.E#EGBDGGEFFFFE4GGGBCGGC,H;G>EGAGGFE((CFEG@/EG;EF(G*GFAGFEGG(E:GAGAC'F/CFAEA<F((FG-EECEA'A@((EGBE:GE(G)F?E6E?:E09GG':??:GE?G?::
@antibody_23_multiplicity_8_copy_4-1/2
CCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACTATAGCATGAACTGGGTCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGTTTTCATACATTAGCAGTATTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGTTGATCA
+
5?A??BBB@DDDDD5DFFGCA0FCBFHIIHI+IIFHGIEHH@E>HFHIIGBIGGAHIHFHEFH-FAHH6HFHIHHFIFFHIHHF=I<IHHHIIHIEHG+HEFFCH(HHF4GEHDHHAHHHEFGE;GFHCFGF*+GI,DGEECG8FEGGCFFFAE(D;FAECGGC(FA/--EECCE(GEG:AEGEGG(6E?EG?E;??ECCE(G*AE/::(CED@7C88EFC<EGGG1:CEE6EE:*;A:CAE0*.?C=C:
@antibody_23_multiplicity_8_copy_5-1/2
CCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACTATAGCATGAACTGGCGCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGTTTTCATACATTAGTAGTATTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCCATTCACCATCTCAAGAGACAATGCCAAGAACTCACTGTATCTGCTAATGAACAGCCTGAGAGACGAAGACACGGCTGTGTATTACTGTGC
+
,?A5ABB<EDD?5BD5GGG8FFIIHIIIFFFFIEHI+GIIIH@IHI-GHIHEHG=CFI-HDEACHH-H-)HIHHIFGII:IFFGIGHFFHAH+EHHIH:IHHHFDHHHHHHG+D1HHHD2FFGFGE-F@=FHGEE/=0GGFGEGGEFFB(GGEEB>GCG*EE*BGCC*E?G<#C'GGFE;FC(:GACFF?G<FGEE;(EG>E(?((;GFH8CA:E?E7,@CGE;E9'(:EGC?GG?G0?E0E:CG*'A:*
@antibody_23_multiplicity_8_copy_6-1/2
GTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTGTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTAATACTACTAATGTATGAAAACCACTCCAGCCCCTTCCCTGGAGCCCGGCGGACCCAGT
+
?????B?BDDBB?D-DFEGCFGEEHHFIIFHIHHH0GIIIHFFIIFFCHBFDIHGFFIFDFB--HH57H5+DFF5CHFFEHHHGF.IHIEIEG+FAHFDCGDFHHG*DHFFF@)(F0HD+BDEGDGGH3.>FDFEG6E8*GFEHFEEFEGGF26CDG;CG?EEE8GE??EA,?G*GCEEGDCEEEG#A/A<AGFG*EC?G.EGAC(?GE#G.AAEG?E?C*EG(?G*G:AF?-EGEE/C?/?CCG:C4*G
@antibody_23_multiplicity_8_copy_7-1/2
GCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACTATAGCATGAACTGGGTCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGTTTTCATACATTAGTAGTATTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGACACAATGCCAAGAACTCACTGTGTCTGCAAATGAACAGCCTGA
+
?,??A<B?@D@DBD<B6B-FGGIHEIHFFI,=IHFIIFD7HGH=EHFFIFIH?IAFHHHCHHEHGHHFIHFHC5HGI<IHFHFHHHIHDHHIF*GIH-DHHHD+HIGG7FDG?H=HD5EFH1EB3G:GHEDG)EGGEABFFE;G@BFEDGG:*AC83EGGG:FGFCE<EGG?E(*E@F:FE6GFC;GEFGEEG:EEE8G?-EEEFE:*ACF*EEG)GFEEC1?CAG4*.*?8G(FCE*E*CA200*8.GG
@antibody_23_multiplicity_8_copy_8-1/2
TGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACTATAGCATGAACTGGGTCCGCCGGGCTCCAGGGAAGGGGCTGGAGTGGTTTTCATACATTAGTAGTATTAGTAGTACCAGCTGCTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGATGACACGGCTGTGTAT
+
?????BB?DBDDDDDBF?GGGF>HIEIHHBHEIHHGEIHIFFGCIDGFECF5HFHHHFDDHHGHFIIHIHGCIIFI?IEF5HGH-=FHHHI>FFHHFHFEEHGDHH:HHFEHIHH*H0HFGGF+)DGEH@FC+=EG.FFG'*G#GE)GEGB;DG?D>*G;?EEAE'0FEGEEG?EFFEE:CGAGGE:(E(;GEE:0E?GA2C((EEHC?AEF@(E0EG8@GC:A6AEGFA:'G;(E(G*>:E/EGEFAE*
@antibody_24_multiplicity_1_copy_1-1/2
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCCATAGCATGAACTGGGCCCGCCAGGCTCCAGGTAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTATTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCATTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGACTGTGGATTACTGTGCGAGAGGATCAC
+
?<5A?<B-BBDBD?BBGGA?F8HCFIFIHICDIEACFIDH?I.-IFFHFGHHHFII@DIH..IIE4AHIFEIAF#5HFH/IHHFIHF@+EI6FH.HIDDHHGHHHHHG<GHHAFE@AHDB)BDE+EHHF?G8GEGF@F6D=GCD;FECEGEE*GG/;F(FGGGE<F:DAAGE*-G;FCE6?6EA(?C:(DGG:GECEFGG*EA/F;?DEHE(-:@.EG?E<;EC.6)E##C)EG1A0C(GCEGE):EE0/
@antibody_25_multiplicity_3_copy_1-1/2
CAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTTTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACGACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCCGTTCATGCTATAGCTTCTGAAGGT
+
=?=???B?BDB-D<+@GGGG>EBHHH.HHF.ICEAHHH(IDFIHFIICHH7H5DFHHFEFHFDIHFHA?H5EI-+F-IHHHHHHIIHHFII-D=IHGGIH+-HI:HD>HHHGFFEDFHHHHGH1GGHB@GGAHG=*FE;EA.*FEEG*CFG9CF?/E6BE'8GGG*GEE0*F:/CGEAGG+EGAC8DG?GE?GC<GC:CG?CEEE6?*D2GEHG(<*C7A>EF;/*6E:EEE/<6ECCG*EFEEEE(G60
@antibody_25_multiplicity_3_copy_2-1/2
GGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTATTACATGACACATTGGTTAGTATTACCATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTGTGGAGATGGTGAATCGGCCCTCCACAGAGTCTGCGTAGTATA
+
<????BBBDBD<D<DDF;GGDGIIHIIHCCHGHCIDHFHHHHH=HGHAHEHHCHHIFFHHHF-CGIFDF;IIHH-A;HEH#>FDHIACFHII;I4HIFHDHHB=ECDFHG*HHF;FFDGH+FG<EGGE=EFG5GGEH0GGFGGD@GGF8EE;,*BEG'GGEEEE=DG;EG*;EGEGFCCGGG((GAEEACEGG9A6EAA6/CAE?(C(CHGCHGCE:*BEE(CC8GEG:**?CC.GCEG(EFACE):)/E
@antibody_25_multiplicity_3_copy_3-1/2
GGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTATTACATGACACATTGGTTAGTATTACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACACTGAGTTCTTCGCATTGTCTCTGGAGATGGTGAATGGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTACTAC
+
=A??<BBB@DDDD@<DGFCFCFFEIIEIHFGIF9AH.IFEHEHFGHID>=HFFIHDIHDHCHFHHH-HFFI-HHF5FEFFFIHHIF+ICEFFIHIHFIFHFEHIH<3DFFHHFFFEHFCHHGEGEDDGDFFFHDFGEF5G3GEEB8G,F1*EFE@;FE((>EE:G?*AG:6)#FE?GCAEEC*<G?CEGDE1*<?GEA=CECEE0*H'D9E*EE@C'G,G?E*AG??CGE'A.C*:EG:00G:GCE:CC?
@antibody_26_multiplicity_119_copy_1-1/2
CGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATTACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAATAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGAGACAGTGAGTTATTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCCTCACTGCGTCTGCGTAGTATATGGTAATACTAC
+
?????><BDBDBD<D-+AGGFGIHICH+IIIFHDIHGIAIEIBCIICI(?IFIH-IHHIHHH-FIIIEII?AHEFH?HH?HFGH-HGICFHH-H@IHIBGIEHHGIEHFHH>CEHDHB<-FGHFE'FHHFEGH+EE(G<EFHFGCD6:E@?8G0FC0>C*GGGGGECGBEA'EGGGC'GG<:*:?GEC(GCGFCFEG0C=EF?8F6(06(.C:8ED(?#,?C(*GFEGG.0EGAGEEGGG'(;61*E8?F
@antibody_26_multiplicity_119_copy_2-1/2
GTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTGTCTGCAAATGAACA
+
??,??BA?DDEDD7BDFFGGGFHI8FHCHEF-IFHFIIHHIHCHHFC;HIHHHFHHH?IFFAFFG-HF+C-IHDHFHHGFHEAFHIIHIIIFIFHFFEHFGHFD9HHHH<CFFEH?BHG@GFFFHD*DFGG:G,EG#*EG9G@E9*FCGDEEH0.GC3@(GG8F*EE*E1GFG(?(*GCGAGAA(C?CEECEEE;E0GEEGCCGCEHEE;C(8G@:>EEG:/CGEEAGC/ECE(</E8E?C8AE-G*?CE
@antibody_26_multiplicity_119_copy_3-1/2
GACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTTATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGGTACAGTGATTTCTTGACATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCCTAGTATATGG
+
???AA75BBDDBDBDD/?FGCFIHICHCHHDH-HH+HHIIHHCIIHH#IFH?HGIHHHIFEAIFHFFDIDCFHFDH@IH+EG?AIIIHHHIIIIDHEHHDH+HHFHFGH;G@GHEFG@;DH7AH*EFE)EFGE=EG*GDGGG)EECG?E0EE<FE>7GE9C6GGACEB;G;/G<ECEEE.E6EGG))'(E6CF4;*EGCFGEGFGC6C(HEE(7CG:EG;7,E#9(*GGCEG.CD((FA*E*EE::CCGC
@antibody_26_multiplicity_119_copy_4-1/2
AGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATATCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGTGAGACGAGGTCACGGCTGTGTATTACTGTGCGAGAGGATCACAGC
+
?<???B?B@DBBB@DBEF/EGGHAIHIHF?H9ECIII?H>HIFI9EFFHFHHECH7IHHEHFFIGCIFEGFIFHIG-EIHHGDIHI+HHHHE=CEHFDIHHFH;=GHBHFHFH8FG)F?FBHHD?3HFDG@H8G4BDFE:9CF.E(FEEGGEGGG'GGE8EF8FE?GGGC*.FE8-EGE0FCFE:FE*E-:6GAGAEG<E;?EG(G*EEEGC(E(:?D<GEC*CG'GEG46/CG.CF2:CE0(FF)*1C?
@antibody_26_multiplicity_119_copy_5-1/2
GTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCGGAGACAATGCCAAGAACTCACTGTAACTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCTCAGCTGGGGATCCG
+
??A??BBBA@DDDD@@;GGGCGFHHHIHIHEAIEIHDHCGHIFFGHGHECGHAICHEIE@FHDFH.IIH5FE5HHHE->HDHAFGFCHFGIH+@BHC5HHAC,DIHHDHHHHF+EHEFGG(FF*GGGHGFFGGG:GDG1HGGGDHBCDG(/GEEGB?F=GBGG8E(GGG*GG(G:(/ECGEEF/*EC?>E?EE:F0:F)8GG(GG8HGE?G:HE@G7G:CCE**FG6)E::C8:?*C:(6EGAACG?EEE
@antibody_26_multiplicity_119_copy_6-1/2
AGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTAATACCATATACTACGCAGACTCTGTGAAGGGCCGATTCGCCATCTCCAGAGACAATGCCAAGAACTCTCTGTATCTGCAAATGAA
+
???,?BBBBDD5?DA<FFCCGFEFAHIHHFHEH=EHH-IIIH5?CECHHFIG-DIAIHIG9FHHHICC)=CIHD<IGEHEHHHHIHIHFHFGD.DH,FI,G=+CF=9HFH??FHHFGHCHGFEHFGFF+FGFFGG*GGG@F+E9HCEE6GEGC#EGE?EFG??EG(EGGC(EECEEF;)G'EE?E:<;CGG:-:E)::G0EGE0??E)EEGE;CGGE807*/A0?08E?*F*'C8:GG?AC:*GG*ED:(
@antibody_26_multiplicity_119_copy_7-1/2
GATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGATGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTTCCATATACTACGCGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGTTCACAGCTGGGAATCCGTATTATGATTAC
+
??5??BBBBDD@DDDDGCCCEGIIFE-IIIHIIHHGCC7HIHHHAHH.HHC(H@I5FIIFIFAHIH>=ICHHIBG+H55FIEFHFEHHDH==#EHIII+H=HGIHI#F+3HHEEFHG@FHHGHGHGGHGGFGD=G,6GE:GE0BGE*EGEAE@?C;(**GGFE.GE8GAF6;1;EGGE?E0E6AGEEGEEE??:C8EE6(;?:AEE>A:E(A87F(E?G:#CE;E(CAEECG(E:CAE(E9(0A6(C';A
@antibody_26_multiplicity_119_copy_8-1/2
TTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTTATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTAGTCTCTCTGACTGTTCATTTGCAGATAGAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCCGAGTATATGGTAATACTACTACTAATAA
+
????,BBBDDBDDDED?G>G+FIHII?IF>FFIHIIEFHIIIFDGFHHFHGFCF+/E>IHDA-?HI/IEHH5HAEBG-HIIDD8HDAIFIHH?HHHHHHIFHI?HEECE01CDDDHFFHHEFEFB9EGG@GDGGEE*GFEGGF6*G*ECGEGEGCEGFEGG?8F(E:*BGE:E*?FGA?A<F0EECAE:GC2/EG08*9EGEEEF(?E?E*E@:@GEECGC#*ECGFE((<(E*EA.G8CC=0GCCG;1?
@antibody_26_multiplicity_119_copy_9-1/2
CTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACCACGCAGACTCTGTGAAGGGCCCATTCACCATCTCCAGACACAATGCCAAGAACTCACTGTATCTGCAAATGAAAAGACTGAGAGACGAGGACACGGCTGTGTATTAATGTGCCAGAGGATCGT
+
A?,?=7@BD5D?5DD5F;GFF8EHHHI/CIHCFIGHIHGIIFIIAFIHGI@IIFHGIFHCCEFH,H=IHGHFIHC--9HHIHGIC5FAGIFHBHDCGE-IHHEHFFHFGFHFCFFEFHFHGHGHFH**A/H+GDG?GEFDGEG;(BEE*,EFG6EE(EE=FE?EG)EEEAGEGGEG*:C/?GG:*CF*';?EFE1EEG68/.E(GAHGEA*G@G/A>GC>/G(G?0C((E8/F#1E?0E(CEG(E*?*('
@antibody_26_multiplicity_119_copy_10-1/2
GGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGTCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCTGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACG
+
?????BBBDDDDBDDDF;FF>F+.FEHHHHI7IFHFIHIHFFEHAD@HEH=F;>FFF-+IHIIFEHH>?HHGI-AADEIH-+IA@FHHFHGIHFFHI@I=HHHHHHHH#HF,HEBIGHF,EHHHEDGEEFEB@-*GGHGGGAGFE,FBG=C?:A3EEGG#CC>EC?E<;?((EGF/GCCGEF(F(1?EG6E?EGGG.?8?E:A0/.:.CEG/AGGC/7,,?E?GC:GEE*(::?AACEC*?C6GC.:E:?
@antibody_26_multiplicity_119_copy_11-1/2
AGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACACTATTAGTAGTAGAATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTGTTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTTCGTTTGGGGGAGTTG
+
???,?B@-DBDDB@D<G?GGFGFIIFIHCIH.HF;FIGFHHID.AI@9-.IGIDGIHFFHF-H8FIGAEIIIH-,IIA-ICIGCD'6HFFHHGFIHEFIHDHH,HHIHH+HH*D=DDB3GGGF52EHEGHH2FE:E,6BG;*G<BGEE0E=F<FGA:FE(EE1A*?G2C.GE1EFCE6GEE6CGG:0(GF*E?8GACFEGGC?G0*AE:??GCFE?(GB(ECE(ECA/:('/A<.E?C?EGEC;C;EC:0
@antibody_26_multiplicity_119_copy_12-1/2
TGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTACTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAGTGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGA
+
?????9BBDDD@DDDDFGGCFFHEFHIHFH7?FHHIHAGCHCFDHIH/IHDGCHHHDH5H5?HFHFFHHHHDI-GH-EHIIIG8HDHIHHGII=EHGHB*FHDFHH+HIHHHGEHDGGDEEGDBHFHDA*DFGF+GC.GAGF3EH*FEFG)'FC?EG.G60:GGGGG*GEAF6C66CGF.GG/E/?((CG6E*GEGF?GEG8CGEE/*CH6<E;GGEGG,F(EG#/EEAEA:GG:ACAC';E:**/GE*E
@antibody_26_multiplicity_119_copy_13-1/2
CCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGTCCCGTCACAGAGTCTGCGTAGTGTATGGTAATACTACTAGTAAT
+
<?????<>@BD@BBDBFGGCFGCHHIIHIIH-EDH8HIDH.HIF-FHFEFHIAHFIHEFFAIFF-;GHIHEIFDFFH+HIFFHHACGHHH@HHH5HHHEHDHFHHHHFHHFB,CHBFCHH++FGFGED@GGEBC#++GEGFG*F6GGE)GE,G*GEF:FGGEC0GC9GAFFGEGEFEE<E?FE0FCECE?CDGFEE0FECC<A**)FEE(<GF(*CCE(/GAEG::C?)*GC<:E?<?*GA?G:?(G(DG
@antibody_26_multiplicity_119_copy_14-1/2
GACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCGCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTATCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCTGGAGCCTTGC
+
????5BB<DDD5DDBBEGF;FFFAHIFIFFHC-FH=>HCIF9IEHFHIA?.HHGH@F>5HHHIHIHHI#IIFIIHHCAHFEHII7HIFH-DFHBIFHHFHFD.E:HHEHFH=-HH=EHF?HHFFHEHFHDDEFEFF-EHG*F*0D'?FGGGGECEEGE4GGE:AGGGGEGGEEGE'GGFGEEF0G:EFEFEC:EF(EEG*EFE?E/ACG*?CE.EE?;?'*GA:E0<8G::E*G(E(?:GAEA/E/E-?/
@antibody_26_multiplicity_119_copy_15-1/2
CAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTGTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTCGGCTTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCCGCGTAGTATAAGGTAATACTACTACTAATAATGTATGA
+
?????@=BBE?DD+BDFFF+FFIIHHFHII9FHI+BDC0HCCDHCHGI?=IHHHGDFIHFHIHDHHFIIGH-HHHIFBHGDH-HEH5HFI?6HHFGHHFFCIGHHCH@FEHHHHFBDFHGE+G8H-FEG(HH(EGGFEG(GFFFC3GEEG?GGG/G(F?GF:GFEEE=*D?G*GEC(EGEC8E?0F.6CAG*EGG.A>?CFEAGD(9EE68(@G@CDAEGFE*;CGAG0E?G?EEGE(C?0E?CCE*/4E
@antibody_26_multiplicity_119_copy_16-1/2
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCCCTGGATTCACCTTCAGTAGCTATAGCGTGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGCATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATGTCCAGAGACAATGCCAAGAACTCACTGTATCTGCGAATGAAC
+
?A?A<BB?DDD@DDDD,GGCE8FBHIFHHIHIIIIIIHDFGCHFH@IHHHI>HFDFAH.HFHGAHD5HIE#FGGHCHHIGEIH/EIFGFG=HDHI-H(HHEH-HCHIHEHEGHHH@H3G:FGHGDHG7GFG;BGGEFGCGGFEGEBG=CECG?>FE*EEG(E(@AGGGG*GEEEC8F?C0GE((GEEG68G:EGCGF:GE?G;(<E8*#E6F;8G7GA0,E(::GE6E)*:?GC?69E:88A*CEGED<(
@antibody_26_multiplicity_119_copy_17-1/2
GACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCAAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCCCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGAAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTCCGTAGTATATGGTAATACTACTACTAATTATGTATGAAC
+
?????B<BDDDB=DDDEFGAEFCHIFIFIHAHEHHIHHHFFGHF+HEECIFGHHIGIHIIA+HFH5FCHIH-FDGGHHH*HBGFHFIH<HHDHBHHD*HI(F+FHFHFCHFHHHDGD@EEHHGG6DCED(DDEDGGGFC)BFG0E@FGE(ACGG**;BCECFGF/EEG;GGEEGE?2?6E?CG:?G?E<E'ECG?EAGCEGC/E?EHC('(>AGEEGG:/E:E***EC)**#C8CG'??(??:G:GC0FG
@antibody_26_multiplicity_119_copy_18-1/2
CACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGCGAGCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTCCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGTCCTTCACAGAGTCTACGTAGTATATGGTAATACTACTACTATTAATGTATGAACCCCACTCCAGCCCCTTCCCTGGAGCCTGGCGG
+
?5???B/BDBDDDBDBF+FFFFFHBHH/IIHH'IGIFGICIH@HIHIFHDIIHFHIH=IH*HF)FHIHCHIIEIHDGFH-HHIFIHEHHCHHHIH7HFHH-HHEGEGIHC#FHHHHF@G6EAG37E?GGHFGEE>IFFGEGGGGGGEC':ECC;EEEE;CEG;#6CGG.GA(G?FF0?*1CEEGEG;;ECE/:G/A6*:<GE?GG*CG?E.G/EEGEG.7?E?ECC(EC6(CE<?E?GEECEDE?:C)0E
@antibody_26_multiplicity_119_copy_19-1/2
CGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAAAACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGCGTCCGCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGCTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTAC
+
??<A?B?BDDA@9DDBG/FFG;FFHEH+CHBIIFIFB9HIHI@HIIIHIF9IGGCIHIIIF?ICFHGHHDGEDHICGHIF@IEHFHHBGH9HHI)7HGHFH5HIHG=?DHGFHH*EFGFHBFGHFGH;?FFGGAGDGHE#G1DG#E9E*ECA;(:FF:GGGCGEEEGAEAAECFAC4EG:/:C>:EGGGGGE0E)E;G)G:AAE/F*:;HCA1GE?EE?@C0GEF(>*G?(0F?GG2G8AGEG*ECC8:G
@antibody_26_multiplicity_119_copy_20-1/2
TTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAATGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGGGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTAAGTTTGGGGGAGTTATCGTTATATTAACCAATGTGTCATGTAATCCTACTACTACCGTATGGACGTCT
+
??,<?BBBDDDD@ADBFFGGECEHHIHFIIHIHIIECHHHDHGFHFHCHHI+H:HF)EHI5HHHFHIHFH@HEHI5IHDHF?HBDEHDHFBHIIFCHFHI,HGEFGFFEH-HHHHH*FAGGECFDFGHHFG(EEDGGF@?CBG,'G**??EGEGEGEDFEGEEAGG6GEC*GEGGEGGE(6A#F:EEFG>:GGE:GDAE(FEGAEE*CEFDG.DC?/-,.?:):(:)CEECA??G00'EGE8EGF88(;;
@antibody_26_multiplicity_119_copy_21-1/2
AGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGAATTACTGTGCGAGAGGAGCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGGAGTTATCGTTATATTAACCAATGTGTCATGTACTACTACTACTACGGTATGGACGTCTGGTGCCAAGGGACCAC
+
?=,??B>-B9D<DBDDF@FFGG?IH>HBIHFIIGHHIIHFIHGIIIFD:IHIIHIEIHGIBIHIDFHCCFH-IIIHIEI+AHI)FIFEFHCHHIHHFD-HHHHFGF=FH+FHHFH.DDEG*FDGFHFH=FEG8*AFED4AEE=*,24DCE0C#E(EBECE*G?8GEGCGGE<EG?EGCG?G+EGCEAG8F?:EEAC):GG0E0E?C;<G:EE=:DFGGE.EG??CFGC(EC0:EGE*.'G?CCEF0CE.0
@antibody_26_multiplicity_119_copy_22-1/2
TCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTATTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACGGTATCTGCAAATGAACAGCCTGAGAGACGAGG
+
?=A??BB>DDDD9DDDGECACEIIIHHIIEF=GFFFIIGHFAAFHHDHIFH-HHIH:GFIHHIC-FGI>IGF5HIHA2@IGH+AFIHHGCFDIFGIHIHHHEDIH=G,AH,HF2HH#FFFGHGGD@FH:EG(G2HF?EFDAF#GGGFGB:AH)GEB:@AAF6AD;@)CGFG.CGG:EE'GE?GF;E(CFAFCC(GE?G/8EG<-E/?;E?0?E(*GC0;=C(F(*EEAEGE?EGCA*GEE0G0E(:EC?(
@antibody_26_multiplicity_119_copy_23-1/2
GGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCTCAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACCGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAA
+
?????B@BDDD@DDD@GGEGFFHIFH>FHHGF?B=I,GGI@D.IHI9GHFF@I?IFI4HFH?HHEHHEAIAD?C@I,CEHHHHHIHIHIH6FHH=)FHEHHFHHHIGH@HEHG?DFHB?HHCDFHEFE#GHFDGBGGGEGEGF;(GEG8GGGG*EGD8CD(AGA/<;GGFFEECFE?AEC+CC*CG(G-A?.E=CFCEECA?((EFE).;C8EG;0G>)GE?*?EC4/1GED2EEGC:(ECCG:?/A:AC
@antibody_26_multiplicity_119_copy_24-1/2
CCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGGTCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGGGTCTGCGTAGTATATGGTAATACTG
+
<??<=BBBDDD-B5DDFFGGFEFIIBFHHHGI0@IEIHIFFEFHEI@IF@HIFDIEFCIIHFHHFH-DCIHH5ICFIFEEFADIFBAHF7H=FHIHCI.FHHIHH@DFFGHHH'H,?HHF*FFE(FBAEDFCHF:EFDG=GF8EFGFGGEDGGGBGEE:GGG?GAC?(F;;EGA;E?GE0?G(:G?:AGA?E2ECCGECEGE?G)EC?AHCEHCGEF1(EC??E#G6GCEEC?(?CCGG(G:EEFE?DG?
@antibody_26_multiplicity_119_copy_25-1/2
CCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAAAACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGGCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTTCTACTAA
+
??5?AB>BDBBDB+A<F.GC;GIIF+H8HEDIIFFIEHI'I@H??ICHIIH+HHI@HFCDHFAHHFGIIFIHFHIHH;CGI,GHHFIFI6HHHHDCCH@938HGHH/EHDHHDDGHGFEFFH@)GEBH?E'BEGG?FGEE.BDDEGC@DFGGF#GDE6BEEBGG;E6GEEBEGFGDE>F(GEGEEG)GGAECEDAG0DFE0.1(G*CC?9C<EAG:8(:1?GE*?((CCF/EG:EE?:6ECE):.(C<*G
@antibody_26_multiplicity_119_copy_26-1/2
TCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCGCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTGACAGAGTCTGCGTATTATATGGTAATACTACTACTG
+
??5A?BBBDDDDDBDDC/FFFGIHCHCIFHI=HIIIFIHIHHIAIHH=HFFEEDIGH0F@HCCF/BCF5ICHH#HFHHHDIIHDCFHIG=5DEEHFFHHGHI@DHHHGFDHFDEGFHDEDEEFGG86;HGFFGGHFGF=?GGE=C=E.EGCGDGE0GG?GEGEBFE#E::E78>AECGEGGGG?FECF?EEGE6:?E:FGAC)EEA*0?E-=E'E?C.,GGEEAGGEC2CAE(C6E':G;('EC(;'CA*
@antibody_26_multiplicity_119_copy_27-1/2
CTGGGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATTAACTCGGTCCGCCAGGCTCCAGGGAAGGTGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTCTATTACTGACCAAGAGGTTCACAGCTGGGGATC
+
??<?5<B?B-DDDD5DGFFG8GIEIHIEFHGCFHIGHGH(G@ID#*0HFGHFEGHCBHFHDIHHGH-C(HCFIAHIAHHGCDIGHHHIDAHG)D8GH=HHHHDH(HG@H6HHEGE=@+8E@GH@HHGG7DEH@GF@F4DC?(;EEEFGEG=FE1GA/EG<GE8.?GAGGE?/ECE?GB(E6<:EA/GCEGEE?GEEEGCCEFE?:;E4EEEGHGB:(:EE.?;A6((F(C:E:G(C1CEG:?E1:*A:?6
@antibody_26_multiplicity_119_copy_28-1/2
GAGGAGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAAGCATAATACGCATCCCCAGCTGTGATCCTCTCGCACAGTAATAGACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTGTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGAAGTA
+
???,A-B?DD-5DD<DEFGFGFH6>IHCIHDHIHHIHGAHEBHIHHHI9GG7>>?CIHFH.HFIC@HHHIFH-IHHHDHHHDHIFI.FHGAH8HHEHE-DCF#DEH)IHHHG#FFEFFHHHHF,E+E?DEEFGEG.3G*HEFEE?*GFEFEEE2EG8G:EAE),(G86E:1;GFG6GFGAACGGDCGEA(4EE8GE(GGE0GG*EE:CA(FFAEEG/CECEE::G*G'(EE0EC:?:AFECEA(:/GAEA
@antibody_26_multiplicity_119_copy_29-1/2
ACGGTGACCGTGGTCCCTTGGACCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGCGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACTGTGAGTTCTTGGCATTGTCTCTGGAGATGGTCAATCGGCCCGTCACAGAGTCTGCGTAGTATATGGT
+
?????=-<DA@DD?BDGGGGF6CHE>HF+HHIIHHEHHFCIHHHH?HE-F:FFEIHFFAFIIEHGI.DHFFHI@FHDIIEFIHICHHHIHIHHDHCBHFH-HFIIHFCHEFACB+FHG#GFHF?<,EDGG<GFFFFD:G8ECCFED8A*8GE*EF<E*E:GEGE?E/EGGG=;/GFE+GE:G(;AECGFG(EEG*GE6E?*?E?CD(GE(CGHC*?0C3GC7C6/C.EEE*G(E0C66?G8GE6=ECC:E
@antibody_26_multiplicity_119_copy_30-1/2
TGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCAATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAG
+
=?A?ABBBE+B@D<D5FF@GCFE/F/HIFFHHIHIICHFCHHFFHHFECGDF4GGFHIFIEIHDGH=HBFIH;D?IIG@BIFH.I=GH7HGFH6HDHHIH@HHDIH=ICD=BHHDGHG3HFFDCFHFBFE*G@F)?C6;EDCF**GEGFFG:?6DG(G/EB2DEFEF(EGEG:;G;6E0G?GGE*AA.<CFEE8/?EG?:FG6G/66<F?**:*E?B'CEC:>*AA?*=E:*EC*FE:.CC8CG:6:E6E
@antibody_26_multiplicity_119_copy_31-1/2
TGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATACTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCCGTTCATTTGCAGATACAGTGAGTCCTTGGCATTGTCTTTAGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTATTA
+
,9<??7?BEDDD?-B@EFFFF8HIH6EHHIHHAHHIIHHIHEHIEIIHEGIIHHHCHIHDIFI87GIICHHIHEH,AHHFBFEHI6IH-HI)=H;CD35FHHDF+HFAHIGHFHFFHF#*DH+EF;FG@FCGEF?EEFE0E;GH,EE*GD.;?4EG?0FEF#?2EEE)*/6E?#EAC(C?CDEEE(EG1<?G<E(G(EG*E(EG(?:A?EEE-8BE:GCA8G;C?<=AG8CC86A:CEEG;?EAE*0()E
@antibody_26_multiplicity_119_copy_32-1/2
CCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTATCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTTTCTCTGGAGATGGTGAATCGGCTCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAA
+
=?,?5B<BD9<DD-+DGG-EGCHHIFHHIECCIEIII9HFAI.II.HHIHIIHGFHHIFHCHI-HIIHIHI-HIIFIGII5IHIF8HBIIIAGHCCHBHHHHHFHFHHHHF+FBHHDF-DEHEHGF-EGGHFEE(;HFGGDBHGEGGGDG(GGEFE(FGGEGD/CD?C8(AE@?DG9?EE6EAGG(E'FEGAC:CGEE:GFEA*GGH(.AE:HG:G'GGF?E/G(EEE;GC*AG/:E(:G?G0?GA:G::
@antibody_26_multiplicity_119_copy_33-1/2
ACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCTGAGACAGTGAGTTCTTGGCATTGTCTCAGGAGATGGTGAATCGGCCCTACACAGAGTCTGCGTAGTATGTGGTAATACT
+
<=A??<?--DDBD-D?FGGEGFHH+EI.B/EFEC9IFFIFIHHHHHIFFHHAADHAGHCHHF-IH8IIFHCEHI-FFIHHHEIIHH=7GEHDHHCEI5CDHFHFCHHHGFFEHFDECEEGG?HEH8GG?H3.DFEEBB9GGF1E*CGAFAHCEGFC(E?=CBAFGG:;.A'GG/BGC:?/E<CG66?:EEC(GFEGEG*E:*C16G0E*AEEE7CG?F,(?C(6:E*GE.CG6((?G/)'CEC8(*.<G8
@antibody_26_multiplicity_119_copy_34-1/2
GTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGGGAGACGAGGACACGGCTGCGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGGAGTTATCGTTATATTAACCAATGTGTCATGTACTACTACTACTACGGTATGGACGTC
+
,????>?BDD-DBD?DGFFGEFHFFHCA0IH@HEI=HDI-IIHCHHHG.ADFHHHBFHEGHIH@CHCHHIHHHAHGHGIIHCAFIHHFHIIDHGFIIHHHHDDEF#HCFH+,ICFH#IDGH4HGF?GFGD@CFEF#EE?G@AG@EE8EDD*@EGG'*EEGGF(E8EEE*FEAGEECGEG?+GEEGEEG0*E*FEEG=.E?G.EGE::CG/G(*@EGG/E(8?.(*EG?GCEEE?C:EEFEGEE(*9G(?E
@antibody_26_multiplicity_119_copy_35-1/2
GTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGTCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTGTGGAGATGGTGAATGGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATAATACTACTAATAATGTATTAACCCCACTCCAGCCCCTTCCTGGGAG
+
?=<??5@BDBBE5DD-CGAF5GIHHEICHHGHIHH?H7IAHF?HCHHFHH-HGI@CDIFIHIFFF5GIAF-HHA>IHHFFFF-IFC>H=HHHFIIHIFH<HHHHHHFHFH+HA3HFDH=EEG'GF'FEE?FDGDGG4DDE=DEDE=GF**,EF-??.GFEGAGGEFEF0GAA?FEFGED#EECAEEEEC?:CE-<:GGGGE:<((GFGE:G:FAE?/7,EC?*.A??:6;:GCC(DCEC.)C?F((601;
@antibody_26_multiplicity_119_copy_36-1/2
GACGTTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTCGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATATACAGCCGGGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAATTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGAAGTATTTGG
+
??9?,BB?DB@DBBDD+GGGEFHEHIEICHIHE.IFHGHIHHH>-CH-IFICHFFFCHCFFAAHB;IHGHHCDFEEHIEFECHIH.FIHHEAHGHIHHH,DCDFGHH,F+FHD3HH<:HHG6+EFGE3FH:G;ECFG'FE*=;BAG=D#GAF*B:E6EFFEGEE;F?8GGEG8F.CE?GE<+A?AEGE(E:DCE,ECAG:?C(D6.HGAECEHGG7=GE@CGG(EGE*<E<E)?88A1*G#CCE?C(EAE
@antibody_26_multiplicity_119_copy_37-1/2
ACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTCCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGGCGAGGACACGGCTGTGTATTAC
+
5??<?BBBBDDBD@DD8FC-GFIBHF-FHFHHIHHHHGBIIIAFIHC/DF7CHIFCAFGHHCDHHIEDFG-CEBHDIHE?@FEHDH-F-H/HHEFHDHHHAHHFIFHHD#IEFDBGHC+*H6HFE@5GHGD*F:EFE:EG;E=EGD=FE?GECEGFF/DEGFEEG/:C?E<C*CGGG8ECC?GFGGDEGG/GEFCCGEG/:0E?EE0?EEE0HEGF?A?:<C*G8CA*.?:?CGE*?G?.C0:CE6>/EE
@antibody_26_multiplicity_119_copy_38-1/2
AGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGATACAATGCCAAGAACTCACTTTATCTGCAAATGAACAGCCTGAGAGACGA
+
?5??A<??BBD-ADDDDFGCFGIHIHHIEHHHHIIH=CIGHIGHDDGGHDHFIHIIDFHGIEBGE?+FEIHHHEHIG+FCD5HCHH8IIIFH@HEFHFHICHHHHDHED,FG<+HHFHGFG+DGFF@BHH=;EGHC=FEEF*(G0GFEEB*@CC*GG?8G:A*E;(GCFEGCEG?EEG?;;AEEEEDEFEEGGEE6EEE?(CGE?*;#(D::HEGD:?7(#E(G?E-*0E?8.8GA:/A;EECC??/EE?
@antibody_26_multiplicity_119_copy_39-1/2
AGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTGATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCATATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATGGGCCCTTCACAGAGTCTGAGTAGTATATG
+
?,?<?B>BDD9@ADDBFGGGFCFIHIIFI>II?HIHEA.IIA+5IGFEFFAHHFHADHHEIG5IB+GFAHD'HD5GHHHBIIIHFHHHHFIFHIEI)HFBEHBHHDFGHCHH=HDFF*@)E4E@2F?3EFCF<EFIF(EE?C5D*DGEE,EG:GG?E6CGFEEG(<GF>C.EF:GFEF?#GGFGFF:?GE<E1GA6.:GAEGG?4E*FAAF::C7(:A?/#EE/C*;E:0*G/G::C>*(EG9*?A*EGA
@antibody_26_multiplicity_119_copy_40-1/2
TCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCGCAGGGTCTGCGTAGTATATGGTAATACTACTACTA
+
A5?=?A<7BDBDDDDDGE-GFDIHE5F@IHHIH@+CHAEIIHHHHIHGDHFHIAC?CHD5/HIHIIHE(IAIHHH=HAHIHIHH5HHEEIFFHCIG3HH4HIHEHFFDH+>EHHH)EGDGGF+EG*GHGFHEFGG<CCEGDEBC>@CEGE@E=AG'BGG/CGEGEE6GGEG6*/D?AGG?C/GEBGEEECG'?CGGG.GEEEGEG?(6.HCC'@*?7E.F1GFC?EA:G;(C(G:G::*?1CG2G)C.EE
@antibody_26_multiplicity_119_copy_41-1/2
CATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACTCAGCCGTGTCCTCGTCTCTCAGGCTGTTGATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTACTATCTGGTAATACTACTACTAATAATGTATGAACCCCAAT
+
<9,A?BB?DDBD@DDDGEFCFFHIFHAIHHFIHFIIHHEHDHHFFE9EHHFA0--FHAFFHHEH55GHHHFIFIDHBF,H+GI6HIHD5IHIHIFHIIGHHHFIHHHH+HH+CF;HFGHFFFE;EGGEGDHD?ECG/#G3GE:G-AFEGE*D8EEE=CGGEG;G<EGAEEC>:E:>GGGEEG*E;E8CG*AEGEC0*:CEGGG(C(?:G*GAH))8E:EE?,6:EEAEGG?EE6F6:.A66AE0CE?4(/
@antibody_26_multiplicity_119_copy_42-1/2
GTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGTGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCGCCTTCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAG
+
?,A<ABB-6BADBDD<FFGF>;H>IIFHC;9I=IIIHF-HHEHICF=HH0FH@-I?IEH5FIIGIHGH=GCIHHIIDIHII-H?5HDI-8,FIIIIHFFHHHHHFFFHE=GE?FFC=G@@HBFG5EFGG)EFF4?(EFFGGA=GFF9GCCG4EEGE*ECGEGE6'E8EAGC,*E'F;6EEDEE(-EE0*('EGCFG6GCCEGEFCECEE(:8EG:ECGGEGG0G<GGCF?(C:D;E1G?GGE0AE?00:*
@antibody_26_multiplicity_119_copy_43-1/2
CCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCTAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGAAGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAG
+
A??A??=<BDD59?EDFFGFGE6HHAH>IAHIGIIDD-FHHIHH9HHHIH7HI?>HDIHCIE9FEIHGIIIHIGFI+-HIHHGGHH/IGHBG5DIEDHHCFHHEDEDDEH?HFGF?DF<GCDADF4FGFEH.?GEE=FFEEGEGEG0GD?EEEFG+GEGCGGE6FGEGE?C*1G#EG.C8?GFGEEG?:FF6E8?<*G2E6EE>CEH:F<C.3:GEGG,/EF;6(EC*CEEE8?(E*G(G8A)?E(1EG:
@antibody_26_multiplicity_119_copy_44-1/2
CTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTGCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTTTATCTGCAAATGAACAGCCTGAGATACGAGGACACGGCTGTG
+
??A??<BBB?DD9DDD.GFFFGH.HFHHHHIFFIH-.HIFHGIHIFD+?HHHHEHEHEI5IIFCIIDIG-D;G@HFH(FHH#EGEIHICHI/HFDHFGHHGHHIIHFFHHBFHFH=EH,FF+FDEHHGDFFGDEGC9@GG0GCGE@.GG8BE:GFEGE@/8GGE<GFC#E:*EE(GF.EE;G2CGGGEC:FE(E.:CGECAGEG?EE(EAEG@G<:E:G:CEGC<(EFG?:80F*C>GC(9:GE8:G(CE
@antibody_26_multiplicity_119_copy_45-1/2
CTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGCTATAGCATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAGTGAACAGCCTGAGAGACGAGGA
+
??AA?BBBDBBD@DBD?G>>G;HIIIIIHBDEH=AIIHHGIHI:HDIH9IH.5D-IC#HHAI5H5CH+H@FHIEHFHH-HHHHH#HHDHF-HF=HGEBG,EIH?CFGHIGEGEHDEGHFEDF?GGG?HGF*;FFCG-GE,DGFFGGGEGEG:0GGGE)GEFGE?EG*EEEE(C@E8?EE0:C???2*G8GCGE(60G:EEF?E/E??G(H)8@@CECEEEC,E..E:*((EE?;G(E6'E0*GA??0G*G
@antibody_26_multiplicity_119_copy_46-1/2
GTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATAATACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCACAGACAATGCCAAGAACTCCCTGTATCTGCAAATGAACA
+
??A??B@BDDDDDADBFFFGFGCEIFFI@HIICIEIGHH9IFIIHG=IIHHFFHHDBI9EHICHHFH=,@C(G?I5HI,FHHHIHGDHFF(IDCHIHF)HGCHIEG+HF.E.H=*DGDH)FHHH?GGG*GEEG;E@FE.3ED;CE=E.EE0'E/GFGEEG?GA70GCG?CGGG(/?;ECE:EEEEDA?(G/<GCCG6FEC8E:(E??G)EE:7:GEE?,E:8(*EA*G:F:A?CC*GF((CC:EF:ACEC
@antibody_26_multiplicity_119_copy_47-1/2
AGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATACTACGGATCACCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTGTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATG
+
?A?5?BBBDBDDDDDECGF;GG-IH*HHFIIHIHHHIBHFHHIEIHEDHHEEFFA5EHHHHHEHIIEIAI@HF@IFHCHEIIHFEHFHF=E*HHHHHHFHHHE4HDFFF3HF#CHDH?HDD6DHGHEBFHHDECE<EGE*G@EGE;>CC*FE8GEGGG)EGGGB>?EG0*G*?<(FC:/F=G?CFF:EF;.E:GGC8C:?C*AG?AEEEEAGAE<8CCG:FGG(GFC*:EAEGGD0:0GGG;G:*0CEE<
@antibody_26_multiplicity_119_copy_48-1/2
GTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAAGGGCTGGATTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACAATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCGGAGAGACGAG
+
?<???B.BBDDBDDDDF-FFFFIHICHAHHDGI-IHHIG.H?GE-(IG-CIFHHIHHHHHEIIAIHHHH5HFB=HC=GH?HHGECGI+*HHEHHFHD.EH=IDE6HFBE@E+HHEHDDHD(FFG*HED+F==FEEGAGGE6@FG)GGBBFEB?2G?0CE8HFBE*GCAF?GGEEFEEEGG:C/CD.EEC8FCG**GGC<EF8C;F8H<EE/G):<D?G0G0G:)(?(GG:CCC)G::EC'?EG?(0(<01
@antibody_26_multiplicity_119_copy_49-1/2
ACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTATTATACAGCCGTGTCCTCGTCTCTCAGGCTGATCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCCACACAGAGTCTGCGTACTATATGGT
+
?<???BB@DD@D@DD<GGCGC>HHH+FHI>4IEH>HGHIFAIIFIFFIEHHGH?>F>HI=HIIIH-F5H@GI=FC-HHI*CHGIHHEHCAIH8HHHI+HH@EGDHHEFE@FFHHEEFG=GH*FHHBFGBEEEGHFEFGG(1CEG?G:GEBECBG?;;GGECCG;AEF(CE(EGE?,ECG.F?C(<E:CE8GGEE6G8GGECG*?EAC(G:0EEEEG<G?G):GE#(C0GAE??GEG:0(*A0E*F:G/1:
@antibody_26_multiplicity_119_copy_50-1/2
TAGTAGTAGTACATGGCACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCTTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACGCAAGCCCCTT
+
?=???BBB-DDBDDD+GCGFFGI/IIAIHH@EHHHHIGFI9EAIHHIHHH@FHIFFHHDEBFHIHCFHHHHHIHHHDHF+GGF?FIHBHHGH8IHHCIGHH,HHHDFIIHIFDFGGE8HHHDFHD:GE9DDGDGE-3G*.F*EGE3EG>EE*F:#GAGCD1F?EEGEEFEFCE<B*AGGECEE*EE(GCCAE/E(ECE=8/'EE:'HEGE0?0FBGBAFGG0?(FAE:'GA.'*G6.EG*>(ACEG?6;1
@antibody_26_multiplicity_119_copy_51-1/2
AGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGCGAATCGGCCCTTCACAGAGTCTGCGTAGTATATG
+
?A??,BB?BD9DDDD-FFG6GFH>FHEFIHHHHD+HIIIEF.I:IH>F>7G9H@B-HFFH@/FHEFGDAFGHFFHECHHEHBFFEHG>)II?IDIAHFFHHHDCDHGFGCHEEBHHHDHH3GHHHG<E?F:HED=F>F;GGG6@;GGG9FG?DF>AECFFGGEA=G'CD:8@6?E@:D?A8'EEEGG66EG)ECAF:A6EE?GEEC(G#>61@EE(DE4E;(FGC0EECE?/.?GEGGDG:F*CCGE/CG
@antibody_26_multiplicity_119_copy_52-1/2
TTCACCTTCAGTAGCTATAGCATGAACTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTGTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTCTTACTGTGCGAGAGGATCACAGCTGGGGATCCGTAATATGATTACGT
+
,?A??BB?DDDDBDDDGCCFGF+HI,EHHC-IIIGGHBH9HFHIHEFGFHHDCHI,HCHHFHFAGHH-IE?GHHFFIHIFFHHHGHHEHAHAHCECIIDH@FDHIH?HF(DHHHF?F)FC=DEHEG*EFC@GFEEF<FEFFGECFGE:GGD-;GGEEG(.=>GGFACGGGEEF(GCGCEG?GGCFG.:G/?*A6G*C?GC:C(GCG?A?H<EH:-E.8GG?7(E?GFG:E:C8<CE:G0EGA:EE?<GE8
@antibody_26_multiplicity_119_copy_53-1/2
AACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGTTCATGCTA
+
?????+B+<<DBD@D@GFG8FGHH;IFFFH9IFHGIH-IH@HIIHH>HB-HHIAEIIHFECGDHIHFGHE-HIIHHHIDIIIHH=IH8H=FHHHEHEHI(I*HHIGEHFGGDFB.G@HGGH2FFGGH(EH(EHG@GEEEG.-1EB:<EGG;GGFBFEAFG=FE9EE*G6EF<EGGGGGCGGEFG;*CFA6FEG8FAGG>GC(:/G(*F(CEG)CE>C7,G?GC9):EG*GGCG*EE.EC/:9*:EEE:(E
@antibody_26_multiplicity_119_copy_54-1/2
GCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGTTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGAATTATTGTGCGAGAGGATCACAGCTGGGGATCCGTATTA
+
????,/?BD9?-BD@DGFFGFGFHFHHIIIHIHIFH+HEHHFHIIHGHA-HGHI7AFHIFFHC+HGHH(I5HDHH5F-HH5E;IDC)HHIIAH>B,HHHHHHCIEH)HHHFH:FHEGHHEGHFDHGDFFG;@ED;G9:EHGGG*EFD+ECE;<GE;FFG;EGC(?EGCFCCEA>FFG.GAC?EE;GGGEE1:CE:E***GCCCGE6EE;A#EEC>#C/G/E,?0EEGEE(C0A((06CGC(G6E;CEGEE
@antibody_26_multiplicity_119_copy_55-1/2
TGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTAAAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCTTATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGAATCTGCAAATGAACATCCTGAGAGA
+
?A???BBBDDDD@DD5FGFCFF>HCHIHHHGHHFIF7IEIGIHHHIH9HFEFIFI?IIHHHCBDG=HHIHFFHIIEHHFH-H+I-I?IIIHH8HHHIF?H@GDIFDDCHHHHDHHEH.EGH'D+H2FGEGGFCHEF<GG.DF*FEGHA*CGGCA*;CF'GDFCFEGCGE?GGGGECGEFGGEG?GGD?EE/(:CFG?0EGCEGACEHA:C?:::E9:*EGEEGG0EECG?A:#?EA(CG:*6C:A0CE90
@antibody_26_multiplicity_119_copy_56-1/2
CTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAAATCACTGTATTTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCAAGAGGATCACAGCTGGGGAGCCGTATTATGATTACGTTTGTGGGAGTTATC
+
?????BBBDDD?DD@B?CGGGGHI/HAA0HHIHIGIHFHFBHGIBH0EIIAHIIHIFH=GFHEIGHH-,HFBDIIFG-HFII2IHHI=EIHHHIG6HD=HHGHIEHFHH.@HHCHGHGG=GDGC>CDGEEE?G?=@HE#GE;FEDE.?*GCF*6G=C=GGEC(EE:GEFGBAGGG?CGECEG-F('GA:G:G?:CGA8C0GGCGG?:6:EEGEEEEEE,GE:FGC9GGA:*?*C<GGC-/:E*(AEE2?E
@antibody_26_multiplicity_119_copy_57-1/2
CCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTCCTACTAATAATGTATGAACCCCACTCCAGCACCGTCCCTGGAGCCTGGCGGACCCAGTTCATGCTATAGCTACTGA
+
A??A??B?6DDD5DDDFAGCAG+H?8IFCH;D.H?HIHIIHHGHFAFIE@CF+CI>DHGGFHHF?HIIHIH+EAHHEIHH-II5.ICFHHHCEHHFEHEHFIHH?FFFEI+FH+FHHGCHD+HFFFHG@DFFCEEEGGG?FGEEG*EGFFE#FEE?8E/CGGG6?CE8,CCGA#A<(F4FCGF*A??EGCGG9GGC:DE?G(*;(CD*8EGECEEGG(?GC7EE*E0:.FE*GE?G/G(>CG(*?EG;E:
@antibody_26_multiplicity_119_copy_58-1/2
CTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTCCATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGTTCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGCCATTGTCTCTGGAGATGGTGAATCGGCCCTTGACAGAGTCTGCGAAGAATATGGTAATACTACTACCAATA
+
5?A??BBBBDDEDB<@GEFGCG>HF/>HICHIHGHG-CFGHHFH@GHIHBHIIHHEHHHHIEHHHFIHHFB=5HHC-F5HHHHFHFHE.HIIHHHHIHEFHGGI+BC6GDH2*HFF*DH1GG*FDF.@@EF1G8-GCAHGEGGEEE,EFGEDEFGG@G/ECFE;GE./G*GCGGGD<(#GGE?E<8CE8E'E:EF(0G/(G*CGGA>0A=*<H@G8D:FEEF;#<*(CG/CG8'E/?(:E:?*:E#C;1:
@antibody_26_multiplicity_119_copy_59-1/2
CGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGGTACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAGTAATGTATGAACCC
+
,????<BBDD<@DDADFCGAF?AHHHIIIHGIIIHE>AHIIICHFFFHH-I=@IHHGHHFG,EF*IH==F=IBEHGHICF+-FA,EIH-HIHHBIH?HHDIH@=-HHHHH9HHFHHHHFHEDEHFDEFH;GGG#HGGFFFEGEDCEC:@G#E.CEEE*;E:(C*(C(G#FEEEGGG?9(EG(9(AFE(GGEGGG(G<*E=F8F?-E8AG:GF:0GEGAEE87E).EGAGEEEGC(#/0?(?;EECC<?**
@antibody_26_multiplicity_119_copy_60-1/2
AGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTAGAGATGGTGAATCGGCCCTTCACAGAGTCTTCGTAGTATATGGTAATACTACAACTAATAATCTATGAA
+
<?A???BB?DDADDD@CGFG.CHFIHH>FEHHIHHHIHE:CIFIHEBHDHHDICHHIEIBHHHHEF(DIDEI>HIHIAF5H5FHEIGADFEHIIEEEEG=HH;HF5EEDHF+HHH+GA@HFFGFEHGGDDGG;GEF#GG@EABBHHCE;EEFG9AD612DEG?EGG8GE(*/?AC?AEGE8C;4EEEEEE**EAEC/G?EGAG/F8A*G;E*EG::BGG,C(/6?FECE(9C?*E0:(:6:G:*FC:8A:
@antibody_26_multiplicity_119_copy_61-1/2
GGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATCAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGATGATTCACCATCTCCAGAGAAAATGCCAAGAACTCACTGTATCTGCAAATGAAC
+
???95B9BDB?DDB<DFGG/GFFIIEHHIICHIHIIHIECDGH.HIHDHEEHHHHHI7FI'GHH-FHHFIHHFFH@E=FIFHHDEDIDEEAEHH=HCHEGHI+<FHDHHHH=DDEGFDHHFH;DGC2H+EEGEEGG+:EGG@G*EAF*EEG*E'C8?E*AGE0=G(*G:EFGGE(AGECC/?EE=GEE>FG/8G?*#A(6(F1GA68?GEEGH:C2*8E@GEC0CG:C::E:*G0C*?G((E(GGA*)EG
@antibody_26_multiplicity_119_copy_62-1/2
CATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCATTCACAGAGTCTGCGTAGTATAAGGTAATACTACTACTAATAATGTATGAACCCAACTCCAGCCCCTTTCCTGGAGCCTGGCGGACCCAGTTCATGCTATAGCTACTGAAGGTGAATCCAGAG
+
A==?ABB@B5B@-D@DFFFG+GH6HBDC;CG:GHHF?HHHH7HHHI@/GFHGFEGIFHAHIHHFA=HDHFH5GGHAFHCICIFHEIHHHHDHDHIFIHHG-FHGHCHDHH:=HFH>EDHHH8FBHEFH1BE9FGFE4CF*=G=*@G=E:*E5:*C0EGGE:BFG?C<CFGCGEEGGE0EE8(F?*.CE(C::FG'(?:A(/GGGAGFG#:C4:<C?BGGC?1E0.E6AGDC*??GG:EE:#:A6C)C*)C
@antibody_26_multiplicity_119_copy_63-1/2
TGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCGAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAATATTACCCTATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAG
+
A5???BBBDED5DB-BGF>F+GHIC>IECHGCHIH.HAHF?HGHIFIH/IF/I-IA@HFFEHGIHIIF5HHB5CHIHHHHHAHHCHHFF=HHI@HH8F5AIHE,'+IHHHDCHIH)FFEHFHFF:-=AEBEE+GE+GEFD8GEGGCGEGCECA#GD*GEE=#G?FEACG#G(GAGGEGCC?GFEGEGGEECGEC*?GCFFCEGAGF=CEEG(EEEC:EBG7GEG?F0:8G(EAG*?E?G?.E?E?)6ECE
@antibody_26_multiplicity_119_copy_64-1/2
AGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTATTACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTCGCAGATACAGTGAGTTCTTGGCATTGGCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCT
+
A???A<BBD=B<55DDGCFFFGHAHFHHFHCF?HH=HF-=HEDHFHFDHHHCHBFDHIHIGIFHFIH5EHAHIFEEIHHHFD)DGFG-ED+H?FFHF.HHHHFH@H+>FGHHHH+DDFEFGEEHGGE*G)GFG6CIGC1>G))FG*HAECG@F<,CGEDFE/?@;E>(GA=FB?CAACEGFC/AE8FEE6?/=ECC*EEG'FE?(*E?C;::E@E?EAG8E:?GGE?GAGGAECGEEC*.G;>CE((:?(
@antibody_26_multiplicity_119_copy_65-1/2
AGACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAATGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCTGCCCTTCACAGAGTCTGCGTAGTATATG
+
?A<??BBBD?A@D@B<GGFACG>HH>HHCFHIFHHI-HHIHI-GIFHIA7=EICIHEFEGIIDCGH-GEHFIGFFGHIFI-HC+H;H-HIHFHHHEHHHHD<HHFCA@BG+D=CDHDHHHHEDG=H0GEGFGHDEEEFEF>EGCG@?8<6#7EAGF6GCEGGAG@F>GAGEECEG<G.CG:C*FE#CGGGCGFEE*CGGGEC?0(:AF?FED7G<GGEEGE,E?F<A:8?*'GA.GECE*;?CC:G?.E/
@antibody_26_multiplicity_119_copy_66-1/2
GCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTTATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCGAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCAGAGCTGGGGATCCCTATTATGATAACGTTTGGGGGAGTTATCGTTAC
+
<5???BB-D@DBDDDDFF-GFGIIICIHEHAFI+H+IA.HFHI9>GIF#I9HH8GHDEEGIFIHFGHDHHIIDI,FEIHEIIIHIGFCHHHH8HFG.@HHIHHAFHGHHD-G;)D+FGC@EHHFFCHFEG@DDGEGEHE0AEFDEGE#EE;(E(E(@EEF8GGEEE:*EE6F:G/FFEFA6GAFGGF:??GD-GGEA2FGGGE(EEHC:EGAC7/C*GEA8DG<CG(G*FEGE:#A(EG:<EEG'G;*E*
@antibody_26_multiplicity_119_copy_67-1/2
ACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAAGACACAGCCGTGTCCTCGTCTCTCCGGCTGTTCAATTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCA
+
????9?BBDDD-@BDDG9FFCEIIHHF;IEIDH@IHFHHIHFIHHIGHIAIAFH79FFCAHIFC5=IGIFFFHECFCH)BIIEEHFF>HHEFHHHHHG-HHF#FHCHHHH4HHF)FHEGFHHHFFF,C,6GGEGDA#28GG@FGEFCD(GGGGGEEEEFEEEC0AFAAGE;FFGEAEGFEGECFEG8'AGEGCG*FEC*CG<8E/EHECE*?;E*GC:GG0?GE?G<'??A:EEGG?GAGCC8G/:EDCC
@antibody_26_multiplicity_119_copy_68-1/2
ATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTACATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGAGGGTGAATCGGCCCTTCACAGCGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCTGGAGCCGCGCGGACC
+
?A=A?BBB@5DD5DDDFEFGFFCIECFHCIIII-IHHG;IHHIHGHFIIIHEA-CFDGIFFHFAHEHGHHFCFEHII;HIIHC=HFHIIFED=HFHI+EHHHH=+GI(HHHGE@H(GBHFG?GGG@FGAGDHF0+FF*F@GEG?GE?CF0GC@E**GEG(E-G(8(EG*<(GGG0EAAG*CFCEACF6(E8DE2DG6/E:?E64C>EGEEG-@:GEEEGF1,:G9FEAG:E:GGA<010GF*'0<FG*?F
@antibody_26_multiplicity_119_copy_69-1/2
GGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTTCAGAGACAATGCCCAGAACTCACTATATCTGCAAAGGAACAGCCTGAGAGACGAGGACACGGATGTGTATTTCTGTGCGAG
+
???5?B<<?@BDDDDDFCG/GEHIIHIIIAGIHHIGFIHGCII.IHHGHHGGICEHH@HHE9H+IFF=FIHHHGHH-E>IIHEHIHHHHDFIFI'ADFDHEH=-EHHEHHAHFFGD.>HHEBHG3GHE@;HEH3EAG=EFHGEE?*FA=E*EGGCGE>=GC:AA?GE((/F(G:C)?6ADFC*C:CAGEEF'F(?(GG*GGGGG(AH;C6E:EGEG:*EGECGAC6A?*C:(=6G?DEE/#??C:0?C:0
@antibody_26_multiplicity_119_copy_70-1/2
GGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATAATTAGTAGTAGTATTACGATATACTACGCAGACTCTGAGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTTTATCTTAAATTGAACAGCCTGAGAGACGAGGACACGG
+
?,A??@B7BDD-DEDD-GGE>FIHHCHIHBGGDGHGHFH.F:7I7+H9IGFI5DHHFEF,GIFHD-=IFH+HH5HH5EIIHCIIFFGIHIICHEHIEIIHHIFD.HI@CH5(IHHFEED/B=DHE6HG+HEFGGGGGG0(F;(F2G(E?BEEEGCGGBEG;(E*GB#F6-FG>FCAECGGF??/*EGGGEG6EA:CE:1G?GEEE(H8CE(0(@;.(:)#GG0A:?G'E*G(GCDCCCE(:F0>0AA0EC
@antibody_26_multiplicity_119_copy_71-1/2
CATGACACATTGGTTAATATAAGGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTAAATGGTCATACTACGACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCTGGAGCCT
+
?A?5<B><-DDE?DD@FFA+?E7IHHIII>ID7IFDHHFHA+HEHFFBIHB.IDHHHHGHHFIIDD-IHFFIF-AIGH-FCDF.GEHEI4IHGIHHBHHHHIHD+H?FGCHHFEHHGE=FE<DH,GFBE?8C=GE?GFFCGF(CGG<E8C;EEEEE@,FE?GGCFEEE8AG(GGAGEEEFGE??.FGAGE(*CGE4C/EECEE?A#:(CEF?A*ECGCGE.GFCG:E<A?GGGC:<CC?*:0AE81:.E1
@antibody_26_multiplicity_119_copy_72-1/2
TGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCGGACCCTGTGAAGGGCCGATTAACCATCTCCAGAGACAATGCCTAGAACTCACTGTATCTGCAATTGAACAGCCTGAGAGACGAGGACACGGCAATGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGC
+
?<??ABBBDBD5BDDDGCGFFGHHHIHGFEIIGHAGIIIH9GIGDHF.IFHG9D5H+HDF7DDGHFIHCIHDDFHG55HIFCGHGHFGFHIFHAIHHHFHHIIIDHFEHIE@BHHGD#7GF#-E=H*GGEEEEEEF+G(GGCG-2FFEEG*?G6EG0FFG2/CEEG8EF:AEE?EEGC(E:+G(:C#?*E::FEE:CGG0*4FECA6AG8#(<F(C8(G;E,CCE:E./C:6E)F6A(E:8E:C??.E?(
@antibody_26_multiplicity_119_copy_73-1/2
AGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCGAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACCCGGCTGTGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTAAGTTTGGGGGAGTTATCGTTG
+
???A?BBB7BDDBD-DCFFG/GCHHI.HIIFGIHFHHAEHGHCHFDFHHHGHHH=EH@IG>EIIIEFFFHIHDCHHFID+HHHDGHH-IGH+HGIHHDI8HIH7?FHGDIGHHD@D*HDHBHHHDHFH:F2HEH+FDG=FGGEE(FG*E8GFGGE@G;@GFCG=AGGFF*AEGG.GEGG)+GF(GA?EEEE<GED<EAG<C;G<0G0EG)FGHCGGG:CAG/EGE9.8E*C*?>?C:C:.C**CE)?C:#
@antibody_26_multiplicity_119_copy_74-1/2
CTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTAATAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCCGCAAATGAACAGCCTGAGAGCCGAGGA
+
?=???B?BDDBB-DBB>GGGCFHIFHIHHE@IHHFACHHIFIFFHHHHGFFH/IGFHF8EHCD?HHDIBIIHIDIGHH?EIH'-GGF8IHFHHHHGAIGEHFHHHHDFEEHEHHEECHF9DHGHEEEFCHG:DFG#E3EFE<*DGDF388?EGGC@?GGEGEE4AE6FEED6FEEEG:FGAGC:GGE/E?ECG?E:GEGE:BE(G6EE?CEEA/G<GCBDG,'F?C):8(FCACC?E6.*EGE*(E?(:G
@antibody_26_multiplicity_119_copy_75-1/2
CAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTCAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTCTGAACCCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGTTCATGCTATAGCTACTGAAGGTGAATCCAGAGGCTGCACAGGAGAGTCTCAGGGACCCCCCAGGCT
+
A??A?BBBDDEDBA<DFF+AFFHH=6EFIFHIIIIHHHDEFD@HFDC,HCADHHIHHB8HHHHFHFIDACGGFH-IHDIFFIH-HHHFHH,FHHHE(HHAIIHEGH@EH(HE'FEG-7+HH/@FGHGFFDGFDEGG3*=#,GD-EFGEGGCFGE;EDG8*AGEECECEEEEEEGF'EEEC<G6*?AEE?FGEFC86GEEE:::G.GHEC?0E0@GCEA7(1'EGAG*?AFGE(6C01AGEF*?(?6A*EE
@antibody_26_multiplicity_119_copy_76-1/2
ACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGGTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATGTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACGGCCTGAGAGACGAGGCCACGGCTGTGTATTAC
+
????ABBBBDDDDD?DCG>GGFHFHIH8IIECH=IHHH>I+,GHGHFHGGFC/AGGI#HIHI5DIIHFHHAHHH7E>G+HIGH+HFHHEAG=IHFIH.D2HFHH#HI=BIH?FF@1HHG@H;DHGFG?G#BFEG@EE;EG:BGEG,FFGCGEE6E0G<AE<E'EC;*GCEFEGE0FEGCC/;*EAEE0FGEGCEEGGEG8?CE:/GHGE?:FE@@GG',EGEEA:::.(*<;E*CE#CCDGG?A8E?0EC
@antibody_26_multiplicity_119_copy_77-1/2
CATACCGTAGTAGTAGAAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCAGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCACAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTAGTACTAATAATGTATGAACCCCACT
+
?<?,?-<B<DDDDDDB+8FFCFEHHEFEIEHFGDFIDHHFGFACHIFHIID@FGI>HCFHGIII5EHEHFHCHHFGHHDHHGH@#HDHHHFCHE.HHHHF8GHHCIDHHFEF)IG)FHHDF<FHEFF,AEEDH+5;'DGGGC?GBGGGEF.,GE*?*EA?/GE(GE:G)6EGCGGFEFE8CE;86?C:GFD(E**AF:8GAFEGEEE0:0?EFEGGG<7G*EGEE#(C86;E(*AEC*EG8/C*E?)EE8
@antibody_26_multiplicity_119_copy_78-1/2
TAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTGGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCAGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCGGGAGCCTGGCGGACCCAGTTCATGCTATTGCT
+
?,A,?BBBBDDBDDDBFDF;GEIIHH6IIFI.GI=HHHGIF/=IHICDAGFIH9HFHIDGEBHH=HFHDHGHIHHGGHHHE5H5CFHICHFGIIC#GHHHEBE@HHHDGFHHFFHGHEFH<HE*GF*B@GHEGBFF,BGFFGE3<EFGG?GG2CGGG(0:F*FE@B>CE5(?GEC,G0(FAGFC:E?:ECCCD*(FC<0*A4??EEAEGAA:@.EEG*GCC:'(?(FF;GGE.8*G(CAG#G.:(G'G#F
@antibody_26_multiplicity_119_copy_79-1/2
GTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATAGGCCCTTCACAGAGTCTGCGTAGTAGATGGTAATACTACTACTAATAATATATGTACCCCACTCCAGCCCCT
+
??<A?B?<DD5DDDDB;GFCCF>I.HCIEAD=IF.EIFGHIGHHIFII?G@EID8'HDIIFC-FH5HFFIBEFIIFCIEEFGHEHHFFIEFFHFH+GEGHEH?HF+5HHFHDHGGFCHH@DEFGGCGBFB3GGAFDBFH>2GEGE4EF*EGBGE*EFGG@*G8G.G>CE<EE8*EE8(C;E?E?FEGCCEFCCGAEEEG/GCE(E:EE:.GFAC*2*GECC?((:AE#*C.G(G(C*E;;G:.:G8A(0/
@antibody_26_multiplicity_119_copy_80-1/2
AGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTCTGAACCCCACTCCAGCCCCTTC
+
?????>B?DDDDDDDDGFFEFGIFIHIHFEGAHCGDF?H-IIIHHE9HHHIEGHHFFHCHIHIHHFIAGFBEFIIAEIIIHHEIH'GIHHHHDHF+3EBHHEHBEHEHH?G?HH>FHGFFCDDFHGF+HFFGHEGD0@GFDEGCD'G?EDGGF*AEFGFFEAEDFCFGEEE(:ACEA<GGEEG>E-GAGE*?GEFEGCAE4GE?:(HE:EEG@@7(B/?@FCEE(A?(GFE*E:AG:?CC.*CAAEAGGG
@antibody_26_multiplicity_119_copy_81-1/2
CCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTGGCACAGTATTACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCATATACAGTAAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAGTAATACTACTAA
+
??,=?B5BDBB<<D5D0FGFFGI>IIICHHHAHHFDFFAIHF+HA0GCHFHEFHFCHFFD5IFHFHIH-IHHFHFGHIHEFFHH+.IHFFIGDD8HIIEIHHHCFIH>HEFDH3HH=HEFBC*EE9*E*DCG@G2FGGGG0B(GDGEEGG*.;,EE;EG=G?0-/;GGGEF)GFG?FCFEAGEEG61*F0>EAAECECCE*4E'GC:EG(8:HGEE*GEF))AAA.G*E?EEC8EAE(*C):GG6EC:C>
@antibody_26_multiplicity_119_copy_82-1/2
TGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTAATACATTATTAGTAGTAGTATTACCCTATACTACGCAGACTCTGTGAAGGGCCTATTCACCATCTCGAGAGACAATGCCAAGAACTCACTGTATGTGCAAATGAACAGCCTGAGAGA
+
????A><BD<EAEDBDFGFFFECIHI-HIIIGHFHHHHF(IFDIEGHHE-EHEFGIDGHCFFH*HDHEI+EHFGHHIFFDFHIHAHHF-BHFHCFDF0GF5HCFDH:CCFFGCFEEHHHH1DEFFGGHGCCH#EEACEEE'G1?CEEACBADEFG5EG(B(A?(GE?(6FE8EECG(G=A<EFG6F'EE(GE?:E*GG/(EE::<E8?DCEF'CE7:EGEEG?**G0'F:)A':E:GGC??:8?EGC*EA
@antibody_26_multiplicity_119_copy_83-1/2
TAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCGTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATACGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTCCGTAGTATATGGTAATACTACTACAAATAATGTATGAACCGCACTCCAGCCCCTT
+
???,?A5=DDBDDDDDFGFGEF8FHCC;FIHFE.FIGFI,IFGFFC=I>GHFHHHHIIHEHFH+FIIIEHIEBEHGGHFHE5I?HHHHHFIEHGECF@,HIHI=CHHHF,DH=DHHHFFEHFGFHHGE:G*1GH@IFGFHGGFH:EG**EEGG:EG8CC@:CCGBEGGCEG<CE:E6/E8E+*E:EEAGGE.:((EEGEGAC:G*C?:EHA0)CE;*:E(-?/?A2G(*C(C#:;*EE::EE?E:/*??F
@antibody_26_multiplicity_119_copy_84-1/2
CATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTACTATTACCACATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATTTGCAAATGAACAGCCTGAGTGACGAGGACACGGCTGTGTATTACTGTACGAGAGGATCACAGGTGGGGATCCGTATTATGATTACGTTTGGGGGAGTTATCGTTATA
+
?<??A?BBDDDDBDD+FFGFGG-BHI>/HFGFHCHFHFIEAIHGHCG:HFHHFHHAFIC=CHFHH-IDFIGHHA+EFHF;I-HFHGHCFHEHFHBBHAFAIHHH3HHFCEGAEDG5H?D,HFFDEGF5HHCGGHEGFEDGGG'25E=GGEGF.E(D<EE1EG'?FE:AGE8FC8GEFGAED;:EE:GGFD(8<(CGEE?C0C8EE#(AG?GAE/'<?G9.B:;E:EEG?(?CAC*.C/CCCA(0E(A)(E
@antibody_26_multiplicity_119_copy_85-1/2
GGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGAAGACTCTGTGAGGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTGTCTGCAAAGGAACAGCCTGAGAGACGAGGACA
+
??==??BB9BD@BBDAEFGCCEIEAIEIFI+>IDEHGIHHCDHHGGHHHHII.HDAHG@IGA5FFF-HEHDGII)FFH;BH(AHHFHEIIEF*FHEHH.IHDFGCFHHCHHHHHEGE2HDHAGHFFDCDEAGFFDG0?EB;=*93DGEEFFDGECEGEF=#G.EEDEEEGGG.HG:AFEGCA:?GEFE:CG:C'GGC?E*:EG?EGEGE8F(E(@?E/)FE#(((G(A:ECC:AGG:AGGEE(8E<D:CE
@antibody_26_multiplicity_119_copy_86-1/2
CATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCTTTTGCAGATACAGTGAGTTCTTGGCATTATCTCTGGAGGTGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACCAATAATGTATGAACCCCACT
+
?A???5<BDDDDB@<<FGGG8CHHAHII+EIFBEIGF779HHHIHH.EHH.H+HE?E55FEIHG>HIFHIGFGBEBIFGHAGGBCIEHIFHDDGHF1HHHGD.IFE>FHH1H<GIDEDHDGGFH3@@=GHGB@G@FBD#GG.G,FGD**:CFGGEG-G'GFG*GG?E*EE'EEGE?E#@E6E>GEGGEEGC=EE8CGEEA<EGG?E6GECCF7EEEECB0:GA#AEA:?(EECEEG:FEG::EC*?:EGE
@antibody_26_multiplicity_119_copy_87-1/2
AATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCAATTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACAAGTAATGTATGAACCCCACTGCAGCCCCTTCCCTGGAGACTGGCGGACCCAGTTCA
+
?????BBBB@@ADDDD0,FFFFH/BIFHHIG@GCHAIFHDHHGIH9HH9E=GHHGHHHEEHHFIII?HDHIHFFH+GEHHHI+DGHI?FEFIIHIHH+H*HHH+IF+FHHHDGIF3FFBHGGGGFGFDG6DEF(EFEE(*@HCGGGGEA2C(G8F?G?EECGG(GCE;GE?*EEGECG6EGEEEECGCEC)*:(**AE?:AE?(28EE(H:G@GE'BAC,GC1*D:1((C9?*CA8E0FE(*E?*:?AEG
@antibody_26_multiplicity_119_copy_88-1/2
CTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGGGTCCTCCTCTCTCAGGCTGTTCATTTGCAGATACAGTAAGTTCTTGGCATTGTCTCTGGATATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTTTATGGTAATTCTACTACTAATA
+
?????BBB@BDBDDD?GCC?GCFFHI6ICCHHIIBHHHGHIIIGGHHE+HFIIHCHHDGIG.FEIGHF8DAICAFHIIIIHFHHC+EIEHHHH<+HHHBH,EHDFIIEHHDGE.CF3FEEC:9*B<GGHHE#@3BF.>(#:BEECGGEBCGEEGEF*AE';G'C*?,6E/6ECF,FE+6GCGCGGGEG:(GC#GG*6G:E(?<A-?/EA;CG:GE*G8(.:GC:G?<(=CE?G(F(?#EF88EA2<C*CC
@antibody_26_multiplicity_119_copy_89-1/2
TGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTCCCTGCAAATGAATAGCCTGAG
+
<????B>BD@DD<DD?FEFGFFFI0HIEEFHGIEIDII,HBIFEHIFF@HDHCGHD-FGDH8HHEFIEF(IHI@HHIDI;-CHDHFGHHI+H*HEE?EHHEF4?HHHG8HH=IFEHHHFEGFHG@B+DEFGG1GGFGF;GEG*E?D;G;FCG8BECEFE(CEGDDF,>C?6G*:A?EE;F2EE=G=ECG?C?G<F:GGCA*E:6GECA*E/8;FC8*/E(B/?8?.C?#'E*E):AEEGE?(GEE?(GCE
@antibody_26_multiplicity_119_copy_90-1/2
CTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCGAATGAACAGCCTGAGAGACGAGGACACGACTGTGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGGAGTTATC
+
??<??BBB<-DDEDD@FFEFFFIAIHHIB8EHIGDIIHD(H+IHIHIF>AIHHHHHCEHFFH?ECE?5IE5HFIFEHDHHFHECG*IHEH/HECIGG=HFFH=HHF,CHHH2FBDHBCGFGGB*H@FDD6GGGGEDDEE*BE6GFEFGECDC#ECGGG;,GGGFG?/?GE?*0CGGGEECG(FGE*FCGGDGG?EGEG)?C?AEF:AEG(GE*EEEF?.E<EE:GA*C8.FEA6::AEG:EF(FCEC;*E
@antibody_26_multiplicity_119_copy_91-1/2
GGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCACACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACATTGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGACAGACAAGGACACG
+
????9?BBB+DDBD=DFFCFGFHHIFHHHCIHIHDI+HIGHHDIEFHIHIHHE?=DFHIAIHHHGHHGFFIII=IAFH55HHHIHHDDF=FEIIIFHGH@HH:HHHHDHHEDG*BEHFGBF*FE*EGGHFHGE+EAHBEE=GGGG(;FEGGGGCCGG6FFGEE4EGCE8G>BF*6E,??E/8DGEGG?GE'E/CGG?8CC*EGGF(CG?FACHGBCE:FEEFAG::EEA//CG(?E*GC?E(GEG:.ECG
@antibody_26_multiplicity_119_copy_92-1/2
GTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCTCCAAACGTAATCATAATACGGATCCCCAGCTATGATCCTCTCGCACAGTAATACACAGCCCTGTCCTCGTCTCTCAGGCTGTTCATTTACAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCCGCCCTTCACAGAGTCTGCGTAGTATATGGTAAT
+
??<??B<BD-5?D@D?GFGGFFHIEFFIHIHI@IHFFHH;IIDFI+GIFEIHHEHIHIHDHFCIEIDHHIHFHIHHIAHEFF)5HHIFGHHE*HBEHFIDEHH8GEHFFFHHHH(FDHHHFF.FEBH*FGDHEH+GBGDG@8F(GFE<FEGAG*GB@GCGEEGGEGGGGAE#C?(A'EEEGEGGEG:GEEE6;E2GC*E:A<:GE:0EFE:E09EE(GCEC8FEEGE8):AACE:0GAEE.*A::/(<*C
@antibody_26_multiplicity_119_copy_93-1/2
GACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCTGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAAGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGTTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGCAC
+
?<??=B/@@DBEB9BDCFCG0CHEICIHFEBIGIAHICIAIEA-FFIHI.FID-B-DAHHFIFHIHFIHE+HHAHIHFGFFHEHHHH-HHH3F8HFHCDFGDH*FFHIHFEB?HHHBG*H3GHFGGHEH9GEEFEG+DGGG4)GGGGGEGGEEG.CEGFE-EGE:C==FG*E*.CGG<GD3F(EC.(#*GD4?CECGGEEGG*GGCFGEE?G@AEGCEGEB<EEE?:C8(0)F8GEEEE?;)8EAGC(A?
@antibody_26_multiplicity_119_copy_94-1/2
TGAGACTCTCCTGTGCAGCCGCTGGATTCACCTCCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCAAGAGACAATGCCAAGAAGTCACTGTATCGGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCACA
+
?????B>BDBADDDDB;FGC*FH8;HIHFFHIC)HHHHI@7D*HHFHHHH.H*HI80HHFIED@EHHIFH-GI3-HGHFDFF5FIIG+H;GHFHHHFEHHIHFHHFECCHFG+GHIFE*1EFFH;DFFF=EFGGDF=FGDCCGCGGCD8CEEG,CGCGEG)GEGFGEGEC?GF:/E(C#6GCFEE*EGG(G(G?GE/CEEGGAE(C6(G68EEG@7(G,(GG(G8GE?A0(:(?G)G**G::E(:)0:':
@antibody_26_multiplicity_119_copy_95-1/2
GAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCAGGAGTGGGGTTCATACATTATTACTAGTAGTGTTACCATATACTACGCATACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCACGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGC
+
=????5BBDEBD<BA-E9FGAFFHAHE,ABHF.IIEIH9HHGBHHFH9FIHHF5AHHFHHHDAHA-I7HIH+FHH@>CCHAIAH5FCHHHGF+HIAHHDCHHD5HHCH*FDBFFHFHHBFGGHGDGHHF?;C#EEF=E@=#EDEG;GF858GGGE*FE#?G6EGEGAEEEGE,=G#CGEEGGCFF*GCEGECG:9C0E/E/'.::(9EGH8GEEE?E?GA7CG/E*EGEECEEE((E4EC*G?EC)/:?(
@antibody_26_multiplicity_119_copy_96-1/2
TAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTAGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGTTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCC
+
????AB<BDD<+<DDDFGGC/FFII8IF8EHFIFCHHEHBIHB/F/HI.FC9HH5GHIIHBH>IIEHHHEHGIIHFIDFIHH5FCAII7HHDFHCE*IHHBH+@GGGFHHFFFFHHGHGHFBHHH@CH1;FBGFEC5HGGG=CEF:9DGF4DG2CGAEGCFCEEG(G*'EGGF?ACCEG?;GE6#(*?EGE?A?G??EAA.?<GEE8./'A?H.DG0E7EEG.(8G<ECE'E*:CEGEG*E;?EA(CEEE
@antibody_26_multiplicity_119_copy_97-1/2
GGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCGGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGACTCGGCCCTTCACAGAGTCTGCGTAGTATATGGAAATACTACTAC
+
=5???B<BDDDD5DEDBFFGGAAHHFCFCIIG./IHH9F>HE-HI+?+GFIAH8H+GIEHI8.I@+HH:IHHEHF?HHACI5FHCCHHBIE?IF?8FHHGHFD6,HCHDEHCFDHGFEDGBFG?HHCDGHGEC(FDFG0G=)8FCG@G@EDE08E*(GCFG:?/:GCGEEGGEGEGGFE(?'EA00C6(GGGG/G4GA(EGGECE(<DFHE)H-B*:G::E.0E:.F9CGGAEAG?C1':.C?*EG/(E?
@antibody_26_multiplicity_119_copy_98-1/2
GTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCATTTCATGCTATAGCTACTGAAGGTGAATT
+
???5??BBE@DBDD?DF;FFGG>H>I-0HHHHHFHIHGHHH=I-H*I?9FHIBHGDGHEDD.IHFHHIIFGHFFH-FGAGHHGIFIEIHH=HHIHIGEHFHFI+HG0?ICHHH2HD,,7FGBED?HBGA86GE,GBFGEE;(D*09C9=DFGE.0GGCE;EE*GEG;:GEF(E./F<CGCGE?CEA8EEEG68G.GG?'FGFGEGG<*?0C/EGDC7E/G?(*EG6?GC?CC0?*(:>.ECEE:C<EE.#
@antibody_26_multiplicity_119_copy_99-1/2
GGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGATGGAGTGGGGTTCATACATTATTAATAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCGTCTCCAGAGACAATGCCAAGAACTCACTGTTTCTGCAAATGTACAGCCTGAGAGACGAAGACA
+
????????DDDDDDD+FFFCA;HFEIFIICIHHHCFHHHHIFFF=CFHIII(IHFCGHAFI<-GHCHEHFHHH@)HEFFCEFBEIHHGCHH5HHHFIDHHHFEDGE.HHF''HBEHHHAHFHHDGFGGGDEDFGF='FHF;#FH=(GGGGGEGGFEADD*FGCCE(EEEE?GEGGFGEEGEC?C:()ECCE2?(EG)*CFEEE6ECHE(DCC'GG:G(G:CCAFC'ED*.=EGGGC?F2?>E(?C#EA(A
@antibody_26_multiplicity_119_copy_100-1/2
TCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGTTGTGTAATACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGG
+
AAA9?BBBD<DBDDDDF.GGFCBF8IF/HHIHHIIGHH+IIHDF-IFHI.GEDHHEGIFCHDIB5HHHFHG=+HG-HHHGI-H6HHFCGHF7IED+IHHDF*EFHHFDHIHF)FFH(HHFGDFFFGFEF8GH:*DGGF1EFGGFCEDCCAGGEEE/?0EG<@GCA2:8G?EE/E;C(EGCGEAC*GE?(.6:AGEE*FGG(CC0*EE.?AC8*GE/G0BG:E*ECE>EA6ECE*EEE:G*EA:E?(G8/?
@antibody_26_multiplicity_119_copy_101-1/2
ACTCTCCTGTGCAGCCTCTGGAGTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGTCGATTCACCATCTCCATAGACAATGCCAAGAACTCACTGTATCTGCAAATGAAGAGCCTGAGAGACGAGGCCACGGCTGTGTATTACTGTGCGAGAGGATCACAGCTG
+
??,??B=?DDDDDDDDG>GECG-F>HI8ICHHIHIHHAI+HHH=@GH-HHEHHE@H++H'CFG7CFHHHHHDFFFHI=HFHIAFCE-CEHCGCHHF8F/H;HHG8D+HEGE@FFFGHFH+E*FFG1HGEHEEGD*GE*GGF**2EEG@;EBEEG*?GG(AGEGEFGEAG::E<?EFGC#(G?EE*EGGEG=C;..(GE?GFDC(F.FECEEC(:(/GG.@E?GGCGGAC:?:EF:CG*8?GGGG0(*(G1
@antibody_26_multiplicity_119_copy_102-1/2
GTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCCTTCCCTGGTGCCCGGCGGACCCAGTTCATGCTATAGCTACTGAAGGTGAATCCAGAGGCGGCACAGGAGAGTCTCAG
+
????,<BBDDB@?BDAGEFGFGH/FHIHE8IAIHHIHCIHH=IIFG/DHHIAGFBH5IFF-AGIH7HGDH=IHIHIFICCF@FIHHHHH-+HCHFIH=FHHGHDFGDHFF,HGFG@HCHFDHHEEEEHEGG8BFEF8FEE2EAFGGGG*FCBEBGGE8G2GE?86EG??AGCG(*GGGGGE/;1C#(*0G8(CC8E*(G??EF;EG1EFHCA*EDCEEEGBFGG6.C:/<EC(?FE8(6(GE?)?(C1C/
@antibody_26_multiplicity_119_copy_103-1/2
GGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACCACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTG
+
?,???BBBD@BDBD@DG>F>FFCFII+;(HHHHBAFIHFGIH-FHDDFFHGH5HDIHDIHHH@FHEHH-I4IH5FCEHHHE?FFIHDFIDIHH<7FFH8FH@FFDHHGDBBGEGH=E=FEEF2;F>FHHFEGGG2*EFEGGGB:E<BGCG,FC8GGBCG?(?GG((GEFE<E;EEEFGB(GCE0EE*GGG4G;.G<0EFG/(A?D*H:*?:GFG(?C/;@.A??C/EEFACGA#:(*:8/EA*AA-G'80
@antibody_26_multiplicity_119_copy_104-1/2
CTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCGATAGCATGAACTGGGTCCTCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTG
+
<=?A?BB>DDDDD@DDCFEGFGHEI8HIH@HIFEHII@IHIHAFIIB.EFHIFGAFHIECIHIE-H/IH)HHHHIGH@GHHEH(IIFFHHHHGHIGD-E-.HHHGH@/HHHEIGEHFHDCFHHHFHEGHGG+FEG9;G=GE0CEFFE=EFEGECG(B?GAGECE*/E<(G:EGE9E;EGF;?EFECGGEE?E/E:6FGAFFEAE/E??08*ACE407G/GCAEE*FGGE:EAG(4)CC?EFA.:6:C?:E
@antibody_26_multiplicity_119_copy_105-1/2
ACGGTGACCGTGGTCCCTTGGCCCTAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGT
+
??A5<BBBDBB5EDDB-GEGGC>H.IECEIHAHHDHIIAHCFHAI/FIIHHIIHHIHIAHIHIEDAI?5IHDF=FEAHD?GI5FHHEFHGBFB=HFDHGEH9HHCHCEHFFCFGGBDHFHEG@FHHH2EEEHEHGGG0/FEEG#6E?CDG8GEB@@;;CEEGE6FEGEEGA8E;8EFC#/02GEC/GE?7;GGG*E?GAGGE.CG;*EE*FF8E@EF7<,?D(<A*(E(?EG.G?*.AEFCCCE8(?*0E
@antibody_26_multiplicity_119_copy_106-1/2
GAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGGAGTTATCGTTACAGTAACCAATGTGTCATGAACTACTACT
+
?5???BBBDD?<@DDDEFFFEG8HHIEFB8GICEBHIHIFC=GFHIFIFHFHFGCIFFFHHHFHIGDI-BDCDHHIHII-HEH7HI-CFFHI=,H5GHIG'BHDHE@GDIGHDE+,D3CGFHGFHCFE5FH6GGEF*E=CEGBG:CGED*;GGGEG./E;FEAE8E/:8AEE/GC>1;FE?GC;EG:GGEGE/>)<G6C.C(FEG8HGAECECGG7E8(EG(:(:<<8CF?(G/CE<?EE(/CC*AEEEE
@antibody_26_multiplicity_119_copy_107-1/2
CCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTGGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCTGAGTTACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTATTGTG
+
??A?,B<>DD<D?DD@+FGEGF5IH>HI.IHHEHFFIGHHIHFIHACGHIHHEIEII8HIIFHDIIHIF-FDHHDBHFHHFGAHFGHEHHEHIIHHIEHDFHG)GHBEBHHGE4EHF#H;FDGE@E;4GGE9FG:;FCEG=EDEEF@,F?<<EGEFAFG*C6:'#A8EEECG.FCECEE6GG@?FGG(EF*(G=(GE8C:GG*GECE**::G/E8GC7G.G(/G:1EG?80:*:8EEFGG*/E8E(.:1*
@antibody_26_multiplicity_119_copy_108-1/2
GCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCGTACTTTATTAGTAGTAGTATTATCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACACACTGTACCTGCAAATAAACAGCCTGAGAGACGAGGACACGGCTGT
+
???AA7@@-@BDDDB9DFGGFF0FFHCIIIHHHGHHHI+H?EFHIHH>DF5HI=@DHE@HAHDI?IGHHH?IHGHH;DHFHH=HIDHHHI8HHFHHC.FIHGHEHFI+HHEDFFHFHGHDF2#>EFHFFCF>GEEFGEFE?*FGEE=?.;EE@EGF*F@FGGGF?CC0G*E//>GEF(GG;ACCG95GGCEG<CEEGGEFG:G*CEE:EC)#HCCFEEEE*?A?F#GEGDAGG:G;(DCE/EE*/:GGGC
@antibody_26_multiplicity_119_copy_109-1/2
CTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGGGTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTTAGTGTATCTGCAAATGAACAGCCCGAGAGTCGAGGACACGGCTGTGTATTACTGTGCGAGAGGCTCACAGCTGGGG
+
?5???BB-B9BDD-DBAGFCFFHIH>FCHFFGH7DFHCFIEHFIHEEHCHIHEHHHHIIGFDIIE@@IEFHH-=HHFIFHHFEI+IHHIHEEID?DFD-HHHCHHHFDHHHC4A=8:HH*F@DEEEFGGGEEEF4DDEFG=E:BFBDG3AGEE8(GEEE?CGEGEF6G:GGC?(E'?)GC?E(FG(EAE:E(:<GG(#F:FEE*E<*'?HAEECB?C*E:;?:CE/?E/*GGEC(?G*?1)GGC;:(G?E
@antibody_26_multiplicity_119_copy_110-1/2
CCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATACTACTACTAATAATGTATGAACCCTAC
+
?????B@BDA+DD@@-FFFGCFHCFFEIIIGHFIFHHH+HI+AFCFFHH8HIHFA-HFHHEC@H?FEH-EAIEEEGHHEFHIFGEHH=IFHEHHIHEDFEGGCHHFDFCGHIFBFHH+HHEG+HF*FGCH1GECF@GGEGDDGGEEFCEE2G?:GF;CEEBE;GGFGEEEEGGEGEGEGE6GAA000?EEFG:GE.EEF?/?=)G1EGEC?GCE:EGAG@*E6;EGA??0ECC(D?118GECE/:*E*AE
@antibody_26_multiplicity_119_copy_111-1/2
CCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGAAGACTCTCTGAAGGGCTGATTCACCATCTCCAGAAACAATGCCAAGAACTCACCGGATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTG
+
??=??<BB?@D<DBDDGFFF,FHIFIIHH>/FIECHFI>H7HHIHCHHI>AIHIHIHHGDHHHHHHFBHHHH-FHIHCFFEHCIG-IAHGFG(IDHHHI=CHHDIE-GFFHH99HF=HGHA9DA*FHF@HGEFEFEGF*@<G*B*GG;EE(FFCGFGGA*G)EEE*G<F(EGGE:(?(:GE:E>EEGCC?E??GFG(F*FGEEF(GH?G(8E:GGG?G:F0E/CEG?EEACC(4:(**?(.DC??A6F:A
@antibody_26_multiplicity_119_copy_112-1/2
TAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCACTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGAAATACTACTACTAATATTGTATGAACCCCACTCGAGCCCCTTCCC
+
????AB7BD<DDDDDDGFG@G+EHHIFFHIHCH7HHHIIHIHIIGIGEEFFIFHGIGHFCHIF>I>HHIHBI-AHG-@HFGBEIHHHFH=HDIIFI+IHIFHHGHFIHGHC.HFHHEG5HHGCGFFGFFAEHGCEGGEFB?GD9EBGGGGFFEGE8E;F0C=/AEE*;(FE<EGCG5?F.<CGGA?(GEE*GG6;CE?EF(2'E(AE4E::GE.F*CF,(C/GA;8G*CCGEEG6E8E#G)8FE>CGG?(
@antibody_26_multiplicity_119_copy_113-1/2
GATCCTCTCGCACAGTAATACACAACCGTGTTCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTAAATGGTAATACTACTACTAATAATGTATGAACCCCACTCCAGCCCGTTCCCTGGAGCCTGGCGGACCCAGTTCATGCTATAGCTACTTAAGGTGAATCCAGAGGCTGCATAGGAGAGTCTCAGGG
+
5?<??<BBDDBD<DD@FAFFFGFC-HEHIFF+IHHDHCDB@HHDFAFHEIAIHF=H@EG5HI5HFHHII,@IHICI-HHFHIDFFF?HHHHGHH+IFHHCH+BFHFFHIEDGDFHGH#CFGH'@F*3HHH5GHC@GFFGFH,<AE+GE+9(FG(GE*GCGGEEGGGGDEE*EF=G??FFBGF*GG#AGGFFG=CG*?FCGCEC6G:C/G:CG(EEFE*EEGAC/GC66:E*E:C#/FA:EEFEE?;C*?:
@antibody_26_multiplicity_119_copy_114-1/2
CTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAAATGGTTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTTTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTTCAAATGAACAGCCTGAGAGACGAGGA
+
?A???7BBDDB?DDDDCGGEFFIIHHCIA-HI(FHHGFIECCF.H9IHHI9DDI@HEEHFFFFFHII-DHFFIHFGHFEHFFIHD#EHF#IHFE+IDH-FHFHF9DIHHDF*HEGHEHFGHEEDGEDHCDDGF=DGEBF0E?3@EF7GFEEEG#GEC9EEEGE8'GGC*EEEGEGCAGA(EGECGE*AEE(0CE?C=:G?GA'E(G/?GCAAC(GCCGG7CG?(AECEG?*EF*CG(E6G0D8EE.01**
@antibody_26_multiplicity_119_copy_115-1/2
GGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGCATTACCATATACTACGCAGACTCTGTGAAGAGCCGATTCACCATGTCCAGAGACATTGCCAAGAACTCACTGTATCTGCAAATGAA
+
,??AABBB<DBDDBDDFFEGFGHHHHHFHIHHFIHEHF-HEFAIHHEICHIGFG?HIHCGHH-IHHAEICI?H?,BHEAII-FCHHIGEDIIIIHHHIHF@HGHIGHHHIHH+6HFGH*H<HH+HGFEFFGGDDECGB(GBFECGEGECGDEG?EGG8=EE*C#CGA@*A(A#EEGGE:;CEE?G8*F???GAE#FC?)EE*GEEEAC*EFC7CG(EGF(8/(EF(?:;?FGCED/8(E;EAGG'EGEEE
@antibody_26_multiplicity_119_copy_116-1/2
GGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACATTCAGTAGCTATAGCATGCACTGGGTCCGTCAGGCTCCAGGGAAGAGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAAACTCTGTGAAGGGCCGATTCACCATCTCCCGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACCC
+
????A?BBBD?DB<5BGFEGFCHHHFICEFHIH9GHFIHHHHGIIGDHIGFDH5ICFIFHE+HI5-HFICIGIFFHIHFH?HIHII(FHF--GHIHHHIHHH+HCFF(+HH@GGHFEHH@EHCHFBEDGBGE.G=BBEBBDGE(EEEGDD,GBAEGEG:A8#G<GGE6EFCGEGG6?E(EG/C8CG*GG::*:(>.(F:EDEE8EC?GGADGCG*GG/GG?.GE08E2((ECE;E;F.6FCEE-EE*E#(
@antibody_26_multiplicity_119_copy_117-1/2
CAGACGTCCATACCGTAGTAGTACTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCCCTCGCACAGTAATACACTGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTACTTGGCATTGACTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATACGGTAATACTAGTACTAATAATTTATGA
+
??AA??B?D-D5DEDBGGFGFA>+.HHHIBFIHFHFHHHEH7FI/>DHHHGFHHFHBHF0IHIH-H'H-HIHHCGHEHF>EIGIHIHHH=HHHHFICFGD+EHHGDFHIHHDHFDDEH#:5HHHEDGFGDGGFFE?GG*GF#-EECFGCFGEEGCG/;EGECE9G(CGGCEECEGG(EFAAEFGC.FE?<AGEGGEG?AGF#?1E=(EGE(?AF7GGGB8:G(GF(AF?GE0G(;C;?6:.:EC*G?(GG
@antibody_26_multiplicity_119_copy_118-1/2
GGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGGTTCATACATTATTAGTAGTAGTATTACCATATACTACGCAGACTCTGTGAAGGCCCGATTCACCATCTCCAGAGACAATTCCAAGAACTTACTGTATCTGAAAATGAACAGCCTGAGAGACGAGGACACCGCTGTGTATTACTGTGCGAT
+
,?5??BB?DDDDDBD<FFGCGGIAFHHH8CI?IIIHIHIHHHFIII9HD8H@HHD?FHHGIHHHHGFGAD=HHFHHDHEGI5HHHIHCHHHHEDFIHHFHIFGHHBF=HHHHHDFG?BHHHFE:GG*DEE=EGF1GGEGG@EE*GGFG:EFGG/0EG5G?E.ECGF*E:GCCAGE*G2G(EE'DF.*E:#GF*C*G.0C?(GFAF:CE?CEG0ECGGCC)C?FEFGCG)'8*G(CE8(;EA*DEE*CEE/
@antibody_26_multiplicity_119_copy_119-1/2
TACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCAGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTAATAGTACTACTAATAAGGTATGAACCCCACTCC
+
<????>@B6DDDBD<DFFFFFF8>HCI>HIIIHGCHHHHHCC=GHCD9HHFCEGEIHE+FDIEIDGHI*@GCEHHIHI+HHFHIIIHHEHIHHDHHH6HHCCHGHHFGFF0*HHHHHGD+E@F*E.H4<FGEGGGEBC1GG;GFGFEFAGFFGAFBCEDE;=GGGFE;*EGGFFEEBGCEF.AEA*GFEC;GE/GEG?FGGEGEC?AG?FC)HGE:GE(E.:CE?;=:E.8EG(<;?E0ECEE?CCE?8E
@antibody_27_multiplicity_3_copy_1-1/2
GTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTATCACCTTATACTACGCAGACTCTGTGAAGGGCCGATTCGCGATCTCCAGAGACAATGCCAAGAAATCACTGTATCTGCAAATGAACAGCCTGAGAG
+
?????BB7BBBBDD-DFFFFGFEIEHFFHA.IHFHFCHFHIHIHDIFIFIGDHHAHCGAIHCICGFGHIICHH5FIIHHFHEHE,H?DFEAIG)CIFHHDGHI.HFHH:H@HHH@HGDBHFEH(E7HGGE#B=HDGD<FEGGCFFEFBGG?C;:CE@??(F??G?EGEFE*EAA?#GG?EGEGGE<EGEGG:);*?GGGE?G/E?AE1?HF4CE31GE/CC.EC?FG6EFE(FGE/;?:E?*GGE**EF8
@antibody_27_multiplicity_3_copy_2-1/2
TCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATTCATTAGTAGTAGTAGTATCACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCCTCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAAGAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTATTATGATTACGTTTGGGGG
+
??,<?BBBD@BDED@BEGFGGFI-IIHAH>GGHHHFFG+DHFHHIIICHE=HIIHIHD-CFFH#I@FCHFFBH=HH*HHHIIHIHEHGHHHIDDI=FDEIHH;EHHHHFHHFHCEFF;H3HF#@HHDB@F=GDC;;9,HFGF1EGEGDEGEEEEFCCGEEEFDG'E(6E(GEEGGE?GGGGA?=GHE9G9GEG:CGFC*ACGG1FGE*EEGCH:FE:AG7EEECG0CEEE/.C(::G(<CC:*ACG8E;4
@antibody_27_multiplicity_3_copy_3-1/2
GGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGTTCCTCTCCCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCCTGGCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTCTATGGTGA
+
?5?A,><?DDDDBDBDFFGFGGIFHHHFFEAIFIIGAIH?F.IH)BAFGIIFHHHDFFHHHHH5HHGIG5II?HG?IHGGGFIE+HHFCDAI+HIHEFHHGHHHF4HEHDHBGHFGEI#FB=FCHE#DGF/E@F(EGGGE*FFFB3BF2AACEGEC;EF*;GECDEG:>GE?C?GFC;CEEEGGCC?EG'E6F6E8ECAG>)6E?.AF?H<GC0FGE*ED*>EGC<*/GC(/C6GG;:EE/(CE0:EE?:
@antibody_28_multiplicity_6_copy_1-1/2
CGTGGTCCCTTGGCACCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATGTAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTGGTCTCTCAGGCTGTTCATTTGCAGGTACAGTGAGTTCTTGTCATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTGTATGGCACTACTAC
+
<????BBBBBDDDDB5D.GGGFHHH4EA.HHDFAHCHE?+HHGGIHHCHD@HHHAFHFGHIIIF-FGHHHH-=AH-H-DGEF=IIEEHHHFHHCIHHGF5-=?@DHC3HFGHHHHHHDFG*HDG*BEFGGFGHGG@E-B0EG+EE#@EAF/AECGEEC4?;FG6EGCGGE#EE*G(*4EAGEECGE'EG/F6GF?AEE?E??*G?GHC*AFG(AB(#ACGC</A*AGE0.:CA<=F:8:?E*?EAGEA::
@antibody_28_multiplicity_6_copy_2-1/2
CCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATGTAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTTTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGCCTCGGGAGATGGTGAACCGGACCTTCACAGAGTCTGCGTAGTGTATGGTACTACTACTACTACTAATGTATAAAACCCAC
+
,?<?<>ABA@D-DDBDFCGFFFA+HH88/EF?HHIHHEEIGHIID>HHDHFHDGHH/HH=-8CHH=FAFHIHEIHGIFCDIHID.HI=FHDGHF5FHFGHIGHDEFHEHHFHFF,F3'GFGHHFD)HGEEGEHEFCGEEFD0EGEEEEE03BG*GA-G2E?GG;:EE'G(EB26;EFE?<FCEFCC(E;0(EGGE0C81C:GGAG*(EE>GCEC80G:E2?EE?EAC0EEEGAC:AD:/<E*G>C*CC:8
@antibody_28_multiplicity_6_copy_3-1/2
TGGCACCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATGTAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCGGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAATCGGCACTTCACAGAGTCTGCGTAGTGTATGGTACTACTACTACTTCTAAT
+
??????B+BDDD+ADBFFGGC6IHBIHIIAIHH7IIFHIHHHAHIIIFGI@HI=B.9HIIIHHHHFH.)HHH?I=IIIFEHG(HHCHH(HHIDCHIHC'HHH@HHDHFC@H)HHHDHFHH5GHEGFDEGDHE*;CFE,)E@GFGEC=EG;DGGA?EGE(EG(GG9?EEAE8E?GEF.E:GGEGEG(?EE?8C?6?DCG*F=:?E(G?/CC(?*G)GG?ECEFG(G:C?*E0?GCGG?9)GE*:G#>GGE?
@antibody_28_multiplicity_6_copy_4-1/2
ATTGGTTAATGTAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCATTGTCTCTGGAGATGGTGAACCGGCCCTTCGCAGAGTCTGCTGAGTGTATGGTACTACTACTACTACTAATGTATGAAACCCACCCCAGCCCCTTCCCTGGAGCCTGGCGGACC
+
?5????@BD?BDD--DGFFFCCIFHFHIIH+HHHHCIIBIIGHFGHEEIHI=IIFHD>G=HHHACEF8=GI5IGGF-HHIHH5HHHDIHHICDHFFIHH8AGB4IHF(E@IHH4FFGGDBEBEGHG4HEF*F5@F+G:,;C**88EEF3GGE*B:G.?GEGG8G6G)G(02A89D?E#(FGG<G;CGAEFGEE)EGGEGGEG:G/E8FE:CC7F@A88FG'ECEE*CEE?E??G:CEC:;EGG(E:?GC:
@antibody_28_multiplicity_6_copy_5-1/2
GGTGACCGTGGTCCCTTGGCACCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATGTAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCACTGTCTCTGGAGATGGTGAATCGGCACTTCACAGAGTCTGCGTATTGTATGGTAC
+
=?<?AB?-DDDDDDD@AG>FFGIHHCFF7HIFGAIF>9FIIBHGHAHHIHDCHDI.FCFGIFHFHHHHHIHF-EIHGHEEDHGHHFIDHFHHHHHE5FIHEG?FH+IDGDGHH7GGFFH+HFFF(EH1GGG4DGE=GEEEF+CE:G*EEGFAC>GCEGECE?EG:G.2BEE(EGEGGECAC+EF?D0G:E=GGFE(EG1(AF)(EEFE*6GC:E:E*?C@'E0GCGG8E(:*G<-CGG0(*/A?EE(G*C
@antibody_28_multiplicity_6_copy_6-1/2
GCAGCCTCTGGATTCACCTTCATAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGCGTTTCATTCATTAGTAGTAGTAGTAGTACCATACACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGCATTACTGTGCGAGAGGATCACAGCTGGGGATCCGTAT
+
??A??BB?BDDD-D-DGFFFAGFICHI/5H-I8I=IHHAIFIIFIIAICHFEFHEHE@HFHHCIHEHDIICCI*GHIHH-F-FHHHF8H+GHHHGFICHH.H+HHGHH>EHFE.D?HGDFGG8EDFGDGD8G;;GIFEFGGDB;EEC76EEG?F1ECGG69GGA/G?F<GE(?G:E?EGC+C:?6?GE0EE?EEEFCGEEG*E*GGF6?EEC(GE:/EE:?AD(*4GC*?1GAG(;EEC.?/C?(;E.(A
@antibody_29_multiplicity_1_copy_1-1/2
TGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTAAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTGTCTCAGGCTGTTCATTTGCAGATACGGTGAGTTCTTGGAATTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGATTCTA
+
??=5ABBBDBBD@DDBGAGCFCEECECI.HHHFIIEFFIDHAIIHHEGHDHEFIHHCHHDFCIH5HIFAHHIIHIHC=-+EHEHHIGIHICICBHDIGH/DCICHHHHHHHBFDHD5EDGEFFFF>HFFEFHGE6EDGD=FBE:EDEEGFA94GGF(E?F1GEGCF<FEEG8G??CEF#CC?EE1?;8GEG(ACGF8*CFE?GDE:H;GHEA7:G?E7DCEAC*G?G.C:G0EFE:*EC)C:?EC?/0CE
@antibody_30_multiplicity_1_copy_1-1/2
GACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAATACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGACTCTCAGGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCCTTGTCTCTGGAGGTGGTGAATCGGCCCTTCACAGAGTCTGGGTAGTAGATGGTACTAC
+
???AAB=B-<DBDDDDCGFCGFBBIIIIHHHF9GEICGICHHHGE7DFIIHHFHHFGFE@@+GCGHCH?>HHHF=IFFFED+IHHH?E-FFCFIFIHHGHHEEFHFE+HHE,H@HFHHHHDCHG;DFGH8EFEGG*@A-*(E0GEGCBF;,(E(GECC@<EFFGEEGFG(FGCGFGE+>C;ACE?69EECG(8EGE>GA9G10?'G;EGD*6HCG9E(G8CG:EA2?E*F(''/:((CE'/E0):(:(*6
@antibody_31_multiplicity_11_copy_1-1/2
TGCAGCCTCTGGATTCACCTTCAGAAGCTATAGAATGAACTAGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGATTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCCCAACTGGGGATCCGTA
+
????ABB?ADBEDD+?G?CGFGHH-+FFFIGFH-5HIHIDFGCAICEIEGHIEFGEFIHII.?H5BD-IDDCHFFHHHFI?DIFHFHCEF+@FAHFEIGDCHFH@HFHFHHG.GHHHGHD(HEE:9GE,DGB*;0?HEHDBFGCCG3BE*EE*GG:0GE93AC8EECCGAG;*FEAEEE:F:FF:FG?EECEGGG?A6E?ECEE:-HGFE)CHG:)E7?/EGFEEEG.GEA?/((?/G:GC:??0EAEGG
@antibody_31_multiplicity_11_copy_2-1/2
AGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTAGGTCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATATTACGCAGACTCTATGTAGGGCCGATTCACCATCTCCAGAGGCAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCTA
+
AAA,?BBBBDDDB@EBGEGF)G8FBIIIFEEEDDFHIEBE5=HGEHHCIFHIEHDFH?FIFHDHIHAIHE5IFHDHFIHEEFCH@G7HHGHIA-HIHHHEIH?EHFIIEHDHCFDEHE?FHHEH#HHFFGGEF(GCEGBGEEEGGF6G2ABG?FG?EGG1FFECFCF08#GFEAEE(EA5GE..?(AGG7(EGE0E(GE8GEGAGAHGG:*GH7G::?79C:G?G-GG(E.G8):.?4*?A/:?;8ECC'
@antibody_31_multiplicity_11_copy_3-1/2
GGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGCTGTTCATCTGCAGATACAGTGAGTTCTCGGCGTTGTCTCTGGAGATGGTGAATGGGCCCTTCACAGAGTCTGCGTAGTATATGGTACT
+
??<?AAB<DDDBD??BFFCF?CIFHIEHHHHAFHIF9GGIFEEIFFCIIFHIHFEFFG/ICH-HFIIFFFFHHHH+IHIHCFHIH7CBHD3HH;FA*DHFHH,DGHDFF=DHF3FE>HFHHFFHGHHG@F*GE2*GGBD?DFGGGEBG7GF.C?G*:GFCCG:GG;FEE*GGFFGE6+C?G)A:?:?C*(GCG(:E:G?EG4EEGA:(CE??EEE#GGC(G:CF;ECCEG:C(G;G:C(F0:0G(EG'E;
@antibody_31_multiplicity_11_copy_4-1/2
TTCACCTTCAGTAGCTATAGCATGAACTAGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATGCATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACGATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATAAACAGCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCACGGCTGGGGATCCGTATTATGATTACTTT
+
?=<,?@B+?BBBDDDDCFFGFFIFFHHH>EHHHIHH@GHEH+HEFFDHHHD@FDFHIAD-GIHIH@HHHG#EGGHIIIFHHHH?IDIIF=IIIGHHHGFAIFFFH2DHHHFGFCHEFFCHG:GGFFC?#FDHHGEGGFEGDGDG9,4EFCECE6G(E<<EGEEFCGE?E((GGCF0EGF086CE<CEGEGECC*6F(E(EE*EECAHG:E*AEE(GGEGED?('C6ECGF6EGG??86;AEAGA)(A)E?
@antibody_31_multiplicity_11_copy_5-1/2
CTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTAGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGGAGTACCATATACTACCCAGACTCTGTGACGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGGATCACAGCTGGG
+
???A??BBDDD?B@DDFF>FGGFIHBHCHIIHH=GEGH8IH+-+AIHHFHAFHGEAHIFEHCHDEBGHIHHHHHHHGFEIAFDHIHIHFEI,HHDHHHFHE'FHHIG.EHHFD@D?GCG,FF3*?EGH1CGEB*@G*GGDEGGGH;GFDFFG?GGD:GC?(*E@.G42E(E:GC'GE#EGE?GG/G?=EEEEF4GGG)GE*CFGGFHAFA?CE:BG-E.EBE?4F;(F?(?AC1A?(;FEE2:AAE:C?A
@antibody_31_multiplicity_11_copy_6-1/2
ACGGTGACCGTGGTCCCTTGGCCCCAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCAAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGCTGTTCATTTGCAGATACAGTGAGTTCTTGCCGTTGTCTCTGGAGATGGTGTATGGGCCCTTCACAGAGTCTGCGTAGTATATGGTA
+
<????>7BDDBB-BBBG8GGFEEHEH5/ICE7HIHFAIFHHH9GIFHIGHH9IHHDGIEF/HFHGA5HIFFFIGIIIHHFFDGF8EHH@IICHFI-HIHHF,IEGH?FGHHI3CE?F*HGHGHF@GFGGBD*CCDG;E8GBGFD3/EE2A?/*)E=F;GDDAEFEGEF;EEEE8GE=C:AECCEC*G8<GEE:(AFGGC(CGEG0ADAFEFC0:3E<*FE(A::CE(:CC?'CGGE<A-/6GE?/F(A'G
@antibody_31_multiplicity_11_copy_7-1/2
AATAGCTATAGCATGAACTAGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCTGAGAGACGAGGACACGGCTGTCTATTACTGTGCGAGCGGATCACAGCTGGGCATCCGTATTATGATTACGTTGGGGGGAGT
+
?,???B>BBDBD@BDDGEE/>CHIE>HAFHHFHGIH@DGGHH@IIHHHH9HIDAHGDEHHHEIEHI,H@FCH6FH,IGHHHFHIHEFHHIFFDFHIEHHF8HDBCHC2FHHHDEHHG@G?>,FEE=DGGH=HGE2,CC7F>GFE?ECGFGGG(E;EEE:EEBCAFEC(GEFGCADEGGCDFB<GGC:EGC#CFAFCG/CEE9E(E(EAG(GEA/B;EEGC*G'G6E?*GGEC*:CE>1*68'GE*:)E(G
@antibody_31_multiplicity_11_copy_8-1/2
TAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTATTATATGGTACTACTACTACTACTAATGTATGAAACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCTAGTTCATGCTA
+
?,5?A?BBDB5@DDDD>GGGFGH>IHIIHHH/HHFHIHEH@FIHEHHFFDDI=IIIHIH=HFAFIG-IDEHFHGII-GDGHGFHFFHIEF8IHDEHHFHIHDEEHDBHHFDFHGDE*HEEEED*FFGEHEDFFFHDG77FED*E)BG*?8DEEFE;ABE?FGGAEGEE#G*E:0(:CG?EGE6E?FEE(<GF4G)EEE0EE::E?<HF/8A/HEE7<?G@EE.GC1C6GEGAG/1:?.*C<AE6)??;F:
@antibody_31_multiplicity_11_copy_9-1/2
AATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGCTGTTCATTTGCAGATACAGTGAGTTCTTGGCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCACAGAGTCTGCGTAGTATATGGTACTACTACTACTACTAATGTATGAAACCCACCCCAGCACCTTCCCTGGAGCCTGGCGGACCTAGTTCAT
+
??=A?B/BBDDDDDB5FFCCGGIHEF..6.EIIHI9FIIHHH0.FE=IIE9HAIFFFFFFFHDCA-EGIA-FI=FEFGDEHEIIDFFHHH,=GEEHEH3CH=GHDHHHE=H=FH+HCEDH=E+FFEBHHD:FEF@FE2AGA>*F20DCEF@E(A;EEDEEFF8/CCFGEGGF:GC?GGECEG(E0:0FEE??ACCFG6E<6C(?ACE?::FE-G::)?(E*<(CEC:DEGGGAG8G?G8D0*<:GCC((C
@antibody_31_multiplicity_11_copy_10-1/2
TCTGGATTCACCTTCAGTAGCTATAGCATGAACTAGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAAGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACTCACTGTATCTGCAAATGAACAGCTGAGAGACGAGGACACGGCTATGTATTACTGTGCGAGAGGATCACAGCTAGGGATCCGTATTATGAT
+
?,<?ABBBDDDBDDD7-FFFCGHBC8IBIH=HHE@H0IGIHBEDIAEIHHEHFHIHHHHHFIF(5GH>D--ICF5=GF-=-FIF=I+IHHHIH+IHGHHHHHHH@HHHIHH+EHFFFFE:D(,H+#FFFDA?=G(DEGGEGFE?DGFGEG(FG.E(.3EEEGGEEGGGGGAFEGGGEEG.EGGDGAE*C(EGGEE?AC;8AEG#AGH)?H0GFG@E>GGFGDEE/:.CF?E0(E0?A0AG)EEGC/C'*A
@antibody_31_multiplicity_11_copy_11-1/2
CAGACGTCCATACCGTAGTAGTAGTAGTACATGACACATTGGTTAATATAACGATAACTCCCCCAAACGTAATCATAATACGGATCCCCAGCTGTGATCCTCTCGCACAGTAATACACAGCCGTGTCCTCGTCTCTCAGCTCTTCATTTGCAGATACAGTGAGTTCTTGCCGTTGTCTCTGGAGATGGTGAATCGGCCCTTCATAGAGTCTGCGTAGTATATGGTACTACTAATACTACTAATGTATGAA
+
????,@BBDDB@<DDBF5C8FG>IHFEHHHHHFIEFEH@IHG-H9H7GHDG-8HHGI-CHHH<IHFDH-FHHHHGIDHEIIIIIGHGFHH)FE=DHFGHGHDCHHHF@DH-7HI(=HFFF3FHEG8=1FGFE#G5GEF*FE4G/2G?G@GCCB;FGAG(GEECEBEEG*EEEE?EG*GE?EGEG/?GC6G?FCEAF6GE;C(F*<?H?/CEEA@CCE?GG0:EE((?2GGA;#8A:C:EEE:?6E'E?:E
@antibody_32_multiplicity_1_copy_1-1/2
AGGTGCTGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGCCCCCACGTAAGGGACTGGAGTGGATTGGGTACATCTATTATATTGGGATCATCTACTACAACCCGTCCCTCAAGAATCGAGTCTCCATGTCAGTAGACACGTCCAAGACCCAGTTCTCCCTGAAACTGAG
+
?????BBBDADBDDEDGGCGGFIHEIIHFHI+EGHHIH.HIHIGFIEFIGAH5*FEICHDHHD-5IHIFHFCEFHHEI:AGDIHEFHBHHFFEHFFHIDIHHBH+HHEHHFDHFHBHGEECHGFF2H(*7HFG=EG'+4GGE3F(GGGEA8G*GAEG:EGAEE*F(GF.GEGEEEEECA.EEGF?6?:AG6EAFE*FEGGD?E*':EEE#E?CC*FE?(,:8EEGAEE'CECG:CGC6A16/CEEEC?*C
@antibody_33_multiplicity_1_copy_1-1/2
ACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAACACCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCAACTCTTGGGGGACGGGTTTTAGTAGATCCTCCCACTATAATAGATTTACCCAATCC
+
?<?,,-?BD@DDDDDDCFGGC/HH>?HIFEIIGIIHIDHIFIGII@F7HE5IFHHFHEF/HFII=HGI*IHFI5DHCHIIIIIDGHH8I,AGF5GGHIFHH*DH9FGE+FDHDC=HHHHHHHD@+GFHG#GF(+E7EGEECFEFGFDGE?EA<GE?E19?0GG4(8?E-E0CCE*?;D(EEEGGCC/(E>;E:(F;8'G<EGE(EF?F:?CG(AFCFGC>7EGAEEEGEC:?A(A(EFF(6:(6EEECE0
@antibody_34_multiplicity_1_copy_1-1/2
GTAGTAATGCAGTTAAGTTATAATAACTCCCCGAACCATACTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGTGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCCAATGCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAGTGCCA
+
???=?BB>D<?DB?DBFFFGCBHHHHFIF.EAHHFI9CIHFB@HEHIICHHFHGIECEDHFGHIBIHD?HIFII-AH-IIHHCEDCHFHIIIFHHGHHHHDH5?H=ECBD+H*D+DFGGHFGGHBFDG,*EDFEE=FGDG*EE*FFB/BG'GEGEGBGECG(FEE:F9G/#GEE(:;A?E???G*GECF;GE<E;GE#GE-GEEEEHG(.?>AE7CCGG;.E(?::6':6E?1:*E(GC*(G??CC'-AG
@antibody_35_multiplicity_4_copy_1-1/2
CTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGTTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGCGAGCATCTACTACAACCGTCCCTCAAGACTCGAGTCACCATGTCAGTAGACACGTCCAAGACCCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGCCCGTGTATTACTGTGCGA
+
A=???B7BDD-D<@BDE;FG9GIHIEHII.IHEH9HFAGIHHGIHHHIHEHI@GFIH@IHCHFFGF.HHGHEIC=HIHHH+EHBI@BHE+DGHHHDIIIHFHHEHHHHHFHHHEHGFHDGHF=G+HH*HHFCGEFFBEEG).EGDDEGCGECAF0CF0CE.GGG@CCEGGCGGGG?AA/E/E(A?0F#:.E?(A.?GCGF??E:>DDEGE?G;@@EC-EF84*:C6E?EA/)FG:*?GE:A.8FCE?*E*
@antibody_35_multiplicity_4_copy_2-1/2
CATGTAGTAGTAGTAGTAGAAATGCAGTTAAGATATAATAACTCCCCGAACCATAGTAATACCATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGTTGTAGTAGATGCTCGCACTATAAGAGATGTAACCAATCCACTCCAGTGCCTTCCCTGGGGCTGCC
+
<5=,?BBBBDDDADDBFF.,FFH.FIIHHHHHHHHEECIHIH@9BIFHEFHHH.HAHHHF,D,HIHHDIHHHBIIFHEIIHGHHHGHF-FH4HHHHFFHFIHC?F1F+EFI.HHGE?DHBGEDD+HHECGGBD+EF7GFE@FE2D8EEE?F/EHCEGA66*GCC*F(8EFEGD8GG?CCFE/G:.8GGC'/E'DG):G:GEGE1(E(?(?*ECGGE*GECGE*G8(GCG/=E((F*EF?E6C?E?><A2(
@antibody_35_multiplicity_4_copy_3-1/2
TGGATCCGGCAGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTTCGAGCATCTACTACAACCGTCCCTCAAGAGTCCAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTCGACACGGCCGGGTAGTACTGTGCGATGCAGGCAAAATTGTATTACGATGGTTCGGGGAGTTATTATATCTTAACTGCATTACTACTACTACTA
+
<??<9BB<DDD9BDDB?F>FFFHHH+IHCB,FHHHH.?HIHH-5IIF,DFEI5+HH+HFCHFHDI.IIAHII?II-HE--HFIIFHHF5(HHFB-EDIEFGCEH;DHHGHHE:H@FEHHEHFBAGCFH>GDGHFD4G((EGGGGGGD:FAEEGGFE(?C;*EG)?<6*=8E#5;GG0;0GEE?>C#FE:0E=GE?(GC/*EE*FGGEG2HFEE*G**EE<G:EEGGEE?GE*CGG<FE:(C*E*0E0:?E
@antibody_35_multiplicity_4_copy_4-1/2
GTTAAGATATAATAACTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGTTGTAGTAGATTCTCGCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGTCTGCCGGATCCAGCCCCATCAGTTACAACTG
+
?<<,?BBBD-BDDBBDFF/;GFHFCCC6CI@>IE@GIHIHHE+EHFI/HI@HFHAHIFH?CHCCIEHHIFEFHEHDHHEGFFDHAFF-HIBIHF@HHHGG@HIH8H6H?FDGHFEHHH*GG@FEFG3BEFGFEFEECE@EGE*FGEFG8FEGG(?EFCF8GEFA:/GEE'GDEG8CBG?EEFAEFE(CGFEG:A6CCGG(GGCCGEH6D0E0H)EEEE.ECECE.E0EE*EEG0*EG''?/EC*E:E?)G
@antibody_36_multiplicity_55_copy_1-1/2
GCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTACTACACGGCCGTGTCCACGGCGGTCACAGAGCGCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGAGTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTT
+
,????B?BBBDBDBDDFGFF+FHHHHHAFIEHDIFHIHGFIAHHG-IHIGBI+IGGF,HHIIDBHHIH>DIIFHGHHFHHIHHIH-GI.<H,IICHG+GHDFGH(IFHF'@EHHCEHGEHH.HG**FF,#6DEFGEFD*,D@E8GEEFBGE*GBGGBBECBEFG:E<G(?GCE?ECG(.8GE:EG'E:?)EEE?CFGEEGGC?AEGHEGHGEC(CA(*E@/8(ECACC*-A(CG?:E:'E8E?EGG1G(G
@antibody_36_multiplicity_55_copy_2-1/2
CCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACACCTCGTCCCTCAAGAGTCGAGCCAAGATGTCAGTAAACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCTTGGACACG
+
?<???BB<DDBDBDD@FGCGGF+BFIHCFHI/IGHH>AHI:-HFHHHDGHCEECFHC-IHHHHH-DDAFI-FIHHHDFIH=A0FFH-HHIDEHIIH=CHF=HH,GHHH.HG@HGG@6GHGFHH+HHGH4EE@@CBFHHE*FH?EEGEFDCBGA?G26E*?(EE>FFGFECG@CGFGFBE0FG('6G/?E6EEE'GAEF-A1GEEGCCEG2EC.EC<EEE:G7GC6EGG?':CG(.E?E:8G(E(E::A((
@antibody_36_multiplicity_55_copy_3-1/2
TCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTAAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTGGAGAGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCTCTTCCCTGGGGGC
+
?????BBBDDDDBDBDC?GCCGHBHB-C+HHIF,FHIHFIHHGIGHIHIHI9HFD5GDDHIHFEHHIHHCGDIICFHAIHIHHGDIHHDHEDHHGDGFI)HFDGFFH=GHHFHFHHFFGGDHHGFE(-GH0CDDGGGFGBEEF:,F*E8F8DEH:9C;=*0ACEE19AF(E;EBCF'C:2+?EE?EGEG(E#?*CG6E;GEG4;:EH:G0A(CGEFECCCC7CG:(EAE(?:GCC6.CA*EG/4GG)C:C
@antibody_36_multiplicity_55_copy_4-1/2
GGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCAGTGGAC
+
???A?B>B-B5@DD@DGCFGFGIIIHHIIB?IHHIEHIIHEIHBFIHC==AGI8FHHIHGAHEIG55I+IHEHDF5C5EEBFH-HEIBDHHFFICH)DH+@FEHHHIHHD;HHH*D@HFEF3HH*HG*BF,EGDCE+BCGEEGBCGEEGGG?*F*/FF6G?;C0EEEEGGEEB?GF0A;G?6-AG0CEGEE*GG9?DGGCFAG/EEHG(*E?9GE-G8EFG:GE..(EGG*E?(G*EEGEEE0(AG/?/G
@antibody_36_multiplicity_55_copy_5-1/2
GGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTAAGTAGACACATCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGATCGCCGTGGACA
+
??A=?B>BDDBDBDDDCG>GAG>I>FACHHH@HHFHDHHIFIHHHFHH7HHCHHIHA=IHHHIE-DIEHF55EHHI?FHC5FFHCFHFGGC,-<F7EDF+HF;IAHHEDHFE5H9DDGGH8HH=H:BCEFD*#E(=BGEEEGGFG'G:EEGFEFGDG0F<FG?FC?GE9A:F?.C8.AAFG>CCG?GGCD(0C?GGEECF#EC<FGCG8HE1**E*BAGGGG(?:G6GCEDC?*G0':*1.E?6E(:8?6
@antibody_36_multiplicity_55_copy_6-1/2
AGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAAGACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGTGAACTGGTTATCGGACGAGTCTACTGACATGGTGACTCGACTCTTGGGGGACGGGTTGTATTAGATGCTCCCACTATAATAGAAGT
+
???A?>>@@D5<@DDDGFFFG,BHHEH;FIEHD,HHDIIFFIHHH+DHFHCFHFHCHGE,FHHHHF>HCIAHHH5FHEI;I?FFGEH=HI?DGII#EIHGHH.HG=)CFHED.HGF(CGH;HHFGHFHGDEGAEDGFDH/BCDD*GG*?EGCBGGGFEGEGC>(GEGEGGE<,#E1GE::((EAGC?EG>*EE?FEGE6G?G*CGEEG4E(8FEEE*G7'8:EGEACC(E?=CAE?/=8;.:CGG0C(.F
@antibody_36_multiplicity_55_copy_7-1/2
GCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTACCTGGTGGGGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTTATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGTCACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTG
+
??=??9<BDBEBB<BDGFGF;GHIBEH0IEFGAHCHHEGBHGHIGIEDBDHD/G9CHHDHIHAIIEHHHIH5FBII*D5CGIFHFHHA?#IIH.IGFH(HGHIHHHHHAH+HHFC+HHB6H8.F=HHFF#E'FDGECEDEDD8HGC*GC@GBCGGEGG'EGCEEFBG(G@E?EE?EG???E8EG/AC*1CEGG(AEA?E?E(E?EGHE6*GE:CEAG(C'C,G:*;GCE?F:A?E.:AE?CE1G.G:(GG
@antibody_36_multiplicity_55_copy_8-1/2
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTAGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGT
+
??=??BBBDD-DD@DAEFGGFFIHICHHIEIEI+HHH5BHHCFHFHHHFHG++FHIHCHFGFHFFAIIC5GIDHHHHEDIIHII@HIHHGADHHHBIH=?HH6HEHFHHHHHFHHFEGD4<EEHBH4=E@D.GEG8HD(G*GFEFEH(?@3CEEAGCC(GEBGCFGEF:EE=C?F*GE*'G:AEEEC((CGEGGGDEC9GGF/?*GAGCCGCE:*?GC?G(:CG*A?FGCEG<F:?EE:160EG?E:::E
@antibody_36_multiplicity_55_copy_9-1/2
CATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACAGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACTTGTCTACTGACGTGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGAGGGCTG
+
??A??=BBDDDDAD?DGGGFEGHCF+HI/IFH7D=HFHGCEDIGBIFAIFHCDFFHFIGGHH/HIAEFHHHIIFF5FHDDAIGFFI=HHHEGFFCFGFH<?DI+HE<H.EBCEGGHFHFDEHGG:H@FEHGE?FEGHFG*HGBCEG#0FED)A6GD*'(DGFG6CEGC0FC0EFC:EC??GE?:G0EG0E?*A::GE16GGEGC=?EGF'6EECGCEEBF;EGEG*CE:EA*:?CCE:CC:E:(98C#G(
@antibody_36_multiplicity_55_copy_10-1/2
CCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAACTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTCACATGGTGACTCGACTCTTGAGGGACCGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGTGCT
+
<????BB>DDBDBBDDFCGG8GICFHFHHA@IIIHFHFHFEHEG79FHFEFF.EHFHIIH=,FIH#CHFHIHF9=GBH<GIHIIIHEHGCCHDHG#HHHIFFHHFHEHDF>:H+#HFDF)FGFGC0GHGAG;FEH*=AFEFGEEGEDDGGDBEGGE*FEGGCGEGGE'6:EGG'CGEG:CEEE(EEEEA9C;EAFA<:CCCG:AGE:CCAG)(C*E:E3EGEGC(EG:G?E::(E/EGC-?A0?(:(9*0
@antibody_36_multiplicity_55_copy_11-1/2
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGCAAGGGACTGGAGTGGATTGGGTATATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTG
+
?????BBBDDDBD-D-FCFCGGII/H6F@8FHI>9HHHHBDGHHGAHIFEA)DIIEG-HH>-FI>FHHACIFHF6>HI:IADIFCIHHIFF-FHIH=GFDHEHEHHFEGFCHH;;H)HGHC)#GGH@GEF44GGEEEGGGC.F0=G(=EF:GF:ED0F?E=CE(*(EEGDC:E/?FG?GEG+AE:G(?E?GFECGEEA8AGEE?EG*E/'/**CE;?FEG*CEE(CCCGEGE;C.*;6EA6GC:;:CE*:
@antibody_36_multiplicity_55_copy_12-1/2
GAGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGGCACAGAGCTCAGCATCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATATTAG
+
5?5??B?B<B@BD<<EF>AGFGHHHFEHIHFIAHDHIGI.HCEFEFFHGGF+FAH/FIHDH@>HHEDHHDHGFIIHCEEHHHHDIGEFF-HICHHHIIDH=HDGH=@HFFGD@DF0HHE6HH+HGGGGFHEGGF?EGDA:GGEG2G(GEEGDEGC0E/G>*8GGF0?EDEE<A(:CG:<EE8G*0;6GAG(C*G<G(E?C(GEA#GHG0)?F::G?C*0G(7;./EG4/:E2:AC:??/CAC<EF9*:::
@antibody_36_multiplicity_55_copy_13-1/2
TCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTTGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCTAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGAACACGGCCGTGTATAACTGTGCTATGCAGACAAAGTTGTATTACTATGGTTC
+
A??<?BBBBDEDDDDD?+GFFEHCHFCIIHHIFHI.EGHHIHFIFHHGHHIFIHHHIHFHGCHIIGI-IFHIIIHDHDHGHHIHBHDAFHIIHHHH+HHI+DHHAF@HHHEFFD?FHEG?#G)H@GFAEA=EEHDFEEE.CGEF1FBG/H*/F*GGGE*;E;E56GGEC@EF6:E=GF6#F:*C;(:*C?>*CG:EG'6<?F(CGCEG:HG(*GB?'EBA#ECCEE.AE:E**EC*::'C/GD6G*CGE(
@antibody_36_multiplicity_55_copy_14-1/2
GACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCCGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTAGTATTAGATGCTCCCACTATAATAGATGTA
+
?<A??BBB6?DD?DBD>G;5EAHCHHCIHHHBIHHHFGHGHIIHHEHH.HHFHEHEHHDFGIHFFB-HHH?AH0IBFFIF<HHIIECH-GAHEHIHIIFGHGH?HFEHH@E*H+HGD=DEFFHH?GF+GHFDE;E(FGGEG@EFAEAEEEG?(G8;EF?DFGF6G;8EG*/G?EEE8G/GC((CG8ECGGGEEEFEGG1GG:F:GAH.:HGEH#*G4E<,E8E<GAGE?*E<?AE:F??*>?E;?G0CCC
@antibody_36_multiplicity_55_copy_15-1/2
GTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCCCAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTTACATGGTGACTCGACCCTTGAGGGACGGGATGTATTAGATGCTCCCACTATAATAGATGTACCCAATCCAC
+
???,A=BBDBDD=D?DGFGGFEEHIE8>FFAIHIIH7IHHAAGEHHCFICDFGF-EH=F/FHIAGHHHHFCHGH+ADDHCFHHIDHDIHHI8DIDHH+BEFF.H)4IDDFFHDHGFFHF>FFCGEEE3EEEGGEFGEF8G6EEEE8G*GE=EGE1AGECCGG=G>GFGEGEEC2#G?G(;C;E?EFEE:GG6F:#(*EGEEA/(E/'G*((C:EFGC?CE?CG0EG6GC(?/?C0GE0EE4F:AC*A(A*
@antibody_36_multiplicity_55_copy_16-1/2
CCTCACGTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCACCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGAAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTGACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGTTGAGCTCTGTGACCGCAGTGGACACGGCCGTGTAATACTGTGCGATGCAGACAAAATTC
+
??????+?D@<DDADDFFEFFGIFAHFFAHHHFG=IH=7HEC.IFHIIAAGHICI=IEG+I@HBHH'AI/HADHAHF-GHCI@CC4E7FH;CIHFFHFHGFDHHIHEFHHI#H=AHBF+FC;G:H=FFF.)HDFFBEHF?GF?EGEE(GEE0FC>EEF:(G;'2GEC=E*DCFE'E*EEG.5(GE:C'GE(GF(GEE?GAA?G.GGE(?:GC@':G:EG9:G(*('EE:C*EGGFGEAG-EGC.GG(/C#
@antibody_36_multiplicity_55_copy_17-1/2
GTGCAGATGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGTCCCTGTCACTCACCTGCGCTTTCTCTGGTTACTCCATCACCAGTTGTAACTGGTGGGCCTGGATCCGGTAGCCCCCAGGGAAGGGACAGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGAAGACACGTCAAAGAACCAGTTCTCCATGAAGCTGAGCT
+
5??<<=-?<=DDDD<EFCFCFGFCHIIFFFHHIIH@9HFCIBIE+,DGBHHHH-HEIHHFIDIIAG+CAFFIHECHEF4GCH-HHH=HGH#FIHE7EEEFHHFD#HHEIHHBGH#EG;3<H2FGHHHB>>GGG.<GFH=FGHGEGGGEGGFG(=EG*E:<EG0EG?CE<E;*E(ECGCGGAEEAG:?GEC*=?8F:C/GEE(F:*?EGEEF*8AC(EFG<:(EE6?GECE?6E0AGC*F:EE?G*G(EEG
@antibody_36_multiplicity_55_copy_18-1/2
TTGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACACAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACAGGTTGTATTAGATGCTCCCACTATAATAGACGTACCCAATCCACT
+
?,,???<BBDDDDBDDF.GGGF>IH+CIH?HHAH7HIC?EH0IFFFIIGHHBIIIFIAFHEIAFHC:HFCI5DHFH4DHHHEHHDH==HGH7FHG8,HHFHHG)CHHD=;HHFFGG<HHH?F)FDFGE0EGGHAG87EDAE:=#EGFGEEFFGFA;;GE@C@6@EGCEDGG(G*(EGE?C+G*GEA1G?E6EG?GC<A-E6GF/*FEGC'?DHCCEGEC0?EG;(GF;:G*AGGC'E:G*::E:E4'CGC
@antibody_36_multiplicity_55_copy_19-1/2
TCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACTATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTAATGTGCGATGCAGACAGAAT
+
??A?<B<?<DDDD@AD86FGFGHI>IIHFIIHHICHGEIHHI=HIFH5F5I-HHHIFHFIFEHI5HHGIGIHE5FEFIFHIFHHIHHGDIEHCIHEHDHHHHD+HHEBGHHFIHDHEHEFHGD*FHD@?+GHG)HFFCG6GFFGEGGGGCCE(EEEEGGGGEFFEE@:G(AGFGG7GGGE.?8/GFFEEE?E.#AEEEGEE8EC1CE':EE?HFCGD:?:FEGGE:E?GC(EEE*G-EG?:AE0::*GCA
@antibody_36_multiplicity_55_copy_20-1/2
CCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCCCAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGCATTAGATGCTCCCAATATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAGGCCCACCAGTTGCTACTGGTGATGGAGTAGCCA
+
?A=?=?@BDDEBDD@@FFFGFGIFIHIIHIFIIHHBHI5FI0HFHHH.CIIHIIIHFIGHIHHIEC>+?BFIDIFIHIIHIHFHHFF/FIIEHGEIHFIHHEHHC,HHIGHHEHF,EH:GHHHFFCE?FEH@GGHIGFGF=DEED)EFGFCFFA8;EEC:(CCG*CFGGEE8G)F;*AG'(:EFEGG(C?:CEE:FGGEGC/-?6GE:/C:6EGG:GG<:8CEG0(E.':*AA0GE(AG/(4<E1:(*6<
@antibody_36_multiplicity_55_copy_21-1/2
AGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCCCCATGTCAGTAGACACGTCCAAGAACCAGGTCTCCCTGAAGCTGAGCTCTGTGACCGCGGT
+
,?==?BBAB?<@DBD@/FFFCGHH?FFEHEHH,IHIH@CIEFBCHHFH.HIEGHIH-EIHHH-HHHFCHHC/HFDF-HI5EIFHHEFHHDACHBHFH;HHHHHFAIHCGHDHGGGAHHHFBHG,6EEHF7F?HEF4DCCGHEGEAEG=EEGEEEFEG:EE@=F;E@AGEEGE;E:E/GEEEC6*GGEG'=C=D/C*AG((CGEEEG0EFH8?:@B78*,8?CCGE('(F(*:GEGAC*0:'?E8E*A(4C
@antibody_36_multiplicity_55_copy_22-1/2
CTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACTAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCCGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGATGCAGACAA
+
A?,?A5BBDDBD@DDBEFGCBCIEFHF,IIHIHHGHHI-@IF7I-HDE..GCDFFH,IHIHCHEH7HGIIHH=HH@BIFCIIFBFIHFHGDFHIHF*GHIEFHF3DGD@IF3HHDCH,FFFHH=GFFG-EGEHDGIFC@GBFG;E5EC;GGFGGGECEADGGGGBEGGG*F8FEAAFFEGFEEE<C(EG?)F?GEEAAE<CAC8(FDFC8E:E:E(EFEC0E8CCF1(1G:E8EG:C?**CE;<(.?E'*
@antibody_36_multiplicity_55_copy_23-1/2
AGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTAGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAATAGTCGAGTCACCATGTCAGTAGACACGCCCTAGGACCAGTTCTCCCTGAAGCTGAGCTCTGT
+
?????<?BDEBDDDBBGGF?GGHFIFI8EIGAG9HEDIHII.GIHHCHFHHEGAHDGGFHFHIHIH.-HHIGIFFGIH-EEHHHIF-FIFCE?,5IH>I6IHHHCHDBFDFH,?FHFFEEHFG#FGH?GHCGGGF*FG?3+FG4GB/DGEGF*EFE;EG*E.GCGCCE9EF<BEA;GCEEGC:GGGE(EC**EGCC>G(CEEEG:)/(CEEA/G@#E((:C,?(#FC:ECE::A0CC:C**0A6(G6EG8
@antibody_36_multiplicity_55_copy_24-1/2
CTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTGGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCTGTAGACACGTCCAAGAACTAGTTCTCCCTGAAGCTGAGCCCTGTGACGGCCGTGGACACGGCCGTGTATTACTGTGCGATGCAGACAA
+
?,???BBBDDEDDD@DFGFFGCIE.IHIHHHHHHIIHFHFHH*EGD-A5GH*HHDHFHH>HFHCIHCFIIHHHHI*IIAIFHICFCII+HIH=HHICIE8HIHFHHFGGGFHEE?HF<FFHF<H=HHEGDEFC:*GGEE@GG>@ACGGEEEC-EB=EAE@E#GG6GGGC:.?*?EAEE6/(EC.-F?E(GGEGFC(F:G.C'AC=GHGA'*CDCEE:G7@G(GEEAFCEEE/E)E('C(?C*G*C?EG?(
@antibody_36_multiplicity_55_copy_25-1/2
AGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCACGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTCACCGCCGTGGACCCGGTCGTGTATTACTG
+
?AA?,BB?B5DD-D-DCGEFFCFHHEHFCIHHIHEIIHDGHIEHEEHGAI=H>FFHH'-IIHHICHIBF>H5IIHC9FHDEH*FCF@IFAHFHEEI=DAGEHHDGFFHH:H;HHF+DGHGHG9FHEF5FGFHEAB*FFFEGEEFE*FGFFEEBE;A(GCFE(F*?G,GEF?E?G3FGGEEEG0GE?/E/E?EEGFGGGEEEG'GE/ED'/.C/:@EEA<E#E?CC.>AG((CG(?E/)0/1:E;C(*0A?
@antibody_36_multiplicity_55_copy_26-1/2
GACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATACTCCCACTATATTAGATGTA
+
?????BB<DB?DADDBFCFGFGHHHCB?C5HIIADHI.IDF+HHHFHFHFD7.IHH8IIEIGEIHGHFHGHIGEFEHAHEGIFHHAFI-E?)HFHFHGHFIFCFHGHDHEGBAHHH<8H@EH@9D+E=EBFEFGGABEEGG49*0GG?GGDCFEEGEG01;EEGCC(EGEEGEFGFEGGEEAG6GC0EA:EEG6A;EAGCGC:E:*<GG:CAEAECGE(7GEEGF//?C*GAC.(F6:E*C/A0C*E?FE
@antibody_36_multiplicity_55_copy_27-1/2
CTGGTTACTCCATCAACAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCTCCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCATGGAAACGGCCGTGTATTACTGTGCGATGCAAACAAAAATGTATTACTATGGTTGGGG
+
??AA??BB-DDDDBD5AGGFGFB-FIHIFHHCAH=HIII-IHHI.HIBHHHFAHFGHAFIH@=IHCEHCCH5IGII?H7HGH@HGHC+HHIGH8EHEHEGH=HHHFHHDHFHEGFH>FHHAHEHHFEABGF#GAFEF@?GGFFB@64DFGAGGEGF=AGE*EEGG0EEBFE?A:EEAEG(E:GCGF6((/C*FG(E(D/A:EEEG800G-6C@*G0G.7G:EG#E(CECE(E:E;/GA:FCC:'C:.A?:
@antibody_36_multiplicity_55_copy_28-1/2
GAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGACCCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGACG
+
???<?B=9D5DDDEDDFGC+CGFEFEIIFEIIHE@7HEBHFII*IHHHG-HHIIIFDHFH7FHHHHHBIIHEIGEHE-FH5-H5+HGEEHIF=H,HDHHDHFGFIHBDHG+HGGHG6FHECHHEEH(FFGG9CEE@;FEHBEGG+GE:CEEECCGG<GDGGAG*FC?G0FGC:F@=EGCGAGEFACCECG?89::GECFF:E0A?CE(?*GE*CBA(G#AG;E(CGG0?EGE:*(ECEEGEEEG2*:6):
@antibody_36_multiplicity_55_copy_29-1/2
TGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTGTGCATCGCACAGTAATACACGGCCGCGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGTACCGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGAGGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCT
+
??AAABB<DDDDDDBDGFGCGFHHHDEHFCFIHFHHIHHHGHHIGIHFFFHFIAIHFA>HFFH'HCHHHAECHIB5IHHE@CH#FHHHHHG6:I7HCHFIHH;FHDFG6#HDCFCF+HDHFGHFGHEHFGGCEGF/<7FA9EED#FG*E:GGGEEEEGE)E<A(/G0?.GE<?(E?FE?<E/:EFF)<EC?;EE>GEA*E6EGCECEA#(EE/G/GE70:ECC?*G6E::?AG:GCGC(GEEAECCE2GG
@antibody_36_multiplicity_55_copy_30-1/2
CCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGACGTACCCACTCCACTCCCGTCCCTTCCC
+
5<???BB=B-DBBED-GFGFFFHFIH8FIII9,EHIHBI@CHHGH>GEHFH>HAFHHGIHFIHF5FBIG@IHHG?DHHHDI@FHEHDIDDHH/FI?H<ICDHHHEI@HHH=GHF@8DE6FGG3G4)GG9GHDFGCIGEGE2(*GE='GE1@=GCGGCFFEDFG*E0*EEGGEGGED8E:FEDGDGGC6E4EGGC#CE(G0GGFGG?A(GEFC*E(GEC,,EE(C:('G*G(*FE(E.?E()AC.8C*G*0
@antibody_36_multiplicity_55_copy_31-1/2
TCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCATGGGGGC
+
???AABBBDDDDD@5DGGF@FGICHHHACF+IFHIEFHICEII=,IHIH?0B-HFHGIHHFHHHCHIHDIHGHHHHG@HADHEEHHI.HHH+DGHFCHIFFHH-BFHHHFHH=>=GHHGFFFFGHC?:G9F9GE>GGGFEDEDEEE8EEGG'BEG@GGCE*GFGCGF?GAG8F8E?EGF8EE8G:G9(GEEGE<EG/C6GFG*C0EFGCC(077*A/;C(G)GA<E?A*C?GCC?E90CEEC#GE*;G;G
@antibody_36_multiplicity_55_copy_32-1/2
CCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAGTACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTAATGACATGGTGACTCGACTCTTGATGGACGGGTTGTATTCGATGCTCCCACTATAATAGATTTTCCCAATCC
+
?5???+??<D@DB+DB,F>FFFH;IIIHHICIIHHHHHIHH+GI+DA-HDFCH/DHI7FFIGDH.HFHFAEIAHIBI)CHDHH-H5IHABI+H=HHH7ECDHBFF+GF+H#DEHEHH?F(DE*HEGGCHHE6FFE*F*EFGEG5?C/.EE/GG3GCGDEGC*G(FC*ACE(;GGA6?C;FG?EGC?<?EG00G(6EC:'GE(*E(CF?G(*G@EEFG(/EG:GG;'DE8DEGEEEE/?'(?*GFECCEEE
@antibody_36_multiplicity_55_copy_33-1/2
AATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTGTACTGACATGGTGACTCGACGCTTGAGGGACAGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCGAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCTGGTCCAGGCCCACCAGTTACTACTGGTGATGGAGTAACCAGAGACAGCGCAGGT
+
????<B??DDDED+D<DFFF.FIHHCHHHAIHHG=I/F=I+IIHIFHD9>H>HHHFH@?HEI?IFCIFGIFHIFAIHI=IIIIHHHDFHFI7E66HEI.HHFEHHFHHDHFDHF#C5CGHFFHHG+FHHFGGH#FGECDF-GHGAHGC?E?G:=EG?/G?EE.EEFDG(GE-EEGGEG?GBEEEE6AG</:GE?E(((G(GE/C6GAFEEE/77EG?(GE0-EEA0EA1EC(:ECAC':=EGCG.2FC9E
@antibody_36_multiplicity_55_copy_34-1/2
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACGATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTAC
+
??A5?B>BDDBDDDEDGFF-G>GEHICHHEHHHHHIFIIFHC=FH9FHFIHD-8GG5HCHIIEHHIGIHDEFFFH=F5HI*F>-GHHHEHECHHHEHCDDFGHHHFIEFHBF6DFGH.=@HEEF+6GFD,GGFEFEGEG@@GFC?:G4?)B*EFEEGC3*EGG(CCE;G:D4,0D??BCECFEGA*A0CE8GCGGG?A-:EEAEEGHG9?CE*GCA*GECBFAGE?F-EG?:AEG/EG-G8CA:C(EEG?
@antibody_36_multiplicity_55_copy_35-1/2
GCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGGCGTTTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGAACGTGTCTCCTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCGATCCACTCCAGTCCCTT
+
???<A?BBDDDB@DDD8GFCFGFFC?IEIIFIGI.FAI?IHHCIEIHFHCGFIIHCIHGIHHICHIHHHHHFCHAGHIHF,FH+CHDBFH?=HIEBHHIHGHHHF+B*H#FHECHFH=G@HHDEGFFGEEBH*4FE8GEHGGG;,GFGGD*G<C/#GEFC*GA/#GE4GG0EGGGGFDGEGGC(6E(//EE6EG<EGGFEFG:EG(CEC:;?.E@<:AB@/GCEFF?EE08?*A(GCCC(FG:GCE:G.E
@antibody_36_multiplicity_55_copy_36-1/2
GGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTCGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCTGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTTGCCCTATAATAGATGTACCC
+
?=???BBB<D<DDD@DFEGG-GFEICHIIHEEIIH>HHIHE+FIHHHAHHIHED.EFHEFEHH=EFCHI>F5>HIIDHI-EIIH=IIHHAIIHHIIHCHHE@HFHHD@FCCH4,DBH8GFCFEH6EGHFFFGGDCF)EGEFH0G*CGGEFEFAGECBCAGGGGE?(??E*F>(G(*0()EFE:(DGCG8FF0ECGGD*8(/G?4E?:GA<?/HE1?BE7E?GE'ACGGE*(E(<GEE1C-CG:?CAE(*(
@antibody_36_multiplicity_55_copy_37-1/2
TGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCAGTGGACACGGCCGTGTATAACTGTGCGATGCAGCCTCAATTGTATTACTATGGTTCGGGGAGTTATTATAACTCAACTGCATTACTACTACTAC
+
???AABBBDDDBDDDBFFFFCFBFHHIIIHHFFGCED?HHHHIEFHHI;IFEEHHI;GH9?FFGHHHIHFHBIHGDD+BFIHHCCF=EIIFIEHG8EC5IHH=GDHHGHHHFFFHHHH+GGEG*@98FD?EGGFE>=;FG1EBF6GCGGDFEGCE'EEEGGGFFE0GG?EEC:G'?GA?EFG*E?EEG8*E'*?EEAECE9G-AG.EEC(::(<F?G?7,CF*C.F8CAE:EE?*CCE/(F?8GE*6C??
@antibody_36_multiplicity_55_copy_38-1/2
GACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTCATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCGCAGAGCTCAGCTTCAGGGAGAACTGGGTGTTGGACGTGTCTACTGACATGGTGAATCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTA
+
?A=??ABBBDDDDD<B/CFDFFEHHHHHEFGHGHFIIFGCIIIGH+HHD=HHH.DCGIHHF5FHHHHH+5HHIHDGHI-I-IHHIIHGIGDCHHICEHHEHG=H@ECHDDHE<FH*EHFABGEGDDHFHGHG?*EDDF=FGGH#EG)GFEGG=CEEFE/E@#BE(FGCC(*=#(<CG?:EG6CGE*C8EEGGE4CEG:(::*C:/FE*(HEF*0FE::FGGEGAE:*EC*GF0A*;6E?8E/*E:G>C/0
@antibody_36_multiplicity_55_copy_39-1/2
AGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCTTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCATCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTAAAGCTGAGCTCAGTGACCGC
+
??5??BBADBD@DDDDFGCG+FEIEIHFIHHGIHIF@HHI5H9H+HGHHHHHCIFGIHIHFF5D8IHCHB=HHCFHIIFGH<4I#GFIDDHHHHHHGEI;G,HDDD)@@FHHGHGF?HEEAHHHFGF+:F=FFGGG:GGCDF3GCGEEFGGGGGGEFCEGGEEDEA<F<8(EG0E/GGEEGEEEA;0*EEGC;AGGE/EG>ED*E(6D(F/G=EEEGEFC?E'E*GAE((E<C9?::EF:?#0ECECCC;
@antibody_36_multiplicity_55_copy_40-1/2
TGAGAAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCGTGGACGTGTCTACTGACATGGTGACTTGACTCTTGAGGGACGGGTTGTATTACATGCTCCCACTATAATA
+
???=,B>BBDDDB+DDFFFCFAH-BIFHIFHEHHHHBHFHEI?HHHAFEHHHI/H0IAHHHD5EHH+ICFFFBG-ICCEGIIDII-IHCHHHHH+FC+DFFHHH*HGC3HH,HHHFHHE@EHH:FHFGHG@ED(HDGEEGCB(G?GE<GGC>GACE>G?;EEEGEEAB(GAA:A?C?GE/EG?C:EGCE/E6E:/(FCAGAE0E(C#<:EAGCE@EB88G?G.G.:GGE:E/(GE(:E:C:E?GCEE()G
@antibody_36_multiplicity_55_copy_41-1/2
ACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGAAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATATAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGATGCAGACAAAATTGTATT
+
??AA?<BBD@<B+DDEFFGCFGFBIIBHICFCHF=GGHDIIFFH9IHGEGHHA7I,I*HHDIHIAIFHGHHDHI#IIHF5D=HFCHF4HIHIHGHIF?HHH7+FI+FHHHH*HHF2EH=(GHHFDGEGGHEE.FH*FDGD3FEHEG*FE=GC*EGCCC*:AEFC1ECFG?.-GE*A@1.GAG?AD6FGEG(GAE:C?E:?G?AGGC:/E?*G8@<ED)C,GCG:8/ECF#GE::D-EG:?6<:?EE/:EE
@antibody_36_multiplicity_55_copy_42-1/2
TGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTCTATTAGATGCTCCCACTGTAATAGATGTACCCAA
+
??????BBDDDD?DDDGFAGCF.HFFHCEIE+H.G7FII*HHIHBHFIEHHFIHAC0HFFHHFFHHFIHCIBIIH-HDIHHHCHFFIGCEHIICDHIHHHHHHHFHHIHHHHFHDHE>DFE;EEDFHDCFH.0GGEEEEB@@GF==EECG*GGE2=.*ECEEDF?;;FFFGGGGE0*+ECGE6F/>G:ACEGG(E::GGGEGGCGEEGE9<CHC7(F/:/EG*EGEG*CF(.E#CCC0A.?FC;:F?-(E
@antibody_36_multiplicity_55_copy_43-1/2
CCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGCCTACTGACATGGTGACTCGACTCTTGGGGGACGGGTTGTATTAGATGCTCCCACTCTAATAGATGTACCCAATCC
+
??A??B<BDDDDDDDDGGFFGFIIII>FIFFH@FIGH?IDHI>HHICGHHIF5HEIHFEHHH=II5FHBCHIIIHHHI+EHIHHH+HEFHHCFI8EIFH?HH,HFH=CF@F+*DGHD@HGHGHEGHGFEFG(:GFFEGGHGC*GEFEGGEEGBD=GCGEGDCGE;C8F8GF-?F(GCEE<:8*EE=EG6/EEEC1EG?C*</0EG6C:G/C(>EEGG*G)7CEE(FAG/G(A(0(G>A01EE8(:GG0GE
@antibody_36_multiplicity_55_copy_44-1/2
CCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACATGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCTTTCCC
+
=?,A?<9?D+DB-DD<FFC?GGFHEIEH8CHF-IEHIF/IFI5FIHGFIHHHFIDHHGFHH5*HIDGHHHHIFHDECHHAFDHH=.GHHHHEIH+HHHGE.(DGHFHHCFIGHHFHHHGEG=GFGGDEBGGDGHGEEE=F(;BGGFEGE?<@CGG(E0EGG:4E8G(ED;?ECE;A?G/G(?.C6GCF(GEG(FE8EEG-F.E0EFCGEEGEHG**GCGG?CE?:<EGG?(ECCG8?;6(#)EG'E'F:G
@antibody_36_multiplicity_55_copy_45-1/2
CTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTAACCGCCGTGGACACGGCCGTGTATTACTGTGCGATGCAGACAAAATTGT
+
?9??,BB7@D-?ED@DGGBFCCIIFAHIFHFHHHIHEHIGDIHCHHHHHI,H@HHHIEGEII,HGIFHHBAI,H5HGIE5HEII9HGIHIEHHEEEEHIIH?HHHHGDHHEF@DEDHHDGGFEFHGG:DG1>GG*GGF*EEE1FFEGE@8.GFDEE*@EC*FEGEEFE;F*E48?GE9?G?AGGF?DGE0:EGGECC?GE))?8:E(GF<E.EE*AGE:DEC9E;G.E2*?:0EA?:A:.F*9AE?'D(8
@antibody_36_multiplicity_55_copy_46-1/2
GGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCAAAGAGCTCAGCTTCGGGGAGAACTGGTTCTTGGGCGTGTCTACTGAGATGGTGACTCGACTCTTGAGGGACAGGTTATATTAAATGCTCCCACTATAATAGATGTACCCAATCCACTC
+
?????BB5@9DDDE@DGCFFFFFFHI,HFIHAHEIIIGIDHF-GFCIFFGHHI5CHIDEE-HFH-CF(HFCCHDHAFGGHIAHIDIHA3HF=HHHH'<HHGHHD6FFFHHEH+HHDHEEH@HHHFFEFG;C=#7E0FGEEFGEGG@(EEECG??EGG-EE<FE<G*ACGGGEFACEEC*:GCG*EEGCEAGG*E-GEA?E<:8(EEE4(E?G*@'EGG0E:,C?EE::(EG:G*?AE(EEE*EE?EA?DE
@antibody_36_multiplicity_55_copy_47-1/2
GGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGGTACTCCATCACCAGTAGTAACTGGCGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTAGATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTTTGTGACCGCCGTGGACA
+
??=??BBBDDDD,DDDGGFGGFAIHI>HIA+FHCBCI>AE,HI-EEH>CFIB--IH,7EHCEBHGEIDF,GFHFF)HC=HH,IH1ID75HIEH-,DFIGHIIBHEHHIHHHFHH=HHEHHHH=GH?HB6EH,E<GGGEFF@E,*B?G,EGGEF*0E?#GCCGCGG8EGE:CGFCGGEG(:EGEC(F(>FGE6E(GE8CCFEGE?;C?G:?/G@G@AE?E@:?C(?CECG8?E*#'??::EEAC*:'CG<6
@antibody_36_multiplicity_55_copy_48-1/2
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTAAGTAGACACTTACAAGAACCAGTTTTCCCTGAAGCGGAGCTGTGTCAACG
+
???,?B?BDDDBDD+DGFE@FDC?IHEHHGFE+HFGFH0AIGFI7FHIII.B=DEIIHFH,HI-G>FHHGIHIEGIH,IHIIHIC)I>HEHH-HHHH.EEGDIFGFFCFEHEDFDFFAG,FEGFHD*FEDHGFGD,AGBF3(GEEAGGEEHGGFEGGECAG?;C0EDB?F(CFGG:<E0E:0E)G.GFE6)CC;GEF:G)GGCEG:H0G(G0/C:GE)E79EEE(A8FE/GE*:?(C:/C:(EAC(?/*/
@antibody_36_multiplicity_55_copy_49-1/2
GCCCAGGACTGGGGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCAGTCCCTCAAGAGTCGAGTCACCATGTCAGAAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTTGACAC
+
=????BB@DB5--BD<FGGGAFHFF+CHFIHHDIIHFH.DH=EHFIIHHHHI7CDFCFIHEF@GF-CHHCIEEA5H?IFIHIHHCIAFF=IHH68H=DHHGFHHGIFHHHFGHBD);EEFFE6)E@HFEE?HG1GD,;*H'EEGGGGG=ACFEEF,EEE-GG(GGF6GG9GGFEFC@E?EGE:C*GEEE8GE#G?GECGCEGA??/FEE*6EEA*G?ECGF<?F/EEE/C/E?C.EEG??(E(E**E?E0
@antibody_36_multiplicity_55_copy_50-1/2
CCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACGGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAGCCAGTTCTCCCTGAAGCTGAGCTTTGTCACCGCCGTGGACACG
+
?=A??BBBDBB5<DDDFFGFGEEHI,I>FBHFFGIICIIIEDIFHIDIF=FAFHI>HHC-IHFE@FDEE5CGEAII*-IF@DHGIGHHDHHDHIHHDHIGH?)4DHIEHHH(7CFHG7FHH+;EHF2AE*G@=GCEE@GE/EE<EG:A*F;GFBDEGEGCEEEEAG2G*GA6?GAGFE8G0AFGE0CEE?G/GDG8?G*AGAE*6G#G?0ECCA;1CEF1*E;G9.0C*8'GEC#G?#EE.?6EGCG?:E
@antibody_36_multiplicity_55_copy_51-1/2
ACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCAAAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCATGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGACGTAC
+
?????/9BBDDDBBDEG>FFFFHHC?HFFCGEIF9BFBIHHIB7AI..IHFFC9-FCGHHHAHHFIHH-HFHHHIHFIHFF5HHBH.FDHIIIHHFHEAH,HFH<DDG8HHG#HA@FCFG+FF(B:EGEFEE8G(A9@G@;FG;DGCG;GE?CH?E5EDE=G(BG(EG?A:C(GECGG6*GE?6EEFE86;C*<FG??GEE((EGE.GE:GAH:EAG?0(CAAEE6C(C?E6?EG?:*:G<8:6C#E<:G
@antibody_36_multiplicity_55_copy_52-1/2
GAGGAGACGGTGACCGTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCCGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTATTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAG
+
???5?=BBDB@BD5DDF>F>CGCHHIIH>F9HIIHF+HCHHFIEFHHIHFIIFBHI.HFAIGHHEF-FIDIHHII+HHIG?IGG.8F=HHEHDIDHFEHEGHH=HH=FF*HHHF6HFF,=BDGEDHHGDG(GFGGEG*G@,GGG;GGFEGGFAE,EE(AFGAEC=EGGEE;EC.EE*C8ECG2EC:>G;EE)G:C0E:/8G?F:C?FCFH#6H/G??1<EE(EE80GG?'/::GCE::9):964?.CE:'
@antibody_36_multiplicity_55_copy_53-1/2
GGACTGGTGAAGCCTTCACAGACCTTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCACCAGTAGTAACTGGTGGGCCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGTTACATCTATTATAGTGGGAGCATCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCG
+
A????B?>BDD7DBDBFF>FGGHI.8HIHFGHI/FHGHHHH@H-FFE,IFGHEAHECFAIHHHHHI7IGHHIIHIEIDEHHHHIICDCHF8EIHIHGIGIHDIHHHHHA@FHH#HHBH=GEC*DHHGDHDDFEBBB;.GCAC6?CG:EGBA8EAEC?=F9EGG(;*?C68ECEGEGEFAC+EEEG#G0:E?EE/EG6'6?6GEEE?C;*HE0C;E?:ECC;G6GGGE/GGA.E1F?C:EE0?FEEC**:C
@antibody_36_multiplicity_55_copy_54-1/2
AGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCCCGAACCATAGTAATACAATTTTGTCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCGGCTTCAGGGAGAACTGGTTCTTTGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTATTAGATGCTCCCACTATAATAGATGTACCCTATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGA
+
??????BBDD@ED5EDGG-GGAB6EIHF>FHID,FHEDCIHFIFFH@EHAIHE=HG,@I>GF-HFEDHHFFDHDHA-HFHIFFAHIHH8HHHHHDBIFHGHBHHFEHF,CDHGG-;FHGGCDB,HEBHGHEG>@DFE0)ECBEGGE*EAF3EGBEGFGGEGCBGEEE*FEE*G0GFE(8GF?CEEGE?FEGDG<CAGGCEC*F?:F)GF:GCC:8*8GBG??A6EGEEG*:?0*E?FF:D*0/C??EE8/
@antibody_36_multiplicity_55_copy_55-1/2
GTGGTCCCTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTGAGTTATAATAACTCCACGAACCATAGTAATACAATTTTGTCTGCATCGCACTGTAATACACGTACGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACCCGACTCTTGAGGGACGGGTAGTATCAGATGCTCCCACTAGAATAGCTGTCCCCAATCCAC
+
5=??=BB?DD-BDB?@CFGFFFHCE/I8FH@GIHF9FDF9/FGHHHHIIHEF+HHDHFF7@FGI8H-F#FG-HIHEGFAF5FH<CFFIHH-I>HICFIHFE=FI)+CFFFHFHHG#+HHHG#GGFGHHGFBHGFGGF4>0E5FCGACG?BFGAEFG9EFG?GGGEFF;GG?A(GEG6GEC?A=EGGAGE.GG(EGE?DG6C.CC(6?61#EA@G'2F?0@CG2CE(0GC'*'*EA.FE:(EG?/E?:CGC
@antibody_37_multiplicity_27_copy_1-1/2
AGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTATCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTTTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGATGTAGTAGATGCTCCCACTATAATATATGTACCCGATCCACTCCAGTCCCTTCCCTG
+
??=,<?BBDDDDDBDAG>F@CFHIFBFBI-FHHHHIHIHGHHFFIHHHIAI9HHICHFFHFH'->GIIGHDICHFAF-ICBIEIGECCHHHICHIEDHBHFFHH(.HF6HGDFHDH=F>H)HGBFGFGFGFG7@E8B?EDG,FDGGC0CEGCCEE#>/GFGCEGE3(GAE:;EGEEEGE(CCAG#GG:(EGG(EEEFFC*;E>GCGA6G(8:CE*CCGECCE?E<*6*GE0.?A(G??*8A:C(GEC?C:
@antibody_37_multiplicity_27_copy_2-1/2
TAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATACTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGGCTCGACTCTTGAGGGACGGGTTGTAGTAGAAGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTCCCCTGGGGGCTCCGGATCCCGC
+
?????BBBDDDDDD-DFGFECCII5BHFEHIHIFHEC+E-G.IFH#I9HHF,HDHHFFDH5-FIFIDGIGHFGGHCGHEDFHE8I=IFH=-HAGHGFHIFDFHHIHHFEDHHHIHH8G?GHADHGHE3FDFGGEFGHE<CGGHFGGEHDFE8GG*EFDECF5=EEG=ECCG:AGG:EC:G+G(GF-CCD*G:8*EEGG2<AGCEE?H:F./GH7FE::7F=((C-E8(E?:*<EG*0E:GG?FGECC'GF
@antibody_37_multiplicity_27_copy_3-1/2
CAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGCAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAATCTGAGCTCTGT
+
?,??A9BBD@DDDBDDFFAFGF-IIEFCI-GH>ID/IH(IIHHHIBHDHHHHBHG-HIDHIHF-HH5GB5F+H-HHCEHI,FFCIIDHIGGH?HHHEI=G(FGHGBCHF#GFE,HE)H;HEFGFEF?FED8EGF=BGDH@DEFGFE0FC?EGGAA6GEGBFGGEEGF?BFEFA;E'EEEGG;FEE#F?CEE6CCEGCA8G/EECG)CEE2DCA:(G:F:E;GGEACEGGGE*C;CC?***6ECE'CC8?G
@antibody_37_multiplicity_27_copy_4-1/2
CTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCG
+
??=??-B9DDDDBB?D-GGG6-IHIHHICEHHAHHHH8HHIGE?HFHHEGHFGGIF=GEEHIIIHFHFFF+CHEEHHIE(F+FIHFDHIHIHGHH6?CFHHGHFH+HFHDFDDH=HAEE+HDGE8DEBFHG6EEE<EEFEF8FGGGE:;(>5CGEE?GFGGEGAGCEEF0GC<E;:AGCEGEE:E0EF/AE(GA?GFG>CG6G6E*A(GFDG@2*G<EEA0/C(CGG:E.FC:EE)E/*EGEC:GE00?G
@antibody_37_multiplicity_27_copy_5-1/2
CCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCATAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCGACTGACATGGTGACTCGACTCTTGAGGGACGAGTTGTAGTAGATGCTCCCACTATAATAGATATACCCAATCCGCTCCAGTCCCTTC
+
?A<?=<.BDDD=DDDDAGGFFFF>F+6FIF.HECIHF+FEH.F@H8HHIH5FIFFFFGHCHHH5IHHEHIGCIIFHI>FIHFDHHH7ADIF.H+>HHHIFHFHFDH,B+F7HHEFF5FGEEHE-)FGG;F:F#G;BF=EFEEECGGGGEEBGEFGE;E?B<C#;16EGAGDGCG=?G/>;EE*/;GECEGFF?F#CGC:;?E6EEC(?E<E6HE@.E(E7G?(:/(E*AG?FCCC/(CCCG.EEE*G?.C
@antibody_37_multiplicity_27_copy_6-1/2
CGTGGTCACTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCACACAGTAATACAGGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGATGTGTCTACTGACTTGGTAACTCGACTCTTGAGGGACGGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCCAATCCA
+
?A?A?BBBD?EDD5E<FFGGFFHIEHFHHFIIFDHHIHAFIAAHC@HHHFGF0IDEGHI8IHIDIHIIF>CEDFIFGHAEIHH.HIF:HECG-?HIHHHDH*G'FFFHHG>HCH#HGEH5G5FGBBG+HEDFEGFG;,G6FG,GF,F?EEC.FGGG.EGGG?EE*@A<C(A(GCGEEEFG;+'GGGG';GG86EE:GGC;GG=G:8AEG1E*:E(0BG1EG0G(EC9ECEGAC9?EAFA:(.>6E??8<C
@antibody_37_multiplicity_27_copy_7-1/2
GGGGACGGTGACCGTGGTCACTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCACGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTGAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGTGGGTAGTAGATGCTTCCACTATAATAGAT
+
?A???BBBB9@BDDDDFCFGCFH/IIFIBHIHHHBIEIHHIIIIHHIDHGIIIH+HFFHH,HCHFFHHDF5CCI5IFI5AF->EHA=@GIHHHIC8DHHFBHHFHHD3HED4EEE+FF@HEHF7HG@,FGEFF=*CG@DEEEFGG(GEE8EG*GGGE8G*(EFEEFGEGA6EGGCGGC??EF2EE.C0;C8?GGGEEG.E::61*E(G(?6E)@0ECEFE*(((GGCCGE6.G?:((;G*E/EEAF?(A9
@antibody_37_multiplicity_27_copy_8-1/2
TAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATTGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTCCAGATCCAGCCCC
+
?,??9<5BDDDBDBBDFFFGGGIIFHIHCHI/I>HIDHIHFHIIIDHFHEFH-FFF-FID?HEIIIH-HHHIDHH>IFHHHIDHFHDG+AHAII3HHHHFHGCHCHH6FFH=F-HHH=EHDHH@HHHGGG3E?D?EA0EFEBG*CFG*G@G.?F@9E;GEGGG*@(EE3G8F:GGEEFEAGAC8(FAEG;/G:GGEG?*.::GC2EHE>C-:HECG:GD7*E(=EGGE8GEC6DG?6G/CA9G=G::/0G
@antibody_37_multiplicity_27_copy_9-1/2
AGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTTGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGACCCTCAAGAGTCGAGGCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGATC
+
??=???BB<D?DDDDBGCCAFF6HHII8CIIHHCIHGFDHIFCE5=HIDH=HCAGH-FHCEHHIIHGD7HHIIID-+I-EH@5IEHHEIDHEIDDHIHI,FHIEHDFH5FHHG(GHF0?FDGHCH1HHGHH7GGEE:G,@A(GG(EFEEG8GEG1D*0@G/:GG*C=;;ADEAC?AGGGCF+?:(CE.EGGE*GC0;EAC(GG?8:E*8ECGEG8E:GGGEFAGEG(GE?AE6A(?EECG:)G*G/F0(E
@antibody_37_multiplicity_27_copy_10-1/2
TAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGTACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGCTGTAATAGATGCTCCCACTATAATAGATATACCCACTCCACTCCAGTCCCTTCCCTGGGGGCTCCGGATCC
+
?????@BB-D<DDD@DFFFB/FIIIHHFCIH7HGGIHIIIHIFIFHGHIIIIFIHCHFHHDEIIHDIGAHEHHHHID*H?IH5FHHHCDAIGFHF@.CHCHHHFGFFHFDHE(HHGHDHHEHEHFGHGHFGGEGD*;GGE*FG*FFFEGEECAG;GE;EEGECA=FCCE9GEGGEEE>(CFDG(?GGG6EDG#G>:EEE.GEEEC:=(C?C:H::/88,@EE?ECEG*;D8/0GGE.1EEC/G??0CE?E
@antibody_37_multiplicity_27_copy_11-1/2
ACCCTGTCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCATGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGATGCGGTC
+
???<?B.B6DB@DDDDFFG8GCHFFHHII>FHIEIHDIHEHIGIHAIIHH-HIHCFDIC8)HIIHHHIHDDBCHBII-HHHHFHFHCHHFHHIHGHD7HHEHIGH@EFB9@HHGHDDHHHDFFB,HHD(F2DE-G2@:EEAGD;D1EF(AEBGGEGGE8G(??EA-EE=9GEG?E>C+GCACE1A:(>E8:ECC:EEG:FG6<GCG0G((:?CGDG7E/GF?E6FGG?E2/E?ACG?EEAEGG8G?*.*8
@antibody_37_multiplicity_27_copy_12-1/2
GGAGACGGTGACCGTGGTCACTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTCATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTGACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTCGTAGATGCTCCCGCTATAATAGAC
+
??A??BBBD-DDDDEDBGGGG.CE;FICIHHECHIHGHFIHIGHGFFHDFFBFHFF,EHIIE/AHIHBG+>?IHHFI5-CFGFH?HDA=II8B,DIHI6EICFIH6FH@FHGHCE.*GB;F@BGBEF.EGEEGGDFGGB+?:F;D(@DEEE9EFGG:EGE1@GG.AEG,G*@GFEAFFFA2=DFG?E2FDFGFEGG(CG*;GA:EGE?E?EEE0CEC*F:EC.?8#8:?*?E(EGEEC(8(E(EGA::C.
@antibody_37_multiplicity_27_copy_13-1/2
GTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAAGTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCCGATCCACTCCAGTCCCTTCCCTGGGGGCTCCGGATCCAGCCC
+
A????B-B-DDBDD@@FG-FFGIIHIFHIFFIIHHGDHFEEIH7FHDHGEAI-IIHICDHHHHH;EIEIFHCD.EHHHECHG=IFIHEDI8HFHFH.FH,HEDHFGG@3HFHDFHGFEHGC'FGGHAGB*GHE1GGFDGF;CEEGC/AF#GG(EEGCGEEGCE<ECG.FGGG:BAGEC<AC:>CEG:(EFEE6/FECFF;EE8GGEHE(*GC<:GG-/'FGE?*E-E9GCCC*E?(:8C:;CEEEEEGGE
@antibody_37_multiplicity_27_copy_14-1/2
TGGTCACTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCCTAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTAAGCTTCAGGAAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTAGAGGGACAGGTTGTAGTAGATGCTCCCACGATAATAGATGTACCCAATCCACT
+
?<???AB7BDD,BDDDGCGFGFIFHHFHH;HIEIFIEBIHHIHIHHFGHCHGHHIFGD.AFH-HFFFHHDE:-I+HGF>DHIHFHHIEIIFDFGHHHBGEFHFFHF7CHCFF@@HHHG@GFFHH+FGHGD@B2FGG.G)G(EC;E6.DFA#?GG8GEGGA=GEAE>3F(6E)EG;:*?EGEE(CC6?G.0:?/FEF'FC(G(*E'?F*E?G6HGE?*#<7.CC:;6(;'A?GCAACF6CACAEC?:GA:8
@antibody_37_multiplicity_27_copy_15-1/2
GCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTTTTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTACACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTATGTGACCGCCGTGGACACGGCCGTGTAATACTGTGCTATGCAGGCCAATTCGTATTACTAT
+
?????/B<@DD@<@BDFFF>FAIIE>II;FFHICIHDHIGIFH9GI)IHG7IHIHI-HH>55HIDHHFCFIAHFDDFDCIHEIEDHCDFIFH+5FDH,HIFG<CHEFDGHDEH@G@HHEEGHHGHD)FDGFGBFH>(EEF,FG(GE=GBE=(C*G=CGGEECDG*CG*GCEG6EG(/.GCF+C*0:?C(00EEE?EG?EFE?EGGEH(EHCAHGC**FC/GEEA:)(8?E(-(E(G:(((G??E:GGAE?
@antibody_37_multiplicity_27_copy_16-1/2
GTGACCGTGGTCACTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTCTCCTCGGCGGTCACAGAGCGCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGTGTTGTAGTAGATGCTCCCACTGTAATAGATGTACCCT
+
???AA<-B@DDDB<ADFC-G>FEHEIII.>FIIHIIIIFIGIIH+C>HF@FFHHIIHHHHI8HHHFHHFIHHIHFIHGF-HIGCHF7?BHH5IFHHHFE:FHHDFC<5HG=EFGFHHG+;EHAD=*#HED*G:G*E.9EGFF23CF(A?*EFGEG'EGG,?GGCGGGG.EEG:GGECGGEG:?GG=GC;FEEFCGE?GCC?2:CG0(?)H(((=GGEE;GCG?69;FE.:)AA:#?A(ECGECG-?EE.*
@antibody_37_multiplicity_27_copy_17-1/2
TCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACCCGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTGTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGATGCAGGCAAAATT
+
????ABBBBDDDB?DDEF0GGEIHAHEIHG9@IIHIH?H>H,H9AHHFCH=I'IF?FH-IA8)=IH-HHHHHHGHH@EAF*DE+=HAGGBFHDFHC.HHHEHFH++HBEHGE-HE@GFG+GHGHDE2E/HBEEFCEFGF(G?DG*FGF?EFGEBGGEG:FGC3?(CGFBEF-E*GFGGC'C+GGCEF*CGG;?GD??<(EFFFCGE6ECEEGECG*/E/ECGGFG?/8E0GAGEGE?*?GE(G>CEAE<E
@antibody_37_multiplicity_27_copy_18-1/2
TCCGGAGCCCCCAGGGAAGGGACTGGAGTAGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCATGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGAGGGAGGCAAAATTGTATTACTATGGTTCGGGGAAGTATTATAACTTAACTGCATTACTGCTACTACTACTA
+
??<?,?BBD@DDDDDEAF@CFE>HHHFHH+@GHE4HHHHFIEIIHFHIHI>ECCIIHFHFFHH-IIHGHAHGFHED5?CI-E=DH=;BGHHIFEID=HHHHGA@DFFEHG>HHDHEEHFHG+GHEF@EBH;HED:FGEGD0.(GCGCFGGEEG?C?GEF/EG*G6;EGFEAGEAFG:+E(G-CG?G)8CF?GEAGFE?E<G(-A?G;EGHEGH*E:GEC@CE:0/*GEAE(:E.E*(#E#F:GE?C*::C
@antibody_37_multiplicity_27_copy_19-1/2
CGGGCCCAGGACTGGTGAAGCCTTCACAGAGCCTGTCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCAACTACTACAACCCGACCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTTCAAGAACCAGTTCTCCCTGAAGATGAGCTCTGTGACCGCCGTGGAC
+
,A??A7<<DD-DBDBDFFFCGCIIHIFH?E/CDHI@H-DCHEIIICHGHIHHCHGHFIFHCGHF>HGIHH(EIIEI5IFIH=G-H-IAIEHBHGHH3+HHHH)HHEHH?HFH.'#H+HH*;F@H+GG8GEGE5G=F9GCBFGAGG@EG0EG?'*/*GG:E?G*BG;(GGA<E2ECGFGGGAE(AF0CEGE*8E/EA?E??GEG((AHF?FEEAE(1FAEE(FGEGC':*;CGGC('G'E:E='2((?FA.
@antibody_37_multiplicity_27_copy_20-1/2
CCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTTGGGCTGGATCCGGAGTCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGACCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGATGCAGGCAAAATTGG
+
A????>B5@DDBDDDD+GGFFEHHAFHH>F77HHHFHHGIFD.H.GF.FDGIG.GHF8DHFEH5HAFFHICI-DH5H@@;FH-IHHHBHHH.7F?HGHC:FF5FHHGDIHFEEFD*+H@GFHGGDHEGEFGG*HCFGGGGEC;GGEGG?(EGGAE<9GGEEGEEGF?EE;C(EEG?GE.9FEGEGCG(AGEGE*ECGG(?.AAEG:HGG(.EE*<CC0DG(7GE:C.*?0CCCG0C0*C./EFFE.<::'
@antibody_37_multiplicity_27_copy_21-1/2
AGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGAAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTG
+
???5?B9?D@BDBDDBGFFCF+HIHECBHHG+HC==ICFHFHHHFCI=GGFHGIH7@IDHHHHAHHDHIHFCFIIH=IHHF=FII?I?IDHHHFHH(IFHHH-IHIHHHFFDGH@FH?GHEEFBGDGGCAFGHFGFFEEEHGGEFG8E*GEE?(FGAEFEFAEEGA@EGF(GEFC1EEEFC:6E:GEE??*(EEEEG(0EE6C:GG?EC*?G:CCC?*(E?,E(EAEACE*6GEAGCGC(GGG4?>EEAE
@antibody_37_multiplicity_27_copy_22-1/2
TCGGGCCCAGGACTGGTGAAGCCTTCACGGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTAGGTACATCTATTATAGTGGGAGCATCTACTACAACCCCTCCCTCAAGAGTCTAGTCACCATGTCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCAGAGCTCAGTGACCGCCGTGGA
+
???A?5BBDD,D-@DBFCFGE/H-IEIH/HFH.IGHIIFIFGFFHDH@FE+HEHHEHHIIDAFD5HH.H5IIGEC-HIAIBBHGHFHHIHF=HHFIH2I8@HIHDBHH5HHD#DHHGFDFBGF,FHH'*H4?G.G0BEGCCEECGC*CGCG2/E:EE8EE.FEGGE((GGB?AGE*?EC9'??*FCE:E<EEGAEEGEFGE-*G(EH?>AD?EGBC<*EG?AE?F:*E(GACGCA(8??CGGGCE:*.?G
@antibody_37_multiplicity_27_copy_23-1/2
AGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCCACTCCACTCCAGTCTCTTCCCTGGGGGCTCCGGAT
+
?<AA?BBBDD@DDDBBCFGFF>H.HHI>-H5IHII@GHIIFAHHII.-G.H+A7-HH-IHHIGEIDFFIFFBGIIEH*FD-IDCIE-HEIDIIH?IIGDHHHIEFHH@HHFIHGAHHCE@@G,<E@*EGC9FG/GAHEDGEGGBE,4ABEEE<EEEFEGCG*GF6GG0@A(F/G(EG6G>E;FGF?CCGCGGCGEEEDEGGFEGEECEG:GECEB:(GEG;EGEC??/G**EGFECC11A?.(GFA0G?G
@antibody_37_multiplicity_27_copy_24-1/2
GGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGT
+
?????BB<@<DDDDBBFGFGF8-@HEHF66FHHIEHHCHIEHEIHHD.FH.HH5IFEGHFH9/EIEIHFHFHFHHIEI-HH5FF@FHFIHHFHHHH?H9HEGDHCHHGHHAEHGHHHFDHH2BFHH(,F6FGFGEGG*DEFEGE8EB6GEGGE:CE,CEEE?C/8GGGG?EEG@#GG?(GG#ED6(*:AEGGG:G.)G(G8CC#GCHEFHCEH.//08?CG8AGAA(C?*ACC(C?CA*:AC(?E/CG>(
@antibody_37_multiplicity_27_copy_25-1/2
GTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTATGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCTGTAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACAGGTCCAAGAGCCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTA
+
?????BB?@DDDDBBBGFGCFFEHI@BIIF@HII+FFGHH(EEIHHCC?IFHEHCEHFAHHEDH@DIFHHIHI?HFHHHIH+G+HHEH-GBHHFFHHEDEI?IHDGDIDHHIHE*F0E+9HBHFFBECFFFEGED(HE(@DG@=@AFBEGECGAGEE?G(GCEEGGEGCE(GE?GGEE.,CECCG?#?EG?C8G.(EFG2CGGG0GFEEHE*@8C7CCC/=GECEECAC?EG:CGACE-/DG8(*E6E:E
@antibody_37_multiplicity_27_copy_26-1/2
CACCTGCGCTGTCTCTGGTTAGTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCCTGGACACGGCGGTGTATTACTGTGCGATGCAGGCAAAGTTGTATT
+
5=<<?-?>D@EDAD@D8GGGGGFF88FH,/H@EHFHHHIDHIIIHCHI@GHIGIEH.HA5HHCIFFHA+HFHHFHFHFCHHHHEHIIHHIIFH,E@G+EGHHDDI#HGEHB?FHFDGD2DDHGHHH;EHEHF+=G*=EEEAGFGE00?D:EE/;E*6GE2:CG=EF?F:G?DEG<0'AABEG(E*EE8C0?EE*G/F.GGG0AD)EE*((ACHC*#.E4CGC0AE(D?.A?*EFEEA:EA:6(6E.6GG?
@antibody_37_multiplicity_27_copy_27-1/2
GACCGTGGTCACTTTGCCCCAGACGTCCATGTAGTAGTAGTAGTAGTAATGCAGTTAAGTTATAATAATTCCCCGAACCATAGTAATACAATTTTGCCTGCATCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACGCGACTCTTGAGGGATGGGTTGTAGTAGATGCTCCCACTATAATAGATGTACCCAAT
+
??A?,@BBED5@DDDDAGFGGFI88HHHBIHIGHHHIIEIHF.AHHHIHEHHHGHHADEFEI@HFHBDHF>DHAFGI?FGFBA>HIII?DDF2F6FIDHFHHHFI,HHAEDGFFHBDG6EHDHHGHDF9H*GGGAGG8EGEGEGA=:EG@GEEGE=EFGGFGEEEG=AGF?CEFAGGEBFFA?<-FCFC?E90*EEGG(GE<6:(C*('CEEF*'GGCE<F0CG98E.0EGGG.-(E1(EEE??G?;EG(
@antibody_38_multiplicity_1_copy_1-1/2
GAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTATTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCATCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACAGACGTGTATTAC
+
?A?A?BBBDDDDDD-DF+FF+FIIFFHEF8FIIIIHHFIHAIHHFHEIHHEHEEGHHII-.DI-BHGIIFG>CIHHHIG=HHH+.AHHAHHCIHD,AHI@9FDEFHHIHF5G@HGCHEH,HFCH;EHD@GECCFFFFEFEGG8+EGBE.=E*GFGG;G=CEEEGB=EGF;EEGEEEAGGC8ADG*AG:0/EFF=E-D2*:AEG?4EHCEEGE*AE/FE?GE(EC::DFAE*G6#6?C)G*EGGG;C(0/?
@antibody_39_multiplicity_32_copy_1-1/2
CTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTCTTAAAAGCAAAACTAATGGTGGGACACCAGAATACGCTGCACCTGTGAAAGGCAGATTCACCTTCTCAAGAGACGATCCAAAAAACACGCTGTATCTGCAAATGATCAGCCTGAAAAC
+
=<?A??5BDD?9BD?-GCG,BFBIHHHIHIFIIHIHIIEIIGIA>-BHDIHFFIDIFHI@HE-HII+HIEHHHGHHGIHHIF=EFFEHACIHGIEFHECHHHEDD4.H(HFH+GCEHF?6G3H:+:FHEGF(EHCG(DE(HGG(E:DEEEE@EECFEGEGE=#(8?F8E::E64EF?(:GEG66:EGGCCG#EG(G*F(EG:?.?(HE((EEHEF.:EGE0EEGCEEECEAA(FD?F?*GAEA??:CE(A
@antibody_39_multiplicity_32_copy_2-1/2
CTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACTCGCTGTATCTGCAAATGATCAGCCTGAAATCCGAGGACACGGCCGTGTATTAATGTATATGCGTTAAGTATTAC
+
?=??A7B>D?B9DBBDAGG;GGEHHIHIHIDFAHI9IIEHIHHHIIF-HD=HDFDH=IHHHHIIGHIEHDIHHHFHHHHCIHHD?+-DIHIHGHHIHHC@H:HGH+ADHHFHGDHHDIH>GHH0GE(BHAEFD/@*3DCG?GEG.EECEEE:EC?4F?CEEFAGGEGGG0G*GAG'GEBC.GEE:GEG*(EEGG?E?/E4:?:6E06EEE'FCE@EB(EC*.*GG?C:C*AF?E(*G0ECEE:6:EGEEC
@antibody_39_multiplicity_32_copy_3-1/2
CGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATAGAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCAACATTAGTTTTGCTTTTAAGTCAGCCAACCCACTCCAGCCCCTTCCCTGGAGCCTGGCGGACCCAGCTCATCCAGG
+
9<?5,BBB<@5@BDDD,GGGF>IFI8HCHHIHHHIHGH=HIBHCH=>HH5FEAEH,FFCIIBHHIHDEDEHAFGF+HFHFGIHHEFHHHIHH4FDIIFC=H#DBFHC.+HFGH@CIGHGEHD2HFDGFG(FE(GFEEGEEF)/D=CCG@G<-@AGGEGDAG*GGGCAC>GGGG(:/AEGEE.EGAEEGC/:<6(*/CAEE?EE:EF?G?:EG@:EEG?E@CGEEGEG?/?*AGEEC?*AE:)CE::?6E*
@antibody_39_multiplicity_32_copy_4-1/2
ACGGTGACAATTGTCCCTTGGCCCCAGACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCAGAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTTAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACACACAACCCACT
+
5????BBB-BDDB5DDDGFFGFEIIFFIHFHHD@GHIIH-F9IH@FGF@,IIF@HBG@-;HHHHICGIAIIF#H5@>HHDHFCIHI=.=AAHIIFH;HGDHEHH+HH@EEFHHGHEGHEG,FEHEGFFE3G>EEGE@GFE2*EGF@?A8EG=7B1E#F6EGGE<CEEE?@6BAE<'GD?G+>08E:FEGG(FGEG::EGCGGG;D*;?EE:EH@GAEE(DC,<>E:C(G?CG??0GAA6))AEGGA:C-<
@antibody_39_multiplicity_32_copy_5-1/2
GACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTGTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACAGCCCACCCACTCCAGC
+
?????BBADDBDDD5+GFB..GHCCFEHFI+7EHFI9CD.9HIHGIHCFHDFHHHI.IGFHGFIIHHIII--FIHIIE-E4EHIIFIIEEF*HHIHHHHGHHG=HBIFF+HFDFEDHBCBFFBDE?HHHFEFDGFI+FEEF=*HFE@EEEG6*GDD9CA*'EECEAAEGF6EG:EEEG:;A#ACGFG1/0:0GGC?/GG*E/FC?A/G;?0E@C*?:GCA*ECGC)9EG8E??CGEG*E8?EGE:(/C(E
@antibody_39_multiplicity_32_copy_6-1/2
AGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCGTCTCAAGAGATGATTCAAAAAACACCCTGTATCTGAAAATGATTAGCCTGAAAACCGAGGAC
+
????=BB>DD-DDDDBFFGGGFH/HHHHA8IIICFIIHDEFECH@@;HGIFFGHFIE+HG8GEIHHIFF5HHFIGFIHIGGFHIDCIHCH(EIEBHI-,D=HIFGFHFHHHFDHFFHE+=H,EHEFECFEEG@E?GG,=GG;@@GFGG(GHGGEF;H:EEFGCGCEE:EGGEG:GGGEFGAFF80CC0EGF?G/86EG??E?GEEFCA?1?EH*G(C<771GC'*E0FCC-/G(E?E/G.:0G8:E:G*C
@antibody_39_multiplicity_32_copy_7-1/2
TCAAAAGCATCATGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGACCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGCATCCTCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGGGTCCTACCATTAGTTTTGCTTTTAATACAGCCAACCCACTCCAGCCCCTTCTCTGGAGCCTGGCGGACCC
+
?A??ABBB?<<D-D9A/.GCFFFF@HCIECGCBIH7IGGIHHHHDHHDHHFEDHHFFHAHIHIAHGCFIHEFCIIFFHH5F-FHII(DHCIHHHIED=H<HIGIHFED@HEG*HBHGB9FE*B:G;E)C7:#/FHG,A2??EG@,G2F;>:E?CF(E3*G>:GAGF:GG?.:EGCFGEE(FEEG#<'EA(<E:(G(E*GEA'G)G?HEG;EEH@DGEDB(EEEGECGCEF2)F*-E?G?880G0C?.0(C
@antibody_39_multiplicity_32_copy_8-1/2
ACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGAGTATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACAGCCAACGCACTCCAGCCCCTTCCTTGGAGCCTGGCGGA
+
=????/?9DDDD@DDDGFFGFGIHHFI/HCIIIH+GHEH>ICHBIHII@DHH+FCGHAHFFH?E+?HHFDHFFFHEIG==HHHHCIEIAIEGFFHFHGIIHHD6(HEIDF6HCHHFHHEHHGF=7BFFGEFE+GE,FG*GB9GE'EGGDBG9HBA0EGG?BAEC62DFGEE>ECFEGEE:GAAGEE-:DGCG6*8?8E*20EAF(6AGGH*G;AGG*G1EFEA#EE:G:?*A)C8*EE(CC*?GC:GC:*
@antibody_39_multiplicity_32_copy_9-1/2
GGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCATGTCAAGAGATGATTCAAAAAACAGGCTGTATCTGCAAATGAGCAGCCTGAAAACCGAGGACACGGCCGTGTTTTAATGTAT
+
??=??BBBBB@-DDD9CCFFGGIIEIIIIA5FIEIHCG9HHFHEHEFIGHECGECH@AH/EHFCIDHIHHHF+4HHFIHIHI5CAEIEGHFHAHIIIHIHFGIFHH5HHHHDFHFG7FHFHCD=HC;GH9DBFDF=GF.ECGGGFCEGGCBGEEGEG)>F8EGGGEGG?(CEG:CEEG?<8E'F8G8(GCF-#EGG:GEEG*/E;E:FAE(E0(@?GC?GG/(GGGG*ECECEE;G:CEE/E::FEEE2.
@antibody_39_multiplicity_32_copy_10-1/2
CACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCACGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCGGCGTAGTCTGGTGTCCCACCATTAGTTTTGATTTTAATACAGACAACCCACTCCAGCCCCTTCCCTGGAGCTTGGCGGACCCAGCTCATCCT
+
??5,?<BB@DB=DDDBGCCAFE-EIHFEIHEFEFFIHIGHHHICHEHHGHH-.HE-FHEECHHFIIFFHIIEGHG?55HHIEHI#IIFHDHHHCCH5HIHFI-HHG+HHHEF*HE*HDEFFHBD?EHB)GHEG*DEFEB@1FF6E.9EDEGGE89FE*GEGG(EGC1EGCGG(EGEE0*GEGG//GGE(E?GE?EEEE*C*G?*?<EGAFG)FE7GE'EEEGD;8/GGG#?GGE(6(E.?C(A?EE::E(
@antibody_39_multiplicity_32_copy_11-1/2
AGGTGCACCTGGTGGAGTCTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATCGTGGGACACCAGACTACGCTGCACCTGTGAAAGGCAGATTCATCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCA
+
?9???BB?6?DDDDBDGFC-FBI+HIHIFIH-IHHFHGHHHHA9HGID.5EGCCGI?DHH.FHIICFFHIICHIE;F=FGBHIFIHEIHIHHD=H=E;FI5D=HDFHHG:=HH:2GGEFED,;F?HFEH,E,DEGFGE@EED9CE?G.EEEGEEBEEG3E#EEB*=G#F6E?EEEGGE*AGE6C)C(EC6GCECFFEEFCG:E?G??EGA(EH01GE9C(BAA.G6GEGE*EGF(E/;?(E?EEC'D81.
@antibody_39_multiplicity_32_copy_12-1/2
CCATTGTCCCTTGGCCCCAGCCATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATTGTAATACTTAACGCATATACATTCATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCTTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTTGTTTTTCTTTTAATATAACCAACCCACTCCAGCAC
+
?<?9?B>>DBDDDD5D;+FF/F8;IFEICFI:H?CF+FHIHGFE-FI>FFHFHHGH>HHEAGFHHH-HIHGHIIIIDH=H5H@HHHGHG=-HHFECIEHHHDFH;DHF(H-3HBHEHE;EF?H*FBBFFHEECHAE?*G>'GBGG8;GEB;GE3G*B9EG80<C(DG<EECEAF??GD6?FA:8C4:F?GECGGG';E:F:E;E?EH8((CF@E#GG8E:*:E**E*?<:.C#?.<((C(**FAGF:E*'
@antibody_39_multiplicity_32_copy_13-1/2
GAAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATAGTACTACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCATTTAAGACAGCCAA
+
A5??<B?BBDDBDD@DGGGFG8H@HFI.HHGHH+@HHGH-F9F=IHHIFFG>FADIGIIBHFHAFIIIFGIHHFHHIEFDHIF-@HIHHHH<=HDFH7FHHFF5H@HHF,H4)C;>H*HEHFFHBGDGGGFD;*EG>*EF.EF1FG@EG*GFFAEG(GEGE=8G?EEEE:.FEGG;E(EE+E6FFFEGE;E?CF*F?F8GG<EE*CFECA:DHA:E0GCF/,*EG0?6GC0GGG?':2EEE(;C?E:CCF
@antibody_39_multiplicity_32_copy_14-1/2
ACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGATTCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACAGCCAACCCACTCCATCCCCTTCCCTGGAGCCTGGCGGACCCAGCTCATCCAG
+
5????B-?BBDBD5D@+GCGGG>FHFIH>IHDEFI7EIFHDFIHFHIFH7EGIFHGHHCIHH5H-IIEHBIIGIHIGGD;HHHFIGIHD@HHHHHHHFAEH=E+*IHGF<HHGDFFHEBHFGGDEC=HFDB:EE<EE*HG;EGGGBCEEEE0A?CEEEE,GG;AACGGCFFEBEB:GEGE;@EEE(0(EE/CC?FFEDE-;;EEG(HFEE<G#GCCGEEC<EGE(ECE8*GC?C08C((:E::E:F88?G
@antibody_39_multiplicity_32_copy_15-1/2
GGAGTCTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGGCTGTATTAAAAGCAAAACTAAGGGGGGGACACCAGACTACGCTGCACCTGTGAAACGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGATCAGCCTG
+
??A?ABBBDD5DDDDDEGEFEFEHE/>FHHHHHHIHEHF9IFHH5HEFEHHH++-D.@HHHCDFHD5'HF5HHHEICHCH>I7@I@F*EIHICIDICEIHH+GFHHDHEFFFFFGEGHEHH;H=5I8DD,?H3GEGEFFG;8CEFGGBGC?GE#GE#0GA:)??FE*>CG*EGC/E=+G0C+GG*GC*)?A:AEC.?E?E?C:8G?F*AE6GE0EF.8G7C:AGGG(8A?GFF0(ECEE(?GG.*CG6GG
@antibody_39_multiplicity_32_copy_16-1/2
GCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGTAGTGGGTTGGCTGTATTAAAAACAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGAAAGGCAGACTCATCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGATCAGCCTGAAAACCGAGGACACGGCCGTGTAT
+
?=9,?B/?9B@BDD?DGGGFFGHFHAHII/FIEGIIFIFGFHH)@IHIGFFIBIEI-HI-H@I+GI#IHEECHICIHHHEA3DFIHE+E=.+DI,HH,HHEHH3HIHHHHHHHBDHHFH#GH*HG,FF4??E(HEGHEEG4CFGEGEAEBA8.A(GCECEGEGGECEEG(AGB#FGGA6CECEEEEE*<GE*EAG/FEEEE'CG':HGEHA4A(G.EA7G?E(G.G*GCEA*EG(E0GEEG0G88G?#:C
@antibody_39_multiplicity_32_copy_17-1/2
TTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGAACCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGATCACCCTGAAAACCGAGGACACGGCCGTGTATTAATGTATATGCGT
+
??5?<BBBBBD@DDDDE>FFGFIIHFHH-IHHGHIHFI8HD+IHHHFIHIGFHEFAHHHHHFF>IFHFEH+GHICFGHD@HHG?7IEHHIGFEHGED=HGHHIHGAHIHB;DHGF+FGH5GBFH.HDD+HGGEGE*HD#FE5HEFEE;5CAGEFGEE/GFGGEEE(EECE:GE8DCE'EEAGEGE?E8CCGC:CGFDC:G(CGEE?*6?EGECAE(E/70E,DGDCE*(G)(:GEG:F.EA(?G?)'100
@antibody_39_multiplicity_32_copy_18-1/2
AGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTTATAGGCAGATTCACCATCTCAAGAGATTATTCAAAAAACACGCTGTATCTGCAAATGATCAGCCTGAAAACCGAGGACACGGCCGGGTAATAATGTATATGCGTTA
+
,????BBBB?B@BBDDFGGGF;IIH+IHCFIFIAHH9IGG@HHF9E9G0IFFIADGA5DFF-HDC@ID=FHC5DHAGHHHHIIH8C5DEEHHFEIHFHHG=FHCHEE@.HHHHHDHHEB=GHHH4GFEFDHFGFGE*>E19BG#G(GGC:GGGGG.EEE/GEGE=EG?GDC#F2'E6GEE/CC*:A8FGFGE?E/E?(G4C866?6HC/?G:FA@(FDFE=E:E:?6EA(FG8'*C/'*::*C*A'*:CG
@antibody_39_multiplicity_32_copy_19-1/2
GGAGTCTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTGCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTTAAAGCAGAACTAATGGTGGGAGACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGATAAGCCTG
+
<????+BB-D@DDDDDFGGC+FIHCHBIHHFIFICHIHC-@FII>FHGDGHDIGH5>IIIHDHICIFBHHCHI8HIHCGHHDIHHHHIHHHEHHCIGHA.?EH*FF#HHFHEHHHFFFF@<BFHGGH?B+BEE)EGEEG(GECF8A>EGFGGG?GEGGG8G#E=(G*D@GE:?GGC(+'GFFGEGF1GEG(AGEEGCEAFCGGFEG6EG6EEHC7G4?GE:G*6AE0G:CEE?EC*CEFC(?/#G<G*EE
@antibody_39_multiplicity_32_copy_20-1/2
AGGTGCACCTGGTGGAGTCTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGACAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCA
+
?<???B/>DBBB@D?DF?GFF>E8ICFII/EGCI+IH0IHGEIH,IHH8G@GHFHHGIFGIHI@HII5IIHFCFIDFHIFIIIHFG?IFHFEEDGH<FH+FFFHHEH=HHGHGFFHHFHD9=FEE.AEE3EGEGEC@>E,GGGEECCCG7EGA?CFBE8GFEE:E(EG=GG*GFE?*GEGG<G:D?GGG)EEF:F<<:)D/GE'E*;EGHEG/E/EG)CG.,AG<1/EA6/C*ECEGGCFE1EGFGCE'*
@antibody_39_multiplicity_32_copy_21-1/2
ACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCGTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACAGCCAACCCACTCCGGCCCCTCCCCTGGAGCCTGGCGGACCCAGCTCATCCAG
+
????9B@B+-@BDDD5FGEGFGEHIEEIBFIIIHHI/IH5IIGFG=F0HHIDG=IEF9CGG>GFHIFHH,HHIDIFFFF=-EFHFDIHF+DH@HCHHHHGHF;FH5HIFD4FFF0HHHG+HHH,F2HDFEG@GGFEHEEEGEGC))?FGGGGGFGCFGFCAEE;C?FBF;GEGFGGG)EFGAEEGC(F>E.E6EFEGDGEEE:EC*?8.HG(:CE:GE#:B,GEEE6E0*AGEEA6EG?GE>G)GE:G?:
@antibody_39_multiplicity_32_copy_22-1/2
AGGTGCACCTGGTGGAGTCTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGTGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGAAACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCATCGCAAGAGATGATTCAAAAAACACGCTGTATCTGCA
+
=??A?BBB?-DBABBD@GGF68FEIHFHA>FFHIFFHIEH-H+D-EIAIHG(HIDHFH>GHFIFFCHICIHDHHGHIFIIIFIHC=EHHF3FHIHA=F6EFHH2F(HEEH@DH+H?=CHHGHDEG)FGEF=GEGGGGF.*CACABAEEE9@.GEEEE-EGFEG1CGG*EG0G:C(EECG6E6;EEF8:GE:E?(EEGEF<EG(F?*:(C/6.<AE#1G7(C?CGA:C:G;C?6E/CE?C8CE?G6*G?G*
@antibody_39_multiplicity_32_copy_23-1/2
CCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGCGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCGAATGATCAGCCTGCAAACCGAGGACAC
+
????AB/AB5D?DDDDFGGCGCIIHHIEIFIHHFIHDIIHIHHF9FAHDIIIAHIHFH>D/IHHDHEGFCIEIHHIIHHDHHAIE/HHHHIHHHHICHFHIFHH+FH+@FDH#FHDFFHBEH(,EF*FDE@DG+:GEGGFB<EBEDE*GEA?CAAGGBE6GFEEFEE;ECGFEC(:GE<E8EGEG2AECGF:E:G<GAC;GA(AG*EEEH:G@/C7:GFEED(:FGDE:*G*AGC:(/GE(0E?:/CC*?
@antibody_39_multiplicity_32_copy_24-1/2
CTGGTGGAGTCTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACGCCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCAGCTCAAGAGATGATTCAAAGAACACGCTGTATCTGCAAATGATCA
+
?,???@>BD@DBDD@DF-GGF.E8FEIAHHCFHHIEI=HIFGCI-FFFFA@HAFIGHHH;CHFHFFIDFH5H<EH?H+HIAHHF+HIHGGHHE<FHFEHHIIG3D<CH=HHDFHGFEF)HHGFBGHHB;G,6GF>GFDGG3F3EBFGF;GE0EGBEG:FGGF*EA>E(EAGFGG;;E0GG(AGE?:/6CG/?E8GGCCG)FEFEE(H</H/47)GC;GEEEG(;(G1A?*C4E;GA<GEAEGEG(C?:C/
@antibody_39_multiplicity_32_copy_25-1/2
TGAAGAGACGGTGACCATTGTCCCCTGGCCCCAGACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATCGTGAATGTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACGGCCA
+
<??5?BBBDDDD<DDBCGFAGBFI6IEIA@IFIHGEI+-HHHDHCH@FHHGFIIFIHHHHHH@HCGIBHIHCGIIHH=-FIHIHFDH8IFIH6-FEHDF,ACDHCDDHEEEAHBHDFFEEHD++DEDGFGHGH:E>DF8F(EGGFG;7CEECGEC6GFGEEGBE(FECDG(D?GAGEE*((EAG.EG(CGEGGGAGE(:/G;E*6G(GA/GCE:@GG<G@:A:/?E(*E86ACFCEECC0EAE?E(:E:0
@antibody_39_multiplicity_32_copy_26-1/2
CAGACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTACAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGTTGTCCCACCATTAGTTTTGCTTTTAACACAGCCAACCCACTCCAGCCCCCTCCCTGGAGCCTCGC
+
???????@BD5BD9@DFGF;GGECHI/IIEHGHFDIHHCI@D9HEDCHIHHHFIIIIIHHACCHGFG*IHI-IIHBA+I?HHH@HH(GHHDHIGFFIIFHHDHF=HHDHFFF#CFFHF*FDDD@GGFFFHE@=CFCHBEFGH*F?EA86BFDEGEAF8GB.AE?E:EEE1::/;G@G:CGD0?(-G?G(:/1EEC/GGE<*GC6-ACGEHG)*7*7*A(0E.;/EE:DEGGEF?(GECG;AE?CGCF*'G
@antibody_39_multiplicity_32_copy_27-1/2
GACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACAGCCAACCCAC
+
???=??B<DDDDDDD<FFCGGFEHHCFHHHHEC?GHFIHCIHHH?FHH+IEIFGGAHIHGFFHGG.5IIHIHFHFFI?+I5EIHIGHHEH+HIH7EH@AHI=FDHHHHHHH**FFHHDFDHFHG=HHH7:F*B.CIGHFGFBGFGEEGFH*EEG0EG.E(<6*E;BD/A*GGAGE2?;GG;GCEGE?GEGGGGG>6:E<EF:D/*8:?C6=E1E@*:EGGCEEAEGEGEGAC0(E:1GDE*G::EE?G?:
@antibody_39_multiplicity_32_copy_28-1/2
GCACCTGGTGGAGTCTGCGGGAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCGGCTGTATTAAAAGCAAAACTAATCGTGGGTCACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATGTGCAAATG
+
=?=???BBD@DDD,DDFGF+GGHEIF.@HHFIBHHIIHGHIIDFIHDGHHGGG=HFGHGEHIEHF+FBHIHHH)+HHEAGIHIFHHHEHEH)8HHGH;HHIFDHFDE@GFHF=GHHEGBHHHH(FFEEF0/FEDBGEE+.*FE<CE-F.AE#*C(FGE9EE>.(EBG/G#:GFF6(0;F:E<:EE::EEA*<E6?6C:;C:CAG2E';FEC:HEGEG*0EB8G*?::GCC=E'EE/:EA*A(??E6*E:6
@antibody_39_multiplicity_32_copy_29-1/2
GAGCCTTGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTAAAAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGAAACGCAGATTCACCATCTCAAGAGATGTTTCAAAAAACACGCTGTATCTGCAACTGCTCAGCCTGAAAACCGAGGA
+
??=<?/7B<DDDD+<DFFFGFGHFEIIHEHFHHHI9HIIHHH-DHA?CHG:EFHHHHHF-FHHHCHIHFHFCFFF9GHEE+FHFBF9IIHIEDH.FDIAHHGH@HDDEHFGHHBB+FDHFHHG*FGEHGFFE4EFGFGBDCG;?*DAEF?(E8GEGEGE?E:EFE<E:(GECFFEG*GBF(C661EGEEEG8FEG?GCEGA*:/GGHGE>EEEFGGCGE,BC::50E*E/#(880**.'E?CA0?;*G1E
@antibody_39_multiplicity_32_copy_30-1/2
AAGAGACGGTGACCATTGTCCCTTGGCCCCAGACATCAAAAGCATCACGCGGAATTTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTTACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATACAGCCAAC
+
<?A??BBBBDDDD@<DFGGGGFH8EHIHHIIIFHEIHIFIIFFHGG?.C8H=HFAII?GHIEHF(H?HHGFHHHECDFDFG)GCFHBFHH+HIH=IFDG3HHHFHHHHDHEHHHHEF7GEGG=GDDFFF:G@*DFFABEE=GB3F?E?C6E,GFG0GCGEEEFEGA;)EGEGEGGC-AECE:D?G:CGE6C/E*ECCGC(E*G?GFF(/?CEEGGC4?BFCGG1GEE?C*?00:C.*:00EEG:CEFE08
@antibody_39_multiplicity_32_copy_31-1/2
TTTATAATAACTACCCGAACCATAGTAATACTTAACGCATATACATTAATACACGGCCGTGTCCTCGGTTTTCAGGCTGATCATTTGCAGATACAGCGTGTTTTTTGAATCATCTCTTGAGATGGTGAATCTGCCTTTCACAGGTGCAGCGTAGTCTGGTGTCCCACCATTAGTTTTGCTTTTAATAGAGCCAACCCACTCCAGCCCCTTCCCTGGAGCCAGGCGGACCCAGCTCATCCAGGCGTTACTG
+
?A?AAB<?DDADD@-<FE*-G-IICHHIHI>IIIIIH+BGHFIDH,FIEFICFIAGFIFIIFIICHHHHICFECHHCIHGEHHHHIC8HH6HIIFBHBIG.@HEEH?GGH-HGHFDGHEEDFHBEEE;FDFFEFHG83DF*EEF>2GGGC?,G=A<EEC<GGGEEG@EGEAG/GE@'E6GGAGEE8G8G=CG;;?G*EC(<G(AEEEE:HE0:CGGEF(C*A??EE/F;EGE?G)/CEGEE?GGGGECEG
@antibody_39_multiplicity_32_copy_32-1/2
TGGTACAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTGCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCTGTATTGACAGCAAAACTAATGGTGGGACACCAGACTACGCTGCACCTGTGAAAGGCAGATTCACCGTCTCAAGAGATGATTCAAAACACACGCTGTATCTGCAAATGATCAGCCTGAATACCGAGGACAGGGC
+
?=???B=5DDDDDDDDFFFCFGBHHFHFHHIHIIIHGAHGHFIFCIIHDFIHF5D5FIFAHFHH@H/HHHIFIIH=HHI,.HHGI3HD(IFHCIEFHEIDIHHHHEHFHHG*GEFFE(GEH,-8*EEFFDGF?EEGFDEF9GFFB;;F;G*,G6;GEEE5G?F8E0,AEEGEEEAFGECG@D(:E:2)GE8GGGGE()GCEG*(DAF?G8?8E@B;EE?C:C:0A:EA;EGGC(G(AE?:(ECE*((EE?
@antibody_40_multiplicity_11_copy_1-1/2
GTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCCGCTTCAGGGAGAACTGGATCTTGGACGTGTCTACTGACATCGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCAGGGGGCTGACGGATCCAACCCCACCCGTTACTACTGCTGATGGAATAACCAGAGACAGCGCAGGTGAGGGACAGGGTGTCCTAAAGCTTC
+
?A??9BBBD<DABD-@.FEF8GHEF/IIH8HD.IHAH+IGAEHFHHHHBI:DHHF,HDIDEHGFFIGIIEE-HIFEHI+HH=+GIGHHHHI-+EFFDHE@?HCHHHICHIHF9IHHFFF@HEBHGFEHEG+FEBBIG?;E?8GC6GAEBGG@;G?GEEG#CGEG*GGG(GE=*CE9?GFEEEGGE*E*EC*.;EG?CE>DEFFE8?HC0E*F0GEE#:EEEGFGCE:(?CC(?:ECEC*E6/C?*0**?G
@antibody_40_multiplicity_11_copy_2-1/2
CGCTGTCTCTGGTTATTCCATCAGCAGTAGTAACTGGTGGGGTTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCTAGAGTCGAGTCACCATGTCAGTAGCAGCGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATAACTGTGCGAGGATCAATCAGGGATCGTATTAC
+
,???A?BBDDDDDDD9E+GFG0FHIH>ICHFEIIIIAHHIFCH>HDCHD>F-AHH5DHIFDEH@@HIEFHBHHIHFCICG-HGCF7EHHD=IHH:HE7HHH-EG(4HC*6H3H@D?CFHHHHHDG+H#:GFGGHEG*B.,DG96GEA9G/8G#.*F5GF?GC0EAEECGEC:AE?<GECGEEFEEG?FF(GEA-6EEE)A;CEE(GH(C:'-FEE?C..:0.GC8(:GE;9(FGCGEAG1EG:AE*G66*
@antibody_40_multiplicity_11_copy_3-1/2
GGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTATTCCATCAGCAGTAGTAACTGGTGGGGTTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGCGTACATCTTTTATAGTGGGAGCACCTACTACAACCCGTCTCTCATGGGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACA
+
?A?A?B?<D@BD?-DDFFGFGFIE+I?F8HHHHHHFCIG@7HHCHDIEHHHHFHIEG(HHHGB-5HFDHHFHFII==HFIFCHHHF;EFIIIF0IFHEHE+IIFHHGHFIHHAEHIHHDBG@@HC@E(EHDFHBHG#EGEEEEFG9FGGGGE:8EDCGEGGGCG(BE(GCEC(G)'0FF*FFEGG0?:(F(GECEEFAEEG/(G.*H:GE=C@GB:*EC,BC'GGECE**?G6?E;CEC:9GGEG:G((>
@antibody_40_multiplicity_11_copy_4-1/2
TGAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGGCTGCCGGATCCAACCCCCCTAGTTACTACTGCTGATGGACTAACC
+
???AAB+>DB@DDD9DBGFGGFAIFE/IIB0IIHHHDHII/9FHIFD9EII+GIIIDIHC.IIIGHHHFHGFHH-HCEHHAGHHGFHHEFIFDIDHHHFIFHFIHFGHH?FHGIF8E*HGEH3FGDDD?GCFFFED*,@G?FEGF,G+0GGEEG,A;CEC6GGGEE.EEA?F#GEEGEF(AEEGAE:EGGG.EGG:?GFG;*E;G:HGFEG/8A*E';7G//*G(G.?GG:1(GA#1?G(/E/?28(4C1
@antibody_40_multiplicity_11_copy_5-1/2
GAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATCTTATAATAACCAGTGAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACCGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAAGTGCTCCCACTATAATAGATGTACCCAATC
+
5???=BBBDDDBD<DDE>FFGFHHF-6EFAHHIBICHHIFIGHHHFFHFHFD/IHFIHHFICHIFH>-E-FEG+IIFDHHIAII>HF;H>GHFDHH-HHFH4HB7G@FHHAH4?HBH<DFCG@FHGC+EHE7*)C:EEECDG)EGFFGGGD0FEFFBGFFG6GG61*FEE(GC(C>G+,E(EFF)CCA?6-:?G0C):0EG1E:8'CG*EE.*@G.E:C,BE:ECA0EE;8CAGEEG:EGG:*#EG*?6C
@antibody_40_multiplicity_11_copy_6-1/2
GGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATCTTATAATAACCAGTGAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTTCTCCCACTATGATAGATGTACCCAATCCACTCCAGTTCCTT
+
?<???B??-BAB<<D@GFFFF>F>@GAEHIIG7HIGD/HEFIHF.CHHHDFAFHDFCFHHDHCEAIHF+FHFEAHFFF<IHF;IDFGFHBDIHFEHFIBFEHHHHGIDH.CGFDFHGH=E;EDGGFF8FGEGFAEEGEFFEG<+<FGGFG:GAEE(*;6EGEEEG(GEEE<*EC0F/GEGGEE/616:??G?GAGGAGAGCEG((.E/(:GGHC(/E7B#C::AE/:*GE(A:(A;*6A/A?)AG*EC:*
@antibody_40_multiplicity_11_copy_7-1/2
AGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATCTTATAATAACCAGTGAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTCGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAACCCC
+
A5?AAB?-DDDDDB?DE-CFFGHHFHHFIEIIGEIFH@FFICEHFFHHFHEHHHFIF>EEF?BHF,5<AFGIHHHI5DHGIIDHHHH@HHGCIHIEH,FHFHHIHEHHGH?GGF1E4FFHEH2DF+F<1HHEGFEEHE)E*;*EE8GFFDE,AECGEGGFGG?FEF*C8-G:?GGG/FEG/(GAE;6>8.(*G<FC(GG6GFA6E8(GGCE*CEC.GEB)EA/EEG/EE'GEE<GCCG?C?*CGE*)CEA
@antibody_40_multiplicity_11_copy_8-1/2
GGCCCCAGTAGTCAAAGTAGTACTTACTTGATCTTATAATAACCAGTGAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGATCTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTTGGTGTACCCACTATAATAGATGTACCCAATCCACCCCAGTCTCTTCCCTGGGG
+
????A=BBDDDDDDDDGAGGGGIFHEH/HHD>CHI=HHIGGHEIFIHD5H-.FIF,DI5IFDIHHIHGGHIICCHH=HIBCICHIHH=HHIIIIHHHDDCHB1+EHHFFFHHEHDBFHEHGDHF>EEHFF4EG=E:#0EEE?*G*C6E@EEGF@EGEGG<EGEA(0D(;(EG;EF?GGF.>6'GCEG(CE<GDG:E(EE:E((GEF6AEHDG.DGC*EEC<GAGFE?G:G*((/GEG**A*C>406E:G?
@antibody_40_multiplicity_11_copy_9-1/2
CAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTATTCCATCAGCAGTAGTAACTGGTGGGGTTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGACGCTGAGCTCTGTGACCG
+
?5???BBBDBEDDBDD?FFFFFHHAHCEIHIFII9+HHIC8IIHEH=FIHIECHIF9/HIHHDHFEHIIHA-G5HHHH@HH5#HHI8HIHHHEIEHCHHBFHCHHHHHHHEDHE*F@9D8HHH:G1GHHE;D?D;*BGFHEGB@ABFEDGE?GCCEE6ECEFEF.GGCECBGCE;EGG*?GEEFGGAA(GFEEC?F:*0FCCFG.GD(GE?F8GC7FGEFG??CEE<(EAE8'C/*CE/?:C4C?EE1C<
@antibody_40_multiplicity_11_copy_10-1/2
GTAGTAACTGGTGGGGTTGGATCCGGCAGCACCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTAAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGAGGATCAATCAGGGATCGTATTACGATATTTTCACTGGTTATTATAAGAT
+
?9=9?BBBDDD@BBD@F?GGGFIHIHCICI-IIEIHHH-FHHH/?EDGFIFFGBIFH5D-IDIHGHDCHEHE++F@EHHHGI+IAIFIIH-HIIHFHHHE+3H-6HBFFH.HH4HHHDHHHHGGH?2FHFHHGEHGD;;GH@FGCEFAGE:FEGEEGE.G8GGGEGEG(GE((=GBGEEE/G?EEE8E:=EA;C:E;GD?E*?F?///EFEEE(C7EEG#G??4FEG*CA?6CE(GG-(CGE:AEEEC?C
@antibody_40_multiplicity_11_copy_11-1/2
CAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATCTTATAATAACCAGTGAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGTAGTAGGTGCTCCCACTATAATAGATGTAACCAATCCACTCCAGTCC
+
AA???B?BDB-DDBDD.FF?FFFFEHIIFHIEHFHIFIH-EHHHI+D-GI@IGGDHCCHHIFHHHGH/FD5HIHFIHHI>F5-IHEHHHEEFH9IGHHH+HHHHD5HHHH*7H-(DEG0HHEDGFC=,GG2EDGBFGGEEEEF?EFEGBEG?G.GDB*E.FEE.CGF?F;G?FEEA/G?CE-EC6EGEEAE?G:C?*0EG?A*.GEC'CEA*F*E'ECC9G,EF;(.?2E6C/:E*G.*?GAAEC*E8C2
@antibody_41_multiplicity_2_copy_1-1/2
CTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCCGCAGTAGTAACTAGTGGGGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGAAGTGGAATGGGTACATCTATTATAGTGGGAGCACCTAATACAACCCGTCCCTCAAGAGCCGAATCACCATGTCAGTAGACACGTCCCAGATCCAGTTCTCCATGAAGCTGAGCTCTGTGA
+
?A???BBBDD5DDBDDG>GCGFCHFIEIHHA/HIHIIDHHIIHH>8HIAFB>HFH5C,+HHAIF5FFIH?HHICF-DI+FDCHIHE(HE+H*BFFDHH?FHH,HHFH=DHGF51FGEFFGFHGGE+H=G#FGGFFF#EFBD@GECA6FFE@=EGGGGF(GFEEC=*G=EFEGG@B;EEG?(0DE(?CG(CEF(96<:4DGG(EF?*(GEH6E(E/*(C(((EF(GG<6/G((GEF8FG/>E>(F*.G*EG
@antibody_41_multiplicity_2_copy_2-1/2
GTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTAATACAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGAAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGCACACGGCCGTGTATTACTGTGCGACGATCAATCAT
+
?<??<=7?BDDDD-5A/FFGFGIAHHCAECHHFCCHFEHHDF=IFAAFHHDCG-F=HGD/HHH-IIGAACHFHIEI+GDH<GIHHEHEHIFGH-HGIIH8CFFHDHGDCHIEDHHH?F.HFEE>EHFEHCE1FHGGFD;G;;=E+/??FB:;FEC6EGEC?'EGG?GEE'EG8E:;FCDCFEEC8GEEG**:*E0(GGECG/:1GCAEGH(ECE*EEE?DECFF)GGGGC?GEE*A*A*(<*EGEEC;?(
@antibody_42_multiplicity_46_copy_1-1/2
TCAAAATATCGTAATACGATCCCAGATTGATCCTCGCACAGTCATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTGCTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTACGTGCTCCCACTATAATAGATGTACCCAATCCATTCCAGTCTCTTCCCTGGGGCCTGCCGGATCCAGCCCCACCAGTTACTACTGCTGATGGAGTAACG
+
?,???B?BDDDDDD55FGGGF?H)HHIIHI/>IHHH-IFHHE+ED0FHIBFFE+FHHCH=AHC/BHHCH-HFEHHHI*EICHDGHHDFIHH+FH6HGHH?HHHBEDHBD)'FHDHFH:HHHEHE,HHFGGFFCAGFEEGFEG7@*(FG7EG*GED*ECE=,?GCEEGG*GEEEFGEFEEG6CG/(?8EEFFF(E0C//C6G(FCFE0D*FA:7@@8EEEA?C4?*<G8A:A?;1G.E(EGF.*(AA86**
@antibody_42_multiplicity_46_copy_2-1/2
GCAGCTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTTACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTAAAGCTGAGCTCT
+
???<<B=B@@D--DB?GFCGFFHIHFFHEICHHIIHHIEIAII@HADFHFF>II*GEF;HCEEHD5FI-HHAGGECHHHDI,EIIFGEHHIIHAH3D-IDHHFC.HFHD+HC.D?+GGDE@@DHEH+FHHGFFAGFGBC:C@DEEEE.8GEBGFA@ECGEAE:GG*EGCGGF(@,EGEEG=(<8EEC;G?F:GG*G(EEA?E*AG6HEECEGEG0:CEC@G:DG:EE:8:EEGF(E(#?EC*E*'G<?AG
@antibody_42_multiplicity_46_copy_3-1/2
GGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCCACTTCAACCCGTCCCGCAAGAGTCGAGTTACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTATGACCGCCGTGGAC
+
5????BB?DDBD5DD<FFFGFFIIIHHHHFEHIIA@GIFDHHHHHGH.HAIDHI7GFHC7IGHHDIIHHCIEIGIGIHGHIF-HF@9IHEIHHHGIHEHEGHHF+GHIDEHBHHHBHH+G?HEHGGHD6FFF4B)8GG2.@GA*F*@EGB?0@E#GBGAEEG*E8*EGGF(9E?:?ACG=F+A'EAGG;<AE8C:?CG?CE?E:EGDG<?8(CE*)G((7;?GCF.G:(0EEC?G-8A*CG:C;GE?GE?
@antibody_42_multiplicity_46_copy_4-1/2
ACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGACAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTGGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACTCAATCCAC
+
??A??BBB?DDDDBDDEAFGGEH>ICEHIHIFHIIIHHHHHGFCH.8IAGIIHH-HIEFHIF-HA#FHHIFCEIF,IF+-IIIHH+FGFHCE=DHDDAII+F7EDFE=HEBHD@FH@HEFFFHGGFH*GGHGC)<EEEFDGG8;GE,;CEFGGEEG6EGGDFGFFG:;CGE?EFEE?EGEGEEGG7E/FC)49GGGF(68GECECG6EC'?CCGBC**EGCE'ECGE:GGAEE(;*'CEAC/((*?A/A.
@antibody_42_multiplicity_46_copy_5-1/2
GCTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTTGGGCTGGATCCGGCAGGCCCCCGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGAGCCACCATGTCAGTAGACACTTCCAAGAACCAGTTCTCACTGAAGCTGAGCTCTGTG
+
<?5=?B/BDBDD=?DDGFG6>FIHIFIHIF=IICBE-CIIGHFHIDCHH-HHHHGFIDAHHDHHFIIF5HFGHH-FID+HEHHHF-DFFF@IHIH(HFFIDHFHHF<GH=EIHHH?H+FCEFA*FG*EBEBECF=G8BEGEGG?EEDEFGF,EG0GF6BGEECG>EFCG6::G'CEEGG?EEA*EC(?EA:6GE(8.FEGGF-GFC<A;:EGH(#EC(G,B/:?E:EG*0E(GGGE?//E?GC?GC(=EG
@antibody_42_multiplicity_46_copy_6-1/2
ACCAGGGTCCCTTGGCCCCAGTAGCCAAAGTAGTACTTACATGATGTTATAATAATCTGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGAGTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCCCCCACTATAATAGATGTACCCAATCCACTCCAGT
+
???=5<??@DBD?5EDGFFEGFEI.IIEIF>FIHHIIHAIFGIHGIFFFIHFHICHH#IHFI5BHH5FECFHHFA5EHGHHC*@8DHIDHHHHHHCEHHHI(CHFFHHH@EFEEGFFEEHHHEFG3G*HDFGDGEF=3C7BFFEHA*EFCCECF9,GG2F9FEEEG6F0EGC0E'/F(ECC((FF6GE(G::EFE:FGGG?G;C<;E(?9CE:CC(E:CE8FGGCE*<A)6EGC60EE6*(EG:0::GDG
@antibody_42_multiplicity_46_copy_7-1/2
AGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCGCCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGGCTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCTCACTACAATAGATGAACCCAA
+
,??,?BB>DDDDD+D@FFFCFFH=IBCI/HH9HI?HHHHDHG9HFIHIG9BAHHDHIFFIIIIHH-CCHIF@DGHHFEHIFHI-GDHEHICHHADHCFHHDAIGHG=IHHHCFHDH(HDGHFCFFF>GHHF@-EGG.GFGEE8*CDGC?@((F@EBGG0FFFGG;EE?C<:GFA#.EGCG;CGGEE;CAA6.(*G:EAE*EE*A**CF*HE<AE:.8CEEGFEGGE6C(EEECE*CFC>GC*6(EA.')E
@antibody_42_multiplicity_46_copy_8-1/2
GTGCAGCTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCAGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCGTCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTTGGAGCACCTACTTCAACCCGTCCCTCAACAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGCTCTCCCTGAAGCTGAGCT
+
,??A?B7BDDBD<DDBFF;FAGHHHIIHEFIFHDECHFIEB-CDHHHFDHIFHH-CF,IHFHIAIAFHF=IH@CIIHFA---FHHGH-GHHIHH+HHEDCFDHHFHFCIGD+GHGD=FDF@HFGFFCDGEEBGCG9G?DGGFGDCEEE*G*?GEGDG<FGF?(DEGEC*GAGE>:GGG?GE?0EG*GG?EE#GECCCGGEG8AACE:<?C6(H>CEBCBE.(E(E/C//?E)C*A(EE:*:C*.GEF:.:
@antibody_42_multiplicity_46_copy_9-1/2
CTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAAGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAATCCGTCCCTCAAGAGTCGAGTCACCATGCCAGTAGACACGTCAAAGAACCAGTTCTCCCTGAAGCTGAACTCTGTGACCGCCGTGGACACGGCCGTGT
+
?,A<ABBABD5DBD?BGFGFFFHEIIHFHIIIII>HG+=HHAEHHF7HHHIFFHHDGDH?*F=IACHHCHEHHHHFIH-HFIAIHI9><HD=,FICHGHH:,FHHIEHGEEIEFHHEH+FFDFFFFG<HFG0FDHAD@GGE<GGFGG*FGEB83GGEFGEBGFG3E:EG'CC:?AG*8GG(C*8EGG8FGG(ED#F/6:'6EC?GG:(G0F(EG:7G7?E*7EEEECGFEG(?:?=.E?.F00?*?EGC*
@antibody_42_multiplicity_46_copy_10-1/2
GGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGCGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCGACCATTATAGATGTACGCAATCCACTCCAGTCTCTTCCCTGGGG
+
A?A?,BBBDDBDBDDDFECFFGEIHHIIHFHHHH@HGHG+EHIHFHFIIHFFGHE+DAHHHFFFIG5DIGDDCCIHIDGHHICEHHEHH=HDGIHEFHGFAHHFHGHHHFFGEHHHC9GHBD=GDGHGEE:F?GG5BGG(ADEE1DECE5=FDCCF,CCEGE#GAG,EFGEG@8ECEGF(/GFE>/8ACEG:1G:CE?(C:ECEG'H?#EA*E0EG:G<EB/#E#6)EC*1EEE;EE:(E(?EEC?EG4(
@antibody_42_multiplicity_46_copy_11-1/2
CAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGGGTCGAGTCACCATGTCCCTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTTGACACGGC
+
?????B9BDEDDD-D@.@GGFGIEIHHAFHHIFECI?EHIEFFHFIHF9HDHG)IFHFH-@5IFF/EFEHFH-HBFHIHHHIF+IFFHHIHH-HDFHHHIDAGEHHHHHEF?EHAD=GHHFGGFBHHHEGGGGD(GHFEF#GGCFGEGEEE8:AGC>F@FE1CCEC;D*E**DGC.G#GAEEEEG;.(#AFCD0GGE/AEFCE9</?*/8AEEG@D7CE7G?E?CE;*EEEA0AEAC(CE8(?((EC0:1
@antibody_42_multiplicity_46_copy_12-1/2
CGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGATCCCACTATAATAGTTGTACCCAATCCACTCCTGTCCCTTCCCTGGGGCCTGCCGGATCCAGCCCCACCAGTTACTGCTGCTGATGGAGTAACCAGAGACAGCGCAGGTG
+
??A?ABBB<DBD<55DACGG8FH?HFHBH>HIHGGHFB.GHFEHFFHGGGFHHHHECDFHFIHIFBFHFG-IHFH5HEHAHIHHHGIIHFH6FG+HHFFIHFIHHHHFHDGH=DEHHDGEGEFHHFGFH*EGEEE=,=E#E0FED/D.D.E)E'(CEFGEFCB:GGCG(GGD#E(AFCC/EG1GG6?CG:GEE?GC/6A/-?E-'ECE(HGCH'CG0G=)*:EEEC6EEEGF'AG(*?E/:CE6C4*E*?
@antibody_42_multiplicity_46_copy_13-1/2
GTGCAGCTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGTGACTGGCGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCTTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTATCCCTGAAGCTGAGCT
+
<=<<,/B=<BDD@-D<GFG-,GFBIH>FHHHHIHIIHHIH9HGEHIFGE8GE0HF/GGGI<IHIHFH@-HI>EEFIAHFFIIHIHAIDHGDHFHHIAF(C-HEE>HDDFHHFGFEEFDGDGH)9FGHG+##2GDEI*FBECHGGE@@GEG?AF?DBGC2GC2*?DE=E2E(CEGAG:EGFC0(/ACC?GE;:E?C/FEEG:E?FEEEF:ECEEDG*G:?FGE(CGCEE9:ECG):CEG<(CGE:AC??GF
@antibody_42_multiplicity_46_copy_14-1/2
CTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGCCATGGTGACTCGACTCTTGAGGGTCGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCTCTTCCCTG
+
?=<??B<BADB@BD9DCFGGGFICAHIFHHIII+HFHHFIFH?HGC?HGIHFGEHHHF-E,I@HIHBHGGGIAHGHHHEEHHH-AFHIHHDHHFHH?H=HDHGFCI#IGED7<)=DEHCBFF+7HGFHEGFGD4;E.8EFEGGEGGG?F*E;EEAC8GBEEGC'(EE0E/G,GEEFCEG*EC;(GEA(CEE*E(.ECEG1FE:E*GCC?CDGHFGF<=GE(CGECG?(E80?F?.G:C?E*#C(ECE*GC
@antibody_42_multiplicity_46_copy_15-1/2
CTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCACAAGAGTCGAGTCACCATGTCAGTAGATACGTCCAAGAACCAGTTCTCCCTGAAGCTCAGCTCTGTGA
+
?????BBBDDBBDDDDC@F>FCIAH-F6HHHCIFHHBEF@IHGGH7DHCHIHIHIFHEGDIIFIFIFG=HH-E4GI?HHEFG=EA-HIFD.BDGIHEE.FIHFCHI+HHH?>=DFDD?8GE>HGFG@H1CEHGG?FG?EEGEFHG1A8@CGFEEA7BE*DFDCE?E?)GFEF?>E/AG<EA'<GEEGG(*?GCECF?EF0AAGEEEFGC(EG(GEEBECCEF::CE(GAF(G0GCF?:E':?F>:C(E8A
@antibody_42_multiplicity_46_copy_16-1/2
CCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTC
+
,?,??BBBADB7BA-<GG>;FF-HFHAHAHHCEHHHF4FHHHHIIH9HHBHIHHH@EHIFFHHHAADGCH-HDHH=EIHI-GIHCHIHFHIHEGGGHHIHEIHGHFHIDEHDHH3+C(FGHEE9HHFFFFDGEHD=DH9ECGG;FG>GGFEG:GG*FEE?GG.EGDE:CGFFGEGCE/?DGF:#E*)?EEEDEEGC*EECC?::G.EC:HG*E7)::.EFE0;?F:FGG???ECEEE:6#10(G?*1E6F
@antibody_42_multiplicity_46_copy_17-1/2
TGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCTCTCAAGAGTCGAGTCACCATGTCAGTAGCCACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTA
+
?????<@<DBBBDDDBGAGCG8FHHEFIBEEHIIEGIHHHIIIIHF8HGIIFIDIHGEGHHHFFHHHGAF,5DII*DIHHIH@HI?FFFIIIHFFAICH7HH@HG.HH+FFH;GGHHHE@HD?EGFFFG=FBGG(EGG;GBFGEBED*CF?3GDEEG(=E:GG(FGCEFEEG<AAEFFE*CG8A8E(0E;GG2EGGE<C?G);*AEE.?86F(@0:(7?EB7EEGCCCF(FE**EAE?D-EFGE1*(::?
@antibody_42_multiplicity_46_copy_18-1/2
AGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACACCAGTCCCTTCCCTGGGGCCTCCC
+
??A5?B9B?DDEDDDDGGFF6FHEFIEIGFIIEIIHFIHHHIGAFI,CHHIHCG5HGFFIHCHIIHHDHCHD>@FG*FHHIHHB8HHH(?HHEEHDIFGHHCHHE@CEGH9FFHHFEF=EFG,H*G6H8FFGGDE2EFE)EEEG?AEEFFG?CG0CF<CGGGEE;GEEE*F(E=(GEEA8:;CE6EGGF?EE:1*C(F*EGFEC(E:D0EE?H/G(EGGA7DGAE(GFE#?EE(*FE:=EG*/E8*G#(E
@antibody_42_multiplicity_46_copy_19-1/2
GTGCAGCTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGCGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGTGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCT
+
,??5?BBBB@DEDDDDFFFGFGIFH7HFIII.HHAICHHHIAHE7DIGHFEFFCHIDEFDEEDIIFH>-EHIF?CGF=I?GDHHFDHHH=IHFAHFGGGHH6G=CHHGHGHDHC*DFHHHHHHDHEFEH3)F>EGE<DGGGE<GG?G@GG?GF(0FEF6DG8*#EGCG=@G:GGGE4GG.G8GE8(:EFA-ED6E1(#G:=EC6EAHG?HG0(GE8GGGE:(;F2GG6GGC8EGA?<;4E0/G6*CA(A?
@antibody_42_multiplicity_46_copy_20-1/2
TACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTCTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGCCTGCCGGATCCAGCCCCACCAGTTACTACTGCTGATGGAGTAACCAGAGACAGCGCAGG
+
???<?B/BBDADDDDDG;GFFGHFHEHHHFHFH-HGIHAEEFIIIHHIHHCCFIHI@=HHGD5ADHHC,HFE1D?+HIIGH=H8+F7AFHII-I.EHHGHEHHF8IFHHEFGF7GFFHGHFFGFFGH*EDFG?E?CDF=AGEGCFEG2<CGFGFACE8DGEGGECGGGE/(EFGGC?EEEGC:G3E:EEEE.ECF(AEFGFGCCE:HGG?CEFEEG7FEGB?G)GE*9?G80EEE?GA;EGFAEC*CEG:
@antibody_42_multiplicity_46_copy_21-1/2
GGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGTGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGAGTGGGTACATCTATTATAGTGGGAGCCCCTACTTCAACCCGTCCCTCAAGAGTCGAGTCACCGTGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGCAGCTGAGCTCTGTGACCGCCGTGGACCCGGCCG
+
??,AABBBDDDEDD?BFFCCGFHIHIIFHECFIDCIHIHGGFFI.HDGAGHI/FHHEHI-IAEHFGH5DCGHHIHHFI-HFHGF>FIFIIGI6HHFDFGGHIB=HHHAGHHHFCEGFD'FCFEDB7GEE@H+:;=GGG0EFGD,(FFEGF*?2EECE?G*EG/EG?EG1E?FCEGCACGA+GE8C-E(?A*F/6?(CGGEA.>FF*4.D*CE*(GD/?ECEE:GGEG:AEGGG0EE:FEFG:A)::CAE6
@antibody_42_multiplicity_46_copy_22-1/2
GTGCAGCTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTACTATAGTGGGAGCACCTGCTTCAACCCGACCCTCAAGAGTCGAGTCACCATGTCAGTAGAGGCGTCCAAGAACTAGTTCTCCCTGAAGCTGAGCT
+
,???5??BDBDD<DDD>FCAGEFIIHIIHIFH=IHC+5IHFGHG.FF@IGDHHHHHFHHIFIFFH<HHAHFGIIIIFE9DHFIHIHBF?HBGHHIEHFIHIEDHDAHHFHHCDHHDEHFFGGHDDGFHDFFBGG9=/HGEGEG>EEEGE*B;G?E*,)GCEEEEEFEEFD6E(GGDC>=G?E/*GE1GE.::EGE:EAG:G(GGGE??GE<94A=#(CGED,G:GECC(AEGAEE?:.E2E*?(AE(A8G
@antibody_42_multiplicity_46_copy_23-1/2
GGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTATCTACTGAGATGGTGCCTCGACTCTTGAGGGACGGGTCGAAGTAGGTGCTCCCACTATAATAGATGTACTCAATCCACTCCAGTCCCT
+
?<?==?B<D<DB@?DD8GGCGGHI+IIHFFG5HIDHCHH+IFF7G=HHIGHHGFHGFH8H.HIHG-AHHIHHE-HH@EEII5HFHHIIFIHFGGIIH-HEI@IDCH*E(EEHF:@HH*H,HFEEHDDFEGGDHGF;EFEEGGEDGECEE;FEF0GFD<;G(*6GGF2ECE#ACCF=G(GE:E*GEGE(9FG:GG8EE?6*G6A<E.EC0A*?H/:D/GE@EAC?AE.0*::(AE:*FGC(:E<6FEE(A?
@antibody_42_multiplicity_46_copy_24-1/2
ACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGATTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGAGTCACCATGTGAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGGGCTCTGTGACCGCCGTGGACATGGCCGTG
+
?????B>BBDDDBDD5FBGGFFFHCFIFHHIICFHHHHH7AGIHFEHIFFHI+CHCHHG.CF+FHH*FCHFFIDIEGFBIIIIICH8HAHHFIHHHFHHHDDHBFHGIBHH,HHHHD*GEGEGFDE,F?H?E?4FFG.F*GE2E?*AE,GGFBF=E4@;A;CFCEA)BCEC8:EECEGGEFG?(CDEEFGGG6E?EGA(=*AC:G(ECGE(E@@EFG:?E(8C8FGGE:G(?;AE8C:E?GE)8.E*(G?
@antibody_42_multiplicity_46_copy_25-1/2
CCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATCTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTGCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTC
+
?????BBB-BDDDD-BFFCFFFIIIHIIIHHHCE=IHHDHIHDFHDHIIHDG9BFIIAIHIGE-HFIFI-@HHF5DHHBFFFIGHDFHFFDEHHEHIBIHD7HHFH=IEEEHHD<EFFHHH;=GGEDFFCEGD+GGGGG*;1FGCG@GD4FA?G(GABEGEGGGGEFFCDGEEEEG?FEEGAG*6##C?DCGC:GCFE06(GFEA;AE'*AGAAGEBG,EBCEGEC:C*AE*?CEEE)CF.GEC:C6EC:
@antibody_42_multiplicity_46_copy_26-1/2
CCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTCGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATATTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAACTGAGCTCTGTGACTGGCGTGGACACGG
+
=?A?AB=BDB?BDDDBGFFFGGCHHF8FHHIHEIHBHHIGIAHHHE=HHHDFHFIDH-HCHHIHEFIH8IB+IIHH@IGIHHDA?CFHD8IHHIHIEFHFEHFDH@/HIGHGEHHF9;DEBC3H8FGEHEGCC@EIDFGD<EGEEEGEG;GGDGGEEEGEGFG:GB8?GGE2EEEG:EDGFAG/?EEG2EA)?8:;EAECA8EGF:HGF;GCEFEGB?FEG0E:?GCG;*?E:(E*8?((EGC?E6:1C.
@antibody_42_multiplicity_46_copy_27-1/2
AGTATTCAAAGTAGTACTTACATGATGTTATAATAATTAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACAAGGTGACTCGACACTTGAGGGACGGGTTCAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGCCTGCT
+
???<,B-BDB-DDBD@6FEGEGHIH>HIF>IIIFIIH#GEEHIHHHIH>@HFHEFGFHFHIDHHHHGEHIHIFHH=EFIFHHHF+@IFIEDIHHH-G+E2IHHDEFEHHD(FIHH(HGFHHGGEFDEHDGHAFGEIEGFA1EF0DE1A;E638GEE6)EEGEFEE8CGG(-*EG8'=>?CGCEG:-EA0.GGEEC*EGGEG(FDFGD(6HCG:(GC.CG:DE88:E;(C:E?:AG*?A.D:CCCEC*E)'
@antibody_42_multiplicity_46_copy_28-1/2
TGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCGCTCAAGAGTCGAGTCACCATGTCAGCAGACACATCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTTTATTACTGTGCGAGGATCAATCA
+
5A??ABBBDDDBDDDBFFC>G>AIH.FIHIFHIIAHFIEIHH@HFHIIF0.EAB@HCGHHFIFAHHIIFAH-IIHCHFB5GDFHFHEH+HFFHHHEEFCHHHHFHEHFHHFC0HHFE?3EHFGGABHFG??C2GGG?E=G@F8CEHGG9G88BGGE.G'GG;((.FG?0*:BEAE4ACGE?(EEGC/G8/F/?F6BC(EE*GGF:EHE*H*?HE'F*.F::CAC:E#FEE?ED?CG)AA.:CC86C*;EG
@antibody_42_multiplicity_46_copy_29-1/2
GGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTTGGTACATCTATTATAGTGGGAGCACCTACTTCCACCCGTCCCTCAAGGGTCGAGTCACCATGTCAGTAGACACGTCCAAGAGCCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGTCCGTGTATTATGGTGCGAGGATCAATCAGGGATCGTATTTCGATATTTTGA
+
????ABBBBDD<DDBBFCGGFFHEIFFFI..IFHCEHIIIHH/DFFGIGDH-GCDEHHHHHHFIGGAIE-IIHIAIEHHHIFIFH=HDHFHEA?BHHEHIFHHHG#HHHGGF+FHHFGHC#GF=HGGEHEEDHABE@*?GFGEFBBDGGB.G(E(G@GC?:FE.GGE:GF*EEE:GFEEEGGEGAEFE?0GEGCEG?/(:G.FCEG>?C(#AFC;0(*F@8EG*1CGCE(EC*C(EA:*(;*?/CE:EF/
@antibody_42_multiplicity_46_copy_30-1/2
GGACAGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGACAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGCGGGATCACCTACTTCAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGACGTGGACACGGCCG
+
?,??,B?B<ED@BDB5GGFFEC56EAIHIIHIIIHIHIIIIG-CDFD@AHHFHHG=HEHHBBG.,5IHIIHHEHIGICH@ICHHH=HHFFCHHHHHHHEHFIFHHECGFHHE+DHHEHEH5FEF@)@HFEF1EHG*B#EGGB,GE*FGG,GGE:EG:FFG:AGE?FEEF<?EECC*C8(:;G)GGEE1:?GCEG(GEEA;GEGC);CCCCEE@EC<:.CCBAG(;(GGE80EG()(:CAE*0A?G(E2.8
@antibody_42_multiplicity_46_copy_31-1/2
GAGGAGACGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCAAAGTAATACACGGCCGTGTCAACGGCGGTCACAGAGCTCAGCTTCAGGGAGAAATGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGTCGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCA
+
???A,BB?6D?-DDDDFAG8FEHHFFFIIIBGBHFCGCGH=HHI,GHGHFH-HDHIH.IHI5I.HEDBFHHHDAFEH4HCFECIHIIDIIHIIHIH(BHFHGI5HFECF6FHFGHHFHBFFHEFGE?GE(?DE=E8EGD'GGG@DF=GDDEGCGE1;EGFE((6:D?F:EF(AE?F?EEEG+E:G*A/E:G?:GCC:E6C?GCEDF?F:'C-**@(/E/GGG00EEE(?EAEE'<8EE)(EA*FCAGE6(
@antibody_42_multiplicity_46_copy_32-1/2
CAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACATACTCCAACCCGCCCCACAAGAGTCGAGTCACCATGTCGGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCG
+
,?<?<-ABBD+EDDBAGGGFF.H6HHIHCHDEEFIFFAFHHFHG?IHIHHFFH>FFHF'IIC@EHIHI,IFHFICGHIFHGHIAIGHHHHGHHH-DGH.GHGC,FFGDEHHHHHHGDFC.HGHGBHHGFH?BEECGGG65FGGEGG/0CB:CG(G<GGGEG*F;E(*?G:CE8@#G:+*EC;GA:GE6ECEEEAFGAG::'EF4GF0/G:E:CEEEB8G/ECE8GA6?8AE8*??*2C6*FG>:A)*G8(
@antibody_42_multiplicity_46_copy_33-1/2
TTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGTTCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTAGTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGCGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGCCTGCTGGATCCAGCCCCACCAG
+
?A9??BBBDDDBDDDBFFGGGGCBAII8)FIHFIHIFEGIDID.HHECAAA?.FDACDDCH5II)FHFHAEI-GIIBC-EECFFHHHHIHIHHHFHD=AHDFHEHHB:HDF=FHFIF)HFHGHFFEEGEFFG*E*I*@,GEEGGCEGGEED@CCGGFAF8GCGGGGGG7GEEEEEG.CFE'+G?CE:2#G?G?8G*.EG;EDG01AH:FEGFEE/8???@<E:EG.E(GC:C*0E:CEC:??./*:?AEE
@antibody_42_multiplicity_46_copy_34-1/2
GGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCAAATCCACTC
+
A?A,?ABBBDBABBDDGFFFGGEI;HIB/IHIFH/H=HHG>IHGDH@?-HHIHHHHFHIFGHFHEGDFIHH-HFHHIHI+EFIIDHHHDG7H-HFFIHHIFGIHHGHH@GHF*HEDFHHHEHEEFHGFEFEG*EGIGEG3*GE+GGCCG@1=?EEFCE?GGFFG0DG*GG:GFFGEEAGCEGEGC;EGEFEECAEEGEEECGE9EEE0GDECC4<GBGF/ECF*GAEE*=?C0(FEECGC*A*CE?C.::
@antibody_42_multiplicity_46_copy_35-1/2
CGGTGACCAGGGTCCCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGGCTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCACCCACTATATTTGATGTACCCAATCCACT
+
?????BBBBBDD@DBDEGFEGFHIIHIHII/HFFIH9GEFHI5IFFHHA*+IGFHEIHHHGIEICDGEHHHFHHD-=IHDIH=FDIHCHHI0FBIHFFH-7GFHCHHEFGGFEHHGGFH@4GCEH;(CFGDFEFDEB-GGFE?#,*EFEEGF./:G=:;F)EAC8EGDFG;B;CA?EGG/BGGCGGA/6EG:*6E:GEEDAGGE?:HG8HGEEF)EEAEG(E0-EE?C?)*E#(?:8:/A0**GG/CEC:
@antibody_42_multiplicity_46_copy_36-1/2
CGACCAGGGTACCTTGGCCCCAGTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGAGCGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCTACTCCA
+
?,??<B?B@--D9ADDGCGGFCFEHHIIHH-@HHIHFAHHCHCEH.9HCHFH-H*HDIHHHHI@AHIHIF55IEFHEFCGCHDDCDIGDHDHCBIEIHHH0HHHBCGFHHIHDC+FF+HGF?EGDD4B+H*8GG*)1EEFCEEFFE4;E)G<<BGEE*GFGGGGEGGGDBEGGGCEEEF/EE?FG<<E?(>?G*6CG(:AAE6:EEF8.C?E0EB*GEE:EGEC)E((F8?6GEAE68G:E0('FA*E0E
@antibody_42_multiplicity_46_copy_37-1/2
TGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCTTGTGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGCCTGCCGGACCCAGCCCCACCAGTTACTCCTGCTGATGGAGTAACCAGAGACAGCGCAGGTGAGGGACAGGGT
+
5?,A?BBBDB<DD<BBFFAFF@HF>FHCIII9@I/IHIHEFHI@H7GAHHGIHBCIGI5GHIHIIHHHHFHI5HIIHG+B?H+IHDHCAHHIHBHHHH:EHH=IF:H+GHCHECG-FEDG<HFH0CEGGF0FE@FGCEGGB(FF@?FFEGBFGGEG*'GGEGEG)/FBEE?GEGEG*:EE:G?*EG(EGGECE(AE/0(EE?D?6(/::EGCC:C/*EG#??A*AFECGG:E/E(<F/E*FCC:E*AGE<
@antibody_42_multiplicity_46_copy_38-1/2
GCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTAACCTGCGCTGTCTCTGGTTACTTCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGTGTCACCATGTAAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCATTGTGACCGCCGTGGACAC
+
???9?BB-<-DDADBBGFA?FFFICHHIHHIGDHHI7#IC.HHECIH-DH@IDGHF/FDH..DEHH=HHIIHHH5IHHIIFIHHGG7HHEFIFH?-FDH=CHHHEIHHHGH4GFH+HHGH;HGFFGFH#DH?HG*DGF?EAHFGEDGE;E?BDGGGEBGEEGGEFGGEE88G6GEE8E*AG?EA2C?GF/CCG?(E6':F6AE?:;HAF(EE<A/CGA:ECE*C*0.:0?(<EEE(GE?EE4A'EE?C*E
@antibody_42_multiplicity_46_copy_39-1/2
GCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACACCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTGAAGAGTCGAGTCACCATGTCAGTAGTCACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCGCTGTGACCGTCGTGGACAC
+
,?A?<BBBD@DDDD-DEGDGFGAHEFIH6IE9HEIH9HDIICHGHHFIGHI-H-HIEHHFHIG>>DHCIIIHBHCIFHHHAHHHHHHIECFH-HIA8HF(HEHHIIHDGF3H1HFHFHHG@;FBHFE+AG+G(GGIGE@BGCGG?DFFDDDEEGGEE6EEGEEGC@G8F(EEACDEG/;8EEF(ECEGE*ECE6?*C/:64EEC/6*G;?.FHGGC=?CGC/?/<E8FGA((0EC:GE82'?(G6G?C:(
@antibody_42_multiplicity_46_copy_40-1/2
AGCTGCAGGTGTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTTTAGTGGGAGCACCTACTTCAACCCGTCCGTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCGGAGCTCTGA
+
????,BB=BDDBD5DDGFFGFCH@HIIH,I9HGIEHIHHCHHGCHFHGHEF/G+A?HIHHHIFCHHHHEEHIIEAGHIIEDFFHFHICGHIEGFGCI=HCFHADHEHGDHHF=CDFH=HDHGFB.HEH/C<EHDGGFEEG;AEBEGG@GEEFB#GCGAC*EEEEG;CDEGCG(G-EEGFCE;.G:G8:>E<G(FAGGF;EEECECD*)CHCG*EF=EGCGCFECE/?CGE6A:E(F6*GE#?E)(?>E?#
@antibody_42_multiplicity_46_copy_41-1/2
GTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGTATTACTGTGCGAGGATCAATCAGGGATCGTATTACGATATTTTGAC
+
???=AB?B6DD<BBBDCGCGEFEICIFFEFHII9+IIEI+IG?CHF.IFDHHIIH<I8FAFIIEIIAIDII5F,E<FEIIHHHGHDHHFIHHIH+HHAHH=HIGHDH?GG#=DGGHHAF=@@H2HHHF*GE<EEF6FBA@GBD5GG(E;EGCFEEEEC8E/EFE(CEFEGGE6?EG?EEC2AGG';CEEE*F6G:86GGGEG?G1GHCEAGEFEEGG(?ECA?E:EGAAG:0EE*GEG>6::(0(C((C=
@antibody_42_multiplicity_46_copy_42-1/2
GGACACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCGGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTGCACCCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTGCTCCCTGAAGCTGAGCTCTGTGACCGCCGTGGACACGGCCGTGAATTACTGCGCGAGG
+
,,A?<B?BDDDDDDEDFFGCGGHHHHI>CCGDDFHFCIIIFHHC0H+H(IIIHGGEIFFBHHFIB-CFIAFFHIHIHHGHFFHAI<GIHH+DHF8HFE@FFGHCFC-IHGG?H<DHCHGHFGH?#.HEE8GGFE#(F*'EEEEEFGAGEGF/EE@EF>G*BFGG2GGGGG9EEF(:E?..1F8ECC//E(8#E(GGGGEGGG??C?E*EE1EA@@FFCGCC.C:0?.*:EG*C6A*C(00E;G*E:GCGG
@antibody_42_multiplicity_46_copy_43-1/2
AGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTACTGACATGGTGACTCGACTCGTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGACCTGCAGGA
+
???=?B??BAD?DDBDFGGGGGIHHIIIIF7HIHIHGAIIFHI.CEIH@HHIHFHFDFE5HFHHHHECHD--II57DIIFHGFGIIIDF?ECG+HDH?FDFFEEFFFHED8+HFFGFEHHF7*H:H=GHFHE*BFEF*=GBBGGGEE=GD)?E*:EGABGG@AGEGC6(E*@GG?ECGG:<GCFGEAGGEGGG*FD*1E*FEAEEE?.C6?F*FC(?GG:EE*EFG.G(E'EC?A6*E;C(E?*A'*GG)
@antibody_42_multiplicity_46_copy_44-1/2
GTAGTCAAAGTAGTACTTACATGATGTTATAATAATCAGTCAAAATATCGTAATACGATCCCTGATTGATCCTCGCACAGTAATACACGGCCGTGTCCACGGCGGTCACAGAGCTCAGCTTCAGGGAGAACTGGTTCTTGGACGTGTCTCCTGACATGGTGACTCGACTCTTGAGGGACGGGTTGAAGTAGGTGCTCCCACTATAATAGATGTACCCAATCCACTCCAGTCCCTTCCCTGGGGCCTGCCG
+
AA????B9BDDDDDDDFGCG,G8FIHHIFFCFG.IIFHIHGHFFEADH>FH?AHFICIHHFIHH-HHFGF-I+FCEHF(HHHHIFDIHDH@HHIFHHI9=F@IFGCH7HHHFDFEGHADHHEFFDHDHHE5BE2F,CA:GGGC=EFG@G/?FEG?GGEGFGGGCGEE?GE8FEEG(/G?GGEE?AG/6CGG?GGFGE:*AG:0CE*CGGHFE@A*E:7GE.G(GEEE:(GEG*G?FGGEFE?C*GEE/GE
@antibody_42_multiplicity_46_copy_45-1/2
CACCCTGTCCCTCACCTGAGCTGTCTCTGGTTACTCCATCAGCAGTAGTAACTGGTGGGGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTAAAGCTGAGCACTGTGACCGCGGCGGACACGGCCGTGTATCACTGTGCGAGGATC
+
?5?A?A?BBBBD-DB?FF6FFG/CHFBIFBCAE.AIFGHHIAHIHI+IF0FIHFAGHEF-GHCHHEHIHFHHGEF5DFIHGDHEHHHF=CFHHHEEIIDHDIDHDHHF8H>G(HHGFGHGHECFHFHHE6FF*GECE@GEHG0HFGE;FEGE(,,'EGG(*CF,60CEA/(AG/AE*GGFEE:EF?E?:CA>G(A(4EECGEGGE1CF-;CEHE:E(G(:<AC8CG:EEG0C?(;.0FG:-?(*.8E0*G
@antibody_42_multiplicity_46_copy_46-1/2
GTCGGGCCCAGGACTGGTGAAGCCTTCGGACACCCTGTCCCTCACCTGCGCTGTCTCTGTTTACTCCATCAGCAGTAGTAACTGGTGGGACTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGGTACATCTATTATAGTGGGAGCACCTACTTCAACCCGACCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAAAACCAGTTCTCCCTGAAGTGGAGCTCTGTGACCGCCGTG
+
?????BBB-DDDD@DD6>FGFGH0ID/AHHHFHDEFIBDIIHGFIFDIGIHIHBIGFIH'HDFCFHGFHHEHFH-D5EAHCHFIIFFFE*FIDHCHEH+)FEHH(HI6->HDH-8HEF@GFFFGBGEFEEEGG@FGGEGHFEAEEDEGGEEB88(CGDGCGC?EEG?EC*E0EGF(08GGGC=GE??EE6GEE8(.(?ECA0EGG;H(CH(:;:8GECB:E?G:CG?E2((C0CA*G?/:80CCAGA*>G
